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Figure 2.1: Cartoon depictions of our two MDFF-fitted structures 
(“crystallographic” on the left and “averaged” on the right) and the 
Rahman et al. homology model that served as the starting point for MDFF. 
The domains are colored as follows: NBD1, pink; NBD2, blue; TMD1, gray; 
TMD2, green. A slight twist of the NBDs relative to the original model is 
indicated by the gray rectangles in the refined models. The additional curvature 
of TMs 7 and 8, as compared to the homology model, is highlighted by the 
purple rectangles. The pink circle magnifies the proximity of residue S341 
(pink) on TM6 and L1135 (blue) and N1138 (yellow) on TM12. 
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Figure 2.2: Plot of NBD-NBD distance for the three different CFTR 
homology models simulated with ATP bound. The separation was calculated 
by taking the difference in centers of mass of the α-carbons in each NBD. Both 
refined models, averaged and crystallographic, display tighter NBDs 
dimerization than the original Rahman et al. homology model. The dashed line 
and the solid line each represent a different trial.   
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Figure 2.3: Pore analysis of the three different CFTR homology models 
simulated in ATP-apo (black), ATP semibound (green), and ATP-bound 
states (blue). The pore radius plotted for each model was evaluated near F337. 
The dashed line indicates the radius of a chloride ion (1.8 Å). Only the 
crystallographic-fit model shows widening in both bound and semibound states. 





Figure 2.4: Pore analysis of the second runs of the three different CFTR 
homology models in ATP-apo (black) and ATP-bound states (blue). The 
pore radius plotted for each model was evaluated near F337. The dashed line 
indicates the radius of a chloride ion (1.8 Å). Only the crystallographic-fit model 
shows widening in both bound and semi-bound states.  
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Figure 2.5: Comparison of the averaged-fit (red) and crystallographic-fit 
(green) models for the first run of each. (A,B) Comparison at 0 (A) and 100 
ns (B) viewed from the membrane plane (the intracellular side is on the bottom). 
TM9 is indicated. (C,D) Comparison at 0 (C) and 100 ns (D) viewed from the 
extracellular side. TM9 and TM12 are indicated.  
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Figure 2.6: Radius of gyration (RG) analysis for the three CFTR homology 
models simulated in ATP-apo, ATP-semibound, and ATP-bound states. 
(upper left) Cartoon representation of the TMDs of the crystallographic-fit 
CFTR (extracellular side at the top). The TMDs have been divided on the basis 
of their position along the pore axis into three sections. RG for the upper section 
(yellow) is plotted here for the indicated structures, and the middle (gray) and 
bottom (blue) sections are plotted in Figure 2.7 and 2.8. The crystallographic-




Figure 2.7: Radius of gyration (RG) vs. time for slice 1 from the second runs 
of the Rahman et al. homology (A), averaged-fit model (B), and 
crystallographic-fit model (C).  
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Figure 2.8: Radius of gyration (RG) vs. time for slices 2 and 3 from the first 




Figure 2.9: Radius of gyration (RG) vs. time for the first crystallographic-
fit run, extended to 300 ns. The graphs labeled Slice 1-3 correspond to the 
colored sections of the figure in the top left. 
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Figure 2.10: Pore analysis of the crystallographic-fit model in (A) ATP-
bound and (B) ATP-apo states after 280 ns of simulation each. TMD1 is 
shown in gray, transparent and TMD2 is in green; NBDs are not shown. In parts 
A and B, the pore in CFTR is shown according to the following color scheme: 
radius >2.3 Å is blue, 1.15−2.3 Å is yellow, and <1.15 Å is red. The dashed 
lines indicate the position of the membrane. (C) Plot of pore radius as a function 
of position along the channel axis (normal to the membrane) for both bound 
(blue) and apo (black) states at 280 ns. The shaded area indicates the position 
of the membrane, and the dashed line at 1.8 Å is the radius of a chloride ion. 





Figure 2.11: Pore analysis of the second 300-ns runs of the crystallographic-
fit model in (A) ATP-bound and (B) ATP-apo states. TMD1 is shown in grey, 
transparent and TMD2 is in green; NBDs are not shown. In (A) and (B), the 
pore in CFTR is shown according to the following color scheme: radius > 2.3 
Å is blue, 1.15-2.3 Å is yellow, and < 1.15 Å is red. The dashed lines indicate 
the position of the membrane. (C) Plot of pore radius as a function of position 
along the channel axis (normal to the membrane) for both bound (blue) and apo 
(black) states at 300 ns. The shaded area indicates the position of the membrane, 
and the dashed line at 1.8 Å is the radius of a chloride ion. 
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Figure 2.12: Differences between ATP-bound (green) and ATP-apo 
(orange) states of CFTR. Structures are taken after 280 ns of the first run 
starting from the crystallographic-fit model (see also Fig. 2.10). (A) NBDs 
viewed from the cytoplasm. ATP molecules in the bound state are shown in 
purple. (B) ICLs viewed from the cytoplasm in the same orientation as the 
NBDs in (A). The bottom of TM9, connected to ICL3, is also indicated. (C) 
Side-view of ICLs (bottom) and TMDs with one of the discovered salt bridges 
highlighted. (D) TMDs viewed from the extracellular side. The red x marks the 
position of the putative initial pore. 
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Figure 2.13: Structural comparison of the outward-facing hCFTR 
structure (PDB ID 6MSM) in orange and the hCFTR outward-facing 
crystallographic-fit model in blue. (A) Aligned structures. The root-mean-
square deviation between the structures is 5.8 Å. (B) The alignments of TM6, 
TM7, and TM8 are highlighted to show major differences. 
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Figure 2.14: Comparison between the Rahman et. al. homology model 
(blue) and closed-state cryo-EM structure of human CFTR (orange; PDB 




Figure 2.15: Sequence alignment of CFTR and related proteins. The 
sequence segments in the alignment correspond to ICL2 (top) and ICL4 
(bottom). Residues E267 and K1060, which appear to contribute to a salt bridge, 
are highlighted in red.  
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Figure 2.16. Snapshot of the bound crystallographic-fit trajectory after 200 
ns (top), focusing on the interface between NBDs and ICLs (bottom). The 
domains of CFTR are labeled accordingly, and E543, K968, and K1292 are 
shown as sticks and colored by residue type (acidic in red and basic in blue). 
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Figure 2.17: Salt-bridge distances over time for the crystallographic-fit 
ATP-bound simulation. Three experimentally verified salt bridges are tracked 
over time in (A) run 1 and (B) run 2. (C) Two salt bridges newly discovered and 





Figure 2.18: Mean activation time changed in mutants compared to wt-
CFTR. Sample traces of inside-out macropatch currents of (A) WT-, (B) 
E543K-, (C) K968A-, (D) E543K/K968E-, (E) K1292E-, and (F) 
E543K/K1292E-CFTR recorded under the experimental conditions listed in the 
panels. Control, 150 mM Cl− intracellular solution; INH172, 10 μM 
CFTRinh172. (G) Summary data for mean activation time for WT and mutants. 
Statistical data are as follows: n = 30 for WT; n = 11 for E543K; n = 7 for 
K1292E; n = 18 for K968A; n = 11 for E543K/K968E; n = 10 for 




Figure 2.19: 1 mM MgATP reactivated WT and mutant CFTR after 
channels were fully activated by ATP + PKA. (A) WT-CFTR was fully 
activated with 1 mM MgATP and 127.6 U/ml PKA, deactivated by removal of 
ATP and PKA using control solution, and then reactivated by 1 mM MgATP 
alone. Representative current traces for E543K (B), K968A (C), and 
E543K/K968A-CFTR (D) were recorded with the same experimental 
conditions as WT-CFTR. Summary data are shown in E. Y axis indicate the 
ratio of maximum current in ATP alone (I(ATP)) divided by maximum current in 
ATP and PKA (I(ATP+PKA)). Statistical data are follows: n=4 for WT; n= 6 for 
E543K; n=8 for K968A; n=6 for E543K/K968E. **, P < 0.01 compared to WT.  
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Figure 2.20: Representative fits of the ATP-induced activation of 
phosphorylated CFTR and deactivation after washout of ATP. All 
activation and deactivation data were fit in Igor using a double exponential 
(without an X-offset), as follows: (A) WT-CFTR activation, (B) WT-CFTR 
deactivation, (C) K968A-CFTR activation, (D) K968A-CFTR deactivation, (E) 
E543K-CFTR activation, (F) E543K-CFTR deactivation, (G) E543K/K968E-
CFTR activation, and (H) E543K/K968E-CFTR deactivation. The differences 
between the raw data and the double exponential fit were calculated and plotted 
above each fit. Goodness of fit was also analyzed by Chi-square value. The 
activation traces for each single mutant (K968A-CFTR or E543K-CFTR) were 
impossible to fit using a double exponential function; however, the double 
mutant (E543K/K968E-CFTR) seems to partially restore to WT-CFTR channel 
behavior, although not completely, thus enabling the data to be fit.  
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Figure 2.21: K968A exhibited similar single-channel behavior to WT-
CFTR. (A) Representative Single channel current traces of WT- and K968A-
CFTR were recorded using inside-out patch with 150 mM Cl− intracellular 
solution in the presence of 1 mM MgATP with 127.6 U/ml PKA at membrane 
potential -100 mV. (B) Open probability of K968A is significantly lower than 
WT-CFTR. (C) K968A exhibits similar mean burst duration as WT-CFTR 
(WT-CFTR data cited from previous publication Cui, G., Rahman, K. S., 
Infield, D. T., Kuang, C., Prince, C. Z., and McCarty, N. A. (2014) Three 




pore architecture of CFTR. The Journal of General Physiology 144, 159-179 . 
N=5 for K968A-CFTR. ***, P < 0.001 compared to WT. 
 
Figure 3.1: Plasmid map of WT-hCFTR in pFastBacDual vector. This 
plasmid was used for wt-hCFTR expression in Sf9 cells, but also for the 
generation of mutant hCFTR constructs and expression in Sf9 cells.    
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Figure 3.2: Depiction for the overall flow of baculovirus production. The 
purified donor plasmid is transformed into DH10Bac E. coli. Bacteria 
containing the recombined CFTR-containing bacmid will survive antibiotic 
selection and can be further screened using Blue-White screening. CFTR-
containing bacmid is transfected into Sf9 cells to generate Baculovirus (within 
media). Baculovirus can be used to infect Sf9 cells for CFTR protein production 
and purification.      
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Figure 3.3: Size Exclusion Chromatography (SEC) Standards on 
Superdex™ 200 10/300 GL column. Molecular Weight standards for SEC 
were loaded onto Superdex™ 200 10/300 GL column and run at a flow rate of 
0.25 mg/mL. Based on these standards and the molecular weight of CFTR (~170 
kDa), CFTR and is anticipated to elute at 11 mL. CFTR-nanodiscs would be 
much larger, eluting at <11 mL but >9 mL.  
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Figure 3.4: Plasmid map of WT-hCFTR with a 3x-FLAG-tag in ECL4 for 
stable transfection of T-RexTM CHO cells. WT-hCFTR with a 3x FLAG-tag 
in extracellular loop 4 (ECL4) cloned from this construct and inserted into 
pcDNA5/TO containing an internal ribosomal entry site (IRES) and cyan 
fluorescent protein (CFP) for transfection and protein production reporting in 
T-RexTM CHO cells. 
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Figure 3.5: Restriction digestion of pCF595 (McCarty Lab). Results of 
restriction digestion, using PvuI, of pCF595 purified from three different 
bacterial colonies (c1, c2, c3) on a 1% agarose gel stained with 0.5 µg/mL 
ethidium bromide. Theoretical gel (left) was produced for ease of interpretation 
of experimental gel (right). Proper insertion and digestion will display two 
bands, one at just under 10 kbp and one between 3 kbp and 2 kbp. All three 
colonies (c1, c2, and c3) show expected digestion bands.  
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Figure 3.6: Microscopy of a T-Rex CHO cell kill curve at 450 µg/mL 
hygromycin. The concentration of selection agent that will show some cell 
death at 4 days and complete cell death after 8 days must be determined before 
the generation of a stable cell line by selection agent. A range of hygromycin 
concentrations was tested (0 µg/mL to 1.5 mg/mL) and a concentration of 450 
µg/mL hygromycin fits this profile. Depicted in this figure is the concentration 





Figure 3.7: Generation of stably transfected T-RexTM CHO cells with 
inducible CFTR-3xFLAG. The pcDNA5/TO containing an inducible WT-
hCFTR cloned with a 3x-FLAG-tag in ECL4 and a CFP-reporting system was 
transiently transfected into T-Rex™ CHO cells. (A) T-Rex CHO cells were 
induced and were single-cell sorted by flow cytometry using the CFP reporting-
system. The first plot of untransfected cells and the second of transfected cells 
show increased cell debris and death reported by the large side-scatter signal 
(SSC-A). The third plot shows the fluorescent channel separation of transfected 
cells from untransfected cells. (B) Representative individual colonies several 
days after sorting shows growth. (C) Images of two colonies that express CFTR, 
as well as the CFP-reporting system. (D) Western blot shows CFTR expression 
in colony B2, but not in several other colonies screened (D12 and F4). The first 
negative control is parental T-Rex™ CHO cells, and the second negative control 
is uninduced B2 colony. Immunoblotting for CFTR: Primary – mouse anti-
CFTR 596 antibody, 1:1,500 and Secondary – IRDye® 680RD goat anti-mouse 
antibody, 1:10,000 (LI-COR). 
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Figure 3.8: Images of representative agar plates utilizing Blue/White 
screening to confirm successful bacmid production after transformation. 
(A) Initial transformants plated on LB-agar plates with 50 µg/mL kanamycin, 7 
µg/mL gentamicin, 10 µg/mL tetracycline, and 100 µg/mL Bluo-gal and 40 
µg/mL IPTG. Colonies that have been transformed with plasmid and have 
correctly produced recombinant bacmid are white. (B) Selected colonies from 
the first plate were restreaked on new LB-agar plates (containing previously 
mentioned additives) to confirm the homogeneity of each selected colony. 
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Figure 3.9: PCR amplification of a section of CFTR from purified WT-
CFTR and mutant CFTR bacmid. Primers, designed in house, were used to 
amplify a specific region of CFTR from purified bacmid to confirm CFTR gene 
insertion into bacmid. The positive control is the WT-CFTR plasmid (pCF340, 
McCarty Lab) and the negative control is ABCC4 in pGEMHE construct. Both 
mutant and WT Bacmid show similar size bands to positive control suggesting 
the proper insertion of CFTR into the bacmid.  
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Figure 3.10: Images of transfected Sf9 cells to confirm viral infection and 
baculovirus production. (A) Images are comparing Sf9 cells that were 
transfected with bacmid (WT) to produce baculovirus. After 7 days, transfected 
Sf9 cells will appear larger in size when compared to untransfected cells and 
will contain many intracellular vesicles. Infected Sf9 cells will eventually leave 
a region of no cell growth or a plaque under plaque assay conditions. Individual 
plaques are collected and can be used to infect more copious amounts of cells. 
(B) Visualization of Sf9 cells infected with plaque-purified p1 virus for WT-
CFTR (Wt 8 and Wt 3) or mutant CFTR (mutant 2 or mutant 3, D110C/K892C). 
Again, cells infected by baculovirus are identified by swelling and the presence 





Figure 3.11: Western blot analysis to determine high-expressing WT-
CFTR p1 viral stock. High-expressing CFTR plaque purified p1 viral stocks, 
single 1 and single 2, or mixed plaques, mixed 1, mixed 2, mixed 3, and mixed 
4, were determined by western blot analysis using an anti-CFTR antibody (A), 
but were not detected by anti-His-tag antibody (B). Positive controls are CFTR 
expressed in BHK cells (A) and His-tagged sphingomyelinase, purified (B). 
Immunoblotting for CFTR: Primary – mouse anti-CFTR 596 antibody, 1:1,500 
and Secondary – goat anti-mouse antibody conjugated to HRP, 1:1,000. 
Immunoblotting for His-tag: Primary – rabbit anti-His-Tag antibody, 1:1,000 
and Secondary – goat anti-rabbit antibody conjugated to HRP, 1:1,000.  
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Figure 3.12: Western blot analysis of crude CFTR purification from 
infected Sf9 cells expressing WT-hCFTR. Sf9 cells were infected with a high 
CFTR expressing p1 virus (WT, mixed 3) at an MOI of 20. Infected cells were 
lysed in Roche A buffer and 0.1% DDM. CFTR could not be separated from the 
lysate using His-tag affinity resin, confirming the inaccessibility of His-tag. 
Immunoblotting for CFTR: Primary – mouse anti-CFTR 596 mouse antibody, 
1:1,500 and Secondary – goat anti-mouse antibody conjugated to HRP, 1:1,000.  
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Figure 3.13: Western blot analysis of crude CFTR purification from BHK 
cells stably transfected to express WT-hCFTR. Stably transfected BHK cells 
expressing WT-hCFTR were lysed in Roche A buffer and 0.1% DDM. CFTR 
was separated from the endogenous protein in the lysate using His-tag affinity 
resin. The ability to separate CFTR confirms the accessibility of the His-tag in 
this cell expression system. Immunoblotting for CFTR: Primary – mouse anti-
CFTR 596 antibody, 1:1,500 and Secondary – goat anti-mouse antibody 
conjugated to HRP, 1:1,000.   
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Figure 3.14: CFTR expression is unchanged under suspension cell culture 
conditions. CFTR expressed in the stably transfected BHK cell line. Cells were 
transitioned to suspension culture, growing as “pearls” for purification. (A) 
BHK-CFTR-10xHis pearls after a few days under suspension culture 
conditions. (B) Western blot comparing CFTR expression under suspension and 
adherent cell culture conditions. Immunoblotting for CFTR: Primary – mouse 
anti-CFTR 596 antibody, 1:1,500 and Secondary – IRDye® 680RD goat anti-
mouse antibody, 1:10,000. Immunoblotting for Actin: Primary – mouse anti-




Figure 3.15: Microscopic confirmation of at least > 90% lysed cells. BHK 
cells are lysed using a Dounce Homogenizer. Cells imaged before (A) and after 
(B) lysis.  
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Figure 3.16: CFTR solubilization is improved by slow-dropwise addition of 
detergent. The method of solubilization for CFTR not only increases the 




yield. Immunoblotting for CFTR: Primary – 596 mouse anti-CFTR antibody, 
1:1,500 and Secondary – LI-COR goat anti-mouse antibody, 1:10,000 
 
Figure 3.17: CFTR purity improved by changing the His-tag affinity resin 
used in purification. Silver stained Mini-PROTEAN® TGX™ pre-cast 4-15% 
acrylamide: bisacrylamide gradient SDS-PAGE gel showing the improvement 
in purity by changing the resin type. The elution fraction between the Roche® 
His-resin (A) and the HisPur™ Ni-NTA resin (B), shows a dramatic 
improvement to the number of protein bands in the elution lane in the HisPur™ 
Ni-NTA resin.  
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Figure 3.18: SDS-PAGE analysis of CFTR purification. Each lane, and lane 
label, represents the sample at each stage of the purification process described. 
Silver stain of 8% acrylamide: bisacrylamide hand-cast SDS-PAGE gel 
showing the overall purification, especially improving the purity of CFTR. An 
unknown copurified protein was mostly eluted in wash 3 and wash 4. However, 
this protein can still be seen in the final elution lane of CFTR ([Elution]).  
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Figure 3.19: Size Exclusion Chromatography (SEC) of CFTR purified 
from BHK cells. (A) Full UV-spectra chromatogram from SEC with a 
Superdex™ 200 10/300 GL Column after injection with concentrated CFTR 
elution fractions. Void volume is marked by a black arrow and the monomeric 
CFTR peak is marked by a blue arrow. Several peaks present in the SEC 
chromatogram shows the presence of multiple proteins. (B) Silver stained 8% 
acrylamide: bisacrylamide hand-cast SDS-PAGE gel comparing the purity of 




Figure 3.20: Analysis of purification of CFTR from CHO cells using Size 
Exclusion Chromatography (SEC) and Western blot. (A) Western blot 
analysis shows some CFTR binding to and eluting from resin, especially of 
Band B. Immunoblotting for CFTR: Primary – mouse anti-CFTR antibody 596, 
1:1500, and Secondary – IRDye® 680RD goat anti-mouse antibody, 1:10,000. 
(B) Full UV-spectra chromatogram from SEC with a  Superdex™ 200 10/300 
GL column after injection with concentrated CFTR elution fractions. Void 
volume is marked by a black arrow, monomeric CFTR peak is marked by a blue 
arrow, and the FLAG® peptide is marked by a green arrow.   
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Figure 4.1: pMSP1D1 plasmid map. The pMSP1D1 construct is purified from 
DH5α E. coli and transformed into BL21 (DE3) E. coli for production of 
MSP1D1 protein, which can be purified using His-tag affinity chromatography 
and used in the formation of nanodiscs.  
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Figure 4.2: Restriction digestions of pMSP1D1. Results of restriction 
digestions, using PvuI (A) or HincII and HindIII (B), of pMSP1D1 purified 




gel stained with 0.5 µg/mL ethidium bromide. Theoretical gel for restriction 
digestion (left) was produced for ease of interpretation of experimental gel 
(right). Colony c3 was chosen as the source of pMSP1D1because the results of 
both restriction digestion experiments displayed anticipated banding patterns.   
 
Figure 4.3: Purification of MSP1D1 from BL21 (DE3) E. coli. (A) Hand-cast 
12% acrylamide: bisacrylamide SDS-PAGE stained with Coomassie to analyze 
MSP1D1 purity and efficiency of purification. Each lane represents a sample at 
each stage of the purification process. MSP1D1 begins eluting from the Roche® 
cOmplete His-Tag resin (resin packed in a gravity-flow column) at elution 
fraction E1 and continues until fraction E3. The most concentrated MSP1D1 
fraction is E3, which was further purified using Size Exclusion 
Chromatography. (B) Full SEC UV-spectra chromatogram of affinity 
chromatography purified His-tagged MSP1D1 using a Superdex™ 200 10/300 
GL column. Void volume is marked by a black arrow and MSP peak is marked 
by an orange arrow.  
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Figure 4.4: Phosphorylation of CFTR in detergent or in nanodiscs before 
ATPase activity measurements. CFTR in detergent and in nanodiscs was 
phosphorylated by Promega® PKA α-catalytic subunit at 100 U/mL in 1 mM 
ATP for 2 hours at 4°C. PKA, excess ATP, and ADP separated from CFTR in 
detergent or in nanodiscs using SEC. (A) Phosphorylation of CFTR in detergent 
confirmed by Western blot and hand-cast 8% acrylamide: bisacrylamide SDS-
PAGE gel stained with Pro-Q™ Diamond phosphorylation stain. 
Immunoblotting for phosphorylation: Primary – rabbit anti-phospho-(Ser/Thr) 
antibody (abcam17464), 1:1000 and Secondary – IRDye® 800CW goat anti-
rabbit antibody, 1:10,000. (B) Phosphorylation of CFTR in nanodiscs confirmed 
by hand-cast 8% acrylamide: bisacrylamide SDS-PAGE gel stained with Pro-
Q™ Diamond phosphorylation stain.  
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Figure 4.5: Comparison of old Bio-Beads™ to new Bio-Beads™. Old 
BioBeads™ (left), appeared to be clumped, yellowish in color, and had moisture 
along all walls of the bottle. New Bio-Beads™ moved freely, appeared white, 
and had no moisture in the bottle. 
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Figure 4.6: Confirmation of empty nanodiscs formed with two different 
lipids—DMPC and POPC. Empty nanodiscs formed under control buffer 
conditions with DMPC (A) and POPC (B) were evaluated using SEC and SDS-
PAGE. Full UV-spectra chromatogram from SEC with a Superdex™ 200 
10/300 GL Column after injection with empty nanodiscs on the left and key 
fractions analyzed for the presence of MSP on 12% acrylamide: bisacrylamide 
hand-cast SDS-PAGE gel stained by Coomassie on the right.  
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Figure 4.7: Transmission electron micrograph of liposomes present in the 
SEC void volume of POPC lipids. Even at the recommended Lipid-to-Protein 




appears to be small liposomes. Samples were stained in 2% uranyl acetate. The 
scale bar corresponds to 50 nm. 
 
Figure 4.8: Micrograph of negatively stained (2% uranyl acetate) empty 
POPC Nanodiscs. The POPC nanodiscs show a preferred “side-view” 
orientation, providing critical information on successful formation of nanodiscs 
with a thickness and diameter of approximately  8 nm by 10 nm, respectively. 
These nanodiscs devoid of CFTR also provide an important control for 




Figure 4.9: CFTR-nanodiscs generated from CFTR purified from BHK 
cells screened SEC and western blot. (A) UV-spectra chromatogram from 
SEC with a Superdex™ 200 10/300 GL Column after injection with CFTR-
nanodiscs. Arrows indicate the following: void (black), CFTR-nanodiscs 
(purple), CFTR (blue), and empty nanodiscs (orange). (B) Western blot SEC 
fractions identifying CFTR (168 kDa) and MSP (24 kDa) in the same fractions. 
Immunoblotting for CFTR: Primary – mouse anti-CFTR 596 antibody, 1:1,500 
and Secondary – IRDye® 680RD goat anti-mouse antibody, 1:10,000. 
Immunoblotting for MSP: Primary – rabbit anti-His-tag antibody, 1:1,000 and 
Secondary IRDye ® 800CW goat anti-rabbit antibody, 1:10,000. 
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Figure 4.10: CFTR-nanodiscs generated from CFTR purified from BHK 
cells screened by TEM. (A) Micrograph of negatively stained CFTR-
nanodiscs. A few examples of particles are boxed in blue. The micrograph 
shows a good distribution of particles and no aggregation. Scale bar represents 
50 nm. (B) A CFTR-nanodiscs model was built of hCFTR (PDB ID: 5UAK) in 
a nanodisc (PDB ID: 4V6M), in Visual Molecular Dynamics (VMD). The lipids 
in front of CFTR in a nanodisc have been cut away to show TMDs. 
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Figure 4.11: ATPase activity of CFTR-nanodiscs or CFTR in detergent 
(DDM) measured by Malachite Green Assay. After phosphorylation (Figure 
4.4), PKA, excess ATP, and ADP were separated from phosphorylated CFTR 
using SEC. Inorganic phosphate produced by ATPase activity of CFTR was 
measured by Malachite green complexation for the following range of ATP 
concentrations in 100 µL volumes: 10 mM to 0.1 pM. Michaelis-Menten 
kinetics were determined in IgorPro and plotted as “fit”. CFTR-nanodiscs 
exhibit a higher ATPase activity than CFTR in detergent. Error bars are SEM 
for three trials. 
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Figure 4.12: Micrograph of negatively stained (2% uranyl acetate) CFTR 
proteoliposomes. Purified detergent-solubilized CFTR was reconstituted into 
POPC-based proteoliposomes and screened by TEM. The scale bar corresponds 





Figure 4.13: Planar lipid bilayer (7:3 POPE:POPS ratio) single-channel 
recordings of CFTR from BHK cellular membranes. Recordings of CFTR 
under an applied driving force of -90 mV for Cl-. PKA and ATP (50 U/mL and 
0.5 mM final) were added to the cis chamber. Top graphs are of the planar lipid 
bilayer recordings pre-treatment with INH172 (A) and post-treatment with 
INH172 (B). A histogram for both pre-INH172 (A) and post-INH172 (B) 
treatments were plotted for each state—3 open channels, 2 open channels, 1 
open channel or closed channels. Before the addition of INH172 (A), three 
CFTR channels can be seen in a single recording, each with a current amplitude 
of -0.70 pA, -0.61 pA, -0.53 pA and an average amplitude of -0.61 pA. The open 
probability for CFTR in this recording was 37%, as expected for CFTR. After 
the addition of INH172 (B), only a single CFTR channel can be seen in a single 
recording, a current amplitude of -0.52 pA. The open probability for CFTR in 
this recording was 4%. This represents 94% inhibition of CFTR by 10 µM 
INH172.    
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Figure 4.14: Planar lipid bilayer (7:3 POPE:POPS ratio) single-channel 
recordings of CFTR from proteoliposomes. Recordings of CFTR under an 
applied driving force of -90 mV for Cl-. PKA and ATP (50 U/mL and 0.5 mM 
final) were added to the cis chamber. Top graphs are of the planar lipid bilayer 
recordings pre-treatment with INH172 (A) and post-treatment with INH172 (B). 
A histogram for both pre-INH172 (A) and post-INH172 (B) treatments were 
plotted for each state—1 open channel or closed channels. Before the addition 
of INH172 (A), a single CFTR channel can be seen in a single recording 
displaying a current amplitude of -0.68 pA with an open probability of 32% for 
CFTR in this recording, as expected. After the addition of INH172 (B), a single 
CFTR channel can be seen in a single recording displaying a current amplitude 
of -0.72 pA and an open probability of 24% for CFTR in this recording. This 







Figure 4.15: Preliminary class averages of CFTR-nanodiscs.  Initial 2D class 
averages were generated with EMAN2.3 from a total of 918 particles.  
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Figure 5.1: Western blot analysis of SMALP-CFTR. CFTR is present in the 
soluble fraction, but the majority of CFTR remains mostly in the insoluble 
fraction. CFTR-SMALPs also were present in the elution fraction, which 
indicates minimal binding of SMALP-CFTR to the resin. Immunoblotting for 
CFTR: Primary – mouse anti-CFTR 596 antibody, 1:1,500 and Secondary – 
IRDye® 680RD goat anti-mouse antibody, 1:10,000. 
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Figure 5.2: SDS-PAGE analysis of CFTR-SMALPs. Hand-cast 8% 
acrylamide: bisacrylamide SDS-PAGE gel, silver stained. CFTR-SMALPs can 
be seen in the elution fraction, along with several other copurified proteins.  
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Figure 5.3: Structures of cholesterol, zymosterol, and cholesteryl 




three sterol derivatives—cholesterol (A), zymosterol (B), and CHS (C). These 
structural differences include the double bond between C-5 and C-6 of the B 
ring in cholesterol and CHS, but only a single bond in zymosterol. Zymosterol 
has a double bond present between C-8 and C-9 of the B ring, which is a single 
bond in cholesterol and CHS. Zymosterol also includes another double bond 







LIST OF SYMBOLS AND ABBREVIATIONS 
 




3D 3-dimensional  
Å angstrom 
ABC transporter ATP binding cassette Transporter 
ABCA subclass A of human ABC transporters 
ABCA4/ABCR ABC transporter Subclass A number 4 
ABCB subclass B of human ABC transporters 
ABCC subclass C of human ABC transporters 
ABCC7 ABC transporter Subclass C number 7/ CFTR 
ABCD subclass D of human ABC transporters 
ABCD2/X-ALD ABC transporter Subclass D number 2/ X-linked 
Adrenoleukodystrophy 
ABCE subclass E of human ABC transporters 
ABCE1/OABP organic anion binding protein/ABC transporter 
subclass E number 1 
ABCF subclass F of human ABC transporters 
ABCF2 ABC transporter Subclass F number 2 
ABCG subclass G of human ABC transporters 
xxxi 
 
ABCG2/BCRP ABC transporter Subclass G number 2/breast cancer 
resistance protein 
ADP adenosine diphosphate 
AFT arginine-framed tripeptides  
ALD adrenoleukodystrophy protein 
A-loop particular loop structure in CFTR 
AMP-PNP  adenylyl-imidodiphosphate 
Arf1 ADP-ribosylation factor 1 
atm atmosphere 
ATP adenosine triphosphate 
BCA bicinchoninic acid 
BHK baby hamster kidney cells 
BSA bovine serum albumin 
Ca2+ calcium cation 
CAL CFTR-associated ligand protein 
ccc cross-correlation coefficient 
CF Cystic Fibrosis 
CFF Cystic Fibrosis Foundation 
CFP cyan fluorescent protein 
CFTR Cystic Fibrosis Transmembrane conductance 
Regulator 
CFTRinh172 specific CFTR inhibitor 
xxxii 
 
CHARMM36 Chemistry at Harvard Macromolecular Mechanics, 
force field 
chCFTR chicken CFTR 
CHIP a carboxy terminus HSP-70 interacting protein 
CHO Chinese hamster ovary cells 
CHS cholesteryl hemisuccinate 
CNX chaperone lectins calnexin 
COPII coat protein II 
cRNA  complementary RNA 
cryo-EC electron cryo-crystallography 
cryo-EM electron cryo-microscopy 
CTF contrast transfer function 
CV coefficient of variation 
cyclic AMP/cAMP adenosine 3’,5’-monophosphate  
D110C aspartic acid at position 92 in WT-hCFTR substituted 
with cysteine  
D565/A566/D567 diacidic export motif in WT-hCFTR 
D924 aspartic acid at position 924 in WT-hCFTR 
D993 aspartic acid at position 993 in WT-hCFTR 
DDM n-dodecyl β-d-maltoside 
DIBMA diisobutylene maleic acid 
DIBMALP diisobutylene maleic acid lipid particles 




DMSO dimethyl sulfoxide 
DNA deoxyribonucleic acid 
DPPC 1,2-dipalmitoyl-sn-glycero-3-phosphocholine 
DTT dithiothreitol  
E267 glutamic acid at position 267 in WT-hCFTR 
E543 glutamic acid at position 543 in WT-hCFTR 
E92 glutamic acid at position 92 in WT-hCFTR 
ECL1 extracellular loop 1 
ECL2 extracellular loop 2 
ECL3 extracellular loop 3 
ECL4 extracellular loop 4 
ECLs extracellular loops 
EDTA ethylenediaminetetraacetic acid  
EGTA ethylene glycol-bis(β-aminoethyl ether)-N,N,N′,N′-
tetraacetic acid 
ER endoplasmic reticulum  
ERQC ER quality control machinery 
EtBr ethidium bromide 
F12 Ham’s F12 nutrient mixture  
F337 phenylalanine at position 337 in WT-hCFTR 
FBS fetal bovine serum 




GERAD glycoprotein ER-associated degradation pathway  
GGN20 alias for subclass F of ABC transporter family 
GTPase guanidine triphosphatase 
hApo1 human apolipoprotein 1 
hCFTR human CFTR 
HCl hydrochloric acid 
HDL high-density lipoprotein complex 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
His-tag histidine-based affinity chromatography tagging 
system 
HOLE program to explore pore dimensions in ion channel 
molecular structures 
Hsp70 heat shock protein 70 
Hsp90 heat shock protein 90 
Hz Hertz 
ICL intracellular loops 
IPTG isopropyl β- d-1-thiogalactopyranoside 
IRES internal ribosomal entry site 
I-V Current-Voltage relationship 
K  Kelvin 
K1060 lysine at position 1060 in WT-hCFTR 
K1292 lysine at position 1292 in WT-hCFTR 
xxxv 
 
K892C lysine at position 892 in WT-hCFTR substituted with 
cysteine 
K95 lysine at position 95 in WT-hCFTR 
K968 lysine at position 968 in WT-hCFTR 
KCl potassium chloride 
kHz kiloHertz 
L1135 leucine at position 1135 in WT-hCFTR 
LmrA ATP binding cassette (ABC) multidrug transporter 
found in Lactococcus lactis  




MD molecular dynamics 
MDFF molecular dynamics flexible fitting 
MDR multidrug resistance  
mg milligrams 
Mg2+ magnesium cation 
MgATP ATP magnesium salt 
MgCl2 magnesium chloride 
mL milliliter 
mM millimolar 
MOI multiplicity of infection 
xxxvi 
 
MRP multidrug resistance-associated protein 
MRP1 (ABCC1) multidrug resistance protein 1/ ABC transporter 
subclass C number 1 
MRP7 multidrug resistance protein 7 
MRP9 multidrug resistance protein 9 
ms milliseconds 
MS mass spectrometry 
MsbA lipid ABC exporter 
MSD1 membrane spanning domain 1 
MSP membrane scaffold protein 
mV milliVolts 
MWCO molecular weight cut-off 
MΩ megaohm 
N1138 asparagine at position 1138 in WT-hCFTR 
N894 asparagine at position 894 in WT-hCFTR 
N900 asparagine at position 900 in WT-hCFTR 
Na+ sodium cation 
NaCl sodium chloride 
NaH2PO4 sodium phosphate monobasic 
NAMD Nanoscale Molecular Dynamics  
NBD nucleotide binding domain 
NBD1 nucleotide binding domain 1 
NBD2 nucleotide binding domain 2 
xxxvii 
 
NBF nucleotide binding fold 
ng nanogram 
NHERF-1 Na+/H+ exchanger regulatory factor proteins  
NMDG N-methyl-d-glycamine 
NMDG-Cl N-methyl-d-glucamine chloride salt 
NTA nitrilotriacetic acid 
OST  oligosaccharyltransferase 
P/S penicillin/streptomycin 
PBS phosphate buffered saline 
PBST phosphate buffered saline plus Tween 20 
pCDNA3.1 mammalian expression vector  
pcDNA5/TO vector for protein expression in T-Rex™ CHO cells 
PDB Protein Database 
PDZ-binding domain post synaptic density protein, Drosophila disc large 
tumor suppressor, and zonula occludens-1 protein 
pGEMHE oocyte expression vector 
P-gp (ABCB1) P-glycoprotein/ ABC transporter subclass B number 1 
pH log of [H+] 
Pi inorganic phosphate 
PIC protease inhibitor cocktail 
PKA protein kinase A 
PKC Protein kinase C 
PLB planar lipid bilayer 
xxxviii 
 
PM plasma membrane 
Po  open probablity 
POPC 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
pS picoSiemens 
PVDF polyvinylidene difluoride 
Q-loop particular loop structure in CFTR 
R1128 arginine at position 1128 in WT-hCFTR 
R29/Q30/R31 one of 4 RXR motifs in WT-hCFTR 
R303 arginine at position 303 in WT-hCFTR 
R347 arginine at position 347 in WT-hCFTR 
R516/Y517/R518 one of 4 RXR motifs in WT-hCFTR 
R553/A554/R555 one of 4 RXR motifs in WT-hCFTR 
R764/R765/R766 one of 4 RXR motifs in WT-hCFTR 
R899 arginine at position 899 in WT-hCFTR 
R933 arginine at position 933 in WT-hCFTR 
Rab1a/Rab2 GTPase proteins important in secretory trafficking 
R-domain Regulatory domain 
RG radius of gyration 
RIPA radioimmunoprecipitation Assay 
RMSD root mean square deviation 
RPM revolutions per minute 
RT room temperature 
RTC Ribosome-Sec61 translocon complex 
xxxix 
 
RXR motif ER retention/retrieval motif of membrane proteins  
S341 serine at position 341 in WT-hCFTR 
S422 serine at position 422 in WT-hCFTR 
S660 serine at position 660 in WT-hCFTR 
S670 serine at position 670 in WT-hCFTR 
S686 serine at position 686 in WT-hCFTR 
S686 serine at position 686 in WT-hCFTR 
S700 serine at position 700 in WT-hCFTR 
S700 serine at position 700 in WT-hCFTR 
S712 serine at position 712 in WT-hCFTR 
S737 serine at position 737 in WT-hCFTR 
S753 serine at position 753 in WT-hCFTR 
S768 serine at position 768 in WT-hCFTR 
S790 serine at position 790 in WT-hCFTR 
S795 serine at position 795 in WT-hCFTR 
S813 serine at position 813 in WT-hCFTR 
S898 serine at position 898 in WT-hCFTR 
Sav1866 ABC transporter from Staphylococcus aureus  
SDS-PAGE sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis 
Sec24 protein involved in ER transport vesicles formation 
Sec61 protein involved in membrane protein translocation 
SEM standard error of the mean 
xl 
 
Sf9 immortalized cell line from Spodoptera frugiperda 
SMA styrene maleic acid 
SMALP styrene maleic acid lipid particles 
SMA-QA SMA with a quaternary ammonium  
SMA-SH SMA with exposed sulfhydryls 
SMI styrene maleimide 
SMILPs stryene maleimide lipid particles 
SNARE protein complex that mediates vesicle fusion 
SPA single particle analysis 
SRP signal recognition particle  
SUR1 sulfonylurea receptors 1 
SUR2 sulfonylurea receptors 2 
T1134 threonine at position 1134 in WT-hCFTR 
T338 threonine at position 338 in WT-hCFTR 
T690 threonine at position 690 in WT-hCFTR 
T787 threonine at position 787 in WT-hCFTR 
T788 threonine at position 788 in WT-hCFTR 
TAP transporter associated with antigen processing 
TBS Tris-buffered saline 
TBST Tris-buffered saline with Tween-20 







TIP3P water modeling system 
TM1 transmembrane helix 1 
TM10 transmembrane helix 10 
TM11 transmembrane helix 11 
TM12 transmembrane helix 12 
TM2 Transmembrane helix 2 
TM3 transmembrane helix 3 
TM4 transmembrane helix 4 
TM5 transmembrane helix 5 
TM6 transmembrane helix 6 
TM7 transmembrane helix 7 
TM8 transmembrane helix 8 
TM9 transmembrane elix 9 
TMD transmembrane domain 
TMD1 transmembrane domain 1 
TMD2 transmembrane domain 2 
T-Rex CHO modified CHO cell line for protein expression 
Tris tris(hydroxymethyl)aminomethane 
U Units 
UDP uridine diphosphate 




V350 valine at position 350 in WT-hCFTR 
VMD Visual Molecular Dynamics  
WT wildtype 
x-loop particular loop structure in CFTR 
zCFTR zebrafish CFTR 
zSMA derivative of SMA 
zSMALP derivative of SMALPs 
ΔF508 mutant version of CFTR, deletion of phenylalanine at 
position 508 in WT-hCFTR 







Membrane proteins are difficult to study in solution due to the use of detergent to protect 
the hydrophobic portion of the protein that interacts with the fatty acid tails of the lipid 
bilayer. However, a recent technology called nanodiscs provides a packaged lipid bilayer 
system in which membrane proteins can be studied in solution in a lipid environment and 
thus without the use of detergent. Nanodiscs have revolutionized the study of membrane 
proteins, even difficult and complex membrane proteins. A particularly challenging 
membrane protein, the Cystic Fibrosis Transmembrane conductance Regulator (CFTR), 
has shown to be very sensitive to the detergent and lipid environment, especially during 
purification and reconstitution. This dissertation explored new methods of expression, 
purification, reconstitution, functional assays, and structurally important lipids for human 
CFTR. The development of multiple expression systems improved detergent purification 
methods and increased the yield of functional CFTR. The utilization of nanodiscs 
technology has provided a method of measuring changes in CFTR’s ATPase activity 
dependent on the environment and may provide a new method for determining structure-
induced changes to CFTR that are dependent on the environment. The identification of 
possibly key structural lipids in detergent-solubilized CFTR and some preliminary 
investigation into the annular lipid environment of CFTR was completed by lipidomics 
mass spectrometry. This dissertation also utilized both traditional and nontraditional 
molecular modeling methods to refine a CFTR homology model and study a key interaction 
in the translation of ATP binding in the nucleotide binding domains (NBDs) to the 








1.1.1. Publications resulting from this chapter.  
Parts of this chapter will be published in Methods in Molecular Biology on the 
reconstitution of membrane proteins. Other parts of this chapter will be published in 
downstream manuscripts.   
1.2. MEMBRANE PROTEINS.  
Membrane proteins are essential for maintaining physiological processes and are the 
main target of pharmaceutical drugs. Studying membrane proteins can be challenging 
due to the hydrophobic region of the protein that interacts with the fatty acid tails of the 
lipid bilayer. Detergents can protect the hydrophobic region of membrane proteins from 
the aqueous environment by housing those regions in a non-physiological environment. 
However, studying membrane proteins in a lipid environment, the more physiologically 
relevant environment, has traditionally been more difficult. New technologies, discussed 
below, have improved traditional challenges and revealed the importance of the lipid 
environment to membrane proteins (1). Understanding the role the lipidic environment 
plays in maintaining or altering membrane protein structure and function can improve 
our understanding of drug design (2).   
1.2.1. Adenosine triphosphate (ATP) binding cassette (ABC) transporters. 
The adenosine triphosphate (ATP) binding cassette (ABC) transporters represent a 
superfamily of mainly membrane proteins, expressed in both prokaryotes and eukaryotes. 
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Of the 49 known human ABC transporters, almost 50% are involved in the regulation of 
the lipid bilayer (3, 4).  The human ABC transporters are organized into 7 subclasses—




Table 1.1: Table of Human ABC transporter subclasses—ABCA through ABCG. For 
each subclass a common alias, the number of genes currently identified, a general functional, 
and an example member is listed.    




Examples (alternate name, 
disease relevance) 
ABCA ABCI 12  Mostly lipid 
trafficking 
ABCA4 (ABCR, Stargardt 
Disease) 




gp, drug inefficacy) 




1, MRP1, drug inefficacy) 
ABCC7 (Cystic Fibrosis 
Transmembrane conductance 
Regulator, CFTR, cystic 
fibrosis) 





ABCE OABP 1  Organic 
anion efflux 
ABCE1 (Organic anion 
binding protein, OABP) 




ABCG white 5  Sterol 
transport 
ABCG2 (Breast Cancer 
Resistance Protein, BCRP, 
chemotherapeutic resistance) 
Adapted from Vasiliou, V., et al. (2008). "Human ATP-binding cassette (ABC) transporter family." 
Human Genomics 3(3): 281. 
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of the subclasses has a particular architecture, all have the following motifs in the 
nucleotide binding domains (NBDs), or nucleotide binding folds (NBFs): the Walker  
A motif and the Walker B motif, and the ABC signature motif, which is located upstream 
of the Walker B motif in the primary sequence (6). Most of these human subclasses, all 
but ABCE and ABCF, contain two transmembrane domains (TMDs). The TMDs contain 
anywhere from 6-12 membrane-spanning helices, allowing access to the substrate-
binding site from only one side of the membrane at a time (3) (Figure 1.1A). The 
movement of bound substrates across the membrane is powered by the cooperative 
binding of ATP at two sites in the interface of the NBDs, forming a head-to-tail dimer, 
and possibly the hydrolysis of ATP at either both sites or only one site (7-15) (Figure 
1.1B), although the notion that ATP hydrolysis powers substrate movement has been 
contested recently (16). An ATP binding site that can hydrolyze ATP is known as a 
consensus site, and an ATP binding site that cannot hydrolyze ATP is known as a 
degenerate site (14, 17) (Figure 1.1B). ATP binding, and possibly hydrolysis, initiates 
conformational changes translated through the interface of NBDS and TMDs (8) (Figure 
1.1A). For many ABC transporters this transmission interface utilizes cross-matched 
intracellular loops (ICLs) with the NBDs to translate conformational changes to the 
corresponding TMDs (7, 9) (Figure 1.1A); however, the mechanism of transport, 
including how ABC transporters transition from an open state to a closed state and how 
ATP is hydrolyzed, is still debated. First, the reaction path of ATP hydrolysis has been 
elusive (6, 18, 19), until a recent study proposed a three-step mechanism of hydrolysis 
(16) (Figure 1.2). Second, whether ATP is hydrolyzed symmetrically or even with every 





Figure 1.1: Model of an ABC transporter in a lipid bilayer and ATP-binding at the 
NBD interface. (A) The general architecture of most human ABC transporters is 
shown. The Transmembrane Domains (TMDs), boxed in forest green, exist in the lipid 
bilayer and are the site of substrate binding. The intracellular loops (ICLs), boxed in 
orange, translate conformation changes by ATP binding and hydrolysis at the nucleotide 
binding domains (NBDs), boxed in purple. TMD1 is gray, TMD2 is green, NBD1 is 
pink, and NBD2 is blue. Some ABC transporters contain a unique motif known as the 
lasso motif (red). (B) The interface of NBDs bound with ATP (green) and coordinated 





Figure 1.2: The currently proposed ATP hydrolysis reaction path of ABC 
transporters. While the mechanism of ATP hydrolysis in ABC transporters has been 
elusive, recent computational studies of the acidic residue just after the Walker B motif 
predict the above hydrolysis mechanism. For hCFTR, this acidic residue is glutamic 
acid. 
Adapted from Prieß, M., Göddeke, H., Groenhof, G., and Schäfer, L. V. (2018) Molecular Mechanism 
of ATP Hydrolysis in an ABC Transporter. ACS Central Science. 
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highly contested. While many models have been proposed, it is becoming more accepted 
that a “one model fits all ABC transporters” theory may not be accurate (17). Initially,  
the alternating access model, proposed in 1966 by Jardetzky (20), was modified to 
propose a transport mechanism of P-glycoprotein (P-gp) (21) and then for LmrA (22) 
(Figure 1.3). This mechanism was the most accepted theory, with structural and 
biophysical data from multiple ABC transporters supporting this mechanism (7, 8, 13, 
21, 23-26). In the alternating access model, ATP binding in the NDBs forms a tight dimer, 
which opens the high-affinity substrate binding site. ATP binding then induces a 
conformational change in the TMDs, opening the substrate binding site to the other side 
of the cell. ATP hydrolysis induces a structural change to release the substrate—possibly 
inducing a lower affinity binding site—and disrupts the NBD dimer, allowing the release 
of adenosine diphosphate (ADP) and inorganic phosphate (Pi) (7, 17, 21, 22). For 
eukaryotic ABC transporters, this conformational change is typically from the inward-
facing conformation, where the substrate binding site is accessible intracellularly to 
outward-facing, where the substrate binding site is accessible extracellularly (19, 21, 27, 
28). There were two other mechanistic theories that emerged later to accommodate other 
structural and biochemical data. These models were the switch model, also called the 
tweezers-like (12) or processive clamp (29) models, and the constant contact model (6). 
In the switch model, substrate binding prepares the NBDs for ATP binding. Once ATP 
binds in the interface of the NBD dimer, the TMDs undergoes a conformational change, 
exposing the substrate to the other side of the membrane. ATP hydrolysis allows for the 
release of the NBD dimer and also ADP (30, 31) (Figure 1.3). While this model has 
structural, biochemical, and other biophysical data in support (32), there is mounting 
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evidence in support of the constant contact model (14, 33-36). In the constant contact 
model, the NBDS remain dimerized as ATP binding at one site can induce structural 
changes to allow substrate binding and conformational changes in the TMDs to provide 
the substrate access to the opposite side of the membrane (31, 33) (Figure 1.3). 
Controversial new data suggest that ATP hydrolysis is not sufficient for “the power 
stroke” of ABC transporters (16), and thus other mechanisms are gaining support (37). 
With the mounting evidence for each mechanistic model and the variety of substrates for 
individual ABC transporters across the superfamily, both eukaryotic and prokaryotic 
known proteins, the concept that one proposed mechanism might work for all ABC 
transporters would be fallible (17). This is especially true for the Cystic Fibrosis 
Transmembrane conductance Regulator (CFTR)—the only chloride ion channel ATP in 
the ABC transporter superfamily, since substrate-induced conformational changes are 
unlikely in this case.   
1.3. CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR 
(CFTR).  
CFTR, also known as ABCC7 or MRP7 (multidrug resistance protein 7), is a chloride 
ion channel regulated by the phosphorylation of a large intrinsically disordered domain 
called the Regulatory-domain (R-domain) and ATP binding in both a consensus ATP site 
and a degenerate ATP site (38). Thus, CFTR is the only chloride ion channel in the ABC 
transporter superfamily, and as the name suggests, this channel protein is of great medical 
importance.   
1.3.1. CFTR architecture.  
CFTR was first identified as an ABC transporter by the characteristic motifs when the 
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gene was discovered in 1989 (38). CFTR is a monomeric protein of 1480 amino acids 
composed of 5 domains. Four of the domains are consistent with most ABC 
transporters—TMD1, NBD1, TMD2, and NBD2; however, CFTR has a linking region 
connecting NBD1 to TMD2, called the R-domain. While many ABC transporters have 
linking regions (39, 40), CFTR has the largest at about 240 residues and is the only ABC 
transporter known to be tightly regulated by phosphorylation of this linker (41, 42).  Like 
other ABC transporters, CFTR contains two ATP binding sites. Unlike most ABC 
transporters, which have a somewhat strict stoichiometric ratio of ATP consumption to 
substrate transported, CFTR forms a diffusive pore at the surface of the cell (43).  CFTR 
classically contains ICLs that cross-interact with the NBDs, as well as extensive flexible 
extracellular loops (ECLs). One of these loops, ECL4, is glycosylated during CFTR 
biogenesis and is used in tracking CFTR maturation in the cell (44) (Figure 1.4). Both 
termini of CFTR have key structural features found in other ABC transporters. The first 
is the PDZ-binding domain located at the C-terminus, which aids in trafficking and 
anchoring CFTR to the cell surface (45-47). The second is the lasso motif (48), which 
has been found in a few other ABC transporters, including multidrug resistance protein 
1 (MRP1) and sulfonylurea receptors 1 and 2 (SUR1 and SUR2) (49-51) and might aid 
in trafficking (52, 53).  
1.3.2. CFTR biogenesis and trafficking.  
During its biogenesis, CFTR undergoes several post- and co-translational modifications. 
These modifications play critical roles in the folding of CFTR and, thus, its trafficking 






Figure 1.3: Scheme of the proposed mechanistic models of ABC transporters. 
There are three commonly accepted mechanisms for substrate transport in ABC 
transporters—alternating access model, switch model, and constant contact model. In 
the alternating access model, ATP binding induces conformational changes that allow 
for substrate binding. Substrate binding induces conformational changes in the 
transmembrane domains (TMDs) that open the substrate pocket to the opposite side of 
the membrane. ATP hydrolysis and release cause conformational changes to release the 
substrate and prepare the protein for a new transport cycle. In the switch model, 
substrate binding induces conformational changes and allows for ATP binding. ATP 
binding induces conformational changes to release the substrate, and ATP hydrolysis 
and release prepares the protein for a new transport cycle. In the constant contact model, 
ATP binding at only one site can open the substrate binding pocket and ATP hydrolysis 







Figure 1.4: Two different representations (schematic and cartoon) of CFTR 
architecture. Structural domains depicted in both styles (schematic-top and cartoon-
bottom): the lasso motif (red), TMD1 (gray), NBD1 (pink), TMD2 (green), and NBD2 
(blue). (A) In the schematic representation, several more features of CFTR are 
displayed. The R-domain (yellow) is phosphorylated at several sites (orange circles), 
extracellular loop 4 (ECL4) is glycosylated at two sites (cyan hexagons), and the C-
terminus contains the PDZ binding domain (purple box). (B) The cartoon representation 




1.3.2.1. CFTR CO-TRANSLATIONAL FOLDING.  
During the synthesis of TMD1, the emergence of the signal sequence on transmembrane 
helix 1 (TM1) from the ribosome is believed to be inefficient at being recognized by the 
signal recognition particle (SRP) due to two charged residues—E92 and K95 (54). The 
inefficient recognition of this signal sequence prevents a C-trans orientation of CFTR 
but does possibly promote initial location to the ER and Sec61. The signal sequence on 
transmembrane helix 2 (TM2) that interacts with SRP does promote proper insertion of 
the N-terminal flanking sequence into the ER through Sec61, thus forming the ribosome-
Sec61 translocon complex (RTC) (N-trans orientation) (54). Proper insertion of TM1 is 
then believed to be mediated by extracellular loop 1 (ECL1) (54). Next, both 
transmembrane helix 3/ transmembrane helix 4 (TM3/4) and transmembrane helix 5/ 
transmembrane helix 6 (TM5/6) are believed to be inserted into Sec61 as helical hairpins 
due to the short extracellular loop 2 (ECL2) and extracellular loop 3 (ECL3) (54, 55). 
NBD1 and the R-domain are believed to fold in the cytosol co-translationally (55, 56). 
While little is known about the “folding” of the R-domain due to its intrinsically 
disordered nature, much has been done to understand the folding mechanism of NBD1 
because the most common disease-relevant mutation occurs in this domain (ΔF508). 
First, studies showed that NBD1 experiences consecutive folding of each subdomain, the 
first being the N-terminal ATP-binding subdomain (57). The next domains to be folded 
are the α-helical subdomain and the α/β-core subdomain, which most likely use the first 
formed domain as a scaffold; however, the folding order of these subdomains is still 
debated (58). Other studies have shown that in order to prevent steric clashing during 
translation of NBD1 and the R-domain, the ribosome must transiently detach from the 
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RTC (56, 59, 60). Whether the same or a different translocon is used for translation of 
TMD2 is unknown. Transmembrane helix 7 (TM7) directs membrane targeting and 
translocation of extracellular loop 4 (ECL4), while TM8 terminates translocation causing 
redirection of ICL3 into the cytosol. This mechanism only occurs in conjunction with 
TM7, which is a cooperative property specific to CFTR (55, 61, 62). The remaining 
transmembrane helix 9/ transmembrane helix 10 (TM9/10) and transmembrane helix 11/ 
transmembrane helix 12 (TM11/12) are believed to be inserted into the translocon 
similarly to TM3/4 and TM5/6 as helical hairpins (55, 62). Finally, NBD2 is believed to 
fold co-translationally, very similarly to NBD1 (56). Once each major domain has folded, 
CFTR must also undergo significant domain reorganization to achieve the native 
architecture of the mature protein through at least two distinct folding events (63). 
1.3.2.2. CFTR FOLDING AND MATURATION.  
Throughout the process of CFTR folding, both co-translationally and post-
translationally, CFTR must pass through at least four checkpoints of the ER quality 
control machinery (ERQC) (Figure 1.5).  The first checkpoint precedes the first domain 
reorganization event, which requires CFTR to be released from the RTC and the related 
chaperones (64, 65). At this first checkpoint, before the release of RTC, CFTR emerges 
from the ribosome as a nascent polypeptide and interacts with cytosolic chaperones such 
as heat shock protein 70 (Hsp70) and heat shock protein 90 (Hsp90) and several co-
chaperones (58, 63). These chaperones play critical roles in both folding and partitioning 
between wildtype (WT-CFTR) and mutant, misfolded CFTR (64, 66-71). Any misfolded 
mutant CFTR is trapped by these chaperones and signaled for degradation through the 
E3 ubiquitin ligase CHIP ((carboxyl) c-terminal of Hsp70 Interacting Protein) pathway 
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(72).  Once successfully passing this checkpoint, CFTR is released from the RTC and 
related chaperones and allowed to move to the second checkpoint. The second checkpoint 
involves the proper folding of CFTR through N-linked glycosylation and processing in 
the ER. Before the release of CFTR from the ribosome, nascent CFTR receives core N-
glycosylation (14-unit oligosaccharide—two N-acetylglucosamine, nine mannose, and 
three glucose residues) in the lumen of the ER by OST (oligosaccharyltransferase) at two 
residues N894 and N900 of ECL4, each containing a glycosylation consensus sequence 
DXS/T (62, 73). The release of CFTR from the RTC, after checkpoint 1, initiates 
glycosylation processing in which the partially glycosylated structure is recognized by 
chaperone lectins calnexin (CNX) and the calreticulin ER lumenal chaperones that assist 
in CFTR folding (74-76). At this step, misfolded CFTR is targeted to UDP (Uridine 
diphosphate)-glycoprotein glucosyltransferase (UGGT), which induces the re-
glycosylation process (77).  Lengthy processing time at this stage indicates improper 
folding, and CFTR could be trafficked to the glycoprotein ER-associated degradation 
(GERAD) pathway (66). However, proper folding of CFTR leads to the third checkpoint, 
which involves the arginine-framed tripeptides (AFTs) pathway. CFTR’s ability to be 
exported from the ER to the Golgi is confirmed by the following four retention/retrieval 
(RXR) motifs: R29/Q30/R31, R516/Y517/R518, R553/A554/R555, and 
R764/R765/R766 (78). Failing this checkpoint, due to the exposure or accessibility of 
these motifs, causes the imprisonment of CFTR in the ER (79). The fourth and final 
checkpoint is critical for exiting the ER and relies on the specific export diacidic motif 
D565/A566/D567), allowing CFTR packaging into coat protein (COP) II-coated 
vesicles, specifically with Sec24, at the ER exit site (80). Mutation of this motif almost 
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completely prevents CFTR processing to the Golgi, especially in the absence of low 





Figure 1.5: Simplified depiction of the four CFTR folding checkpoints. In the ER, 
CFTR will proceed through four processing checkpoints. These checkpoints occur both 
co-translationally and post-translationally and ensure properly folded CFTR can exit 
the ER and proceed to the Golgi. At one of these checkpoints, CFTR is glycosylated, 
known as Band B, and can be distinguished from CFTR that is glycosylated further in 
the Golgi (Band C).   
Adapted from Farinha, C. M., and Canato, S. (2017) From the endoplasmic reticulum to the plasma 





1.3.2.3. CFTR TRAFFICKING TO THE PLASMA MEMBRANE (PM).  
Once it passes these checkpoints, CFTR is trafficked to the plasma membrane, either by 
traditional or non-traditional processes. First, CFTR is transported in COPI vesicles to 
the trans-Golgi either through typical traffickers like Arf1, Rab1a/Rab2, or Golgi 
SNARE. As CFTR moves through the Golgi, the core-glycosylation (high-mannose 
oligosaccharide structures sensitive to endoglycosidase H, known as Band B in reference 
to its apparent molecular weight by SDS-PAGE) is modified with the removal of some 
glycan units and the addition of more complex units, like fucose, neuraminic acid, or 
sialic acid. After this glycosylation event, CFTR has matured (now appearing as Band C) 
(83). Another well-accepted theory, however, is that CFTR experiences a mode of 
anterograde trafficking between the ER and Golgi. In some cell types, CFTR is dependent 
on the late-endosomal target-SNARE syntaxin 13 pathway (84, 85). Finally, CFTR is 
delivered to the plasma membrane from the trans-Golgi network, experiencing three 
distinct processes of balancing CFTR levels at the plasma membrane—anterograde 
trafficking, endocytosis, and recycling. These processes are regulated by a variety of 
interacting partners with CFTR. The incorporation of CFTR into clathrin-coated vesicles 
is dependent on a small sequence motif on the C-terminal tail. There are two types of 
endocytic motifs—tyrosine-based (NPXY or YXXφ) or dileucine-based (D/EXXXLL/I 
and DXXLL). CFTR has two confirmed endocytic motifs—the YDSI (at 1424) and the 
LL motifs (at 1430); however, FVLI (at 1413) is not believed to be an endocytic motif 
but is needed for CFTR maturation (86-88). These signals are recognized by the assembly 
polypeptide-2 system that forms a complex with clathrin to promote the internalization 
of CFTR (89). Another route of CFTR recycling is regulated by small GTPases of the 
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Rab family (88, 90). Furthermore, while these are mechanisms to balance CFTR levels 
by recycling, there are also mechanisms to anchor CFTR to the plasma membrane, 
including the PDZ domain proteins. The C-terminus of CFTR contains a consensus PDZ 
binding motif (DTRL), which binds to multiple Na+/H+ exchanger regulatory factor 
proteins (NHERF-1, NHERF-2, and NHERF-3) and to CFTR-associated ligand protein 
(CAL). Interactions with the proteins stabilize CFTR expression at the cell surface (91-
98).  
1.3.3. Biochemical and biophysical studies of CFTR.   
Since the identification of the CFTR gene, it has been the hope that understanding the 
function of CFTR will establish how each mutant version is linked to the disease Cystic 
Fibrosis (CF). One of the key features of CF is the abnormally high sweat chloride levels 
of patients; thus, it was suspected that CFTR is a chloride ion channel or that CFTR might 
regulate the expression of a chloride ion channel (38). Some of the first functional studies 
of CFTR identified it as a chloride ion channel regulated by adenosine 3’,5’-
monophosphate (cyclic AMP, cAMP) signaling (43, 99-102). Later studies showed that 
cAMP-mediated stimulation induced the phosphorylation of CFTR in its R-domain (42, 
102-108). Moreover, further studies identified the need for ATP binding at the NBD 
interface (107, 109-114) to allow for chloride ion pore formation in the TMDs of CFTR. 
1.3.3.1. R-DOMAIN PHOSPHORYLATION.  
The R-domain contains nine consensus protein kinase A (PKA) phosphorylation sites 
(R-R/K-X-S*/T*, where the asterisk indicates the phosphorylated residues) at resides 
S660, S686, S700, S712, S737, S768, T788, S795, and S813 (Figure 1.6). Also, to note, 
there is one phosphorylation site outside of the R-domain in NBD1 (S422) (105). If all 
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10 of these sites are mutated, S753 was found to be phosphorylated (115). 
Phosphorylation studies of purified R-domain peptide show that only five sites are 
phosphorylated by PKA (S660, S700, S737, S795, S813), and two sites (S686 and S700) 
can be phosphorylated by protein kinase C (PKC) (106, 116); however, whole-cell 
experiments suggest that stimulation of PKC enhances phosphorylation of CFTR by 
PKA (102, 117). While each of these sites can be phosphorylated, not all sites contribute 
equally to the activation of CFTR. In fact, phosphorylation at S737 (in oocytes) or S768 
shows an inhibitory effect on CFTR (118-120) in the presence of all other 
phosphorylated residues; however, when all possible residues are mutated to alanine, 
these residues show stimulatory effects (121). Residues S660, S737, S795, and S813 
have been proposed to contribute the most to CFTR regulation by showing the most 
dramatic reduction in current when mutated to alanine (122). Only when all 11 sites 
discussed earlier, as well as four other residues (S670, T690, T787, S790) are mutated 
to alanine, is CFTR no longer regulated by PKA (123). Mutation of these sites 
individually, or multiple sites, reduced the rate of channel opening without changing the 
 
650 dqfsaerrnS iltetlhrfs 670 legdapvSwt etkkqsfkqt 690 gefgekrknS 
700 ilnpinsirk fSivqktplq 720 mngieedsde plerrlSlvp 740 dseqgeailp 
750 risvistgpt lqarrrqSvl 770 nlmthsvnqg qnihrktTas 790 trkvSlapqa 
800 nlteldiysr rlSqetglei 820 seeineedlk ecffddmesi 840 pavtt 
Figure 1.6: Sequence of the R-domain highlighting the positions of 
phosphorylation. There are nine phosphorylation sites (bolded and underlined), all 
with varying levels of functional consequences to CFTR.  
Adapted from Sheppard, D. N., and Welsh, M. J. (1999) Structure and Function of the CFTR Chloride 
Channel. Physiological Reviews 79, S23-S45 
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channel closing rate, but also reduced the affinity of CFTR for binding ATP; thus, 
phosphorylation of the R-domain regulates the interaction of ATP with the NBDs (108, 
124).  Complete deletion of the R-domain produces a non-functional CFTR channel 
(103); however, partial deletion (residues 708-835) produces a CFTR channel (ΔR708-
835CFTR) with similar biophysical properties, minus regulation by PKA and reduced 
(1/3) open probability (Po) or the fraction of time a channel is open during a recording 
(103, 108, 125). In these specific ΔR708-835CFTR mutant channels, incubation with AMP-
PNP (adenylyl-imidodiphosphate) could not stabilize CFTR’s open state. The instability 
of the open state in the ΔR708-835CFTR mutant indicates the possibility that the R-domain 
also plays a role in stabilizing ATP binding in the NBDs. In this mutant phosphorylation 
no longer regulates CFTR, only binding of MgATP can (125).  
1.3.3.2. ATPase ACTIVITY. 
After phosphorylation, WT-CFTR channels are activated by the binding of ATP to the 
NBDs. Specific motifs in both NBDs not only indicated ATP binding and hydrolysis but 
also that CFTR was a member of the ABC transporter superfamily. These motifs, which 
exist is both NBDs, are the Walker A motif (G-X-X-G-X-G-K-s/t), the Walker B motif 
(R-X-X-X-X-X-X-X-h-h-h-h-D) and the ABC signature motif (L-S-G-G-Q) and forms 
two ATP binding sites. (38). ATP binding site 2 is composed of the Walker motifs of 
NBD2 and the ABC signature motif of NBD1 and is known as the consensus site in 
CFTR. As mentioned before, the other ATP binding site (ATP binding site 1) is known 
as the degenerate site with respect to ATP hydrolysis and is composed of the Walker 
motifs of NBD1 and the slightly altered ABC signature (L-S-H-G-H) of NBD2 (38, 48, 





Figure 1.7: Diagram of ATP (magenta) binding sites at the interface of the 
nucleotide binding domain 1 (NBD1, pink) and nucleotide binding domain (NBD2, 
blue). As discussed in Figure 1.1, there are two ATP binding sites in ABC transporters 
formed from the Walker A, Walker B, and ABC Signature motifs in the nucleotide 
binding domains. (A) The sequences of these motifs for hCFTR are tableted. (B) The 
consensus site (ATP binding site 2, marked by the black circle) is discussed further. 
Highlighted in this figure is the Walker A of NBD 2 (yellow) and ABC Signature of 
NBD 1 (orange) , which form the ATP binding site stabilized by several residues of 
NBD2: Y1219 in A-loop (dark green), H1402 in H-loop (light green), Q1292 of Q-loop 






Figure 1.8: Scheme of CFTR gating and opening cycle. CFTR is a chloride ion 
channel regulated by phosphorylation of the R-domain. After phosphorylation of the R-
domain, the fully open pore is regulated by two different gating stages. The NBD-
mediated gating (blue background) occurs with the binding of one ATP molecule 
(yellow) at a consensus site and one ATP molecule (yellow) at a degenerate site in the 
nucleotide binding domains (NBDs; NBD1 is pink, and NBD2 is blue). Then the pore 
is regulated by pore gating (pink background) in which CFTR has several 
subconductance states (s1 and s2, thin red arrow) but will process to a fully conducting 
pore (f, thick red arrow). Hydrolysis of ATP (yellow) at the consensus site and the 
release of ADP (orange) and inorganic phosphate causes the channel to close by 
inducing conformational changes in the Transmembrane Domains (TMDs, TMD1 is 
gray, and TMD2 is green).  
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phosphorylation, increasing the concentration of MgATP leads to a decreased mean 
closed time, but no change in mean open time. These data suggest a minimal model of at 
least two closed states and a single open state (C1, C2, O1) (124). Further characterization 
of the single-channel behavior of CFTR shows another short-lived subconductance state 
(O2) and asymmetric transitions between these states in the CFTR gating cycle (124). 
These data, and more, reveal that CFTR has a very complex gating cycle, transitioning 
between multiple states (Figure 1.8) (124, 129, 130). Several studies have shown that the 
presence of MgATP before phosphorylation cannot activate CFTR, but the addition of 
only MgATP after the removal of PKA and ATP does activate CFTR channels (124). 
Nevertheless, in the case of deleting part of the R-domain, CFTR still retains ATPase 
activity and some channel activity (125). In the initial studies of purified recombinant 
NBD1 and NBD2, both have ATPase activity without the presence of TMD1, TMD2, or 
the R-domain (113, 131). While ATPase activity assays are used to demonstrate 
functional CFTR, especially in the case of purified protein, the reconstitution of the 
purified protein into planar lipid bilayers reveals substantial details about the chloride 
channel function of CFTR discussed below (48, 132-134).  
1.3.3.3. CHLORIDE ION PORE.  
The earliest electrophysiological studies of CFTR revealed its high anion selectivity over 
cations (99, 132); however, there is much less selectivity between anions (99, 135). 
Several experiments have shown that Cl- might not be the only physiologically relevant 
anion that permeates through CFTR, including bicarbonate (135, 136) and possibly 
glutathione and thiocyanate (137, 138). Thus, it is generally accepted that the minimum 
pore diameter of CFTR is around 5 Å (139). For Cl-, CFTR demonstrates a linear I-V 
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relationship under symmetrical conditions, with one of the lowest single-channel 
conductances of any channel ranging from 6 pS to 10 pS, depending on buffer conditions, 
Cl- concentration, and temperature (104, 132, 140, 141). When phosphorylated CFTR is 
reconstituted into planar lipid bilayers and is in the presence of ATP, the open probability 
(Po) of WT-CFTR is measured to be ~0.3 to ~0.5, depending on buffer conditions, with 
the observation of the aforementioned subconductance states (112, 132, 142, 143). 
Further exploration of these subconductance states reveals that mutations not only in the 
TMDs (144-148) but also in the NDBs can affect the frequency of these states (143, 149). 
As high-resolution structures of CFTR were unavailable until recently, identifying key 
residues that lined the pore of CFTR was accomplished through a combination of site-
directed mutagenesis, cysteine accessibility studies, and introduction of various pore 
blockers, with the evaluation of changes to CFTR by electrophysiology. Detailed reviews 
of these studies identified several key residues in TM1, TM6, TM11, and TM12 (124, 
150, 151), many of which were confirmed in the several newly released structures of 
CFTR (126, 128) (Figure 1.9). A narrow region in the pore of CFTR, first identified by 
electrophysiology in combination with the techniques mentioned above, most likely 
composes the selectivity filter. In this region are residues S341 (TM6), T338 (TM6), and 
F377 (TM6) (139, 152). Every study investigating the chloride pore, ATP binding, and 
phosphorylation builds on our understanding of how mutations in each domain of CFTR 







Figure 1.9: Depiction of residues believed to be important in pore formation of 
CFTR. A full structure of CFTR (right) highlights the general architecture of CFTR 
with TMD1 in gray, NBD1 in pink, TMD2 in green, and NBD2 in blue. The black circle 
highlights four transmembrane helices, TM1 as pale orange, TM6 as orange, TM12 as 
forest green and TM11 as yellow, and the residues on those helices that are important 
in pore formation. Residues accessible from the extracellular side are blue, from the 
intracellular side are purple, or both are red.  
Adapted from Linsdell, P. (2014) Functional architecture of the CFTR chloride channel. Mol Membr 
Biol. 2014 Feb;31(1):1-16. 
23 
 
1.3.4. Disease-relevance of CFTR.  
More than 2000 mutations have been identified within the gene of CFTR 
(http://www.genet.sickkids.on.ca/), and 346 of those mutations are identified as CF-
causing (cftr2.org/mutations_history). These mutations are categorized into five different 
classes—production mutations (class I), processing mutations (class II), gating mutations 
(class III), conductance mutations (class IV), and amount/localization mutations (class 
V)(153) (Figure 1.10). In recent years, four different CFTR modulator therapies have 
been released for many processing, gating, and conductance mutations and some 
production and amount/localization mutations. These CFTR modulators are single, 
double, and triple combination therapies known clinically as Kalydeco® (Ivacaftor/VX-
770), Orkambi® (ivacaftor/VX-770 and lumacaftor/VX-809), Symdeko® 
(ivacaftor/VX-770 and tezacaftor/VX-661), and Trikafta® (ivacaftor/VX-770; 
tezacaftor/VX-661; and elexacaftor/VX-445) (Figure 1.11). These compounds are 
classified as either correctors—molecules that enable proper folding or trafficking—or 
potentiators—molecules that increase PKA regulated chloride channel gating of CFTR 
(154). Currently, many mutations are being treated with these modulators, but not all 
mutants are impacted by these compounds, especially in the production and 
amount/localization class of mutations. Single mutations in CFTR can impart complex 
molecular defects suggesting recategorization of mutation classes to allow current 
therapies to be tested on orphan mutations. This reclassification can also enable 








Figure 1.10: Diagram of classes for CFTR mutations. The 346 currently identified 
disease-causing mutations are classified into one of the five above described classes. 
Each mutation class houses mutations that affect one of the following: protein 
production (class 1), protein processing (class 2), protein gating (class 3), protein 
conduction (class 4), or insufficient protein on the cell surface (class 5). However, many 
mutations can contribute to multiple classes of disfunction. The most common mutation, 
ΔF508, is classified as a class 2 mutation.   





1.4. CFTR STRUCTURES. 
Structural characterization of CFTR is of great importance as structures can aid in 
understanding the complex molecular defects imposed by single mutations, elucidating 
the complex transitions from different closed and open states, and clarifying the chloride 
channel function of CFTR as a member of the ABC transporter superfamily. 
1.4.1. Initial full-length CFTR structures.  
Two structures of hCFTR were solved by 2D (two-dimensional) electron 
 
Figure 1.11: Diagram of the current CF modulators and the tableted list of FDA-
approved mutations. Currently, four different modulator therapies have been approved 
in single, double, or triple combination therapies and treat 39 of the 346 disease-causing 
mutations. These modulators are either potentiators, like ivacaftor (VX-770), or 




crystallography—one in 2004 at a resolution of 20 Å and one in 2011 at a resolution of 
9Å (156, 157). Both structures confirmed the general architecture of CFTR predicted in 
an initial gene discovery study (38). The first study showed two different global 
conformations, and the second study revealed an outward-facing conformation of CFTR 
without the presence of ATP or phosphorylation. The traditional terms of outward- and 
inward-facing for ABC transporters are used to describe general conformations states of 
CFTR, especially when a conformation lacks a fully conducting pore. In the interim of 
waiting for more structures of CFTR, several homology models of CFTR were 
developed.  
1.4.2. CFTR homology models.   
Several structures of ABC transporters were released, providing a variety of scaffolds for 
homology models (9, 158). The first of these models investigated the molecular interface 
of the most common mutation (ΔF508) and key interactions necessary to reestablish 
channel function (159, 160). The next several homology models investigated the 
transitions of CFTR from the inward-facing conformation to the outward-facing 
conformation and the formation of a fully conducting pore (130, 161-165). These models 
not only confirmed several key interactions but unveiled new interactions significant to 
CFTR’s conformational transitions. One of these interactions includes E543 in the X-
loop of NBD1 and K968 in ICL3, which our lab investigated further (166) (Figure 1.12). 
While these models were built keeping functional information in mind and rigorously 
evaluated, the NBDs are anticipated to have similar structures across ABC transporters, 
but the variety of substrates of ABC transporters compared to the chloride channel 





Figure 1.12: Electrostatic salt bridge triad identified in homology models of CFTR 
and molecular dynamics and confirmed by electrophysiological techniques. This 
catalytic triad has been investigated in the translation of ATP binding at the nucleotide 
binding domains (NBDs, NBD1 is pink, and NBD2 is blue) to the Transmembrane 
Domains (TMDs, TMD1 is gray, and TMD2 is green).  This triad is investigated further 
in chapter II of this dissertation.  
Republished from Strickland, K. M., Stock, G., Cui, G., Hwang, H., Infield, D. T., Schmidt-Krey, I., 
McCarty, N. A., and Gumbart, J. C. (2019) ATP-Dependent Signaling in Simulations of a Revised Model 
of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR). The Journal of Physical Chemistry 
B 123, 3177-3188. 
28 
 
1.4.3. Recent CFTR structures.  
In three years, eight structures of 3 orthologs of detergent-solubilized CFTR were 
released from two laboratories in a broad range of resolutions—all solved by single 
particle electron cryo-microscopy (cryo-EM, see below). The first structures were of 
ATP-free, dephosphorylated zebrafish CFTR (zfCFTR) (inward-facing conformation) at 
a resolution of 3.7 Å and hCFTR under the same conditions at a resolution of 3.9 Å. In 
both structures, the NBDs were of significantly lower resolution, and thus, crystal 
structures of the NBDs were used to construct the final models (48, 126). From the same 
lab, the phosphorylated, ATP-bound structures (outward-facing) of zfCFTR and hCFTR 
were solved at resolutions of 3.4 Å and 3.2 Å (127, 128). All four of these structures 
revealed that CFTR contains a structural motif called the lasso motif. The lasso motif is 
found in several other ABC transporters (SUR1, SUR2, and MRP1) in which the N-
terminus loops into the lipid bilayer (Figure 1.13). These structures also exhibit a 
rearrangement of TM7 and TM8 and a kink in TM8, which is not seen in other similar 
ABC transporters. The functional consequence of the rearrangement and the kink in TM8 
is still highly unclear and continues to be debated (167-169). The release of two more 
structures of hCFTR with different potentiators bound, Vertex potentiator VX-770 
(resolution at 3.3 Å) or Galapagos potentiator GLPG1837 (resolution at 3.2 Å), showed 
both potentiators bound in the pocket created by the kink in TM8 (170). Whether this 
identified binding pocket is the physiological binding pocket for either or both of these 
potentiators or if these potentiators are correcting detergent-induced structural 
deformations has yet to be investigated. From a different lab, two other structures of 
recombinant thermostabilized chicken CFTR (chCFTR), one dephosphorylated, ATP-
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absent (inward-facing) structure (resolution at 4.3Å) and one phosphorylated, ATP-
bound (outward-facing) structure (resolution at 6.6 Å) also have been released. These 
structures show TM8 to be fully helical (171), and thus do not present the significant 
rearrangement of TM 7 and TM8 nor the kink in TM8. There are other peculiar structural 
characteristics in TM7 for these structures in which TM7 is almost orthogonal to the fatty 
acid tails of the lipid bilayer. As more structures are released, the kink in TM8 has been 
thought to be detergent-induced and not physiological (172). 
 
Figure 1.13: Depiction of the Lasso motif in CFTR. The lasso motif (red) is a motif 
found in several members of the ABC transporter superfamily of proteins, in which the 
N-terminus tucks into the lipid bilayer. For orientation, Transmembrane Domain 1 
(TMD1) is gray, nucleotide binding domain 1 (NBD1) is pink, TMD2 is green, and 





Table 1.2: Current released CFTR structures and the conditions of protein. 
Protein Organism Res Environment Modifi- 
cation 
State Method Year Expression 
system 






2004 BHK cells, 
stables 
hCFTR human 11 
Å 






2011 BHK cells, 
stables 










Single Particle 2016 Sf9 virus, 
HEK cells 










Single Particle 2017 Sf9 virus, 
HEK cells 










Single Particle 2017 Sf9 virus, 
HEK cells 












Single Particle 2018 BHK cells, 
stable 












Single Particle 2018 BHK cells, 
stable 










Single Particle 2018 Sf9 virus, 
HEK cells 











Single Particle 2019 Sf9 virus, 
HEK cells 

















1.4.4. Need for more CFTR structures. 
While these structures have provided invaluable information, confirming many 
interactions identified previously by functional experiments, there is still a need for 
additional structures to understand the function of CFTR fully. All high-resolution 
structures published to date are of protein entirely solubilized in detergent (Table 1.2). 
Current studies have shown that the solubilization detergent or stabilization detergent 
dramatically alters CFTR ATPase activity, even after reconstitution into lipids (133); in 
fact, the choice of reconstitution lipid affects the ATPase activity (134). Thus, it is likely 
that structures of CFTR in a lipid environment could be very different from those in 
detergent. Additionally, all of the various transition states of CFTR in opening and 
closing and the disease-causing mutations have yet to be explored in terms of a detailed 
structural description. These data suggest the need for more structures and simulations of 
these structures to connect CFTR structure and function.  
1.5. MEMBRANE PROTEINS AND LIPIDS.  
The importance of the lipid environment in maintaining membrane protein structure has 
been recognized; however, studying purified membrane proteins reconstituted into a 
lipidic environment has been limited to relatively large structural complexes—bicelles 
and sheets—due to the nature of lipids (173). Many recent advancements in small lipid 
bilayer complexes have been and are continuing to be developed, thus improving our 
understanding of the importance of the lipid bilayer on membrane protein structure and 
function by improving membrane protein stabilization during purification and 
reconstitution (174-177).  
1.5.1. Advancements in purifying and studying membrane proteins in lipid bilayers.    
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Studying membrane proteins in a lipidic environment has presented many challenges, 
especially for functional assays, due to the structures that lipid bilayers form—bicelles 
and sheets (173). Thus, studying some individual membrane proteins in a lipid 
environment was almost impossible until recently. The use of amphipathic polymers to 
stabilize the hydrophobic portions of the membrane proteins or lipids in an aqueous 
environment has dramatically improved studies of individual membrane proteins (178). 
Nanodiscs use amphipathic polymers to protect the hydrophobic tails of lipid molecules 
while keeping the entire protein-lipid complex soluble in an aqueous environment (179, 
180).  Depending on the type of amphipathic polymer and technique used, a membrane 
protein can be solubilized and purified in detergent before reconstitution into a lipid 
bilayer, or the membrane protein and the surrounding annular lipid environment can be 
solubilized and purified directly for biochemical or structural analysis (1, 181).  
1.5.2. “Standard” nanodiscs.  
The first type of nanodisc, termed “standard nanodiscs,” was developed in 1998 in Dr. 
Steven Sligar’s lab by modifying the human Apolipoprotein-1 (hApo1)—a naturally 
occurring protein that packages lipid molecules into high-density lipoprotein complex, 
known as HDL (182). Replacing the large globular N-terminal domain of hApo1 with a 
Histidine tag (His-tag) and cleavage site left a ~200 amino acid peptide polymer that 
spontaneously folds into α-helices referred to as the Membrane Scaffold Protein (MSP) 
(183). Incubation of MSP with detergent-solubilized lipids leads to the spontaneous 
formation of the nanodisc (Figure 1.14) of regular diameter as the detergent is being 
removed (183). The length of MSP determines the diameter of the nanodisc. The first 
developed MSP constructs are still the most commonly used and create nanodiscs with 
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either 9.7 nm or 11.9 nm diameter (184). Although the diameter can be increased and 
decreased by altering the length of MSP (185-187), changing the length of MSP will 
ultimately change the number of lipids accommodated upon insertion and thus will 
require optimization of the Lipid-to-Protein ratio (LPR) in each experiment (183, 185). 
Originally, nanodiscs were formed from one of three common lipid types—1,2-
dimyristoyl-sn-glycero-3-phosphocholine (DMPC), 1,2-dipalmitoyl-sn-glycero-3-
phosphocholine (DPPC), or 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) 
(183, 184) (Figure 1.15); however, now nanodiscs are being generated from different 
types of lipids and lipid combinations with relative ease (188). There are a few 
restrictions in forming these nanodiscs. The first is that the LPR and temperature during 
nanodisc formation are highly dependent on lipid type and its phase transition 
temperature (179, 187). Nanodiscs form most easily and consistently when the mixture 
is incubated at temperatures above the phase transition temperature (179, 187). The most 
likely explanation for this is that lipids behave as a liquid above the phase transition 
temperature and as gel-like below the phase transition temperature, thus preventing the 
necessary interactions for forming nanodiscs (179, 187). It is also important that all 
detergent from membrane protein solubilization and lipid solubilization must be 
completely removed, either by absorption of the detergent using BioBeads™ or by 
dialysis (Figure 1.16). The incomplete removal of detergent will also prevent nanodisc 
formation, and thus the amount of BioBeads™ or length of incubation must be optimized 
(179). While at first MSP was limited to reconstituting detergent purified membrane 
proteins, methods have been identified to solubilize membrane proteins with their native 
lipid environment (189, 190), albeit still using detergent to disrupt the membrane. As 
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newer amphipathic polymers are discovered, the opportunity to solubilize the membrane 
without detergent will be a major advantage to studying membrane proteins both 
structurally and functionally (181).  
 
Figure 1.14: A structure of nanodisc formed by Membrane Scaffold Protein 
(MSP). An individual MSP (orange) wraps around an individual leaflet of the lipid 
bilayer (gray). Thus, two MSP molecules form a single nanodisc composed of a lipid 
bilayer. From the top-down view (A), the nanodisc in this image is of MSP1D1 and has 
a diameter of 9.7 nm. In the side-on view (B), a nanodisc has a height of approximately 
5 nm. Images were built in Visual Molecular Dynamics (VMD) software from PDB ID: 





Figure 1.15: Depiction of the lipids first and commonly used to generate nanodiscs. 
All three lipids have the same head group (phosphatidylcholine) but differ in tail 
composition. The abbreviations are the following: 1,2-dimyristoyl-sn-glycero-3-




Figure 1.16: Schematic of nanodisc formation. The incubation of the membrane 
protein (MP) of interest, membrane scaffold protein (MSP) and lipids (DMPC, DPPC, 
POPC, etc.) in a particular ratio with the removal of detergent, either via BioBeadsTM 
or dialysis, will form membrane protein-loaded nanodiscs (full nanodiscs) or lipid-only 
nanodiscs (empty nanodiscs). 
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1.5.3. Native nanodiscs.  
The term “native nanodiscs” is used to describe the solubilization of a membrane protein 
with its native lipid environment using a synthetic polymer (191). While the term is used 
in a more global capacity to describe any discoidal bilayer system containing a membrane 
protein and its native lipid environment, the first native nanodisc utilized the synthetic 
styrene-maleic acid (SMA) polymer to solubilize small portions of the native lipid 
environment around the membrane protein of interest into uniformly sized discoidal 
particles (191, 192) (Figure 1.17). Initially, these lipid-bound SMA particles were called 
styrene-maleic acid lipid particles (SMALPs) (192); they also are called lipodisqs when 
formed from the commercially available SMA called Lipodisq® (193).  
 
Figure 1.17: Schematic of native nanodiscs formation. Cell membranes containing 
several endogenous membrane proteins and CFTR incubated with Styrene Maleic Acid 
(SMA) polymer. SMA will self-insert into the membrane and form native nanodiscs. 
The membrane protein or membrane proteins of interest can be separated from 
endogenous membrane proteins using affinity chromatography. The following PDB IDs 




1.5.3.1. STYRENE-MALEIC ACID LIPID PARTICLES (SMALPs). 
SMA is a synthetic copolymer formed by radical polymerization of maleic anhydride and 
styrene and then hydrolysis of the maleic anhydride moiety (Figure 1.18) (192). Several 
different ratios of styrene to maleic acid copolymers are available, with 2:1 and 3:1 being 
the most common and available commercially under the brand name Lipodisq®, as well 
as in ratios of 3:1, 2.3:1, and 1.2:1 under the SMALP brand name (194). Computational 
simulations of SMA in the proximity of a lipid bilayer show that styrene inserts into 
hydrophobic tails of the lipids in about 20 ns (195). After about 400 ns, the SMA polymer 
is completely inserted into the membrane. Unlike MSP, SMA solubilizes the membrane 
by wrapping around the membrane without a clear orientation (195). SMA requires 
particular buffer conditions for SMALP formation, which can introduce many 
disadvantages for specific membrane proteins (194). First, the presence of divalent 
cations, like Mg2+ or Ca2+, as well as low pH, inhibit the formation of SMALPs (194, 




Figure 1.18: Reaction diagram of SMA formation. Styrene and maleic anhydride 
monomers are mixed and polymerized, forming a polymer of varying uniformity. The 
final step in the formation of SMA is the hydrolysis of maleic anhydride to maleic acid 
under basic conditions. The final SMA polymer is used to solubilize membrane proteins 
and surrounding lipids embedded from the lipid bilayer. 
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gel phase or an ordered phase (198). Several other studies show SMA solubilizes certain 
types of lipids preferentially over others, including cholesterol (199, 200). Thus, SMA 
might not be as efficient at solubilizing a cholesterol-heavy lipid environment, causing 
preferential SMALP formation of non-cholesterol-associated membrane proteins. 
However, several varieties of SMA have been developed to combat some of these 
disadvantages, especially those related to the buffer conditions.    
1.5.3.2. OTHER COPOLYMER VARIANTS.  
Since the first production of SMA, many copolymers have been identified that can form 
nanodiscs providing their unique advantages and disadvantages; this discussion is 
summarized in Table 1.3. The first of these new polymers, called zSMA, modified the 
carboxyl groups of the SMA copolymer to phosphatidylcholine groups (201); thus, lipid 
particles formed from this copolymer are referred to as zSMALPs. The zSMA copolymer 
shows dramatically improved buffer compatibilities for a pH range of 4-10 and a divalent 
cation concentration of up to 20 mM. The ability of zSMA to solubilize membrane 
proteins from E. coli shows dramatic improvement over the first SMA copolymer for two 
membrane proteins (201). Further efforts to improve the first SMA copolymer led to the 
development of the diisobutylene maleic acid copolymer (DIBMA) (202). DIBMA forms 
similarly shaped discoidal particles to SMA and MSP, called DIBMA lipid particles 
(DIBMALPs), but with a slightly larger diameter at about 20 nm (202). DIBMALPs have 
one definite advantage to both SMALPs and standard nanodiscs. The DIBMA copolymer 
lacks UV-absorbing rings, allowing for more accurate spectrometry results of the 
incorporated membrane protein (202).  DIBMA has another advantage over SMA, as 
DIBMA is not as sensitive to divalent cations. However, DIBMA is not as effective at 
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solubilizing membrane proteins from E. coli membranes as the commonly used detergent 
DDM (n-dodecyl β-d-maltoside) (202).  
DIBMA and zSMA are not the only new variants developed. Another new variant is the 
styrene maleimide (SMI) copolymer, forming SMI lipid particles (SMILPs) (203). 
Interestingly, SMILPs are slightly smaller in diameter than DIBMALPs at 11 nm, but 
similar in size to the standard nanodisc diameter. The SMI copolymer is even more 
tolerant of divalent cations than any predecessor, showing lipid solubilization at up to 
100 mM for both Ca2+ and Mg2+. SMI can solubilize membrane proteins from E. coli 
membranes as well as detergent (DDM) at physiologically low pH. SMI is much 
improved over the SMA copolymer; however, SMI is not as efficient at solubilizing 
membrane proteins from E. coli membranes at neutral pH as SMA and detergent (DDM) 
(203). The copolymer showing the most dramatic improvement to the disadvantages of 
the first SMA copolymer is styrene maleimide quaternary ammonium (SMA-QA) (204). 
Nanodiscs formed by this copolymer show no sensitivity to divalent cations (up to 200 
mM) or too low, neutral or high pH, and this copolymer shows the ability to control the 
diameter of the nanodiscs by regulating the ratio of polymer to lipid; however, the ability 
of this copolymer to solubilize membrane proteins remains to be tested (204). One of the 
most recent, yet attractive, copolymers developed again modifies the first SMA 
copolymer by forming an amide bond on the carboxylic moiety of the maleic acid through 
the addition of cystamine. This new polymer, called SMA-SH, does not improve the 
buffer condition solubility of SMA, but it does allow for membrane protein purification 
strategies and a plethora of fluorescent studies (205, 206). These polymer variants and 
advantages and disadvantages are summarized in Table 1.3.  
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 Table 1.3: Structures of SMA derivatives and current characterization. The use of polymers to 
solubilize membrane proteins and package lipids into nanodiscs is a relatively new technology, and 
each polymer provides a unique set of advantages. 
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1.5.4. Downstream studies of membrane proteins in nanodiscs.   
Using traditional biochemical and biophysical techniques to study individual membrane 
proteins in a lipid bilayer has been difficult. The use of nanodiscs, both the original and 
native, has vastly increased the number of studies providing both functional and 
structural data for membrane proteins. This nanodisc technology is especially crucial for 
membrane proteins involved in lipid regulation and synthesis (179).  
1.6. CONCLUSIONS.  
The improved technologies of nanodiscs have created an entirely new environment for 
studying membrane proteins and allows for the investigation of a multitude of new 
questions about the importance of the lipid environment for membrane proteins. This 
work describes the initial optimization strategies for building the foundation to 
investigate the importance of the environment for the very complex, but medically 
relevant membrane protein CFTR. The following chapters describe the optimization of 
three different expression cell systems of CFTR and two different affinity 
chromatography tagging systems. As CFTR has a complex biogenesis, the determination 
of an appropriate cell expression system and the location of tag for affinity 
chromatography is highly important for the purification of properly folded, functional 
CFTR. For our purified CFTR, both the channel function and the ATPase activity were  
evaluated. In other studies, the ATPase activity of CFTR depended on the detergent used 
for solubilization, even after reconstitution into a lipid environment (133). Another study 
reported that CFTR ATPase activity also depends on the lipid environment as studied by 
destabilized proteoliposomes, which are destabilized by the presence of detergent (134). 
We hypothesize that we will also see reduced ATPase activity of CFTR in detergent as 
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compared to in a lipid environment. Because of the differences in ATPase activity, we 
also hypothesize that the channel activity of CFTR will vary depending on the lipid 
environment. From one of the aforementioned detergent-solubilized structures of human 
CFTR, several lipid tail-like densities and a cholesterol-shaped electron density can be 
seen. This suggests that these lipids play an important structural role for CFTR. We 
determined the co-purified lipids in our detergent-solubilized purified CFTR sample.  
These newly released detergent-solubilized structures provide new structural information 
on CFTR, but before the release of these structures, structural studies relied on homology 
models. We hypothesized that a homology model could be refined by flexibly fitting in 
low-resolution maps of the protein determined from 2D lipid crystals. We analyzed these 
new models with traditional and non-traditional molecular dynamics methods and 
discussed more in the next chapter.     
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2 CHAPTER II 
ATP SIGNALING IN A REVISED HOMOLOGY MODEL OF CYSTIC 




2.1.1. Publications resulting from this chapter. 
Reprinted with permission from Kerry M. Strickland, Gorman Stock, Guiying Cui, Hyea 
Hwang, Daniel T. Infield, Ingeborg Schmidt-Krey, Nael A. McCarty, and James C. 
Gumbart (2019) ATP-Dependent Signaling in Simulations of a Revised Model of 
Cystic Fibrosis Transmembrane Conductance Regulator (CFTR). J Phys Chem 
B. 123(15):3177-3188. Copyright (2019) American Chemical Society. 
2.1.2. Individual contributions to the work.  
Original concept proposed by Dr. JC Gumbart. Initial simulations designed and prepared 
by Gorman Stock with guidance from Dr. Gumbart. Final simulations prepared and run 
by Dr. Hyea “Sunny” Hwang. I analyzed simulation data in preparation for the 
manuscript in conjunction with Dr. Gumbart. Dr. Guiying Cui initially designed and 
performed the electrophysiological experiments, while I further analyzed 
electrophysiological data using a variety of software tools. I wrote the manuscript and 
edited after reviewer recommendations and have updated the chapter here for inclusion 
in the thesis. 
2.1.3. Introduction.  
Ever since the discovery of the cystic fibrosis transmembrane conductance regulator 
(CFTR) gene in 1989 (38), the corresponding protein, CFTR, has been studied intensely 
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due to its role in the disease cystic fibrosis (CF). CF is a debilitating disease that 
significantly diminishes the quality and length of life of affected individuals. With nearly 
2000 mutations identified in the gene of human CFTR 
(http://www.genet.sickkids.on.ca/app) and more than 300 currently identified as disease-
causing (207) understanding the structure−function relationship of this protein is critical 
for overcoming these defects of function. Studying CFTR has been particularly 
challenging, as it functions as a channel instead of a transporter, making it unique among 
the proteins in the ABC (ATP-binding cassette) transporter superfamily (208). ABC 
transporters represent a family of transmembrane proteins with typically four domains: 
two nucleotide-binding domains (NBDs) and two transmembrane domains (TMDs) 
(209). ABC transporters, either importers or exporters, move a preferred substrate in a 
single direction across the membrane with a strict relationship between the amount of 
substrate transported and ATP consumed. The energy of ATP binding at (typically) two 
distinct sites in the NBDs is used to enable conformational change in the TMDs; 
hydrolysis of ATP leads to transport of the substrate across the membrane (210). CFTR, 
on the other hand, evolved to use ATP to form a diffusive pathway for chloride ions; it 
is the only member of the ABC transporter superfamily known to act as a channel with 
no strict stoichiometry between ATP usage and substrate transport. CFTR uses a 
modified “alternating access” transport mechanism (211) in which a pore opens in the 
TMDs on the time scale of a second (114). In the alternating access model, the substrate 
has access to the binding site from inside the cell (inward-facing state) or from outside 
the cell (outward-facing state) but not both at the same time (20). In contrast, in CFTR, 
the outward-facing state is no longer closed to the inside, but instead, it can form a 
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channel connecting both sides. One of CFTR’s NBDs bears a degenerate ATP-binding 
site, a feature found in some ABC exporters (212), and thus, CFTR can only hydrolyze 
ATP at one of the two binding sites. CFTR also possesses a unique ∼240-residue 
regulatory domain (R-domain) between NBD1 and TMD2 (38). Flexible linker domains 
are found in some other ABC transporters (39, 40); however, the R-domain of CFTR is 
the largest found to date. Furthermore, it is the only linker known to tightly regulate the 
protein based on its phosphorylation state (41, 42). The majority of what is presently 
known about CFTR has been gained through a variety of biophysical techniques. Most 
prominent among these techniques, due to the channel function of CFTR, is 
electrophysiology, which was used to characterize and classify many clinically relevant 
mutations as they were identified (43, 213, 214). Electrophysiology combined with 
mutagenesis led to the identification of numerous functionally important residues (124). 
However, until recently, high resolution structural data, necessary to confirm the 
locations of these residues, lagged far behind functional data on CFTR, in spite of 
considerable effort. In 2004 and in 2011, a 20 Å and a 9 Å structure of CFTR were 
published, respectively (156, 157). In both cases, CFTR was crystallized two-
dimensionally, and its structure was determined using electron cryo-microscopy (cryo-
EM). Both structures confirmed the general topology of CFTR but did not reveal specific 
residue positions. Within the last several years, four 3−4 Å resolution structures of CFTR 
have been solved by single-particle cryo-EM: an inward-facing zebrafish CFTR (zCFTR) 
(48), an outward-facing zCFTR (127), an inward-facing human CFTR (hCFTR) (126), 
and an outward-facing hCFTR (128), although none of them display an open pore. While 
these structures and models provide information on a few conformations of CFTR, its 
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complex gating cycle suggests there are numerous transitory states (215). Molecular 
dynamics simulations have the potential to reveal these otherwise “invisible” states, 
simultaneously providing more information on the transitional interactions formed and 
broken to translate structural information from one domain to another. Prior to the release 
of the 3−4 Å resolution structures of CFTR, structures of several other ABC transporters 
were solved (7, 14, 158, 216). These structures were used as templates for several CFTR 
homology models (130, 159, 161-165). While the homology of the NBDs across 
transporters is relatively high due to their conserved functions of ATP binding and 
hydrolysis, the TMDs are quite diverse due to the manifold substrates transported. To 
address this variability, experimental data on CFTR have been incorporated as hard 
constraints during homology-model building in efforts to capture the unique pore 
characteristics of CFTR (130, 164). Nonetheless, concerns about the validity of these 
models remain, since they were based upon the structures of distantly related paralogs. 
In this study, we have further refined an existing homology model of CFTR, that from 
Rahman et al. (130), by applying molecular dynamics flexible fitting (MDFF) to fit it to 
a cryo-EM map of CFTR (157, 217). Extended simulations of the best fit structure 
displayed the formation of a complete pore, albeit one that is not yet conductive. These 
simulations also revealed a novel pair of salt bridges involving three residues in the NBDs 
and intracellular loops (ICLs), which were transiently formed during the channel opening 
process and thus would not be represented in the static cryo-EM structures. Both salt 
bridges were experimentally confirmed to be functionally relevant, pointing to a putative 
allosteric mechanism for signaling the state of ATP occupancy in the NBDs to the pore. 
2.2. METHODS.  
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2.2.1. Flexible fitting. 
The starting model of CFTR was taken from the 2013 homology-model study performed 
by Rahman et al. (130). Briefly, this outward-facing model was constructed by aligning 
the human CFTR sequence with the Sav1866 crystal structure (PDB 2HYD) in Modeler 
(7, 218). Additional experimental constraints, consisting of known interactions lining the 
pore of CFTR, e.g., salt bridges, were also used to refine the model (130). Here, we 
further refined the open-channel CFTR homology model using molecular dynamics 
flexible fitting (MDFF) (217, 219) and a cryo-EM map of CFTR reported in 2011 (130, 
157). This map contains 12 copies of the protein arranged in two tightly packed crystal 
planes, which we refer to as the crystallographic map. In addition to the full map, MDFF 
was also performed on a second map created by averaging the 12 copies of the protein in 
the crystallographic map, referred to as the average map. For each of the two maps, the 
homology model was rigid-body docked using the Situs package (220), after which 
MDFF was performed using NAMD (221). The fitting was carried out with secondary-
structure restraints. For the crystallographic map, the homology model was replicated 
and translated to match the 12 proteins apparent within the EM map. To prevent 
distortions at the edges of the map, symmetry restraints were applied to all 12 copies 
using the crystallographic symmetry parameters (222). MDFF simulations were set up as 
recommended in the MDFF tutorial 
(http://www.ks.uiuc.edu/Training/Tutorials/science/mdff/tutorial_mdff.pdf); alternative 
simulation parameters were not attempted. Fitting was run until the root-mean-square 
deviation of the backbone stopped increasing, roughly 2 ns each. Fitting to the 
crystallographic map increased the cross-correlation coefficient (ccc) from 0.26 to 0.40; 
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fitting to the averaged map increased it from 0.46 to 0.56, comparable to the values 
obtained in Simhaev et al. for a different model (0.50−0.53) (223). Even a perfect fit is 
not expected to yield a ccc of 1.0, as there is extraneous density due to, e.g., bound 
detergent molecules. Although the crystallographic-map fit contains 12 copies, the 
symmetry restraints are increased over the course of the simulation to such a degree that, 
by the end, the copies are in identical conformations (Simulation System Construction). 
Careful consideration went into the placement of ATP in our refined model. The 
degenerate binding site of CFTR was modeled after the human CFTR NBD1 homodimer 
crystal structure (PDB: 2PZE) (224). The crystal structure was aligned to NBD1 of the 
model by comparing their ABC binding motifs, namely, the ABC signature sequence, 
Walker A, and Walker B motifs. The corresponding ATP in the crystal structure was 
placed into the fits by this alignment. Because the NBD1 homodimer structure does not 
contain a canonical binding site, we used the crystal structure of human ABCB6 (PDB: 
3NH9) (225)  to model the second ATP in a procedure similar to the first. The three 
models, namely, the original homology model along with the two fitted models, were 
each inserted into a POPC lipid membrane slab generated using VMD (Visual Molecular 
Dynamics) (226). This membrane slab was roughly 140 Å by 75 Å and, after deleting 
lipids that overlapped with the protein, contained 344 lipid molecules. This system was 
then solvated above and below the membrane with ∼72,000 water molecules. Na+ and 
Cl− ions were added at a concentration of 0.15 M to mimic biological conditions and to 
neutralize the system. The total atom count of each system was roughly 280,000 atoms. 
2.2.2. MD simulations and analysis. 
All simulations were performed using the NAMD Molecular Dynamics package (221). 
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The CHARMM36 force field (227-229) was utilized along with TIP3P water (230). 
Periodic boundary conditions were imposed. Constant pressure at 1 atm and temperature 
at 300 K were maintained during the simulations. A 12 Å cutoff with a force-based 
switching function beginning at 10 Å was employed for van der Waals interactions. A 
time step of 2 fs was used for all simulations, with long-range electrostatic interactions 
calculated every other time step using the particle-mesh Ewald method (231). Systems 
were equilibrated in stages as follows (232).  First, all atoms except those in the lipid tails 
were restrained, allowing the tails to melt for 0.5 ns. Then, all of the atoms belonging to 
the protein were restrained, allowing the rest of the membrane to relax for an additional 
0.5 ns. Next, only the backbone of the protein was restrained, allowing the side chain 
positions to relax for 0.5 ns. Finally, the systems were run at equilibrium fully 
unrestrained. Both fits as well as the original homology model were run for 100 ns in 
each of the three ATP states described, namely, with 0, one, or two ATP bound at the 
NBDs. In addition, the crystallographic-fit simulations were extended for 200 ns more, 
giving a total of 300 ns. 
2.2.3. Pore analysis.  
Pore analysis was performed using the modified Fortran code HOLE (233) and the 
Python package MDanalysis (234). The analysis was run with default parameters, i.e., an 
end-point radius of 22.0 Å, a search direction of the z-axis perpendicular to the 
membrane, a sample point distance of 0.2 Å, and no center point of the pore specified. 
The program uses the following van der Waals radii: 1.85 Å for carbon atoms, 1.65 Å for 
oxygen atoms, 2.00 Å for sulfur atoms, 1.75 Å for nitrogen atoms, 1.00 Å for hydrogen 
atoms, and 2.10 Å for phosphorus atoms. All trajectories were divided into 1 ns snapshots 
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that were then supplied to HOLE. The program output the pore radius as a function of 
position along the pore axis. To ensure faster calculation, only the TMDs and some of 
the surrounding lipids were included in the analysis. Finally, we employed a modified 
radius of gyration (RG) method to analyze the splaying of the TMDs. While normally RG 
is a three dimensional quantity, here we only considered the in-plane (x and y) 
distribution of the protein-backbone atoms. The trajectories were aligned along the z-axis 
prior to measuring the modified RG. 
2.2.4. Preparation of oocytes and cRNA.  
Mutant constructs of human CFTR were generated using site-directed mutagenesis via 
the Quikchange protocol (Agilent Technologies, La Jolla, CA) of the original (wildtype) 
WT-hCFTR gene in the pGEMHE vector (graciously provided by Dr. D. Gadsby, 
Rockefeller University). Mutations were confirmed by sequencing the entire open 
reading frame before cRNA generation. A 2−10 ng aliquot of CFTR cRNAs was injected 
into Xenopus laevis oocytes, and incubation occurred at 17 °C in modified Liebovitz’s 
L-15 media supplemented with HEPES (pH 7.5), penicillin, and streptomycin. Oocytes 
were typically incubated between 48 and 96 h after cRNA injections before recording. 
Animal handling methods and oocyte collection are in accordance with National Institute 
of Health (NIH) guidelines, as well as with protocols approved by the Institutional 
Animal Care and Use Committee (IACUC) of Emory University.  
2.2.5. Electrophysiology.  
Oocytes were shrunk in hypertonic solution; then, the vitelline membrane was manually 
removed. Pipettes used for inside-out macropatch recordings were pulled from 
borosilicate glass (Sutter Instrument Co., Novato, CA) and had resistances between 1 and 
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2 MΩ after being filled with chloride-containing pipet solution: 150 mM NMDG-Cl, 5 
mM MgCl2, 10 mM TES (pH 7.5). To activate surface-expressed channels, the 
cytoplasmic side of excised patches was exposed to solution containing the following: 
150 mM NMDG-Cl, 1.1 mM MgCl2, 2 mM Tris−EGTA, 10 mM TES, 1 mM MgATP 
(adenosine 5′-triphosphate magnesium), and 1 μL/mL (127.6 U/mL) of PKA (pH 7.5). 
All macropatch recordings, at RT (22−23 °C), were performed using an Axopatch 200B 
amplifier operated by pClamp 8.2 software; data were filtered at 100 Hz with a four-pole 
Bessel filter and acquired at 2 kHz. The following voltage protocol was applied every 5 
s: hold at Vm = 0 mV, then step to +100 mV for 50 ms followed by a ramp down to −100 
mV over 300 ms prior to returning to 0 mV. 
2.2.6. Source of reagents.  
The medium L-15 was obtained from Gibco/BRL (Gaithersburg, MD), and the PKA 
catalytic subunit was obtained from Promega (Madison, WI). Stock CFTRinh172 was 
initially prepared as 50 mM in Dimethyl Sulfoxide (DMSO). All chemicals were diluted 
to the stated final concentration in recording solution immediately before use. 
2.2.7. Statistical analysis.  
Unless noted in the figure legend or body of text, statistical analysis values are the mean 
± SEM. For data, a t-test for unpaired or paired measurements in Sigmaplot 12.3 (San 
Jose, CA) was used to evaluate statistical significance; only values of P < 0.05 were 
considered significantly different as denoted as follows: represented by * are values of P 





2.3.1. MDFF fitting of the homology model to the cryo-EM map of crystallized 
CFTR.  
Many groups have tried to circumvent the previous lack of structural knowledge by 
making homology models of CFTR using structures of closely related ABC transporters 
(159, 161-165, 235), including one from our work (130). To refine the Rahman et al. 
homology model (130), molecular dynamics flexible fitting (217) simulations were run 
on the outward-facing structure, which resulted from 10 ns of targeted MD (130), 
utilizing the 9 Å resolution cryo-EM map of wild-type human CFTR from Rosenberg et 
al. (157). The map may represent an artificially stabilized state of CFTR due to its 
crystallization (223), which differs from the single-particle cryo-EM used for the higher 
resolution structures recently released (48, 126-128); nonetheless, it is used here, as it 
represents a physically possible conformation that can aid improvement of existing 
homology models. Furthermore, all cryo-EM maps to date have been determined for 
CFTR in detergent, which may also alter its accessible conformations. MD simulations 
of a cryo-EM determined or fitted CFTR in a native-like membrane can allow it to relax 
to a more physiologically relevant state. Two approaches were used in fitting the Rahman 
et al. homology model to the map. In the first approach, we imposed crystallographic 
conditions matching the dimensions of the cryo-EM map, i.e., 12 copies of the protein 
with crystallographic symmetry restraints between them (see Methods). In the second 
approach, a single copy of CFTR was fit to a spatially averaged map provided by R. Ford 
(personal communication). Thus, two fitting approaches produced two new 
conformations of the homology model; we will refer to the first as the “crystallographic-
fit model” and the second as the “averaged-fit model”, named after the corresponding 
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maps to which they were fit. As mentioned above, the homology model was built with 
constraints on experimentally supported interactions specific to the open state of CFTR 
(130). The fitting of the model to either map lost one to three of these interactions (Table 
2.1), although the map may represent a transient closed state of CFTR (223). In the 
crystallographic-fit model, S341, a pore-lining residue near the gate/selectivity filter of 
CFTR (152), is in close proximity to TM12 residues L1135 and N1138, which is 
characteristic of the closed state (see Figure 2.1). It should be noted that the 2D protein 
crystals used to determine the cryo-EM map were composed of nonphosphorylated 
CFTR in the absence of ATP (157), yet both phosphorylation and ATP binding are 
necessary for the opening of the channel (106, 112, 236-238). Therefore, it is not 
surprising that fitting an open-state homology model of CFTR to the cryo-EM map 
effectively “closed” the channel in the absence of ATP. In this pose, the NBDs are 
dimerized despite the lack of ATP, possibly a consequence of the 2D crystal packing in 
the cryo-EM experiments (157). However, this pose of CFTR may represent a 
physiological state of CFTR wherein the NBDs transiently interact, but the interaction of 
the NBDs without ATP is not sufficiently stable to open the CFTR pore (239, 240); this 
state may be equivalent to the “strained transitional” closed conformation described by 
Rahman et al., which is permissive to opening but not yet open (130). The idea of an 
intermediate closed state has also been recently proposed by Simhaev et al.  (223). In that 
study, two homology models of CFTR, those from Corradi et al. (162) and from Dalton 
et al. (164), were flexibly fitted into the Rosenberg et al. cryo-EM map (157) and 
simulated in the apo-ATP state. Analysis of the MD simulations of these new models 
also demonstrated a lack of pore formation in the absence of ATP. This suggests that 
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ATP binding to the NBDs stimulates significant conformational changes to enable pore 
formation.  
  
Table 2.1: Experimentally validated interactions in the original homology model 
and fitted structures. Numbers in brackets are references for the listed interactions.
[1] M. Mense, P. Vergani, D. M. White, G. Altberg, A. C. Nairn, and D. C. Gadsby. In vivo 
phosphorylation of CFTR promotes formation of a nucleotide-binding domain heterodimer. EMBO J., 
25:4728–4739, 2006. 
 [2] A. Billet, J. P. Mornon, M. Jollivet, P. Lehn, I. Callebaut, and F. Becq. CFTR: effect of ICL2 and 
ICL4 amino acids in close spatial proximity on the current properties of the channel. J. Cyst. Fibros., 
12:737– 745, 2013. 
 [3] J. F. Cotten and M. J. Welsh. Cystic fibrosis-associated mutations at arginine 347 alter the pore 
architecture of CFTR: Evidence for disruption of a salt bridge. J. Biol. Chem., 274:5429–5435, 1999.  
[4] G. Cui, Z.-R. Zhang, A. R. W. O’Brien, B. Song, and N. A. McCarty. Mutations at arginine 352 alter 
the pore architecture of CFTR. J. Membr. Biol., 222:91–106, 2008. 
 [5] E. Y. Chen, M. C. Bartlett, T. W. Loo, and D. M. Clarke. The 508 mutation disrupts packing of the 








Figure 2.1: Cartoon depictions of our two MDFF-fitted structures 
(“crystallographic” on the left and “averaged” on the right) and the Rahman et al. 
homology model that served as the starting point for MDFF. The domains are 
colored as follows: NBD1, pink; NBD2, blue; TMD1, gray; TMD2, green. A slight twist 
of the NBDs relative to the original model is indicated by the gray rectangles in the 
refined models. The additional curvature of TMs 7 and 8, as compared to the homology 
model, is highlighted by the purple rectangles. The pink circle magnifies the proximity 
of residue S341 (pink) on TM6 and L1135 (blue) and N1138 (yellow) on TM12. 
Reference: K. S. Rahman, G. Cui, S. C. Harvey, and N. A. McCarty. Modeling the conformational 





2.3.2. ATP-stabilized dimerization of NBDs is improved in fitted models as 
compared to the original homology model. 
A wealth of evidence indicates that CFTR channel opening is preceded by ATP-stabilized 
dimerization of the NBDs (241, 242). This was supported by targeted molecular 
dynamics simulations of the Rahman et al. homology model (130), which described a 
conformational wave starting with dimerization of the NBDs and leading to pore dilation. 
Our initial models generated from MDFF feature loosely dimerized NBDs, while the 
TMDs present a closed channel. We reasoned that simulating these models in the 
presence or absence of ATP may allow us to observe conformational changes relevant to 
channel gating of CFTR. To identify novel fitting-induced behavior, we simulated three 
distinct initial models, namely, the original Rahman et al. homology model (130) as well 
as our two MDFF-derived models. For each of these models, we generated the following 
three states: “bound” (two ATP docked between the NBDs; see Methods), “semi” (one 
ATP at the noncanonical binding site), and apo (no ATP). Thus, a total of nine states 
were each simulated for at least 100 ns. The dimerization of the NBDs has been 
quantified as the distance between the centers of masses of the NBDs and has been plotted 
for the bound simulations in Figure 2.2. Docking of ATP at both sites led to tighter NBD 
dimerization in both the averaged- and crystallographic-fit models when compared to the 
original homology model. Simulations of P-glycoprotein have led to the hypothesis that 
the adenine moiety of each ATP forms stabilizing hydrophobic interactions with the X-
loop of an NBD (243). We see similar interactions between the X-loop of NBD1 and the 
ATP in the consensus site in the simulation of the crystallographic-fit model but not the 
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averaged-fit model; such an interaction is also seen in the cryo-EM structure of ATP-
bound hCFTR (128). In neither case were interactions between the X-loop of NBD2 and 




Figure 2.2: Plot of NBD-NBD distance for the three different CFTR homology 
models simulated with ATP bound. The separation was calculated by taking the 
difference in centers of mass of the α-carbons in each NBD. Both refined models, 
averaged and crystallographic, display tighter NBDs dimerization than the original 
Rahman et al. homology model. The dashed line and the solid line each represent a 
different trial.   
Reference: K. S. Rahman, G. Cui, S. C. Harvey, and N. A. McCarty. Modeling the conformational 




2.3.3. Analysis of simulations shows the development of a partial pore in the 
crystallographic-fit model.  
It is expected that ATP binding at both sites will induce the opening of a pore in CFTR 
(244, 245). We searched for such a pore in the three models with the program HOLE 
applied every 1 ns to our simulation trajectories (233). Even though a fully conducting 
pore (radius larger than 1.8 Å across the entire length of CFTR) could not be seen in any 
of the nine systems within 100 ns, partial pore opening was observed for the 
crystallographic-fit model when compared to the original model but not for the averaged-
fit model. To facilitate observing possible differences between the models, the pore 
radius near the residue F337 at the extracellular vestibule, which is one helical turn 
beyond S341 and noted as a bottleneck previously (157), was used for comparison 
(Figure 2.3). Upon simulating the original Rahman et al. homology model (130) with the 
addition of ATP, the originally reported pore quickly collapsed near F337 with a radius 
below 2 Å; however, a consistent increase in pore radius in the ATP-bound state of the 
crystallographic-fit model was observed during the simulation. This increase in pore 
radius is due to a coupled motion of TMs 9 and 12. In the simulation of the averaged-fit 
model, TM9 starts farther from the protein center, which allows TM12 to collapse 
inward, preventing the formation of a pore (see Figure 2.5). Repeated 100 ns runs of the 
bound and apo states for each model produced similar results (see Figure 2.4). The pore 
analysis also revealed alternative pathways through the extracellular region of CFTR. For 
example, the pathway described in Rahman et al. (130) was between residue S341 and 
T1134 on TMs 6 and 12, whereas, in our simulation of the crystallographic-fit model, a 





Figure 2.3: Pore analysis of the three different CFTR homology models simulated 
in ATP-apo (black), ATP semibound (green), and ATP-bound states (blue). The 
pore radius plotted for each model was evaluated near F337. The dashed line indicates 
the radius of a chloride ion (1.8 Å). Only the crystallographic-fit model shows widening 
in both bound and semibound states. See Figure 2.4 for repeated runs of the bound and 





Figure 2.4: Pore analysis of the second runs of the three different CFTR homology 
models in ATP-apo (black) and ATP-bound states (blue). The pore radius plotted 
for each model was evaluated near F337. The dashed line indicates the radius of a 
chloride ion (1.8 Å). Only the crystallographic-fit model shows widening in both bound 




the findings based upon both the Mornon et al. (165) and Corradi et al. (162) homology 
models. Additionally, the Corradi study reported two lateral tunnel openings forming at 
the NBD and ICL cytoplasmic clefts. Multiple water-accessible pathways are also 
consistent with results of 0.1−1.2 μs-long simulations of both secondary and primary 
active transporters, which are found to be generally leaky for water (246). In the 
simulation analysis described above, the radius of the partial pore formed depends greatly 
on the positions of side chains, and thus, the precision of the pore reported may exceed 
the accuracy of the CFTR homology model. Therefore, an alternate metric was developed 
to focus on the outer radius of the channel. This metric, akin to a two-dimensional radius 
of gyration, RG (see Methods), is plotted in Figure 2.6. A higher RG value is indicative of 
more splayed TMDs, which may correlate with a more open pore in CFTR (247, 248). 
 
Figure 2.5: Comparison of the averaged-fit (red) and crystallographic-fit (green) 
models for the first run of each. (A,B) Comparison at 0 (A) and 100 ns (B) viewed 
from the membrane plane (the intracellular side is on the bottom). TM9 is indicated. 
(C,D) Comparison at 0 (C) and 100 ns (D) viewed from the extracellular side. TM9 and 




We partitioned the TMDs along the channel axis into three slices, each including two to 
three turns of the TM helices, and measured RG for each over all of the 100 ns simulations 
(data points taken every 0.2 ns). We then asked whether any of the simulations exhibited 
time-dependent changes in RG that would be consistent with channel opening as the pore 
domain of CFTR shifts from inward-facing to outward-facing. Only RG for the simulation 
of the crystallographic-fit model showed substantial dependence on the ATP occupancy 
state in two independent runs. This dependence is most pronounced for the slice most 
distant from the membrane on the extracellular side, shown in Figure 2.6 and Figure 2.7, 
as may be expected (RG for the other two slices are given in Figure 2.8).  
 
Figure 2.6: Radius of gyration (RG) analysis for the three CFTR homology models 
simulated in ATP-apo, ATP-semibound, and ATP-bound states. (upper left) 
Cartoon representation of the TMDs of the crystallographic-fit CFTR (extracellular side 
at the top). The TMDs have been divided on the basis of their position along the pore 
axis into three sections. RG for the upper section (yellow) is plotted here for the indicated 
structures, and the middle (gray) and bottom (blue) sections are plotted in Figure 2.7 
and 2.8. The crystallographic-fit model shows significant widening for the uppermost 





Figure 2.7: Radius of gyration (RG) vs. time for slice 1 from the second runs of the 
Rahman et al. homology (A), averaged-fit model (B), and crystallographic-fit 






Figure 2.8: Radius of gyration (RG) vs. time for slices 2 and 3 from the first runs 
of the Rahman et al. homology model (A,B) and averaged-fit model (C,D).  
Reference: Rahman, K. S., Cui, G., Harvey, S. C., and McCarty, N. A. (2013) Modeling the 
Conformational Changes Underlying Channel Opening in CFTR. 8, e74574. 
 
Figure 2.9: Radius of gyration (RG) vs. time for the first crystallographic-fit run, 
extended to 300 ns. The graphs labeled Slice 1-3 correspond to the colored sections of 
the figure in the top left. 
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2.3.4. Extended simulations of the crystallographic-fit model display a complete pore 
in the ATP-bound state. 
Given that only the crystallographic-fit model shows any ATP dependence, both in 
partial pore formation and in adopting a putative outward-facing conformation within 
100 ns, simulations of all three ATP occupancies of this model were extended to 300 ns 
(second runs for the bound and apo states were also extended to 300 ns). The difference 
in RG between the bound state and apo/semi states grew continuously over the entire 300 





Figure 2.10: Pore analysis of the crystallographic-fit model in (A) ATP-bound and 
(B) ATP-apo states after 280 ns of simulation each. TMD1 is shown in gray, 
transparent and TMD2 is in green; NBDs are not shown. In parts A and B, the pore in 
CFTR is shown according to the following color scheme: radius >2.3 Å is blue, 
1.15−2.3 Å is yellow, and <1.15 Å is red. The dashed lines indicate the position of the 
membrane. (C) Plot of pore radius as a function of position along the channel axis 
(normal to the membrane) for both bound (blue) and apo (black) states at 280 ns. The 
shaded area indicates the position of the membrane, and the dashed line at 1.8 Å is the 




longer time scale reveals a complete pore in only the first run of the bound-state model 
at around 280 ns (Figure 2.11), albeit one that is still watertight on the intracellular side 
at the level of the tetrahelix bundle (235). At the same 280 ns time point, the apo state 
shows a different, mostly closed pathway (radius of 1−1.5 Å; Figure 2.10), which 
diverges laterally at the intracellular side of the membrane. The physiological relevance 
of this lateral pathway for exiting ions, if any, is uncertain. The second run of the bound 
state also displays an expanded pore in the transmembrane region, although not a 
complete one (see Figure 2.11). The pore is lined by TMs 4−9 and 12 at various points 
along its path through CFTR; structurally, it forms due to a radially outward shift of TMs 
7−9 and 12 (Figure 2.12). The pore is continuously solvated, but we never observe an ion 
 
Figure 2.11: Pore analysis of the second 300-ns runs of the crystallographic-fit 
model in (A) ATP-bound and (B) ATP-apo states. TMD1 is shown in grey, 
transparent and TMD2 is in green; NBDs are not shown. In (A) and (B), the pore in 
CFTR is shown according to the following color scheme: radius > 2.3 Å is blue, 1.15-
2.3 Å is yellow, and < 1.15 Å is red. The dashed lines indicate the position of the 
membrane. (C) Plot of pore radius as a function of position along the channel axis 
(normal to the membrane) for both bound (blue) and apo (black) states at 300 ns. The 
shaded area indicates the position of the membrane, and the dashed line at 1.8 Å is the 




inside of it. Arginines, such as R303, R933, R347, and R1128, are present in the pore, 
which could provide a favorable electrostatic environment for chloride ions. However, 
the radius is only slightly above the 1.8 Å threshold for a desolvated chloride ion for 
much of its length, and therefore, we do not expect it to be conductive yet. On the basis 
of a comparison of the ATP-apo and ATP bound states, we hypothesize a causal chain of 
events leading to channel opening: (1) binding of ATP induces a tighter association of 
the NBDs (Figure 2.12), (2) the ATP-bound NBDs stabilize the ICLs (Figure 2.12), (3) 
the close association of NBDs and ICLs permits additional interactions, e.g., the observed 
 
Figure 2.12: Differences between ATP-bound (green) and ATP-apo (orange) states 
of CFTR. Structures are taken after 280 ns of the first run starting from the 
crystallographic-fit model (see also Fig. 2.10). (A) NBDs viewed from the cytoplasm. 
ATP molecules in the bound state are shown in purple. (B) ICLs viewed from the 
cytoplasm in the same orientation as the NBDs in (A). The bottom of TM9, connected 
to ICL3, is also indicated. (C) Side-view of ICLs (bottom) and TMDs with one of the 
discovered salt bridges highlighted. (D) TMDs viewed from the extracellular side. The 




salt bridge between E543 (NBD1) and K968 (ICL3), which shifts the position of TM9, 
among others (Figure 2.12), and (4) this shift of TMs at the cytoplasmic side induces a 
corresponding one at the extracellular side, opening a pore (Figure 2.12).  
2.3.5. Comparison of the Crystallographic-Fit Model with a Recent 3.2 Å Resolution 
Outward-Facing Human CFTR Structure. 
The recent advancements in the field of single particle cryo-EM have led to multiple 
structures of CFTR in the resolution range 3−4 Å in different conformations. We compare 
our crystallographic-fit model to the phosphorylated, ATP-bound outward-facing 
conformation of hCFTR, which surprisingly did not possess an open pore as expected 
(128). We found an overall root-mean-square deviation for the backbone of 5.8 Å. In 
equilibrium MD simulations, fluctuations of 2−4 Å from a crystal structure are regularly 
observed, e.g., as seen for ABC transporters Sav1866 and MsbA (249, 250); while 5.8 Å 
is beyond these observations, it should be noted that both structures may represent 
distinct physiological states. Many features of the ATP-bound outward-facing structure 
of hCFTR (128) align with our crystallographic-fit model of human CFTR, such as the 
bending of TM6 at residue V350. While the positions of most of the TMs in the 
crystallographic-fit model match the 3.2 Å resolution structure closely, TM 6 is 
noticeably shifted in the crystallographic-fit model (RMSD 6.5 Å; see Figure 2.13). This 
is most likely due to the arrangement of TMs 7 and 8. TM8 in the hCFTR structure is 
broken into three short helices, a feature only seen in the recently published structures of 
CFTR (48, 126-128) and not found in structures of related ABC transporters. The helical 
portion of TM8 located at the extracellular side occupies a more central position within 





Figure 2.13: Structural comparison of the outward-facing hCFTR structure (PDB 
ID 6MSM) in orange and the hCFTR outward-facing crystallographic-fit model in 
blue. (A) Aligned structures. The root-mean-square deviation between the structures is 
5.8 Å. (B) The alignments of TM6, TM7, and TM8 are highlighted to show major 
differences. 
 
Figure 2.14: Comparison between the Rahman et. al. homology model (blue) and 
closed-state cryo-EM structure of human CFTR (orange; PDB 5UAK). The full 
structures are shown in (A) and TMs 6, 7, and 8 are highlighted in (B). 
Reference: K. S. Rahman, G. Cui, S. C. Harvey, and N. A. McCarty. Modeling the conformational 
changes underlying channel opening in CFTR. PLoS One, 8(9):1–13, 2013). 
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relevance of this broken TM8 is still being investigated, especially through MD 
simulations (167). Similar differences are seen in comparing the closed-state homology 
model of Rahman et al. (130) with the 3.9 Å resolution structure of inward-facing hCFTR 
as well (Figure 2.14) (126). Despite these positional differences in the TMDs, the 
agreement between the ICLs and NBDs after alignment of the whole structure and model 
is better, with the ICLs having an RMSD of 4.2 Å and the NBDs 3.7 Å for the outward-
facing structures. To further validate the crystallographic-fit model, three key open-state 
salt bridges were examined, namely, R347−D924 (147), R352−D993 (146, 251), and 
E267−K1060 (47). All three pairs form salt bridges in the outward-facing hCFTR 
structure (128). In simulations of the bound state of the crystallographic-fit model, a salt 
bridge between R347 and D924 is only seen once in 300 ns in one run, one between R352 
and D993 forms for the first 30 ns in one run and is stable over 300 ns in the other, and, 
finally, one between E267 and K1060 is present over nearly the entire 300 ns of one run 
and the first 110 ns in the other. In contrast, in Simhaev et al., all pairs of residues are 
within 2.5−6 Å over the course of 20 ns MDFF runs (223). These interactions, identified 
in many CFTR homology models (130, 159-162, 164, 252), have been validated through 
rigorous electrophysiology studies (146-148). Specifically, the first two interactions, 
R347−D924 and R352−D993, have been characterized, especially in our work (146, 
148). Interestingly, the last of these interactions (E267 and K1060) was found via 
homology modeling and was subsequently verified experimentally (161, 235). Charge-
reversal mutation of either residue lowers the opening rate of CFTR in response to ATP 
but not the stability of the open state, suggesting that the interaction plays an important 
role in maintaining the architecture of the ATP binding site in the apo state (235). In 
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addition, K1060 is the site of a disease-associated mutation (K1060T) (253). Although 
this interaction was initially discovered on the basis of homologous residues in the 
prokaryotic transporter MsbA, a multiple sequence alignment of these regions shows that 
these residues are unique to CFTR among ABCC proteins (see Figure 2.15).  
 
 
Figure 2.15: Sequence alignment of CFTR and related proteins. The sequence 
segments in the alignment correspond to ICL2 (top) and ICL4 (bottom). Residues E267 
and K1060, which appear to contribute to a salt bridge, are highlighted in red.  
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2.3.6. Identification and Experimental Validation of a Salt Bridge between ICL3 and 
NBD1. ABC transporters use flexible loop motifs to couple their domains, two of which 
are the Q- and X-loops. The Q-loop is adjacent to the ATP binding site and is known to 
facilitate NBD−NBD dimerization upon ATP binding as well as NBD−ICL coupling 
(254). It has also been suggested that one byproduct of the ΔF508 mutation is a 
conformation of the Q-loop that inhibits NBD dimerization (255). The X-loop is a 
flexible motif present at the interface between the NBDs and the ICLs, the latter of which 
are each composed of two long helices and one short helix arranged in a horseshoe shape 
(Figure 2.12) (256). The flexible Q- and X-loops are contact points to the ICLs and likely 
play an important role in conferring motion from the NBDs to the TMDs. In simulations  
 
 
Figure 2.16. Snapshot of the bound crystallographic-fit trajectory after 200 ns 
(top), focusing on the interface between NBDs and ICLs (bottom). The domains of 
CFTR are labeled accordingly, and E543, K968, and K1292 are shown as sticks and 
colored by residue type (acidic in red and basic in blue). 
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of the crystallographic-fit model, E543 of NBD1 (X-loop) forms alternating salt bridges 
with K968 (ICL3) and K1292 of NBD2 (Q-loop); all three residues are shown in Figure 
2.16. The former interaction has been observed in other homology models (130, 163) but 
not the latter. Over the 300 ns simulations of the bound state, E543 formed a salt bridge 
with K968 36% of the time (73% in the second run) and with K1292 26% of the time 
(0% in the second run; Figure 2.17). In one of the ATP-bound simulations, E543 
appeared to alternate between interacting with K968 and K1292. The E543−K968 salt 
bridge was also present in the semi-bound simulation (80%) and for part of one of the 
apo simulations (37%), prior to the separation of the NBDs. The E543−K1292 salt bridge 
was only observed near the end of one of the apo simulations and was not observed at 
all in the semi-bound simulation. To determine the functional relevance of the 
E543−K968 and E543−K1292 salt bridges, the behaviors of CFTR channels bearing 
mutations at these sites were recorded in electrophysiology experiments. The single 
mutants E543Kand K968A-CFTR exhibited a significantly longer (E543K) or slightly 
shorter (K968A) mean activation time—defined as the time required for currents to reach 
a plateau in response to ATP + PKA—as compared to WT-CFTR (Figure 2.18). The 
mean activation time for the charge swapped double mutant (E543K/K968E-CFTR) was 
similar to WT-CFTR channels, exhibiting rescue. Even though the single mutant 
K1292E-CFTR had a mean activation time similar to WT-CFTR, the K1292E mutation 
 in conjunction with the E543K mutation, as a charge swapped double mutant, partially 
rescued the long mean activation time seen in the E543K-CFTR mutant (Figure 2.18). 
While both charge-swapped double mutants E543K/ K1292E- and E543K/K968E-





Figure 2.17: Salt-bridge distances over time for the crystallographic-fit ATP-
bound simulation. Three experimentally verified salt bridges are tracked over time in 
(A) run 1 and (B) run 2. (C) Two salt bridges newly discovered and experimentally 
confirmed here for both runs. 
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latter has a greater effect (Figure 2.18). These data suggest that E543 interacts with both 
K968 and K1292. It should be noted that, for CFTR to transition from the closed to the 
open state, the R-domain must be phosphorylated. Although the homology model in our 
simulation does not contain the R-domain, there are many other steps necessary for the 
transition that could be observed. To investigate the effects of these residues on the 
opening of CFTR after phosphorylation, we explored the reactivation of CFTR channels 
with ATP alone. For this experiment, we used the following protocol: WT-CFTR and 
 
 
Figure 2.18: Mean activation time changed in mutants compared to wt-CFTR. 
Sample traces of inside-out macropatch currents of (A) WT-, (B) E543K-, (C) K968A-
, (D) E543K/K968E-, (E) K1292E-, and (F) E543K/K1292E-CFTR recorded under the 
experimental conditions listed in the panels. Control, 150 mM Cl− intracellular solution; 
INH172, 10 μM CFTRinh172. (G) Summary data for mean activation time for WT and 
mutants. Statistical data are as follows: n = 30 for WT; n = 11 for E543K; n = 7 for 
K1292E; n = 18 for K968A; n = 11 for E543K/K968E; n = 10 for E543K/K1292E. ***, 
P < 0.001 compared to WT; **, P < 0.01 compared to WT-CFTR. 
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mutated channels the  by 127.6 U/mL PKA and 1 mM MgATP; channels were allowed 
to close briefly by washout of ATP and PKA; channels were then reactivated by addition 
of 1 mM MgATP alone; channels were then deactivated again by washout of ATP 
(Figure 2.19). We attempted to fit both the reactivation and deactivation rates of the WT-
CFTR channel, the single E543K- mutant, the single K968A- mutant channel, and the 
E543K/K968E-CFTR double mutant channel. However, mutation at these residues 
caused the macroscopic opening and closing transitions, upon applying or washing out 
 
 
Figure 2.19: 1 mM MgATP reactivated WT and mutant CFTR after channels were 
fully activated by ATP + PKA. (A) WT-CFTR was fully activated with 1 mM MgATP 
and 127.6 U/ml PKA, deactivated by removal of ATP and PKA using control solution, 
and then reactivated by 1 mM MgATP alone. Representative current traces for E543K 
(B), K968A (C), and E543K/K968A-CFTR (D) were recorded with the same 
experimental conditions as WT-CFTR. Summary data are shown in E. Y axis indicate 
the ratio of maximum current in ATP alone (I(ATP)) divided by maximum current in ATP 
and PKA (I(ATP+PKA)). Statistical data are follows: n=4 for WT; n= 6 for E543K; n=8 for 
K968A; n=6 for E543K/K968E. **, P < 0.01 compared to WT.  
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ATP, to be quite irregular, compared to the behavior of WT-CFTR channels with the 
same protocol, making quantitative fits impossible (Figure 2.20). In spite of this inability 
to quantify, it is nonetheless evident that disrupting the interaction between E543 and 
K968 greatly perturbs the macroscopic channel behavior such that neither single nor 
double exponentials efficiently fit the reactivation data; however, the double 
E543K/K968E mutant began to restore WT macroscopic behavior. The combined 
electrophysiology data lead us to conclude that the K968−E543−K1292 triad contributes 
to the transition from the closed state to the open state. The charge-swapping double 
mutations were unable to completely rescue WT-CFTR channel behavior, suggesting 
that all three residues interact during gating. Another possibility is that, due to instability 
of the loop, any mutation may alter its structure. This same phenomenon was previously 
seen for electrostatic interactions in extracellular loop 1 (251). The final remaining 
question we addressed was whether these interactions also contribute to the steady-state 
channel function after CFTR is fully activated. Comparing the steady-state behavior to 
WT-CFTR channels, K968A-CFTR channels behaved very similarly, with regular 
closed and open states, a very rare subconductance state, and similar mean burst 
durations (Figure 2.21). Moreover, K968A-CFTR exhibited a significantly lower open 
probability as compared to WT-CFTR, which is supported by a previous study (235). 
These data suggest that the above electrostatic interactions contribute very little in 
modulating the steady-state behavior of CFTR channels and may contribute mostly to 






Figure 2.20: Representative fits of the ATP-induced activation of phosphorylated 
CFTR and deactivation after washout of ATP. All activation and deactivation data 
were fit in Igor using a double exponential (without an X-offset), as follows: (A) WT-
CFTR activation, (B) WT-CFTR deactivation, (C) K968A-CFTR activation, (D) 
K968A-CFTR deactivation, (E) E543K-CFTR activation, (F) E543K-CFTR 
deactivation, (G) E543K/K968E-CFTR activation, and (H) E543K/K968E-CFTR 
deactivation. The differences between the raw data and the double exponential fit were 
calculated and plotted above each fit. Goodness of fit was also analyzed by Chi-square 
value. The activation traces for each single mutant (K968A-CFTR or E543K-CFTR) 
were impossible to fit using a double exponential function; however, the double mutant 
(E543K/K968E-CFTR) seems to partially restore to WT-CFTR channel behavior, 





Figure 2.21: K968A exhibited similar single-channel behavior to WT-CFTR. (A) 
Representative Single channel current traces of WT- and K968A-CFTR were recorded 
using inside-out patch with 150 mM Cl− intracellular solution in the presence of 1 mM 
MgATP with 127.6 U/ml PKA at membrane potential -100 mV. (B) Open probability 
of K968A is significantly lower than WT-CFTR. (C) K968A exhibits similar mean burst 
duration as WT-CFTR (WT-CFTR data cited from previous publication Cui, G., 
Rahman, K. S., Infield, D. T., Kuang, C., Prince, C. Z., and McCarty, N. A. (2014) 
Three charged amino acids in extracellular loop 1 are involved in maintaining the outer 
pore architecture of CFTR. The Journal of General Physiology 144, 159-179 . N=5 for 





Recent advancements in the field of cryo-EM have led to an influx of new structures at 
higher resolutions than previously attainable without relying on crystallization. Within 
the last three years, four structures of CFTR have been published using single-particle 
cryo-EM techniques (48, 126-128). These structures have provided valuable information 
on the closed state and the conformational changes induced by phosphorylation and ATP 
binding; however, none of them, including the outward-facing structures, displays a 
complete conducting pore. It is possible that the ATP-bound zebrafish and human CFTR 
structures both represent a state similar to the aforementioned “strained transitional” state 
of CFTR (130), and additional signals or steps are required before a pore will form on a 
much longer time scale than simulated here. Such putative transitional states of CFTR 
can be explored with MD simulations, combined with experimental confirmation of key 
interactions observed. Before the release of the four 3−4 Å resolution cryo-EM structures 
of CFTR, several homology models were built to ameliorate the dearth of structural 
information. Here, we refined one of those models from Rahman et al. (130) by flexibly 
fitting it to two versions of a low-resolution cryo-EM map (157), one with the full 12-
fold crystallographic symmetry of the map and one averaged to a single copy. We found 
that fitting to the crystallographic map produced a more functionally relevant model than 
fitting to the averaged map, likely due to the maintenance of the crystal contacts, which 
further restrict fluctuations at a resolution below that of the map itself. Our study 
complements that of Simhaev et al. (223), who used the same map to refine two 
homology models of CFTR from Corradi et al. (162) and from Dalton et al. (164). Fitting 
was followed by simulations of each model for at least 100 ns in different ATP-
81 
 
occupancy states. Similar to Simhaev et al. (223), we observed that even without ATP 
the NBDs collapse. When comparing the ATP-bound states simulated here, we found 
that the crystallographic-fit model exhibits increased NBD dimerization when compared 
to the original homology model as well as the opening of a partial pore at F337. The 
radius of gyration also shows a significant widening of the extracellular side of the 
protein in the crystallographic-fit model in the ATP-bound state compared to the apo 
state. Upon extension of the simulations from 100 to 300 ns, the crystallographic-fit 
model revealed the formation of a complete pore at 280 ns of one run (Figure 2.10) and 
an expanded partial pore in the other run (Figure 2.11), similar to the pore identified in 
other homology models (165). We note that, although the existence of a pore is a 
promising sign, the simulations are still far from converged, which would require a time 
scale orders of magnitude larger to fully describe CFTR’s gating cycle. We also 
compared our crystallographic-fit model to the outward-facing hCFTR structure (128). 
We found that some elements of CFTR aligned moderately well between our 
crystallographic-fit model and the hCFTR structure, such as the ICLs (RMSD 4.2 Å) and 
NBDs (RMSD 3.7 Å). However, the structural differences in the TMDs are greater. 
These differences most likely stem primarily from a kink in TM8 seen only in the recently 
published structures of CFTR but not represented in CFTR structures resolved under 
different conditions (171). However, as mentioned previously, the outward-facing 
structure of hCFTR could represent a “strained transitional” state and, thus, has possibly 
not yet signaled for pore formation. These transitional states can be further characterized 
through MD simulations and confirmed through experimentation. In addition to the 
transition from a strained state to one with a pore over the 300 ns simulation of the 
82 
 
crystallographic-fit model, salt bridges were observed between E543 in the X-loop of 
NBD1 and K968 in ICL3 as well as between E543 and K1292 in the Q-loop of NBD2. 
These interactions, although previously suggested by other homology models (130, 163), 
have not been experimentally tested until now. Mutagenesis and electrophysiology show 
that disrupting the E543−K968−K1292 electrostatic triad significantly alters the 
macroscopic rate of channel activation, with E543K having the largest effect (see Figure 
2.18). Therefore, we suggest that this triad is part of a structural relay from the NBDs to 
the TMDs signaling ATP occupancy and leading to pore formation, as observed in the 
simulations. Preliminary experiments suggest that, once signaling has occurred, the 
steady-state behavior is not strictly dependent on the triad. In the outward-facing hCFTR 
structure, neither the E543−K968 nor the E543−K1292 salt bridge is seen, although only 
slight movements of a loop would be required for them to form (side chain distances of 
8.2 and 10.0 Å, respectively). Future simulations and experiments will be used to further 






CFTR EXPRESSION AND PURIFICATION 
 
3.1. INTRODUCTION.  
CFTR, only expressed in vertebrates, has a complex biogenesis requiring multiple 
proteins that aid in folding, proper insertion into the membrane, and post-translational 
processing of CFTR (58, 63, 257). Because of the complexity of CFTR biogenesis, the 
cell type chosen for CFTR expression for purification and location of the affinity tag is 
critical for a high yield of highly homogenous CFTR. Currently, several cell types are 
being used for CFTR expression and can be dependent upon the CFTR ortholog. Due to 
the complexity and instability of human CFTR, only eukaryotic cells have been used 
successfully in expression for purification. Purification of membrane proteins, especially 
ABC transporters, is highly dependent on the detergent solubilization step, including the 
choice of detergent and method of solubilization (258-260).  CFTR is no different. CFTR 
ATPase function appears to be highly dependent on the detergent used for solubilization 
and stabilization, which cannot be rescued by reconstitution into lipids (133). In this 
chapter, we describe attempts and successes at expression and purification of human 
CFTR in three different cells types—Sf9 (ovary cells of Spodoptera frugiperda), BHK 
(Baby Hamster Kidney cells), and CHO (Chinese Hamster Ovary cells) – evaluating the 
overall quality of protein expression and purification. In the following chapters, CFTR 
function, both ATPase activity and channel function are evaluated.  
3.1.1. Individual contributions.  
3.1.1.1. Sf9 EXPRESSION SYSTEM.   
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The initial CFTR construct for protein expression in the Sf9 cell system was designed by 
Dr. Canhui Li and Dr. Mohabir Ramjeesingh of the Dr. Christine Bear Lab at the School 
of Medicine, University of Toronto, Canada and gifted to Dr. Brandon Stauffer of the 
McCarty Lab at the School of Medicine at Emory University in Atlanta, GA. I was 
initially taught cell culture and viral expression techniques for Sf9 cells by Dr. Youngman 
Kwon in the Kang Lab at Georgia State University in Atlanta, GA, and Dr. Nidhi 
Williams of Atlanta, GA. I performed the final bacmid transfection, viral infection, and 
CFTR protein expression from the Sf9 cells. 
3.1.1.2. BHK EXPRESSION SYSTEM.   
Stably transfected BHK-CFTR-10xHis cell line was gifted to McCarty Lab by Dr. John 
Hanrahan of the Department of Physiology at McGill University in Montreal, Canada. I 
maintained and designed cell culture protocols for transitioning to suspension culture and 
preformed and optimized protein purification.  
3.1.1.3. CHO EXPRESSION SYSTEM.   
CFTR-3xFLAG-tag construct gifted to Dr. Guiying Cui of McCarty Lab by Dr. Hong 
Joeng of the lab of Dr. Eric Sorscher in the School of Medicine at Emory University. 
Cloning of CFTR-3xFLAG insert into T-Rex™ pcDNA5/TO plus an IRES-CFP vector 
performed by the Custom Cloning Division within the Emory Integrated Genomics Core. 
I developed the stably transfected CHO-CFTR-3xFLAG-ECL4 line, with help from the 
Winship Flow Cytometry Core within the Pediatrics Department at Emory University 
and from Mr. Brian Dobosh (Tirouvanziam lab). Further optimization and protein 
purification was completed by me. 
3.1.2. Publications resulting from this chapter.  
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Optimization of CFTR protein purification will be published in downstream publications, 
as CFTR purification is a new technique to both the McCarty and Schmidt-Krey labs.  
3.2. METHODS.  
3.2.1. Sf9 expression system. 
3.2.1.1. MOLECULAR CLONING FOR hCFTR EXPRESSION IN SF9 CELLS.  
Original plasmid (hCFTR with a c-terminal 10xHis-tag in pFastBacDual) (Figure 3.1) 
was provided by the Bear lab, as noted above. Amplification of plasmid was completed 
by transformation into XL 10-Gold E. coli cells on 75 µg/mL LB agar plates. Plasmid 
(given number pCF340 in the McCarty lab) was purified by miniprep (ZymoPure 
MiniPrep Kit) and CFTR sequence confirmed by full-length sequencing of hCFTR 
(Genewiz©, https://www.genewiz.com/en). Two stabilizing mutations, D110C and 
 
 
Figure 3.1: Plasmid map of WT-hCFTR in pFastBacDual vector. This plasmid was 
used for wt-hCFTR expression in Sf9 cells, but also for the generation of mutant hCFTR 
constructs and expression in Sf9 cells.    
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K892C, were introduced into WT-hCFTR (McCarty pCF546) using the Emory 
Integrated Genomics Core (EIGC). Full-length sequencing of hCFTR constructs were 
completed before the generation of bacmid.   
3.2.1.2. MAINTENANCE OF SF9 CELLS.  
Gibco® Sf9 cells from Invitrogen were thawed quickly in 37°C water bath and 
resuspended in 5 mL of SF-900™ II SFM media. To expand and infect cells, DMSO 
must be removed immediately upon resuspension. To remove DMSO, cells were pelleted 
at 800 g for 5 minutes at RT, and the supernatant removed. Cells were resuspended in 5 
mL of new warmed SF-900™ II SFM media and transferred to 50 mL of media in a 
sterile 250 mL Corning media bottle. Cells were grown in a non-humidified, air-regulated 
incubator at 27°C with a loosened cap, shaking at 150 RPM. Cells were counted using a 
hemocytometer every two days and split at a density of 1 x 107 cells/ mL. To make frozen 
cell stocks, cells were pelleted at 800 g for 5 minutes at RT and then resuspended in 
freezing solution (30% FBS, 10% DMSO, and 60% SF-900™ II SFM media) and frozen 
at a density of 3 x 106 cells/mL to -80°C. Frozen cells were stored in liquid nitrogen.  
3.2.1.3. BACULOVIRUS PRODUCTION.   
A general outline can be seen in Figure 3.2. In accordance with instructions for the Bac-
to-Bac Baculovirus Expression system (Invitrogen™), purified plasmid was transformed 
into DH10Bac E.coli for bacmid production and colonies were screened on LB-agar 
plates with 50 µg/mL kanamycin, 7 µg/mL gentamicin, 10 µg/mL tetracycline, and 100 
µg/mL Bluo-gal and 40 µg/mL IPTG (Blue-white Screening). Colonies were selected 
based on positive blue/white screening, amplified, and purified in accordance with the 
ZR BAC DNA™ Miniprep Kit protocol (Zymo®). Purified bacmid was screened first by 
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PCR amplification of inserted gene followed by full-length sequencing of the WT and 
mutant hCFTR construct (Genewiz©, https://www.genewiz.com/en). Promising 
constructs were used for baculovirus production.  Sf9 cells were plated at ~50% 
confluency in Grace’s Insect Media, Unsupplemented (ThermoFischer™), and incubated 
for 1 hour before transfection. Sf9 cells were transfected for 5 hours at 27°C in Grace’s 
Insect Media, Unsupplemented, using a Bacmid:Cellfectin ratio of 1 (µg) DNA: 8 (µL) 
Cellfectin® II, which was preincubated for 30 minutes at RT.  Cells were allowed to 
recover and produce virus for 72 hours in Sf-900TM II media. Virus-containing media 
was removed, supplemented with 2% FBS (Fetal Bovine Serum), and stored at 4°C 
protected from light (for short-term storage). Viral colonies were selected and purified 
via plaque assay, and then the viral titer was determined also using plaque assay. Briefly, 
cells were plated at ~25% confluency in a 6-well plate and incubated overnight at 27°C 
before treatment with virus for 1 hour at RT. Virus-containing media was removed from 
infected cells, and cells were covered in 1% agarose in 1X Sf-900TM II media solution. 
The plates were incubated at 27°C, humidified until the number of plaque colonies did 
not change over 48 hours; then, viral colonies were either purified or titered. When 
purifying a viral colony, a sterile glass pipette was used to stab the agarose, and the 
agarose plug was transferred to a sterile microcentrifuge tube containing 0.5 mL of SF-
900™ II SFM media supplemented with 2% FBS. This was mixed by vortexing, before 
0.1 mL of plaque purified virus was plated into each well of a 6-well plate containing 
adherent Sf9 cells at 75-80% confluency and incubated for 72 hours. The media was 
collected, and the cell debris was pelleted by centrifugation at 500 g for 5 minutes at RT. 
The supernatant was transferred to a sterile 15 mL conical tube supplemented with 2% 
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FBS and was stored at 4°C away from light. During titering, plaque colonies were stained 
in 0.5 mL Neutral Red solution for 2 hours at RT and solution removed before counting 
colonies. To calculate the titer, the number of plaques per dilution was counted, 
multiplied by the dilution factor and divided by the volume of inoculation virus. 
Amplification of a plaque-purified p1 viral colony started with cells in a 6-well plate (2 
x 106 cells/mL) which were infected at an MOI (multiplicity of infection) of 0.1 before 
being harvested at 48 hours. The cells were pelleted at 500 g for 5 minutes at RT and the 
supernatant was collected (p2 viral stock). The p2 viral stock was stored at 4°C 
supplemented with 2% FBS. The titer of p2 viral stock was determined using the plaque 
assay. For long term-storage, any viral stock was stored at -80°C protected from light.  
 
 
Figure 3.2: Depiction for the overall flow of baculovirus production. The purified 
donor plasmid is transformed into DH10Bac E. coli. Bacteria containing the recombined 
CFTR-containing bacmid will survive antibiotic selection and can be further screened 
using Blue-White screening. CFTR-containing bacmid is transfected into Sf9 cells to 
generate Baculovirus (within media). Baculovirus can be used to infect Sf9 cells for 
CFTR protein production and purification.      
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3.2.1.4. INFECTION OF SF9 CELL SUSPENSION CULTURE.   
Sf9 cells were plated in a 10 cm dish at 1.8 x 107 cells at RT for 30 minutes. The media 
was removed and replaced with SF-900™ II SFM media supplemented with 1% FBS 
before adherent cells were infected at a multiplicity of infection (MOI) of 20 for 48 hours.       
3.2.1.5. PROTEIN EXPRESSION SCREENING VIA WESTERN BLOT ANALYSIS.  
Infected Sf9 cells were pelleted at 1000 g for 10 minutes at 4°C and the cell pellet was 
resuspended in RIPA buffer containing 1x protease inhibitor cocktail (cOmplete EDTA-
free PIC Roche©). Infected cells were lysed on ice for 10 minutes at 4°C, and the cellular 
debris was pelleted at 1000 g for 10 minutes at 4°C. The total protein concentration was 
measured using Pierce™ Bicinchoninic Acid (BCA) microplate assay in accordance with 
the manufacturer’s protocol. Equivalent total amounts of protein (50-150 µg) for each 
sample were mixed with 1x Laemmli sample buffer (prepared in house) supplemented 
with 50 mM DTT (Dithiothreitol) and then incubated at 37°C for 30 minutes. All samples 
and the ladder (Precision Plus Protein™ Dual Color Standards Marker Bio-Rad) were 
loaded into a Mini-PROTEAN® TGX™ precast 4-15% acrylamide: bisacrylamide SDS-
PAGE. The gel was run at 150V for 45 minutes and then transferred overnight at 4°C at 
60 mA onto a nitrocellulose membrane. All blots were blocked in 5% milk in TBST 
(Tris-buffered saline and Tween® 20) for 1 hour at RT, and then stained with 1:1,500 
mouse anti-CFTR 596 antibody in TBST with 5% BSA overnight at 4°C, followed by 
1:1,000 goat anti-mouse antibody conjugated to HRP (Sigma) in TBST with 5% BSA for 
1 hour at RT with three 15 minute washing steps after each antibody stain with TBST. 
Western blotting detection was determined using Amersham™ ECL™ Western Blotting 
Detection reagents, and blots were imaged on a Bio-Rad ChemiDoc™ XRS+ system.  
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3.2.1.6. HIS-TAG ACCESSIBILITY DETERMINATION.   
Infected Sf9 cells were collected by titration and pelleted at 1000 g for 10 minutes at 4°C. 
Cells were resuspended in 0.5 mL Roche Buffer A (50 mM NaH2P04, pH 8.0, 0.3 M 
NaCl) and lysed using a Dounce Homogenizer. Large cellular debris was pelleted by 
centrifugation at 1000 g for 10 minutes at 4°C. The supernatant was prepared for resin-
binding by the addition of DDM and imidazole to make a final concentration of 0.1% 
DDM and 0.5 mM imidazole in Roche A buffer solution. The prepared supernatant was 
mixed with 50 µL Roche© His-resin overnight at 4°C. The resin was “packed” in 
Ultrafree® PVDF 0.5 µm centrifuge filter (Millipore-Sigma®) at 100 g for 1 minute at 
4°C and the flow-through was collected. The resin was washed in 150 µL Roche A 
supplemented with 0.1% DDM and 0.5 mM imidazole. CFTR was eluted from the resin 
with 50 µL Roche B (50 mM NaH2P04, pH 8.0, 0.3 M NaCl, and 0.25 M imidazole) by 
centrifugation at 100 g for 1 minute at 4°C. 
3.2.2. BHK-CFTR-10xHis Expression System. 
3.2.2.1. MAINTENANCE OF BHK-CFTR-10xHIS CELLS.   
BHK cells were stably transfected with recombinant hCFTR containing a 10x His-tag on 
the C-terminal end, as previously described (102). BHK cells were maintained adherently 
by splitting in the range of 1:5 to 1:20 at 100% confluency into DMEM/F12 50:50 
(Dulbecco's Modified Eagle Medium: Nutrient Mixture F-12) plus 10% FBS with 1% 
Penicillin/Streptomycin and 0.5 mM Methotrexate (BHK-CFTR complete media). 
Frozen cell stocks were prepared in 10% DMSO, 30% FBS, and 60% DMEM/F12 50:50 
at a density of 3 x 106 cells/ mL and cooled to -80°C, and then transferred to liquid 
nitrogen for long term storage.  
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3.2.2.2. HIS-TAG ACCESSIBILITY DETERMINATION.   
Cells plated on 10 cm2 plates were collected by trypsinization and pelleted at 1000 g for 
10 minutes at 4°C. The cells were resuspended in 0.5 mL Roche Buffer A (50 mM 
NaH2P04, pH 8.0, 0.3 M NaCl) and lysed using a Dounce Homogenizer. Large cellular 
debris was pelleted by centrifugation at 1000 g for 10 minutes at 4°C. Then the 
supernatant was prepared for resin-binding by the addition of DDM and imidazole to 
make a final concentration of 0.1% DDM and 0.5 mM imidazole in Roche A buffer 
solution. The prepared supernatant was mixed with 50 µL Roche© His-resin overnight at 
4°C. The resin was packed in an Ultrafree® PVDF 0.5 µm centrifuge filter 
(MilliporeSigma™) at 100 g for 1 minute at 4°C and the flow-through was collected. The 
resin was washed in 150 µL Roche A supplemented with 0.1% DDM and 0.5 mM 
imidazole. CFTR was eluted from the resin with 50 µL Roche B (50 mM NaH2P04, pH 
8.0, 0.3 M NaCl, and 0.25 M imidazole) by centrifugation at 100 g for 1 minute at 4°C. 
3.2.2.3. TRANSITION OF ADHERENT BHK-CFTR-10xHIS CELLS TO SUSPENSION 
CULTURE.   
Cells plated on two T75 flasks were grown to confluency. Once confluent, cells were 
washed in PBS and incubated in 0.25% trypsin-EDTA for 90 seconds before being 
removed. The cells were incubated for another 90 seconds before being resuspended in 
12 mL of BHK-CFTR complete media in the same plastic T75 flask. This method was 
repeated over 4 days, or until cells began forming 3 dimensional (3D) structures. Once 
the cells began forming 3D structures, the cells were transitioned into suspension flasks. 
The adherent cells were washed in the T75 flasks with PBS before incubation in 0.25% 
trypsin for 30 seconds. The cells were washed again in PBS and rested without solution 
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for another 30 seconds before being resuspended in BHK-CFTR complete media. Cells 
from two T75 flasks were transferred to a 1 L suspension culture flask filled with 500 
mL of BHK-CFTR complete media supplemented with 0.1% Pluronic® F68 (Gibco®). 
The suspended cells were fed within 24 hours of transition with 550 mL of complete 
media supplemented with 0.1% Pluronic® F68 and spiked with 0.5 mM Methotrexate 
(final concentration) 12 hours before purification.   
3.2.2.4. CFTR PURIFICATION FROM BHK-CFTR-10xHIS CELLS. 
BHK cells were pelleted either in 50 mL conical tubes at 1000 g for 5 minutes at 4°C or 
in 750 mL bottles at 4000 g for 30 minutes with slow braking at 4°C. The cell pellet mass 
was measured, and all volumes described are for 1 g total mass. The cell pellet was 
resuspended in 10 mL of 8 mM HEPES-Na, pH 7.2, 0.8 mM EDTA, 1 mM DTT and PIC 
(1 mM PMSF, 20 µM Leupeptin, 3 µM Chymostatin, 3mM Benzamidine, 0.2 mM 
AEBSF, 10 µM E-65, 10 µM Bestatin, and 10 µM Pepstatin). The cells were lysed using 
a Dounce Homogenizer with 20 strokes from the loose pestle and then from the tight 
pestle. The cell lysate was mixed with 1/7th volume of 2M sucrose in 8 mM HEPES-Na, 
pH7.2, 0.8 mM EDTA, and 1 mM DTT and incubated on ice for 10 minutes. Large 
cellular debris was pelleted twice by centrifugation at 1000 g for 10 minutes, 4°C. The 
supernatant was ultracentrifuged at 100,000 g for 1 hour at 4°C with slow braking. The 
membrane pellet was washed in 5 mL of 50 mM Tris-HCl, pH 7.5, 0.5 M NaCl, and 10% 
glycerol by resuspension using a Dounce Homogenizer—three strokes with the loose 
pestle and then three strokes with the tight pestle. The resuspended pellet was 
ultracentrifuged again at 100,000 g for 1 hour at 4°C with slow braking. The membrane 
pellet was washed in 1 mL of 50 mM Tris-HCl, pH 8.0, 0.2 M NaCl, and 10% glycerol 
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and resuspended using a Dounce Homogenizer. The resuspended membranes were 
moved to an ice-cold beaker in a cold room, and enough 50 mM Tris-HCl, pH 8.0, 0.2 
M NaCl, 2.5 mM MgCl2, 10% glycerol, and 1 mM ATP was added dropwise to make a 
final volume of 10mL. CFTR was solubilized by adding 10% DDM/ 2% CHS (10% n-
dodecyl-β-D-maltoside/ 2% cholesterol hemisuccinate) to make a final concentration of 
0.1% DDM/ 0.02% CHS dropwise over 30 minutes with gentle mixing using a 5mm stir 
bar, while still on ice. Solubilized CFTR was separated from insoluble material by 
ultracentrifugation at 100,000 g for 30 minutes at 4°C with slow braking. Only native, 
solubilized CFTR was extracted from the supernatant and incubated with equilibrated 
HisPure™ Ni-NTA (nitrilotriacetic acid) resin (0.5 mL) (Thermo Fischer Scientific) for 
1 hour at 4°C with rotating. The resin was packed in a gravity flow column and washed 
in increasing amounts of imidazole (10 mM, 25 mM, 75 mM and 125 mM) in 50 mM 
Tris-HCl, pH 7.5, 0.15 M NaCl, 2.5 mM MgCl2, and 10% glycerol. CFTR was 
phosphorylated on the column with 10 U/mL Promega® PKA in 10 mM ATP in the first 
wash for 10 minutes at 4°C. CFTR was eluted from the column using 0.45 M imidazole 
in 5x resin volume in 1 mL fractions, and selected elution fractions were pooled and 
concentrated using Amicon® 100,000 MWCO (molecular weight cut-off) filters at 1000 
g for 20 minutes at 4°C. The concentrated elution fractions were injected onto the 
ÄKTA™ Purifier (GE Healthcare Life Sciences) with a Superdex™ 200 10/300 GL 
column (GE Healthcare Life Sciences), and CFTR was isolated by size exclusion. CFTR 
was expected to elute at approximately 11 mL, in agreement with chromatography 




3.2.2.5. ANALYSIS OF CFTR PURIFICATION.   
Each sample was mixed with 6x Laemmli Sample Buffer (prepared in house) to a final 
of 1x and 50 mM DTT and immediately loaded, with a heated ladder, into either a MINI-
PROTEAN® TGX™ precast 4-15% acrylamide: bisacrylamide SDS-PAGE or a hand-
cast 8% acrylamide: bisacrylamide discontinuous SDS-PAGE. The gel was run at 150V 
for 45 minutes or 1 hour, depending on the gel type. Precast SDS-PAGE gel was 
transferred overnight at 4°C at 60 mA onto a nitrocellulose membrane. To improve the 
 
Figure 3.3: Size Exclusion Chromatography (SEC) Standards on Superdex™ 200 
10/300 GL column. Molecular Weight standards for SEC were loaded onto Superdex™ 
200 10/300 GL column and run at a flow rate of 0.25 mg/mL. Based on these standards 
and the molecular weight of CFTR (~170 kDa), CFTR and is anticipated to elute at 11 





CFTR signal on the nitrocellulose membrane, the membrane was fixed in 50% methanol 
at 4°C for 30 minutes and dried at 37°C for 30 minutes (261). The membrane was blocked 
in LI-COR Intercept blocking buffer for 1 hour at RT, stained in 1:1,500 mouse anti-
CFTR 596 antibody in Intercept blocking buffer plus 0.1% Tween® 20 (Bio-Rad) 
overnight at 4° and in 1:10,000 LI-COR IRDye® 680 IR goat anti-mouse antibody in 
Intercept blocking buffer and 0.1% Tween® 20 for 1 hour at RT with three 15 minute 
washing steps with PBST after each antibody. The membranes were imaged on a LI-
COR Odyssey® 9120 Infrared Imaging system. For the hand-cast discontinuous SDS-
PAGE, gels were silver stained in accordance with Pierce Silver Stain manufacturer’s 
protocol. All protein concentrations were determined using the Pierce™ BCA protein 
concentration assay.   
3.2.3. T-Rex™ CHO expression system.  
3.2.3.1. MOLECULAR CLONING.   
The insert (construct nucleotide 905 to 5461) was cloned from the provided construct of 
WT-hCFTR in pCDNA3 which contains a glycine linker (3x) C-terminally and N-
terminally to the 3xFLAG-tag within the extracellular loop 4 (ECL4), between construct 
nucleotides 3,598 and 3,712 (CFTR nucleotide 2,694 and 2,695 or CFTR amino acids 
S898 and R899). The addition of the tag increased the molecular weight by an additional 
114 nucleotides (38 amino acids), making the final CFTR construct 4,557 nucleotides, 
or 1518 amino acids, in length. The vector was cloned from the provided T-Rex™ 
pcDNA5/TO construct containing WT-hCFTR plus an IRES-eCFP reporter system 
(construct nucleotide 1 to 1,040 and 5,484 to 11,420). The final construct, McCarty lab 
construct name pCF595, is 11,534 nucleotides and contains a CMV promoter with 
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Tetracycline operator, the WT-hCFTR construct with 3xFLAG-tag in ECL4, an IRES-
eCFP reporter system, a hygromycin resistance gene, the BGH polyA tail, the SV40 
promoter and origin, the pUC origin, and an ampicillin resistance gene (Figure 3.4). This 
construct was transformed into XL 10-Gold® Ultracompetent cells in accordance with 
the manufacturer’s protocol. Several bacterial colonies were selected and grown in 5 mL 
of LB-Miller (Difco™) broth with 75 µg/mL ampicillin. Bacteria were pelleted and 
plasmid was purified using ZymoPURE™ Miniprep Kit. The purified plasmids were 
 
 
Figure 3.4: Plasmid map of WT-hCFTR with a 3x-FLAG-tag in ECL4 for stable 
transfection of T-RexTM CHO cells. WT-hCFTR with a 3x FLAG-tag in extracellular 
loop 4 (ECL4) cloned from this construct and inserted into pcDNA5/TO containing an 
internal ribosomal entry site (IRES) and cyan fluorescent protein (CFP) for transfection 
and protein production reporting in T-RexTM CHO cells. 
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screened via restriction digestion (Figure 3.5). Briefly, 5 µg of pCF595 was digested 
with 2 units of PvuI (New England BioLabs® (NEB)) in NEB buffer 3.1 for 1 hour at 
37°C. Restriction digests were analyzed on a 1% agarose gel stained with 0.5 µg/mL 
ethidium bromide (EtBr) and imaged on a Bio-Rad ChemiDoc™ XRS+ system. Results 
of the restriction digest informed the decision of a single bacterial colony for large-scale 
amplification and plasmid purification using Maxiprep (ZymoPURE™). The CFTR 




Figure 3.5: Restriction digestion of pCF595 (McCarty Lab). Results of restriction 
digestion, using PvuI, of pCF595 purified from three different bacterial colonies (c1, 
c2, c3) on a 1% agarose gel stained with 0.5 µg/mL ethidium bromide. Theoretical gel 
(left) was produced for ease of interpretation of experimental gel (right). Proper 
insertion and digestion will display two bands, one at just under 10 kbp and one between 
3 kbp and 2 kbp. All three colonies (c1, c2, and c3) show expected digestion bands.  
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3.2.3.2. MAINTENANCE OF T-REX™ CHO CELLS.  
T-Rex™ CHO cells (Thermo Fischer Scientific) were thawed and plated in a T25 flask 
in Ham’s F12, 10% FBS, 2 mM L-glutamine, 1% P/S and 10 µg/mL blasticidin (CHO 
complete media) and allowed to grow to confluency. At confluency, cells were split at a 
range of 1:5 to 1:20 into a new T25 flask containing CHO complete media. Frozen cells 
were prepared in 10% DMSO, 45% conditioned CHO complete media (media exposed 
to growing cells), and 45% new CHO complete media at a density of 3 x 106 cells/ mL 
and cooled to -80°C and then transferred to liquid nitrogen for long term storage. Stably 
transfected CHO-CFTR-3xFLAG cells were maintained using the same general methods 
as T-Rex™ CHO cells, except CHO-CFTR-3xFLAG cells, which were grown in CHO 
complete media plus 0.45 mg/mL hygromycin (CHO-CFTR complete media).  
3.2.3.3. GENERATION OF STABLY TRANSFECTED T-REX™ CHO CFTR 
EXPRESSION SYSTEM.   
To confirm that a 3x-FLAG-tag in ECL4 would not interfere with CFTR biogenesis, the 
generated CFTR-pCDNA3 construct was transfected into BHK cells (data not shown). 
Optimal conditions for transfection of T-Rex™ CHO cells with pCF595 were determined 
to be 1:2 ratio with a 12-hour transfection in a T25 flask. A hygromycin kill curve of T-
Rex™ CHO cells showed that after 4 days in 450 µg/mL hygromycin, approximately 
50% of cells were dead (Figure 3.6). Transfected cells were induced with 1 µg/mL 
tetracycline, and flow cytometric parameters were optimized using the Emory Flow 
Cytometry Core (Figure 3.7). With optimized parameters, induced cells were separated, 
singly, into two 96-well plates and allowed to grow for 3 days without selection. Once 
growth was observed for most wells, the selection agent, hygromycin, was added at 450 
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µg/mL for 5 days (Figure 3.7). Over several weeks, confluent wells were transferred to a 
T25 flask and allowed to grow to confluency before the evaluation of protein expression 




Figure 3.6: Microscopy of a T-Rex CHO cell kill curve at 450 µg/mL hygromycin. 
The concentration of selection agent that will show some cell death at 4 days and 
complete cell death after 8 days must be determined before the generation of a stable 
cell line by selection agent. A range of hygromycin concentrations was tested (0 µg/mL 
to 1.5 mg/mL) and a concentration of 450 µg/mL hygromycin fits this profile. Depicted 
in this figure is the concentration of 450 µg/mL, which displays cell death on Day 4, 





Figure 3.7: Generation of stably transfected T-RexTM CHO cells with inducible 
CFTR-3xFLAG. The pcDNA5/TO containing an inducible WT-hCFTR cloned with a 
3x-FLAG-tag in ECL4 and a CFP-reporting system was transiently transfected into T-
Rex™ CHO cells. (A) T-Rex CHO cells were induced and were single-cell sorted by 
flow cytometry using the CFP reporting-system. The first plot of untransfected cells and 
the second of transfected cells show increased cell debris and death reported by the large 
side-scatter signal (SSC-A). The third plot shows the fluorescent channel separation of 
transfected cells from untransfected cells. (B) Representative individual colonies 
several days after sorting shows growth. (C) Images of two colonies that express CFTR, 
as well as the CFP-reporting system. (D) Western blot shows CFTR expression in 
colony B2, but not in several other colonies screened (D12 and F4). The first negative 
control is parental T-Rex™ CHO cells, and the second negative control is uninduced 
B2 colony. Immunoblotting for CFTR: Primary – mouse anti-CFTR 596 antibody, 







3.2.3.4. ANALYSIS OF CFTR EXPRESSION AND PURIFICATION.  
Induced stably transfected T-Rex™ CHO cells were pelleted at 1000 g for 10 minutes at 
4°C and resuspended in RIPA buffer with protease 1x inhibitor cocktail (cOmplete 
EDTA-free PIC Roche©). Cells were incubated for 10 minutes at 4°C and cellular debris 
was pelleted at 1000 g for 10 minutes at 4°C. Total protein was measured using Pierce™ 
BCA microplate assay in accordance with the manufacturer’s protocol. Equivalent 
amounts of protein (50-150 µg) were mixed with 1x Laemmli sample buffer (prepared in 
house) with 50 mM DTT and incubated at 37°C for 30 minutes. Samples and ladder, pre-
heated (Precision Plus Protein™ Dual Color Standards Marker, Bio-Rad), were loaded 
into Mini-PROTEAN® TGX™ precast 4-15% acrylamide: bisacrylamide SDS-PAGE 
gels. Alternatively, an equivalent volume of each sample was mixed with 6x Laemmli 
Sample Buffer (prepared in house) to a final concentration of 1x and 50 mM DTT and 
immediately loaded, along with a pre-heated ladder, into Mini-PROTEAN® TGX™ 
precast 4-15% acrylamide: bisacrylamide SDS-PAGE or hand-cast 8% acrylamide: 
bisacrylamide discontinuous SDS-PAGE gels. The gel was run at 150V for 45 minutes 
or 1 hour, respectively. Precast SDS-PAGE was transferred overnight at 4°C at 60 mA 
onto a nitrocellulose membrane. To improve the overall CFTR signal on a nitrocellulose 
membrane, the membrane was fixed in 50% methanol at 4°C for 30 minutes and dried at 
37°C for 30 minutes (261). The membrane was blocked in LI-COR Intercept blocking 
buffer for 1 hour at RT, stained in 1:1,500 mouse anti-CFTR 596 antibody in Intercept 
blocking buffer plus 0.1% Tween® 20 overnight at 4° and in 1:10,000 IRDye® 680RD 
goat anti-mouse antibody in Intercept blocking buffer and 0.1% Tween® 20 for 1 hour at 
RT with three 15-minute washing steps with PBST after each antibody. The membranes 
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were imaged on a LI-COR Odyssey® 9120 Infrared Imaging system. For the hand-cast 
discontinuous SDS-PAGE, gels were silver stained in accordance with Pierce Silver Stain 
manufacturer’s protocol. All protein concentrations were determined using the Pierce™ 
BCA protein concentration assay.  
3.2.3.5.CFTR PURIFICATION FROM STABLY TRANSFECTED T-REX™ CHO CELLS.  
Adherent stably transfected CHO-CFTR-3xFLAG cells were seeded into 1 L suspension 
culture flask at 0.5 x 106 cells/mL in CHO-CFTR complete media plus 0.01% Pluronic® 
F68. Cells were grown to 500 x 106 cells/mL and induced with 10 ug/mL tetracycline for 
12 hours. CHO cells were pelleted in 50 mL conical tubes at 1000 g for 5 minutes at 4°C. 
The cell pellet mass was measured, and all volumes listed in reference to 1 g initial mass. 
The cell pellet was resuspended in 10 mL of 8 mM HEPES-Na, pH 7.2, 0.8 mM EDTA, 
and 1 mM DTT. The cells were lysed using a Dounce Homogenizer with 20 strokes using 
the loose pestle and then again with the tight pestle. The cell lysate was mixed with 1/7th 
volume of 2M sucrose in 8 mM HEPES-Na, pH7.2, 0.8 mM EDTA and 1 mM DTT and 
incubated on ice for 10 minutes. Large cellular debris was pelleted by centrifugation 
twice at 1000 g for 10 minutes at 4°C. The supernatant was ultracentrifuged at 100,000 
g for 1 hour at 4°C with slow braking. The membrane pellet was washed in 5 mL of 50 
mM Tris-HCl, pH 7.5, 0.5 M NaCl, and 10% glycerol by resuspension using a Dounce 
Homogenizer (3 strokes with the loose pestle and three strokes with tight). The 
resuspended pellet was ultracentrifuged again at 100,000 g for 1 hour at 4°C with slow 
braking. The membrane pellet was washed in 1 mL of 50 mM Tris-HCl, pH 8.0, 0.2 M 
NaCl, and 10% glycerol and resuspended using a Dounce Homogenizer. The 
resuspended membranes were moved to an ice-cold beaker in the cold room, and enough 
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50 mM Tris-HCl, pH 8.0, 0.2 M NaCl, 2.5 mM MgCl2, 10% glycerol, and 1 mM ATP 
was added dropwise to make a final volume of 10 mL per initial cell pellet gram. To 
solubilize CFTR, 10% DDM/ 2% CHS solution was added dropwise over 30 minutes, to 
make a final concentration of 0.1% DDM/ 0.02% CHS with gentle mixing using a 5 mm 
stir bar. Solubilized CFTR was separated from insoluble material by ultracentrifugation 
at 100,000 g for 30 minutes at 4°C with slow braking. Only native, solubilized CFTR 
was extracted from the supernatant and incubated with Anti-FLAG® M2 Affinity Gel 
(0.01 mL) for 1 hour at 4°C with rotating. The resin was packed in a gravity flow column 
and washed in 50 mM Tris-HCl, pH 7.5, 0.15 M NaCl, 2.5 mM MgCl2, and 10% glycerol. 
CFTR was eluted from the column using 2 column volumes (CV) of 0.1 mg/mL 3x 
FLAG® peptide and selected elution fractions were pooled and concentrated using 
Amicon® 100,000 MWCO filters by centrifugation at 1000 g for 20 minutes at 4°C. 
Concentrated elution fractions were injected into the ÄKTA™™ Purifier and CFTR was 
isolated by size exclusion on a Superdex™ 200 10/300 GL column. CFTR was 
anticipated to elute at about 12 mL, which also agrees with chromatography standards.  
3.3. RESULTS. 
3.3.1. Expression of CFTR by baculoviral infection of Sf9 cells.  
3.3.1.1.PRODUCTION OF MUTANT AND WT-hCFTR CONTAINING BACMID.  
Full length sequencing of hCFTR in pFastBacDual construct showed the correct 
sequence for expression in Sf9 cells, albeit with a non-standard single codon repeat for 
the His-tag, instead of alternating codons. Bacmids purified after plasmid transformation 
into DH10Bac E. coli (Blue/White Screening) (Figure 3.8), and PCR amplification of the 
gene of interest region showed the correct size of WT and mutant hCFTR sequence 
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incorporation into Bacmid (Figure 3.9).  
 
 
Figure 3.8: Images of representative agar plates utilizing Blue/White screening to 
confirm successful bacmid production after transformation. (A) Initial 
transformants plated on LB-agar plates with 50 µg/mL kanamycin, 7 µg/mL 
gentamicin, 10 µg/mL tetracycline, and 100 µg/mL Bluo-gal and 40 µg/mL IPTG. 
Colonies that have been transformed with plasmid and have correctly produced 
recombinant bacmid are white. (B) Selected colonies from the first plate were restreaked 
on new LB-agar plates (containing previously mentioned additives) to confirm the 
homogeneity of each selected colony. 
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3.3.1.2. TRANSFECTION OF SF9 CELLS WITH BACMID TO PRODUCE 
BACULOVIRUS.  
Positive infection of Sf9 cells was observed via an increase in cell size and the generation 
of many vesicles within the cells (Figure 3.10). The titer of both p1 and p2 plaque-
purified viral colonies was determined via plaque assay and neutral red staining. The 
levels of CFTR expression per viral colony was determined by Western blot using a 
CFTR specific antibody; however, a His-tag antibody could not detect the same CFTR 
expressed protein on a Western Blot (Figure 3.11). The lack of detection of a Hist-tag by 
Western blot suggested difficulty in the purification of CFTR using His-tag affinity 
chromatography.  
 
Figure 3.9: PCR amplification of a section of CFTR from purified WT-CFTR and 
mutant CFTR bacmid. Primers, designed in house, were used to amplify a specific 
region of CFTR from purified bacmid to confirm CFTR gene insertion into bacmid. The 
positive control is the WT-CFTR plasmid (pCF340, McCarty Lab) and the negative 
control is ABCC4 in pGEMHE construct. Both mutant and WT Bacmid show similar 






Figure 3.10: Images of transfected Sf9 cells to confirm viral infection and 
baculovirus production. (A) Images are comparing Sf9 cells that were transfected with 
bacmid (WT) to produce baculovirus. After 7 days, transfected Sf9 cells will appear 
larger in size when compared to untransfected cells and will contain many intracellular 
vesicles. Infected Sf9 cells will eventually leave a region of no cell growth or a plaque 
under plaque assay conditions. Individual plaques are collected and can be used to infect 
more copious amounts of cells. (B) Visualization of Sf9 cells infected with plaque-
purified p1 virus for WT-CFTR (Wt 8 and Wt 3) or mutant CFTR (mutant 2 or mutant 
3, D110C/K892C). Again, cells infected by baculovirus are identified by swelling and 





Figure 3.11: Western blot analysis to determine high-expressing WT-CFTR p1 
viral stock. High-expressing CFTR plaque purified p1 viral stocks, single 1 and single 
2, or mixed plaques, mixed 1, mixed 2, mixed 3, and mixed 4, were determined by 
western blot analysis using an anti-CFTR antibody (A), but were not detected by anti-
His-tag antibody (B). Positive controls are CFTR expressed in BHK cells (A) and His-
tagged sphingomyelinase, purified (B). Immunoblotting for CFTR: Primary – mouse 
anti-CFTR 596 antibody, 1:1,500 and Secondary – goat anti-mouse antibody conjugated 
to HRP, 1:1,000. Immunoblotting for His-tag: Primary – rabbit anti-His-Tag antibody, 
1:1,000 and Secondary – goat anti-rabbit antibody conjugated to HRP, 1:1,000.  
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3.3.1.3. HIS-TAG IS NOT ACCESSIBLE IN CFTR PRODUCED BY SF9 CELLS.  
A crude purification testing the accessibility of the His-tag on baculoviral expressed 
CFTR showed no binding to Roche© cOmplete His-tag resin indicating the inability to 
purify CFTR expressed in the Baculovirus system via the incorporated His-tag (Figure 
3.12).   
 
 
Figure 3.12: Western blot analysis of crude CFTR purification from infected Sf9 
cells expressing WT-hCFTR. Sf9 cells were infected with a high CFTR expressing p1 
virus (WT, mixed 3) at an MOI of 20. Infected cells were lysed in Roche A buffer and 
0.1% DDM. CFTR could not be separated from the lysate using His-tag affinity resin, 
confirming the inaccessibility of His-tag. Immunoblotting for CFTR: Primary – mouse 
anti-CFTR 596 mouse antibody, 1:1,500 and Secondary – goat anti-mouse antibody 




3.3.2. CFTR purification from the BHK-CFTR-10xHis expression system.  
3.3.2.1. HIS-TAG OF RECOMBINANT CFTR IS ACCESSIBLE IN BHK-CFTR-10xHIS 
CELL LINE. 
 Because CFTR expressed in Sf9 cells showed the inability to use the His-tag for 
separation of CFTR from endogenous proteins under crude purification conditions, a new 
cell expression system was tested. A crude purification of CFTR using Roche© cOmplete 
His-Tag Resin from the stably transfected BHK cells showed that the His-tag was 
accessible (Figure 3.13). The accessibility of the His-tag on CFTR tested and confirmed 
in this cell expression system means the possibility of purifying CFTR for downstream 
applications.  
 
Figure 3.13: Western blot analysis of crude CFTR purification from BHK cells 
stably transfected to express WT-hCFTR. Stably transfected BHK cells expressing 
WT-hCFTR were lysed in Roche A buffer and 0.1% DDM. CFTR was separated from 
the endogenous protein in the lysate using His-tag affinity resin. The ability to separate 
CFTR confirms the accessibility of the His-tag in this cell expression system. 
Immunoblotting for CFTR: Primary – mouse anti-CFTR 596 antibody, 1:1,500 and 
Secondary – goat anti-mouse antibody conjugated to HRP, 1:1,000.   
110 
 
3.3.2.2. TRANSITION OF ADHERENT BHK-CFTR-10xHIS CELLS TO 
SUSPENSION CULTURE DOES NOT AFFECT CFTR EXPRESSION.  
Suspension cultures allowed for increased yield of cells and thus are optimal for protein 
purification. The stably transfected BHK-CFTR-10xHis cell line grows adherently, and 
so to transition these BHK cells to suspension culture, the cells must grow in clumps 
known as BHK pearls. It is imperative to confirm that the transition of the adherent BHK-
CFTR-10xHis cell line to suspension culture does not affect CFTR expression. Western 
blot analysis of the expression profile of CFTR shows no change between adherent and 




Figure 3.14: CFTR expression is unchanged under suspension cell culture 
conditions. CFTR expressed in the stably transfected BHK cell line. Cells were 
transitioned to suspension culture, growing as “pearls” for purification. (A) BHK-
CFTR-10xHis pearls after a few days under suspension culture conditions. (B) Western 
blot comparing CFTR expression under suspension and adherent cell culture conditions. 
Immunoblotting for CFTR: Primary – mouse anti-CFTR 596 antibody, 1:1,500 and 
Secondary – IRDye® 680RD goat anti-mouse antibody, 1:10,000. Immunoblotting for 
Actin: Primary – mouse anti-actin antibody, 1:5,000 and Secondary – IRDye® 800CW 
goat anti-mouse antibody, 1:10,000. 
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3.3.2.3. IMPROVEMENTS TO DETERGENT-SOLUBILIZED CFTR PURIFICATION 
INCREASED OVERALL YIELD.  
A typical 2.4 L BHK-CFTR-10xHis suspension culture yielded a total of 4-6 g wet cell 
mass. Cell lysis via Dounce homogenizing showed that >90% of cells were lysed (Figure 
3.15). A dramatic improvement in the CFTR yield was observed in changing the 
solubilization technique. Previously, CFTR was solubilized by the direct addition of 1% 
DDM followed by incubation over 30 minutes; however, by changing to the dropwise 
addition of 0.1% DDM/0.02% CHS over 30 minutes the yield of solubilized CFTR was 
dramatically improved (Figure 3.16). Overall, CFTR purity was dramatically improved 
by changing from Roche® cOmplete resin to Pierce HisPureTM Ni-NTA resin and by 
increasing the amount of imidazole in the wash steps (Figure 3.17). Phosphorylation of 




Figure 3.15: Microscopic confirmation of at least > 90% lysed cells. BHK cells are 




purification protocol yielded the mostly CFTR, albeit with one strong copurified protein 
(Figure 3.18). Even after size exclusion chromatography, this copurified protein 
remained present (Figure 3.19). The final yield of total protein concentration varies but 




Figure 3.16: CFTR solubilization is improved by slow-dropwise addition of 
detergent. The method of solubilization for CFTR not only increases the amount of 
CFTR from the membrane fraction but also improves the overall yield. Immunoblotting 
for CFTR: Primary – 596 mouse anti-CFTR antibody, 1:1,500 and Secondary – LI-COR 






Figure 3.17: CFTR purity improved by changing the His-tag affinity resin used in 
purification. Silver stained Mini-PROTEAN® TGX™ pre-cast 4-15% acrylamide: 
bisacrylamide gradient SDS-PAGE gel showing the improvement in purity by changing 
the resin type. The elution fraction between the Roche® His-resin (A) and the HisPur™ 
Ni-NTA resin (B), shows a dramatic improvement to the number of protein bands in the 
elution lane in the HisPur™ Ni-NTA resin.  
 
Figure 3.18: SDS-PAGE analysis of CFTR purification. Each lane, and lane label, 
represents the sample at each stage of the purification process described. Silver stain of 
8% acrylamide: bisacrylamide hand-cast SDS-PAGE gel showing the overall 
purification, especially improving the purity of CFTR. An unknown copurified protein 
was mostly eluted in wash 3 and wash 4. However, this protein can still be seen in the 




3.3.3. CHO-CFTR-3xFLAG expression system.  
3.3.3.1. PRODUCTION OF A STABLY TRANSFECTED CHO-CFTR-3xFLAG CELL 
LINE. 
The confirmed construct bearing CFTR-3xFLAG (ECL4) in pcDNA5/TO was 
transfected into the T-Rex™ CHO cell line with transfection monitored by the IRES-
CFP system. Individual cells were sorted by flow cytometry allowing for the 
development of uniform cell colonies during the selection of stably transfected cell lines. 
From this method, 6 different cell lines were developed, with varying levels of CFTR 
expression and two, colony B2 and C1, are shown in Figure 3.7.  
 
Figure 3.19: Size Exclusion Chromatography (SEC) of CFTR purified from BHK 
cells. (A) Full UV-spectra chromatogram from SEC with a Superdex™ 200 10/300 GL 
Column after injection with concentrated CFTR elution fractions. Void volume is 
marked by a black arrow and the monomeric CFTR peak is marked by a blue arrow. 
Several peaks present in the SEC chromatogram shows the presence of multiple 
proteins. (B) Silver stained 8% acrylamide: bisacrylamide hand-cast SDS-PAGE gel 
comparing the purity of CFTR from pooled elution fractions [Elution] to purity of CFTR 




3.3.3.2. PURIFICATION OF DETERGENT-SOLUBILIZED CFTR FROM CHO-CFTR-
3xFLAG CELL LINE.  
Purification of CFTR from the CHO line showed a variety of dramatic improvements, 
including in purity (Figure 3.20), shortening the overall purification time, and shortening 
the amount of time CFTR is in detergent, while maintaining yield; however, the yield 
could be improved by the removal of some of the glycosylation signal.  
 
 
Figure 3.20: Analysis of purification of CFTR from CHO cells using Size Exclusion 
Chromatography (SEC) and Western blot. (A) Western blot analysis shows some 
CFTR binding to and eluting from resin, especially of Band B. Immunoblotting for 
CFTR: Primary – mouse anti-CFTR antibody 596, 1:1500, and Secondary – IRDye® 
680RD goat anti-mouse antibody, 1:10,000. (B) Full UV-spectra chromatogram from 
SEC with a  Superdex™ 200 10/300 GL column after injection with concentrated CFTR 
elution fractions. Void volume is marked by a black arrow, monomeric CFTR peak is 




The inaccessibility of the His-tag on CFTR produced in the Sf9 expression system 
renders the purification of CFTR from this expression system impossible. As to why the 
His-tag is inaccessible, it could be that CFTR was not fully translated in Sf9 cells. Since 
the tag is on the C-terminus of CFTR, the last portion of the protein to be translated, if 
CFTR was trapped in the ribosome towards the end of synthesis, then the tag may not 
have been synthesized. However, the protein band on the Western Blot is of correct 
reported size for CFTR expressed in Sf9 cells, and the antigen for the CFTR-specific 
antibody used is in a region (a.a. 1204 to 1211) in NBD2, the C-terminus-containing 
domain (132) (CFTR Antibodies Distribution Program, Cystic Fibrosis Foundation). 
Thus, for this to be the reason, only a small portion of CFTR is not translated. If this is 
the case, moving the His-tag to another section of the protein could improve the use of 
this cell expression system for CFTR purification. Modifications and improvements in 
the purification steps of CFTR from the BHK-CFTR-10xHis cell expression system 
improved the overall protein yield (from 20 µg to almost 100 µg) and can be used to 
inform CFTR purifications from any cell line. One of these modifications was in the 
detergent solubilization step of CFTR with the use of a cholesterol-derived detergent 
known as cholesteryl hemisuccinate (CHS). The use of this detergent has become 
popular in the purification of ABC transporters (262, 263), as well as shows improved 
thermal stability of other tricky membrane proteins (264, 265). It’s possible that CHS 
has improved the thermal stability of CFTR in detergent, and thus provides a higher 
overall yield than CFTR purified without CHS. This hypothesis can be tested by a series 
of thermal melting curves of CFTR in different detergents, especially in the presence or 
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absence of CHS. The copurified proteins persistent with CFTR from the BHK-CFTR-
10xHis system remained challenging to remove, even after increased resin washing steps 
and SEC. This is not uncommon for His-tag affinity chromatography systems, whereas 
FLAG-tag affinity chromatography systems are much improved in purity (266). Thus, to 
improve CFTR purity, a system using FLAG-tag affinity chromatography was 
developed. The CHO-CFTR-3xFLAG improved the purity of CFTR as shown by SEC. 
The use of this system, as opposed to the stably transfected BHK-CFTR-10His system, 
will allow for the quick, ~3 weeks, production of multiple individual stable cell lines for 
a single mutation or multiple mutations. The ability to generate stably transfected cell 
lines, without the need for viral titering, means disease-relevant or thermostabilizing 
mutations can be introduced with relative ease. The clear separation of Band B CFTR 
from Band C CFTR, unlike in the BHK cells, will also provide a way to track the 
production of Band C or Band B CFTR with the introduction of each new mutation. The 
ease of transition between adherent and suspension culture conditions means CFTR can 
be purified from this culture or recorded using a variety of electrophysiological 
techniques. This allows for more comparative studies of CFTR channel activity both pre- 





CFTR RECONSTITUTION AND FUNCTION 
 
4  
4.1. INTRODUCTION.  
Studying membrane proteins in a lipid bilayer provides a more physiologically relevant 
environment than detergent; however, the structures that lipid bilayer layers form have 
always made studying individual membrane proteins difficult. The recent development 
of individually packaged membrane proteins in lipid bilayers, meaning nanodiscs and 
native nanodiscs or SMALPS (or their derivatives), has revolutionized the study of 
membrane proteins (1, 181). In fact, structural and functional studies of even well-
characterized membrane proteins have shown that the lipid environment of membrane 
proteins can dramatically alter the characteristics of the membrane protein—decreasing 
ATPase activity, but improved transport efficiency (267), rearrangement of 
transmembrane helices (268), identification of critical lipid binding positions (263), etc. 
These studies are supporting the hypothesis that lipids play a significant role in 
membrane protein function and structure. Recent structural studies of detergent-
solubilized hCFTR have identified multiple electron-dense regions around the TMDs—
possibly copurified lipids; however, the identities of these lipids are unknown (128). 
Other functional studies of CFTR demonstrate the importance of certain types of lipids 
in the ATPase activity of CFTR (133). This chapter will briefly discuss the expression 
and purification of Membrane Scaffold Protein (MSP) and the formation of nanodiscs 
using two different types of lipids. Also, this chapter will focus on the function of CFTR 
in detergent versus lipids, and between different lipid environments by both an ATPase 
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assay and planar lipid bilayer electrophysiology. Reconstitution of WT-hCFTR in 
nanodiscs demonstrates different ATPase activities dependent on the environment. The 
channel function of detergent purified CFTR reconstituted into proteoliposomes 
demonstrates comparable channel characteristics of CFTR as seen in cellular 
membranes; however, traditional inhibitors of CFTR show reduced efficacy which might 
be dependent on the type of lipid environment.  
4.1.1. Individual Contributions.  
I performed the reconstitution of CFTR in nanodiscs and proteoliposomes experiments 
and the ATPase activity assays. I designed and performed the MSP1D1 expression and 
purification experiments with the help of Ms. Isabela Povkov (a Georgia Tech 
undergraduate student). The planar lipid bilayer (PLB) experiments were conducted by 
Mrs. Kirsten Cottrill (an Emory graduate student). The first model was built with the help 
of Mr. Gorman Stock (a former student), which was later refined by Dr. Curtis Balusek, 
both of Dr. JC Gumbart’s Lab.   
4.1.2. Publications resulting from this chapter.  
Parts of this chapter will be published as a chapter in Methods in Molecular Biology on 
the use of BioBeadsTM and the reconstitution of membrane proteins into nanodiscs and 
proteoliposomes. Other parts of this chapter will be published in downstream 
manuscripts.   
4.2. METHODS.  
4.2.1. Preparation of BioBeads™.   
Bio-Beads™ (SM-2 Adsorbents cat#1523920) were weighed (~3 g) to fill 1% of the 
volume of a 50 mL conical tube. The BioBeads™ were washed by filling the 50 mL 
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conical tube with 100% methanol and rotated for at least 24 hours at RT. The beads were 
allowed to settle, so methanol could be removed and then washed in 50 mL double-
distilled or milli-Q® (Millipore Sigma) water for 24 hours at RT, again with rotating. 
Water washes were repeated for at least four days before beads were stored in a new 
volume of water at 4°C. The BioBeads™ were tested for quality by forming empty 
nanodiscs under the most optimal conditions—with one of the three lipids known to form 
nanodiscs (See below) readily.  
4.2.2. MSP1D1 expression and purification.  
There are several commercially available MSP plasmids. Using a model of the 9.7 nm 
diameter nanodisc formed by the MSP1D1 protein and structures of CFTR, it was 
determined that CFTR could be incorporated into nanodiscs of this diameter with little 
hindrance. pMSP1D1 construct (plasmid #20061) was purchased from Addgene, 
originally gifted by Dr. Stephen Sligar, and shipped in DH5α E. coli cells (184) (Figure 
4.1). The cells were streaked on LB-agar plates with 50 µg/mL kanamycin and incubated 
overnight at 37°C. Several bacterial colonies were selected and grown in 5 mL of LB-
Miller (Difco™) broth with 50 µg/mL kanamycin. Bacteria were pelleted and the plasmid 
was purified using ZymoPURE™ Miniprep Kit. The purified plasmids were screened via 
restriction digestions (Figure 4.2).  Briefly, 1 µg of pMSP1D1 was digested with 1 U of 
PvuI (New England BioLabs® (NEB)) in NEB buffer 3.1 for 1 hour at 37°C and double 
digested with 1 U of HindIII and HincII  (New England BioLabs®(NEB)) in NEB buffer 
2.1 for 1 hour at 37°C. Restriction digests were analyzed on a 1% agarose gel stained 
with 0.5 µg/mL Ethidium Bromide (EtBr) and imaged on a Bio-Rad ChemiDoc™ XRS+ 





Figure 4.1: pMSP1D1 plasmid map. The pMSP1D1 construct is purified from DH5α 
E. coli and transformed into BL21 (DE3) E. coli for production of MSP1D1 protein, 
which can be purified using His-tag affinity chromatography and used in the formation 
of nanodiscs.  
 
Figure 4.2: Restriction digestions of pMSP1D1. Results of restriction digestions, 
using PvuI (A) or HincII and HindIII (B), of pMSP1D1 purified from three different 
DH5α E. coli bacterial colonies (c1, c2, c3) on a 1% agarose gel stained with 0.5 µg/mL 
ethidium bromide. Theoretical gel for restriction digestion (left) was produced for ease 
of interpretation of experimental gel (right). Colony c3 was chosen as the source of 
pMSP1D1because the results of both restriction digestion experiments displayed 
anticipated banding patterns.   
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for large-scale amplification and plasmid purification using Maxiprep (ZymoPURE™). 
The final purified plasmid was confirmed by sequencing through GeneWiz©. For protein 
 expression, pMSP1D1 was transformed into BL21 (DE3) E. coli cells in accordance with  
manufacturer’s protocol. For the transformation of BL21 (DE3) E. coli cells, a range of 
pMSP1D1 concentrations was used (0.5 to 100 ng) and a large range of volumes of the 
transformed bacteria (10 to 250 µL) was plated on LB-agar plates with 50 µg/mL 
kanamycin. The best transformant was chosen for MSP1D1 expression and purification. 
Transformant starter culture, 5 mL of LB-broth and 50 µg/mL kanamycin, was grown at 
37°C at 250 RPM for several hours until cloudy. A 1 mL volume of the starter culture 
was added to 150 mL of LB-broth with 50 µg/mL kanamycin and was grown at 37°C 
with shaking at 250 RPM until an OD600 of between 0.5 and 0.6 was reached. Protein 
production was induced with 0.1 mM IPTG overnight at 16°C with shaking at 250 RPM. 
Bacteria was pelleted at 4000 g for 20 minutes at 4°C and resuspended in 15 mL 
phosphate buffered saline (PBS) supplemented with protease inhibitor cocktail (PIC, Cell 
Signaling®). The bacterial cells were lysed over 10 minutes by sonication, by alternating 
1 second sonication and 1 second resting period, at a 35% output and on ice. The 
insoluble material was separated from the soluble material by centrifugation at 11,000 g 
for 20 minutes at 4°C. The soluble fraction was incubated with 10 µL of equilibrated 
Roche® cOmplete His-Tag resin per each 1 mL of supernatant overnight at 4°C. The 
insoluble fraction was screened for MSP1D1 by resuspension in PBS and loading onto 
an SDS-PAGE. His-tag resin was packed in a gravity flow column and the flow-through 
was collected. The packed resin was washed sequentially in 30 resin volumes of Roche 
A buffer (50 mM NaH2PO4, pH 8.0 and 0.3M NaCl) at least five times. MSP1D1 was 
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eluted in 6 resin volumes of Roche B buffer (50 mM NaH2PO4, pH 8.0, 0.3M NaCl, and 
250 mM imidazole) at least three times, and each elution fraction was collected in an 
individual tube. MSP1D1 for nanodiscs was further purified by SEC. The third elution 
fraction was injected into the ÄKTA™ Purifier with Superdex™ 200 10/300 GL column 
(GE Healthcare) using a flow rate of 0.5 mL/min in Roche A buffer (Figure 4.3). Protein 






Figure 4.3: Purification of MSP1D1 from BL21 (DE3) E. coli. (A) Hand-cast 12% 
acrylamide: bisacrylamide SDS-PAGE stained with Coomassie to analyze MSP1D1 
purity and efficiency of purification. Each lane represents a sample at each stage of the 
purification process. MSP1D1 begins eluting from the Roche® cOmplete His-Tag resin 
(resin packed in a gravity-flow column) at elution fraction E1 and continues until 
fraction E3. The most concentrated MSP1D1 fraction is E3, which was further purified 
using Size Exclusion Chromatography. (B) Full SEC UV-spectra chromatogram of 
affinity chromatography purified His-tagged MSP1D1 using a Superdex™ 200 10/300 
GL column. Void volume is marked by a black arrow and MSP peak is marked by an 




Briefly, each sample was mixed with 6x Laemmli loading dye (prepared in-house) to a 
final concentration of 1x and loaded in proportion into a hand-cast 12% acrylamide: 
bisacrylamide SDS-PAGE. The gel was run at 150 V for 1 hour and stained in 0.1 % 
Coomassie blue (R-250, in 10% acetic acid, 30% ethanol, and 60% water) for 1 hour with 
rocking and destained overnight in 10% acetic acid, 30% ethanol, and 60% water with 
rocking (Figure 4.3). Finally, the protein concentration was determined by Pierce™ BCA 
assay and MSP1D1 was stored at 4°C.  
4.2.3. Formation of empty nanodisc controls.  
To test the BioBeads™, the following control protocol for forming empty nanodiscs was 
used. Membrane Scaffold Protein (MSP1D1; 1 mg/mL; purified in-house or Sigma 
M7074-5MG) was thawed on ice and lipid stock, either DMPC or POPC (10 mg/mL in 
3.5% NaDeoxycholate), was thawed at RT. MSP1D1 stock was gently mixed by flicking, 
and lipid stock was gently vortexed. MSP1D1 and the lipid of choice, DMPC or POPC, 
were added to nanodisc buffer (20 mM Tris pH 7.4, 0.1 M NaCl, 0.5 mM EDTA, 0.01% 
NaN3) in a specific ratio of 80:1 or 65:1. Approximately 8-15 medium-sized Bio-Beads™ 
were added to the MSP-Lipid-Buffer volume and incubated for 2 hours at 24°C for 
DMPC or incubated for 4 hours at 4°C for POPC. Empty nanodiscs were screened by 
SEC on an ÄKTA™ Purifier using a Superdex™ 200 10/300 GL column, SDS-PAGE, 
and by transmission electron microscopy (TEM) (see below). To test for empty nanodisc 
formation under conditions used for forming CFTR-nanodiscs, the following protocol 
was used. BioBeads™ were weighed to a final wet mass of 0.35 g in a 2 mL 
microcentrifuge tube. MSP1D1 and lipid stocks were thawed as previously described. In 
a final volume of 1 mL, MSP1D1 was added to 0.7 mL Buffer G (50 mM Tris pH 7.5, 
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0.15 M NaCl, and 2.5 mM MgCl2) and POPC was added to 0.3 mL of Buffer H.2 (50 
mM Tris pH 7.5, 0.15 M NaCl, 2.5 mM MgCl2, 10% glycerol, and 0.1% DDM/0.02% 
cholesteryl hemisuccinate (CHS)) to result in a final MSP1D1:POPC ratio of 1:65. The 
lipid-containing buffer was mixed with the MSP1D1-containing buffer by pipetting and 
added to BioBeads™ in the 2 mL tube. MSP1D1-POPC-BioBead™ mixture was 
incubated for 4 hours at 4°C. Empty nanodiscs were screened by SEC on an ÄKTA™ 
Purifier using a Superdex™ 200 10/300 GL column with a flow rate of 0.5 mL/min. 
Empty nanodiscs also were screened using TEM on a JEM-1400 (JEOL) transmission 
electron microscope at 120 kV. Empty nanodiscs were diluted 10 to 20-fold before 
incubating 2 µL on carbon-coated copper grids for 60 seconds at RT. The sample was 
blotted using Whatman® #4 filter paper at the side of the grid and then the sample was 
stained in 2 µL of 2% uranyl acetate for 30 seconds at RT before being blotted. Empty 
nanodiscs were screened at a magnification of 15,000x – 20,000x, before imaging at a 
higher magnification (30,000x -50,000x). Electron micrographs were collected with 
Gatan Ultrascan™ CCD camera and viewed with Digital Micrograph® software. 
4.2.4. Reconstitution of CFTR into nanodiscs.  
To form CFTR-containing nanodiscs, total protein concentration was determined by 
Pierce™ BCA assay, in accordance with manufacturer’s protocol. BioBeads™ were 
weighed to a final wet mass of 0.35 g in a 2 mL microcentrifuge tube. MSP1D1 and lipid 
stocks were thawed as previously described. In a final volume of 1 mL, POPC was added 
to 0.3 mL of purified CFTR from BHK cells in Buffer H.2 (50 mM Tris pH 7.5, 0.15 M 
NaCl, 2.5 mM MgCl2, 10% glycerol, and 0.1% DDM/0.02% cholesteryl hemisuccinate 
(CHS)) to make a final CFTR:Lipid ratio of 1:330 for POPC. The CFTR-POPC mixture 
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was incubated on ice for 10 minutes with gentle flicking. MSP1D1 was added to 0.7 mL 
Buffer G (50 mM Tris pH 7.5, 0.15 M NaCl, and 2.5 mM MgCl2) and to the CFTR-POPC 
mixture to make a final CFTR:MSP1D1:POPC ratio of 1:11:330. The CFTR-POPC 
containing buffer was mixed with the MSP1D1-containing buffer by pipetting and was 
added to BioBeads in a 2 mL tube. The CFTR-MSP1D1-POPC-BioBead™ mixture was 
incubated at 4°C overnight. The formation of CFTR-nanodiscs was screened by FPLC 
on an ÄKTA™ Purifier using a Superdex™ 200 10/300 GL column with a flow rate of 
0.25 mL/min. The SEC fraction containing CFTR-nanodiscs was concentrated using 2 
mL Amicon® centrifuge filters with a MWCO of 100,000 by centrifugation at 1000 g for 
10 minutes at 4°C until the final volume was 1/10th of original.  
4.2.5. ATPase Activity Assay.  
CFTR in detergent or in nanodiscs was phosphorylated by the Promega® PKA α-catalytic 
subunit (100 U/mL) and 10 mM MgATP for 2 hours at 4°C. PKA, excess MgATP, and 
ADP were separated from CFTR-containing samples using SEC as previously described 
(Section 4.2.4). Confirmation of phosphorylation was achieved by SDS-PAGE and Pro-
Q™ Diamond phosphorylation stain (Thermo Fischer Scientific) and phosphorylation 
immunostaining by Western blot analysis. Sample preparation and gel running conditions 
were previously described for SDS-PAGE and Western blots (Section 3.2.2.5). SDS-
PAGE, hand-cast 8% acrylamide: bisacrylamide hand-cast, was stained with Pro-Q™ 
Diamond phosphorylation stain in accordance with the manufacturer’s protocol. The 
SDS-PAGE gel was fixed in 50% methanol, 10% acetic acid two times for 30 minutes, 
and was washed in deionized water three times for 10 minutes. Then, the SDS-PAGE gel 
was stained in Pro-Q™ stain for 90 minutes, destained in 20% acetonitrile in 50 mM 
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sodium acetate pH 4 for 30 minutes three times, and washed in water for 5 minutes two 
times, all at RT. The SDS-PAGE gel was imaged on Bio-Rad ChemiDoc™ XRS+ system 
using UV transilluminator settings.  Immunoblotting for phosphorylation on Western 
blots was performed as follows: blots were blocked in LI-COR Intercept® (PBS) buffer 
for 1 hour at RT before incubation in rabbit anti-phospho-(Ser/Thr) antibody 
(abcam17464) at 1:1000 in LI-COR Intercept® (PBS) blocking buffer and 0.1% Tween® 
20 at 4°C overnight. Blots were washed for 15 minutes at RT in PBST three times before 
and after incubation in IRDye® 800CW goat anti-rabbit antibody, 1:10,000 in LI-COR 
Intercept blocking buffer and 0.1% Tween® 20. Blots were imaged on a LI-COR 
Odyssey® 9120 Infrared Imaging system (Figure 4.4). ATPase activity was measured 
using a Malachite Green ATPase assay kit from Sigma (MAK30) using a range of ATP 
concentrations from 10 mM to 0.1 pM in 100 µL reactions with CFTR in detergent or 
nanodiscs, for 1 hour at RT. Michaelis-Menten kinetics were determined by fitting 
ATPase assay data in IgorPro (Wavemetrics).   
4.2.6. Reconstitution of CFTR into proteoliposomes.  
The concentration of CFTR was determined by the Pierce™ BCA assay in accordance 
with the manufacturer’s protocol. The dialysis tubing used was Spectra/Por™ 2 
(Spectrum™) and had a MWCO of 12-14 kD with a flat width of 25 mm. A 2-inch strip 
was cut and prepared by washed with deionized water before incubation in Buffer H.2 
(without detergent) for 10 minutes at RT. CFTR and POPC were mixed at 1:100 
Protein:POPC molar ratio, placed into dialysis tubing and sealed with dialysis clips. The 
filled dialysis tubing was placed in 1 L of buffer H.2 (without detergent) with stirring at 







Figure 4.4: Phosphorylation of CFTR in detergent or in nanodiscs before ATPase 
activity measurements. CFTR in detergent and in nanodiscs was phosphorylated by 
Promega® PKA α-catalytic subunit at 100 U/mL in 1 mM ATP for 2 hours at 4°C. PKA, 
excess ATP, and ADP separated from CFTR in detergent or in nanodiscs using SEC. 
(A) Phosphorylation of CFTR in detergent confirmed by Western blot and hand-cast 
8% acrylamide: bisacrylamide SDS-PAGE gel stained with Pro-Q™ Diamond 
phosphorylation stain. Immunoblotting for phosphorylation: Primary – rabbit anti-
phospho-(Ser/Thr) antibody (abcam17464), 1:1000 and Secondary – IRDye® 800CW 
goat anti-rabbit antibody, 1:10,000. (B) Phosphorylation of CFTR in nanodiscs 
confirmed by hand-cast 8% acrylamide: bisacrylamide SDS-PAGE gel stained with 




Proteoliposomes were extracted from the dialysis bag and stored at 4°C until screening 
by TEM. Proteoliposomes, 2 µL, were incubated on a carbon-coated 400 mesh copper 
grid for 60 seconds at RT, and then were blotted away with Whatman® #4 filter paper. 
Samples were stained with 2 µL of 2% uranyl acetate for 30 seconds at RT before 
blotting. Proteoliposomes were screened on a JEM-1400 (JEOL) transmission electron 
microscope at an accelerating voltage of 120 kV.  
4.2.7. Planar lipid bilayer measurement of CFTR channel activity. 
Planar lipid bilayers were formed from a stock lipid solution of 7:3 POPE:POPS. For the 
preparation of the lipid stock, POPE and POPS in chloroform were mixed at a ratio of 
7:3, and a final mass of 0.3 mg and the chloroform solvent was evaporated under a steady 
stream of nitrogen gas. The lipids were resuspended in 10 µL of decane and painted onto 
the aperture between the cis and trans wells which were filled with recording buffer (10 
mM MOPS, pH 6.9, 1 mM MgCI2, 2 mM CaCl2, and 50 mM KCl). The formation of a 
stable bilayer was confirmed by the emergence of a square capacitive current wave under 
a voltage ramp protocol. Membrane proteins in BHK cellular membranes or CFTR 
proteoliposomes were phosphorylated by incubation of 20 µL of respective samples with 
100 U/mL PKA (Promega® α-subunit) and 5 mM MgATP for 15 minutes at RT. Samples 
were stored on ice until use. BHK cellular membranes, 7 µL with a protein concentration 
of about 2 mg/mL, or CFTR proteoliposomes, 7 µL with a protein concentration of about 
1 mg/mL, were added to the cis chamber containing recording buffer along with 0.5 mM 
MgATP and 50 U/mL PKA (Promega® α-subunit). A gradient across the cis and trans 
chambers was created by adding enough KCl to make a final concentration of 300 mM 
in the cis chamber while leaving an approximate 50 mM KCl in the trans chamber. Single 
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channel data were collected at 1 kHz and 0.1 kHz before digital filtering to 50 Hz and 
were recorded using Clampex 10.2TM (AxonTM). Single channel data were processed as 
follows in Clampfit 10.2TM (AxonTM):  when necessary, the baseline current was 
manually adjusted to 0, single channel properties were evaluated using single channel 
search, and histograms were generated and fitted.   
4.2.8. Transmission Electron Microscopy (TEM) of CFTR-Nanodiscs. 
A 2 µL volume of CFTR-nanodiscs was incubated on glow-discharged (15 seconds) 
carbon-coated copper grids for 60 seconds before blotting with Whatman® #4 filter paper. 
Samples were stained in 2% uranyl acetate for 30 seconds at RT and again blotted. Grids 
were screened at magnifications of 10,000x – 20,000x, before imaging at magnifications 
of 30,000x - 50,000x. Micrographs used for image processing were collected at 50,000x 
with a defocus range of 0.8 to 1.2 µm. Electron micrographs were taken on 2k by 2k 
Gatan Ultrascan™ charge-coupled detector (CCD) camera and were viewed with the 
Digital Micrograph® software before analysis with EMAN 2.3 (269). Particles were 
manually picked from 76 initial micrographs with a particle size of 125 and a box size of 
192 and extracted. After contrast transfer function (CTF) correction, performed in 
EMAN by CTFFIND (270), 990 extracted particles were used in initial class averaging 
studies. Particles of poor quality were manually excluded resulting in about 500 particles 
for class averaging.  
4.3. RESULTS 
4.3.1. The process of cleaning and storing BioBeadsTM affects the efficiency of 
nanodisc formation.  
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We found that the storage conditions of BioBeadsTM greatly affected the ability of the 
resin to form nanodiscs. BioBeads™ stored on the benchtop at room temperature after a 
year developed a yellowish huge, clumped, and moisture within the storage bottle. This 
is different in appearance to new BioBeads ™ (Figure 4.5). However, BioBeads™ that 
have been washed well in methanol and stored in water at 4°C can be used a year after 
washing without a significant decrease in their ability to remove detergent. To improve 
the length of use, BioBeads™ are either stored washed or stored in the original bottle 





Figure 4.5: Comparison of old Bio-Beads™ to new Bio-Beads™. Old BioBeads™ 
(left), appeared to be clumped, yellowish in color, and had moisture along all walls of 




4.3.2. Empty nanodiscs were formed using two different types of lipids. 
Nanodiscs devoid of membrane protein, called empty nanodiscs, formed with the 
MSP1D1 protein of any single lipid composition, DMPC or POPC, were confirmed by 
SEC and SDS-PAGE. If empty nanodiscs have formed, there will be the emergence of a 
peak at 12 mL on Superdex™ 200 10/300 GL column and the presence of MSP in the 12 
mL SEC fraction when analyzed on an SDS-PAGE. In Figure 4.6, empty nanodiscs were 
formed with both DMPC and POPC. Of note, even at the correct MSP:POPC ratio, POPC 
displayed a rather large void volume. When the void volume fraction was screened by 
TEM, there were small liposomes (Figure 4.7). Alteration of the MSP:POPC to prevent 
the presence of these liposomes, prevented the formation of the empty nanodiscs. 
Screening the 12 mL SEC fraction in which showed the presence of MSP on the SDS-
PAGE (Figure 4.6) Empty nanodiscs formed under control conditions and empty formed 
under the same buffer conditions that would be used to form CFTR-nanodiscs were also 
screened by transmission electron microscopy (Figure 4.8). Empty nanodiscs formed 
under both conditions, the control buffer conditions and the buffer conditions for forming 
CFTR-nanodiscs, displayed the anticipated dimensions of 5 nm by 10 nm for empty 
nanodiscs formed with MSP1D1 when screened via negative stain TEM (Figure 4.8). 
Under our TEM studies, empty nanodiscs seemed to prefer a side orientation or an 








Figure 4.6: Confirmation of empty nanodiscs formed with two different lipids—
DMPC and POPC. Empty nanodiscs formed under control buffer conditions with 
DMPC (A) and POPC (B) were evaluated using SEC and SDS-PAGE. Full UV-
spectra chromatogram from SEC with a Superdex™ 200 10/300 GL Column after 
injection with empty nanodiscs on the left and key fractions analyzed for the presence 
of MSP on 12% acrylamide: bisacrylamide hand-cast SDS-PAGE gel stained by 






Figure 4.8: Micrograph of negatively stained (2% uranyl acetate) empty POPC 
Nanodiscs. The POPC nanodiscs show a preferred “side-view” orientation, providing 
critical information on successful formation of nanodiscs with a thickness and diameter 
of approximately  8 nm by 10 nm, respectively. These nanodiscs devoid of CFTR also 
provide an important control for reconstitution of CFTR into CFTR-nanodisc. The scale 
bar corresponds to 20 nm. 
 
Figure 4.7: Transmission electron micrograph of liposomes present in the SEC 
void volume of POPC lipids. Even at the recommended Lipid-to-Protein (LPR) ratio 
for MSP and POPC, a void volume can be seen and contained what appears to be small 




4.3.3. CFTR was incorporated into POPC-based nanodiscs.   
Initial attempts to form CFTR-nanodiscs used DMPC as the lipid of choice due to its 
prevalence in membrane protein reconstitution. However, the formation of nanodiscs was 
inconsistent. By changing the choice of lipid to POPC, a lipid with a much lower phase 
transition temperature (DMPC is 24°C and POPC is 4°C) improved the consistency of 
nanodiscs formation. CFTR-nanodiscs were screened first by SEC, as CFTR-nanodiscs 
being of much larger molecular weight will elute earlier than both monomeric detergent-
solubilized CFTR and empty nanodiscs. SEC results of CFTR-nanodiscs revealed the 
emergence of a peak shoulder at around 10 mL on Superdex™ 200 10/300 GL column, 
while monomeric detergent-solubilized CFTR alone eluted at 11 mL and empty 
nanodiscs eluted at 12 mL (Figure 4.9). Western blot analysis is one confirmation method 
of nanodiscs formation by the presence of CFTR and MSP in the same SEC elution 
fraction. We confirmed the presence of CFTR and MSP1D1 in the same SEC elution 
fraction using Western blot analysis (Figure 4.9). Another confirmation method of 
nanodisc formation and membrane protein confirmation is TEM. Before screening by 
TEM, a model of CFTR in a nanodisc was built for comparing particles seen in the 
proposed CFTR-nanodiscs SEC elution fraction to model. CFTR-nanodiscs are 
anticipated to be about 10 nm by 15 nm in size and demonstrate “mushroom” like features 
(described in more detail below). When the SEC elution fraction was screened by TEM, 
particles identified in micrographs displayed several characteristic features expected for 
CFTR in a nanodisc. The particles identified were 10 nm by 15 nm in size and 
demonstrated “mushroom” like features meaning an elongated “stalk” below a “cap”, or 
the nanodisc as well as, several particles appear to have two separate densities at the base 
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Figure 4.9: CFTR-nanodiscs generated from CFTR purified from BHK cells 
screened SEC and western blot. (A) UV-spectra chromatogram from SEC with a 
Superdex™ 200 10/300 GL Column after injection with CFTR-nanodiscs. Arrows 
indicate the following: void (black), CFTR-nanodiscs (purple), CFTR (blue), and empty 
nanodiscs (orange). (B) Western blot SEC fractions identifying CFTR (168 kDa) and 
MSP (24 kDa) in the same fractions. Immunoblotting for CFTR: Primary – mouse anti-
CFTR 596 antibody, 1:1,500 and Secondary – IRDye® 680RD goat anti-mouse 
antibody, 1:10,000. Immunoblotting for MSP: Primary – rabbit anti-His-tag antibody, 





Figure 4.10: CFTR-nanodiscs generated from CFTR purified from BHK cells 
screened by TEM. (A) Micrograph of negatively stained CFTR-nanodiscs. A few 
examples of particles are boxed in blue. The micrograph shows a good distribution of 
particles and no aggregation. Scale bar represents 50 nm. (B) A CFTR-nanodiscs model 
was built of hCFTR (PDB ID: 5UAK) in a nanodisc (PDB ID: 4V6M), in Visual 
Molecular Dynamics (VMD). The lipids in front of CFTR in a nanodisc have been cut 
away to show TMDs. 
138 
 
4.3.4. ATPase activity of CFTR is improved in a lipid environment over a detergent 
environment.  
CFTR phosphorylation, whether in nanodiscs or in detergent, was determined by SDS-
PAGE and phosphorylation stain (Figure 4.4). CFTR concentration, whether in nanodiscs 
or detergent, was determined by densitometry (data not shown). The production of 
inorganic phosphate by the ATPase activity of CFTR was determined by the malachite 
green assay using an ATP concentration range 10 mM to 0.1 pM and each reaction was 




Figure 4.11: ATPase activity of CFTR-nanodiscs or CFTR in detergent (DDM) 
measured by Malachite Green Assay. After phosphorylation (Figure 4.4), PKA, 
excess ATP, and ADP were separated from phosphorylated CFTR using SEC. Inorganic 
phosphate produced by ATPase activity of CFTR was measured by Malachite green 
complexation for the following range of ATP concentrations in 100 µL volumes: 10 
mM to 0.1 pM. Michaelis-Menten kinetics were determined in IgorPro and plotted as 
“fit”. CFTR-nanodiscs exhibit a higher ATPase activity than CFTR in detergent. Error 
bars are SEM for three trials. 
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lipid, POPC, environment has an increased rate of ATPase activity rate of 63.5 ± 9.75 
nmol/min/µg as compared CFTR in detergent with an ATPase activity rate of 7.9 ± 0.36 
nmol/min/µg (Figure 4.11). There is also an increased Michaelis-Menten constant (KM) 
of CFTR in a POPC lipid environment (0.172 ± 0.117 mM) compared to CFTR in 
detergent (0.00692 ± 0.00176 mM). An increased KM usually signifies a reduction in the 
binding affinity of the substrate to the enzyme, but the increased Vmax is proportional to 
the catalytic rate of the enzyme. These parameters indicate that ATP binding to CFTR in 
a lipid environment is reduced, but the enzymatic rate of ATP to ADP conversion has 
increased compared to that of CFTR in detergent. 
4.3.5. Purified CFTR has the same channel function as CFTR in BHK cellular 
membranes.  
CFTR was reconstituted into POPC-based proteoliposomes, and the membrane 
formation was screened by TEM (Figure 4.12). CFTR currents were recorded for CFTR 
from the BHK cellular membrane fraction, and from CFTR that was detergent-
solubilized, purified, and reconstituted into proteoliposomes. Once fusion of either 
cellular membranes of proteoliposomes to planar lipid bilayer was observed, CFTR 
currents were recorded over several seconds. CFTR currents recorded from BHK cellular 
membrane fraction showed the expected -0.61 pA current (average for each channel) with 
an expected open probability, the percentage of time the channel was open divided by 
the entire recording time (Po), of approximately 37% under a functional voltage of -90 
mV (composed of an applied -45 mV and a Cl- gradient voltage of -45 mV) (Figure 4.13). 
To confirm this channel is CFTR, the CFTR specific inhibitor INH172 was added to the 
cis chamber and showed a 94 % inhibition of the CFTR current from BHK cellular 
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membranes (Figure 4.13). Currents from CFTR proteoliposomes were measured to be -
0.68 pA with an open probability of approximately 32% (and up to 50% in some 
recordings) (Figure 4.14). Again, to confirm this channel was CFTR, the use of INH172 
was used. Incubation with CFTR inhibitor only showed approximately 25% inhibition 
(Figure 4.14). The difference in efficacy of INH172 on CFTR from proteoliposomes 
compared to CFTR from the cellular membranes could be due to two possibilities. The 
first could be the difference of lipid environment between the cellular membrane, which 
provides a multitude of lipid types. The second is that CFTR in POPC proteoliposomes 
was detergent-solubilized, purified and reconstituted. The detergent solubilization step 
could have introduced structural defects to the purified CFTR that are unable to be 
rescued by the reconstitution lipid environment.  
 
Figure 4.12: Micrograph of negatively stained (2% uranyl acetate) CFTR 
proteoliposomes. Purified detergent-solubilized CFTR was reconstituted into POPC-




Figure 4.13: Planar lipid bilayer (7:3 POPE:POPS ratio) single-channel recordings 
of CFTR from BHK cellular membranes. Recordings of CFTR under an applied 
driving force of -90 mV for Cl-. PKA and ATP (50 U/mL and 0.5 mM final) were added 
to the cis chamber. Top graphs are of the planar lipid bilayer recordings pre-treatment 
with INH172 (A) and post-treatment with INH172 (B). A histogram for both pre-
INH172 (A) and post-INH172 (B) treatments were plotted for each state—3 open 
channels, 2 open channels, 1 open channel or closed channels. Before the addition of 
INH172 (A), three CFTR channels can be seen in a single recording, each with a current 
amplitude of -0.70 pA, -0.61 pA, -0.53 pA and an average amplitude of -0.61 pA. The 
open probability for CFTR in this recording was 37%, as expected for CFTR. After the 
addition of INH172 (B), only a single CFTR channel can be seen in a single recording, 
a current amplitude of -0.52 pA. The open probability for CFTR in this recording was 






Figure 4.14: Planar lipid bilayer (7:3 POPE:POPS ratio) single-channel recordings 
of CFTR from proteoliposomes. Recordings of CFTR under an applied driving force 
of -90 mV for Cl-. PKA and ATP (50 U/mL and 0.5 mM final) were added to the cis 
chamber. Top graphs are of the planar lipid bilayer recordings pre-treatment with 
INH172 (A) and post-treatment with INH172 (B). A histogram for both pre-INH172 
(A) and post-INH172 (B) treatments were plotted for each state—1 open channel or 
closed channels. Before the addition of INH172 (A), a single CFTR channel can be seen 
in a single recording displaying a current amplitude of -0.68 pA with an open probability 
of 32% for CFTR in this recording, as expected. After the addition of INH172 (B), a 
single CFTR channel can be seen in a single recording displaying a current amplitude 
of -0.72 pA and an open probability of 24% for CFTR in this recording. This represents 




4.3.6. Preliminary class averages for CFTR-nanodiscs display expected 
characteristics of successful reconstitution of CFTR into nanodiscs. 
Particles from images of negatively stained samples were manually picked using EMAN 
2.3 (269). Initial class averages used standard EMAN 2.3 settings. Several classes 
contained particles of smaller sizes than expected for CFTR-nanodiscs, with dimensions 
of ~ 5nm by 10nm (thickness and diameters, respectively), closely corresponding to 
nanodiscs devoid of CFTR.  Approximately 80% of particles had dimensions of ~ 15nm 
by 10nm corresponding to the expected dimensions of height and diameter for CFTR-
nanodiscs. Following classification (Figure 4.15) of these larger particles, structural 
characteristics were observed that are consistent with the expected overall size and a 
density consistent with NBDs of CFTR protruding from an elongated density expected 
for a nanodisc in a “side view” orientation.  Next, a 3D model will be calculated, which 
will be followed by cryo-EM studies. The large percentage of successfully reconstituted 
CFTR into nanodiscs, the homogeneity of the sample, and the good particle distribution 
without aggregation, are important steps towards cryo-EM as well as biochemical studies 
of CFTR.  
 
 
Figure 4.15: Preliminary class averages of CFTR-nanodiscs.  Initial 2D class 




5 The nanodisc bilayer system has revolutionized the study of membrane proteins both 
structurally and functionally by providing a method for the individual packaging of 
membrane proteins in a variety of lipid environments, and this includes the studies 
presented here. In these studies, we report the emergence of a large void volume during 
SEC of empty nanodiscs formed using POPC, but not DMPC. And screening the void 
volume on a transmission electron microscope identified the presence of small lipid 
vesicles. The formation of these small vesicles is most likely a result of the lipid tails and 
can be confirmed by forming nanodiscs with other single lipid combinations with the 
same lipid tail, but different head groups, and TEM screening of the void volume. As for 
the studies on CFTR ATPase activity and the contributions of the lipid or detergent 
environment, these are the first studies in which both the orientation of CFTR is 
unrestricted to buffer conditions, unlike CFTR in proteoliposomes, and no detergent is 
present, unlike destabilized proteoliposomes. Other similar studies measuring the 
ATPase activity of CFTR in different lipids have utilized destabilized proteoliposomes, 
which still require the presence of detergent (133). The determined Michaelis-Menten 
constants of the ATPase activity for CFTR in detergent was a lower KM,  0.00692 ± 
0.00176 mM compared to CFTR-nanodiscs (0.172 ± 0.117 mM), and a lower Vmax, 7.9 
± 0.36 nmol/min/µg compared to CFTR-nanodiscs (63.5 ± 9.75 nmol/min/µg). These 
results make for difficult interpretations. First, as KM is an indicator of substrate binding, 
the lower the KM the tighter the substrate binding to the enzyme. This suggests that ATP 
binds tighter to CFTR in detergent than CFTR in nanodiscs. In addition, the ATPase rate 
of CFTR is much higher for CFTR in nanodiscs than in detergent but can be expected 
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for the high KM values of CFTR in nanodiscs. The increased ATPase rate for CFTR-
nanodiscs does show a higher catalytic rate for CFTR, which could signify the ease of 
CFTR transitioning through the NDB-gating cycle. However, the variation in the values 
for the ATPase activity for CFTR-nanodiscs leaves room for improvement and 
optimization. Currently, only a single lipid nanodiscs system for CFTR has been tested. 
More complex lipid environments in the nanodiscs could result in dramatically improved 
the kinetic parameters for the ATPase activity of CFTR. The theory that a more complex, 
physiologically similar lipid environment affects the function of CFTR could be true for 
the differences in the efficacy of a specific CFTR inhibitor. For the first time, the 
difference in inhibition of CFTR by a common CFTR inhibitor (INH172) based on the 
lipid environment, or preparation state using a detergent for solubilization and 
purification, was observed. And while it is still unknown if the difference in INH172 
efficacy is due to the detergent solubilization or the lipid environment, there are 
experiments that can elucidate the answer. The first of these experiments will be the 
incorporation of more complex lipids in the formation of the CFTR-proteoliposomes. 
The efficacy of inhibition by INH172 on CFTR from these complex lipid CFTR-
proteoliposomes can then be screened again using planar lipid bilayer channel 
recordings. This work only further suggests the importance of the lipid environment on 









Nanodisc technology, including SMALPs, has revealed that altering the lipid 
environment of a membrane protein can dramatically affect the function of and also the 
structure of the membrane protein (267, 271). Initial mass spectrometry (MS) of 
detergent-solubilized V-type ATPases revealed the identities of several copurified lipids 
(272). Native MS has additionally revealed that oligomeric states of membrane proteins 
are stabilized by the presence of specific endogenous lipids (273). This provides 
substantial evidence that lipids can play a critical role in the structure of membrane 
proteins, including CFTR. The most recent detergent-solubilized structures of CFTR 
reveal areas of electron density that could be several copurified lipids (128, 172); 
however, the only investigations into the identities of these lipids or the native lipid 
environment of CFTR are fluorescent microscopy studies. These studies show that CFTR 
localizes to cholesterol-enriched microdomains in the plasma membrane under certain 
conditions, but CFTR does exist outside of these microdomains (274). Determining the 
identity of the copurified lipids of detergent-solubilized CFTR by lipidomics MS can 
illuminate the importance of lipids structurally. Determination of the annular lipid 
environment by SMALP-purified CFTR will reveal the types of lipids critical for 
function and structure. Here, I show the first, critical steps towards SMALP-
solubilization of CFTR. In addition, I discuss the lipidomics analysis of detergent-
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solubilized CFTR and of SMALP-purified CFTR. 
5.1.1. Individual contributions.  
SMA preparation and purification of SMALP-CFTR was performed by myself. 
Lipidomics experiments and analyses were performed with the help of Georgia Institute 
of Technology’s Parker Petit Institute for Bioengineering and Bioscience including the 
Systems Mass Spectrometry Core Facility, which has been supported by the 
CF@LANTA RDP Center with funding from the Cystic Fibrosis Foundation. Dr. Josh 
Chandler (Emory University) provided useful critiques and quality control parameters to 
the lipidomics data processing.  
5.1.2. Publications resulting from this work.  
Parts of this chapter will be published as a manuscript on determining the lipids critical 
for CFTR function.  
5.2. METHODS  
5.2.1. BHK-CFTR-10xHis expression system. 
5.2.1.1. CFTR PURIFICATION FROM BHK-CFTR-10xHIS CELL LINE.   
See the previous section (3.2.2.4).   
5.2.1.2. SMALP-SOLUBILIZATION AND PURIFICATION OF CFTR. 
BHK cells were pelleted in 50 mL conical tubes at 1000 g for 5 mins at 4°C, and the cell 
pellet mass was measured. All volumes listed are for 1 g cell pellet. The cell pellet was 
resuspended in 10 mL of 8 mM HEPES-Na, pH 7.2, 0.8 mM EDTA and 1 mM DTT. 
Cells were lysed using a Dounce Homogenizer for 20 strokes with the loose pestle 
followed by 20 strokes with the tight pestle. The cell lysate was then mixed with 1/7th 
volume of 2 M sucrose in 8 mM HEPES-Na, pH7.2, 0.8 mM EDTA and 1 mM DTT and 
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was incubated on ice for 10 minutes. Large cellular debris was pelleted twice at 1000 g 
for 10 minutes at 4°C. The supernatant was ultracentrifuged at 100,000 g for 1 hour at 
4°C with slow braking. The pellet was washed in 5 mL of 50 mM Tris-HCl, pH 7.5, 0.5 
M NaCl, and 10% glycerol by resuspension using a Dounce Homogenizer (3 strokes with 
the loose pestle and three strokes with the tight pestle). The resuspended pellet was 
ultracentrifuged again at 100,000 g for 1 hour at 4°C with slow braking. The membrane 
pellet was washed in 1 mL of 50 mM Tris-HCl, pH 8.0, and 0.2 M NaCl and resuspended 
using a Dounce Homogenizer. The resuspended membranes were transferred to a 5 mL 
tube. The total membrane mass (protein and lipid content) was measured by Pierce™ 
BCA assay in accordance with the manufacturer’s protocol. To solubilize CFTR, enough 
10% SMA was added to achieve a final concentration of 2.5% per 40 mg/mL lipid and 
protein mass. The SMA-membrane sample was incubated for 1 hour at RT. Solubilized 
CFTR was separated from insoluble material by ultracentrifugation at 100,000 g for 30 
minutes at 4°C with slow braking. The supernatant was collected and incubated with 
equilibrated HisPur™ Ni-NTA resin (50 µL) for 1 hour at 4°C with rotation. The resin 
was packed in a gravity flow column and washed in increasing concentrations of 
imidazole (10 mM, 25 mM, and 75 mM) in 50 mM Tris-HCl, pH 7.5, and 0.15 M NaCl). 
The purity and confirmation of CFTR was analyzed by SDS-PAGE and Western blot 
(see section 3.2.2.5).   
5.2.2. Untargeted Lipidomics. 
5.2.2.1. PREPARATION OF DETERGENT-SOLUBILIZED SAMPLES FOR 
LIPIDOMICS MASS SPECTROMETRY.   
The detergent-solubilized CFTR samples were vortexed with 0.6 mL of 2:1 
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chloroform:methanol (CHCl3:MeOH) at 3000 RPM for 5 minutes (in pulse mode). An 
additional 0.4 mL of water was added, and the samples were vortexed again for 1 minute. 
The samples were centrifuged at 21,100 g for 5 minutes to enable phase separation. The 
organic layer was removed, and lipids were dried by vacuum. The lipids were further 
extracted by incubation of the aqueous layer with 0.4 mL 2:1 chloroform:methanol  two 
additional times and dried as previously described. All dried extracts were resuspended 
in 0.4 mL isopropyl alcohol (IPA) containing deuterated lipids as standards and controls 
(3.3% v/v of the sample), sonicated for 5 minutes, vortexed for 5 minutes and centrifuged 
at 21,100 g for 5 minutes. The supernatant was extracted and stored at 4°C until injection 
into the mass spectrometer. 
5.2.2.2. PREPARATION OF SMALP-CFTR SAMPLES FOR LIPIDOMICS MASS 
SPECTROMETRY.   
The samples were vortexed in 1 mL IPA for 3 minutes at 3000 RPM. The samples were 
then sonicated in an ice bath for 3 minutes before 3 freeze-thaw cycles with liquid 
nitrogen. The samples were centrifuged at 21,200 g for 5 minutes, and the supernatant 
transferred and stored at 4°C until analysis.  
5.2.2.3. ULTRA-PERFORMANCE LIQUID CHROMATOGRAPHY-MASS 
SPECTROMETRY (UPLC-MS).  
Samples (2 µL) were injected into a Thermo Vanquish Ultra Performance Liquid 
Chromatography (UPLC) instrument equipped with an Accucore C30 2.6 µm, 150 x 2.1 
mm column.  The mobile phase A (40 % water / 60 % acetonitrile, 10 mM ammonium 
formate, 0.1 % formic acid) was exchanged to mobile phase B (90% IPA/ 10% 
acetonitrile, 10 mM ammonium formate, and 0.1 % formic acid) at a flow rate of 0.4 
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mL/minute using the following gradient protocol: 20 to 60% in 1 minute, 60% to 70% 
in 4 minutes, 70% to 85% in 0.5 minute, 85% to 90% in 0.5 minutes, 90% to 100% in 
0.2 minutes, and ran at 100% B for 2.3 minutes before dropping to 20% in 0.2 minutes.  
The flow rate and temperature were held constant at 0.4 mL/minute and 50°C. The 
fractionated sample was then injected into a Thermo Orbitrap ID-X Mass Spectrometer 
using a scan range (m/z) of 150-2000 with a resolution of 240,000 FWHM. The data-
dependent acquisition was collected under the following conditions using high-energy 
collisional dissociation (HCD) at collision energies of 15, 30, and 45 with an isolation 
window of 0.8 m/z and a resolution of 300,000.  
5.2.2.4. DATA ANALYSIS FOR DETERGENT-SOLUBILIZED CFTR SAMPLES.   
Lipidomics features were extracted from chromatograms (m/z and retention time) and 
identified through Compound Discoverer 2.X. using the following databases: mzVault, 
compound discover, mzCloud, and in-house mass list library (determined by theoretical 
masses of lipids of interest). For the detergent-solubilized samples, a total of 35,088 
features were detected (28,482 features in positive mode and 6,607 features in negative 
mode). After the removal of background features and any features with a quality control 
score of greater than 30%, 1859 features were identified in positive mode and 267 
features in negative mode. Each biological replicate sample was run in triplicate and 
normalized peak area was averaged. Features enriched in the three biological replicates 
as compared to the blank were determined by calculating the log2 (fold change) of the 
averaged peak areas for the sample blank to the same feature peak area in the sample. 
Only features enriched by more than one log2 (fold change) in the sample over the blank 
were analyzed further. The coefficient of variation (CV) was determined for each feature 
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across the biological triplicates, and features of less than 50% CV were analyzed. 
Confidence in the annotation of the final 383 lipid identities was determined based on 
the five confidence levels described by Schymanski et al. (275), listed in Table 5.1. 
5.2.2.5. DATA ANALYSIS FOR SMALP-CFTR SAMPLES.  
Lipidomics features were detected in an unbiased fashion, as described above. A total of 
13,784 features were found across positive mode and negative mode acquisitions. 
Features that were enriched in the three biological replicates of the elution fraction 
containing CFTR were analyzed by log2 (fold change) as compared to the blanks and 
with a CV score of less than 50%, as reported above. A total of 1,520 lipids were 
identified at a confidence level of 4 or 5, in accordance with the Schymanski confidence 
levels (275).    
 
Table 5.1: Schymanski level of confidence for MS identification.  
Level Confidence Data Requirement 
Level 1 Confirmed structure MS, MS2, retention time matching, 
and reference standard match 
Level 2 Probable structure MS, MS2, library of MS2 or 
experimental data. 
Level 3 Tentative candidate MS, MS2 
Level 4 Unequivocal molecular 
formula 
MS isotope 





5.3.1. SMALP-CFTR purification requires further optimization. 
Both SDS-PAGE and Western blot analysis showed that CFTR can be solubilized by 
SMA but requires optimization to improve the solubility of CFTR. Another option to 
improve the overall solubility might be the use of one of the other available polymers 
(see section 1.4.3.2). There is CFTR present in the elution fractions, but the overall 
purification needs to be optimized as the majority of solubilized CFTR remains in the 
column FT fraction and is a result of weak binding of CFTR-SMALPs to the resin 
(Figure 5.1). There are many copurified proteins in the elution fraction, indicating the 
need for optimization (Figure 5.2).  
 
 
Figure 5.1: Western blot analysis of SMALP-CFTR. CFTR is present in the soluble 
fraction, but the majority of CFTR remains mostly in the insoluble fraction. CFTR-
SMALPs also were present in the elution fraction, which indicates minimal binding of 
SMALP-CFTR to the resin. Immunoblotting for CFTR: Primary – mouse anti-CFTR 





5.3.2. Lipidomics Mass Spectrometry (MS) of detergent-solubilized CFTR.  
Three biological replicates of detergent-solubilized CFTR samples were run in triplicate. 
A partial match in the mzCloud software, with a confidence level of 3, was 5α-cholesta-
8,24-dien-3β-ol or zymosterol (276) (Table 5.2). Zymosterol is a precursor 
of cholesterol found in the plasma membrane and is structurally different from both 
cholesterol and cholesteryl hemisuccinate (a detergent used to solubilize CFTR) (Figure 
5.3).  This match along with the structural identification of cholesterol, or a cholesterol 
derivative, from a recently determined hCFTR detergent-solubilized structure, indicates 
the possible structural importance of cholesterol for CFTR (128). The cluster of other 
lipid identities falls under level 4 identity confidence. For 382 lipid features, these were 
 
Figure 5.2: SDS-PAGE analysis of CFTR-SMALPs. Hand-cast 8% acrylamide: 
bisacrylamide SDS-PAGE gel, silver stained. CFTR-SMALPs can be seen in the elution 




identified by their chemical formulas linked to a possible name through several 
databases. Of these compounds with possible identities, approximately half (15 of 25) 
are of odd chain lipids, which only compose a small portion of cellular membranes (277); 
however, these lipids were enriched in the detergent-solubilized CFTR samples (Table 
A.1). The other 277 features can only be identified by the chemical formula (Table A.2), 
and the last 80 features are at a confidence level of 5 and can only be identified by 
molecular weight (Table A.3).  
5.3.3. Lipidomics Mass Spectrometry of SMALP-CFTR.  
Of the initial 2,097 lipid features identified, 1,520 lipids have linked chemical formulas, 
making for a level 4 confidence (Table A.4), and 577 lipids received a level 5 confidence 
with only a molecular weight determined (Table A.5). The copurified proteins taking up 
the majority of the SMALPs, however, complicates further interpretation of this data. 
  
 
Table 5.2: Lipidomics results of detergent-solubilized CFTR and analysis results. 
The abbreviation FC is the fold change, and CV is the coefficient of variation.   






















Figure 5.3: Structures of cholesterol, zymosterol, and cholesteryl hemisuccinate 
(CHS). There are apparent structural differences between the three sterol derivatives—
cholesterol (A), zymosterol (B), and CHS (C). These structural differences include the 
double bond between C-5 and C-6 of the B ring in cholesterol and CHS, but only a 
single bond in zymosterol. Zymosterol has a double bond present between C-8 and C-9 
of the B ring, which is a single bond in cholesterol and CHS. Zymosterol also includes 
another double bond present between C-24 and C-25, which is a single bond in both 




5.4. DISCUSSION.   
6 The current work shows a preliminary search into the lipid identities of the annular lipid 
environment of CFTR; however, this data, in conjunction with the many copurified 
SMALPs, complicates the confidence for an interpretation. Also, as the majority of 
CFTR remained in an insoluble fraction, the lipid profile of the SMALP-CFTR in this 
fraction most likely represents the non-majority of CFTR. Work to investigate the 
annular lipid profile for the majority of CFTR might require a different strategy, 
including using one of the aforementioned polymers or the use of MSP (189). As for the 
copurified lipids in the detergent-solubilized CFTR, a precursor of cholesterol called 
zymosterol was identified, which is also supported by several other studies. The first and 
most crucial study shows electron density similar to cholesterol, or a cholesterol 
derivative, bound to detergent-solubilized hCFTR (128). Studies of other ABC 
transporters in nanodiscs show that cholesterol clusters around the TMDs (262). Further 
analysis and replicates with reference standards for the lipidomics data of the detergent-










Nanodisc technology has revolutionized membrane protein research, leading to the 
ability to study individual membrane proteins in different lipid environments and to 
determine how the changes in these environments lead to functional or structural 
consequences. In order to utilize this technology in these types of studies, first, the 
membrane protein of interest must be purified in an active form.  
6.2. REVIEW OF WORK. 
6.2.1. CFTR homology models and understanding transition states.  
In lieu of CFTR structures, homology models of CFTR were built to investigate the 
complex transitions of conformations in this protein (130, 160-165). This work compares 
a homology model by Rahman et al. (130), to two of the recently released structures of 
CFTR (126, 128) and investigates the optimization of a homology model by flexible 
fitting into electron density maps of the initial structures of CFTR (157). Through this 
work, the interaction of three residues (E543−K968−K1292) between the ICLs and 
NBDs that might play a role in translating the consequences of ATP binding at the NBDs 
to the conformation of the TMDs was experimentally investigated by molecular 
modeling and electrophysiology. Thus, this initial work shows this interaction is likely, 
but not without complications. These simulations do not include the R-domain, and thus 
details of its role or the role phosphorylation of the R-domain on this region was not 
explored; even though this region of CFTR does play an important role in both (278).  
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As more structures of CFTR orthologs are released, simulations of these structures can 
provide valuable insight into the mechanism of CFTR’s conformational transitions as 
well as the interactions of CFTR with the lipid bilayer (167).  As all of the structures of 
CFTR released in the last three years have been of detergent-solubilized CFTR, the use 
of molecular dynamics (MD) will replace the detergent micelle with the more 
physiologically relevant lipid bilayer environment; however, as these structures of CFTR 
were solved in detergent, the likelihood of detergent-induced artifacts is high. The 
strategies we employed for the improvement of the homology models could be employed 
to these newly released structures in detergent. The initial electron density maps of CFTR 
were solved by 2D crystallography, meaning CFTR was in the more physiologically 
relevant environment of a lipid bilayer, and not detergent. By allowing these new 
structures to relax within the constraints of a low-resolution map through the use of 
molecular dynamics flexible fitting (MDFF), it is possible that detergent-induced 
artifacts could be reduced.   In fact, one study has explored this idea through the MDFF 
of two inward-facing structures of CFTR recently released (223) into these released 2D 
crystallography maps of CFTR. The states of all of these structures were closed, and so 
an open, fully conducting pore was not expected, nor was it seen (223). Thus, further 
MDFF studies of the outward-facing structures of CFTR, which is expected to be open 
within these maps of CFTR in a lipid bilayer, could reveal key interactions of the CFTR 
open state. Simulations of these modified structures could unveil the necessary 
interactions CFTR must undergo to transition from the variety of closed states to a 
conducting, fully open state for CFTR. The fact that none of the release structures or 
refined structures has displayed a fully conducting pore of CFTR begs the need for more 
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structures, especially structures of CFTR in a lipid bilayer.        
6.2.2. CFTR expression and purification.  
The complexity of CFTR biogenesis results in overexpression difficulties and places a 
high level of importance on the cell type, as is true for many other membrane proteins 
with complex biogenesis (279). We investigated three different cell types for the 
overexpression of WT-hCFTR and two different tagging systems for affinity 
chromatography to improve the yield of WT-hCFTR; importantly, we did not introduce 
solubilizing or stability mutations into our protein—a common strategy in the field. From 
these studies, we developed a reproducible protocol for the purification of decently pure 
and functional WT-hCFTR from BHK cells. Many of the optimizations methods learned 
in this system can be translated to other CFTR expressing cell lines, especially the 
optimization in the detergent solubilization step of the CFTR purification. The use of 
cholesteryl hemisuccinate (CHS) and dodecyl-maltoside (DDM) to solubilize CFTR 
improved the overall yield of CFTR from each purification. The use of this detergent, 
CHS, has shown to improve the thermal stability of other membrane proteins in detergent 
micelles (264, 265). Thus, the improvement in yield of monomeric CFTR could be 
contributed to the improved thermal stability of CFTR in a detergent micelle containing 
CHS. This hypothesis can be tested by measuring any shifts in the melting temperature 
of CFTR in different detergent micelles, including micelles containing CHS. And while 
many attempts to improve the purity of CFTR from a His-tag affinity chromatography 
system were somewhat successful, the complete removal of several co-purified proteins 
proved to be problematic. His-tag systems are notorious for having strict buffer 
incompatibilities, reduced selectivity for proteins from specific expression systems, and 
160 
 
high amounts of leached metal content in purified protein samples (280). The 
establishment of many other affinity chromatography systems, like the FLAG®-tag 
system, have dramatically improved the buffer compatibilities, purification of proteins 
from a variety of expression systems, and the overall purity (281). To improve the overall 
purity of CFTR, a modified T-Rex™ CHO cell line utilizing the FLAG®-tag affinity 
system was developed. This modified T-Rex™ CHO system utilized a CFP-reporting 
system and flow cytometry to single cell sort transfected cells for the generation of a 
homogeneous population of cells stably expressing CFTR. This newly developed system 
allows for the generation of new stably transfected cell lines in a few weeks, allowing for 
the production of many cell lines expressing different mutant versions of CFTR quickly. 
The purification of CFTR from this system still requires optimization, especially in the 
yield. One theory to the low yield could be occlusion of the tag by the glycosylation of 
CFTR, especially as the majority of solubilized CFTR remained in the column FT or 
unbound to the resin. There are a few options to improve the binding including: 
increasing the amount of resin, using deglycosylation enzymes to remove some of the 
glycosylation, or increasing the time of binding. If these strategies do not improve the 
overall yield, the FLAG-tag can be easily moved and several new cell lines development 
in a matter of weeks. The improvements and optimization of CFTR expression and 
purification allow a host of new questions to be answered, especially regarding the 
preferred lipid environment of CFTR.  
6.2.3. CFTR reconstitution and functional studies.  
The ability to purify CFTR has set the stage for the investigation into the functional 
consequences of changing the environment of CFTR. Previous work has begun to 
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investigate the consequences of the choice of detergent on ATPase activity and how the 
reconstitution of CFTR into the lipids of destabilized proteoliposomes, destabilized by 
detergent, may not be able to rescue the effects of detergent  (133). The work presented 
here on CFTR-nanodiscs is the first study of CFTR ATPase activity in a lipid bilayer 
system without restricting access of the NBDs to ATP (i.e., proteoliposomes) or in the 
presence of detergent (i.e., destabilized proteoliposomes) and compares the activity to 
that measured in detergent. While only one lipid system (POPC) has been tested, the 
results clearly demonstrated differences in the ATPase activity of CFTR in POPC than 
in detergent alone. Additional single-lipid systems and complex lipid systems, including 
the presence of cholesterol, will provide further information on the importance of lipids 
and the critical type of lipids for the ATP function of CFTR. Pairing these ATPase 
functional studies of CFTR with the thermal stability studies of CFTR in different 
detergent micelles can correlate the changes to thermal stability with the changes to 
enzyme kinetic parameters measured by the ATPase assay. Not only in detergent micelles 
but these same studies, the thermal stability assays and kinetic enzyme assays, can be 
measured for CFTR in nanodiscs of varying lipid composition. While ATPase activity is 
commonly used to confirm functional purified protein, ATPase activity speaks indirectly 
to the channel activity of CFTR. Thus, we began investigating the effects of lipids on the 
channel function of CFTR, although the initial test was to confirm that our purified 
protein retained channel activity. Here we have shown that reconstitution of the purified 
protein into single lipid proteoliposomes, POPC only, and then measuring channel 
function by fusion of proteoliposomes into planar lipid bilayers confirms the channel 
function of purified CFTR. Not only does our purified protein retain channel activity, but 
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the effect of a common CFTR inhibitor, INH172, is reduced in studies of purified protein 
versus protein from cellular membranes. The cause of this difference, whether due to the 
presence of cholesterol or from detergent-induced structural changes unable to be rescued 
by lipids, has yet to be determined. Experiments to determine the cause of the reduced 
inhibition by INH172, first, would be to reconstitute the purified CFTR protein into 
increasingly more complex proteoliposomes and measure the efficacy of INH172 on 
CFTR from these different proteoliposomes. The next experiments would be to remove 
cholesterol from the cellular membrane fractions by treatment with methyl-β-
cyclodextrin (MβCD) and recording the efficacy of INH172. The differences of efficacy 
for this specific CFTR inhibitor could ring true for other CFTR-specific inhibitors or 
even some of the approved modulators of CFTR. The mechanism of action for these 
modulator therapies is still being investigated, but the highly hydrophobic nature of these 
compounds hints towards possible binding to the TMDs. In fact, two recently released 
structures of CFTR show two bound modulators, one clinically approved and one not, in 
the TMDs (170). These results offer support for the importance of the lipid bilayer for 
the channel function of CFTR.  
6.2.4. Determination of the lipid environment of CFTR.  
The recent advances in the utilization of mass spectrometry to identify lipids and changes 
to the lipid environments of cells and membrane proteins have been fueled by the 
increased recognition that lipids are significant contributors to membrane protein 
structure and cellular function (282). This work utilizes the advancements of mass 
spectrometry lipidomics to investigate the annular lipid environment of CFTR by 
SMALPS and identify the copurified lipids of the detergent-solubilized CFTR. The lipids 
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identified from the SMALP-CFTR samples make for complex interpretations due to the 
many other copurified proteins in the samples. Currently, only one polymer, the 
commercially available SMA polymer, has been attempted in the solubilization and 
formation of native nanodiscs containing CFTR. As more polymers are released with 
various improvements, different polymers can be attempted, the first being polymers that 
have been shown to have similar capabilities of detergent (DDM) to solubilize membrane 
proteins. Moreover, the yield and purity of CFTR containing native nanodiscs can be 
improved by alteration of the affinity system used for purification. As previously 
discussed, His-tag affinity chromatography systems are not always the best choice due 
to buffer incompatibility, low purity, and challenges from a eukaryotic cell expression 
system. The development of the FLAG-tag affinity chromatography system in the CHO 
cells could provide increased purity of CFTR containing native nanodiscs. And while the 
purification of SMALP-CFTR and lipidomics of these SMALPs requires considerable 
improvement, the lipidomics results from the detergent-solubilized CFTR samples leads 
to two interesting conclusions. First, a cholesterol precursor known as zymosterol was 
identified at a level 3 confidence. This result, along with the identification of a cholesterol 
shaped electron density observed in one of the recently release CFTR structures (128), 
begs many questions about the importance of cholesterol for CFTR structure and 
function; this is an area of great interest to the McCarty lab as functional studies to 
investigate the importance of cholesterol has been much discussed in the previous 
sections. The second significant result is the large population of odd chain lipids present, 
which comprise a small portion of the lipid environment of cells. These results were both 
identified by untargeted lipidomics mass spectrometry with a relatively low confidence 
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level, level 3 and 4 respectively; however, confidence levels can be improved with the 
use of more targeted lipidomics studies. The introduction of reference standards with the 
detergent-solubilized CFTR samples can confirm the lipid identities currently 
hypothesized, at the lower confidence levels, to be bound to CFTR and will improve the 
overall confidence in the lipid identities. The lipids identified in the lipidomic results will 
inform our understanding of the structurally important lipids of CFTR and will inform 
our functional experiments of CFTR in a lipid environment.  
6.3. FINAL REMARKS. 
This work highlights the importance of the cell expression system and affinity tagging 
method for producing pure and active WT-hCFTR. This work established the 
development and use of new techniques for studying the lipid environment of CFTR and 
the need for more investigations into the functional and structural consequences of the 
environment of CFTR, as well as the need for more structures of CFTR, especially in a 
lipid environment. This work also highlights the need for computational simulations, 
both structures already published and hopefully of more structures within the lipid 





















  Table A.1: Lipidomics results of detergent-solubilized CFTR and analysis results. 
The abbreviation FC is the fold change.  The listed features were identified by the mass 
list developed by members of systems MS lipidomics core, giving a confidence level of 
4.  
Name Formula Molecular 
Weight 










Cer 37:1;1 C37 H73 N O2 563.56446 7.962 18 1.60 2.33 8.01 
Cer 45:0;2 C45 H91 N O3 693.70045 9.397 16 1.54 2.43 12.65 
Cer 45:0;1 C45 H91 N O2 677.70545 9.597 17 2.73 3.78 16.77 
Tridemorph C19 H39 N O 297.30327 2.766 12 2.31 3.23 17.54 
LPA 25:0 C28 H57 O7 P 536.38452 5.895 18 3.44 3.41 18.10 
N-Acetyl-D-
sphingosine 




C12 H23 N O10 341.1323 1.426 16 1.58 1.52 19.50 
Cer 39:1;1 C39 H77 N O2 591.59601 8.396 24 1.65 2.7 19.60 
Cer 45:0;1 C45 H91 N O2 677.70545 7.785 19 1.98 3.11 19.62 
AcCa 18:0 C25 H49 N O4 427.3664 3.544 11 2.22 2.92 21.87 
LPG 23:4 C29 H51 O9 P 574.32681 3.099 22 2.26 2.32 21.95 




C24 H47 N O3 397.35575 3.37 22 1.15 1.76 23.48 
PA 29:2 C32 H59 O8 P 602.39638 1.876 7 1.17 1.6 25.26 
Cer 46:0;1 C46 H93 N O2 691.72116 6.44 26 1.20 1.62 26.10 
Cer 47:0;2 C47 H95 N O3 721.73178 9.586 22 1.90 2.86 26.42 




C24 H47 N O3 397.35574 3.493 8 1.58 2.63 30.27 
Cer 42:1;2 C42 H83 N O3 649.63781 8.458 24 2.50 3.62 33.32 
LPA 23:1 C26 H51 O7 P 506.33745 3.905 10 2.35 2.38 34.53 




C27 H44 O 384.33935 3.929 1 5.20 5.19 41.82 
Cer 43:1;1 C43 H85 N O2 647.65855 9.307 29 1.69 2.92 44.59 




C27 H42 O 382.32371 3.011 13 3.03 3.14 49.88 
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Table A.2: Lipidomics results of detergent-solubilized CFTR and analysis results. 
The abbreviation FC is the fold change. As only a formula can be determined for these 


















 C57 H119 N9 P2 S2 1055.852 9.476 25 3.53 3.53 0.00 
 C H3 N7 O3 P2 222.9776 4.523 13 3.39 3.39 0.17 
 C26 H47 N8 O P 518.3617 3.009 25 4.29 4.29 0.36 
 C23 H45 N O3 383.3401 3.219 7 2.46 2.45 0.47 
 C55 H115 N3 O12 1009.847 9.187 12 3.81 3.81 0.79 
 C67 H107 N5 O 997.8467 9.445 21 3.39 3.4 1.06 
 C56 H104 O18 P2 1126.669 3.897 30 3.68 3.7 1.28 
 C32 H44 N10 O17 840.2878 2.88 13 2.70 2.71 1.54 
 C27 H53 N O3 439.4027 4.643 6 3.20 3.19 1.57 
 C50 H112 N7 O4 P3 967.7996 8.486 10 4.38 4.35 1.94 
 C80 H88 S 1080.659 10.005 18 2.19 2.21 1.99 
 C44 H99 N9 O9 897.7581 10.006 4 2.65 2.62 2.08 
 C64 H112 N9 O2 P 1069.868 9.475 24 3.26 3.29 2.15 
 C49 H109 N9 O10 983.8312 9.546 25 3.56 3.59 2.34 
 C31 H50 O6 518.3613 2.84 24 3.92 3.94 2.73 
 C43 H49 O11 P 772.3004 2.88 11 2.84 2.81 3.13 
 C90 H134 N8 O12 1519.012 3.907 10 4.60 4.68 3.20 
 C68 H109 N5 O 1011.862 9.447 17 3.24 3.28 3.27 
 C88 H144 N9 O7 P 1470.093 3.904 3 7.49 7.47 3.28 
 C22 H41 N O7 431.2885 1.564 16 2.82 2.85 3.29 
 C25 H56 N6 O18 P2 790.3112 2.835 18 3.12 3.16 3.39 
 C18 H26 242.2035 10.006 16 2.67 2.68 3.40 
 C23 H26 N2 330.2097 1.262 4 6.73 6.79 3.44 
 C60 H121 N3 O5 P2 1025.878 9.448 18 3.98 3.9 3.48 
 C63 H99 O4 P3 1012.675 3.906 7 3.16 3.15 3.49 
 C2 H7 O10 P 221.978 4.515 11 2.95 2.97 3.63 
 C25 H49 N O3 411.3714 3.876 9 3.88 3.87 3.74 
 C23 H52 N10 O12 P2 722.3234 2.839 21 3.43 3.38 3.75 
 C34 H47 N10 O P3 704.3127 2.876 14 2.84 2.82 3.76 
 C62 H99 N O8 985.7375 3.906 4 6.42 6.42 3.82 
 C30 H57 N O7 543.4138 1.784 25 2.07 2.1 3.83 
 C27 H44 368.3445 10.008 4 2.55 2.52 3.86 
 C27 H42 366.3288 3.905 1 5.25 5.23 3.92 
 C61 H98 O5 910.7419 9.448 7 3.00 3 4.00 
 C54 H103 N7 O P2 927.7686 9.459 7 2.98 2.94 4.01 
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 C66 H98 O P2 968.711 3.903 4 6.03 6.03 4.06 
 C29 H55 N O6 513.4033 1.792 23 2.53 2.51 4.22 
 C56 H111 N3 O4 P2 951.805 9.667 22 3.96 4.05 4.23 
 C31 H50 O4 486.3712 4.516 25 3.79 3.8 4.24 
 C49 H110 N7 O4 P3 953.7842 8.49 18 4.35 4.33 4.27 
 C58 H94 O4 854.7156 10.008 5 2.82 2.75 4.30 
 C16 H35 N O 257.272 1.666 4 3.14 3.15 4.31 
 C22 H41 N O7 431.2885 1.687 4 2.11 2.06 4.37 
 C22 H51 N10 O2 P 518.3935 1.562 5 3.57 3.55 4.37 
 C89 H143 N4 O11 P 1475.048 3.903 10 5.98 5.9 4.43 
 C52 H105 N2 O13 P3 1058.681 3.895 28 4.58 4.53 4.48 
 C24 H51 N O8 481.3618 1.942 9 4.81 4.77 4.53 
 C17 H33 N O3 299.246 2.087 8 3.25 3.21 4.60 
 C67 H113 N S2 995.8313 9.187 17 3.11 3.04 4.65 
 C16 H34 O4 S 322.2177 2.152 24 2.17 2.12 4.65 
 C5 H12 N9 O P 245.09 1.688 15 2.88 2.94 4.66 
 C20 H52 N10 O10 P2 654.3357 2.838 18 3.98 4.07 4.67 
 C27 H42 366.3288 9.838 2 3.00 2.99 4.68 
 C53 H99 N6 P3 S 944.6852 10.01 8 2.70 2.63 4.70 
 C40 H60 N2 O3 616.4607 3.006 3 8.14 8.14 4.79 
 C7 H10 N2 O2 154.0743 0.911 19 6.18 6.19 4.85 
 C57 H93 N2 O P 852.7001 9.838 7 3.03 2.98 4.86 
 C33 H63 O11 P 666.4097 2.03 9 4.05 3.95 4.93 
 C42 H54 O2 S 622.3834 2.046 7 5.15 5.06 4.99 
 C14 H31 N O 229.2407 1.25 5 2.71 2.66 5.03 
 C32 H60 N9 P 601.471 3.011 12 3.27 3.18 5.03 
 C61 H101 O4 P3 990.6928 3.905 7 4.73 4.7 5.11 
 C52 H105 N3 O6 S 899.7735 10.008 8 2.45 2.44 5.11 
 C21 H32 284.2505 3.907 7 3.64 3.54 5.15 
 C33 H53 N2 O7 P3 682.3051 3.31 12 3.20 3.13 5.20 
 C29 H51 N2 O11 P S 666.2947 1.951 12 2.66 2.62 5.22 
 C39 H86 N9 O8 P 839.634 2.98 8 3.46 3.54 5.40 
 C20 H47 N4 O7 P 486.3173 1.944 23 2.71 2.7 5.54 
 C3 H8 N2 O7 S2 247.9775 4.514 12 5.78 5.84 5.68 
 C18 H40 N5 O7 P 469.2654 1.486 11 4.19 4.24 5.70 
 C63 H103 N O7 985.7741 9.477 10 3.04 3.05 5.94 
 C32 H51 O3 P S 546.3303 3.315 10 4.27 4.31 6.14 
 C23 H54 N10 O10 P2 692.3512 2.415 22 3.17 3.17 6.16 
 C41 H52 O3 S 624.3637 2.408 24 3.44 3.43 6.26 
 C27 H45 N5 O2 S 503.3304 1.816 6 5.29 5.19 6.27 
 C27 H47 N 385.371 10.006 17 2.87 2.77 6.34 
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 C62 H103 N O4 925.7895 9.838 15 3.65 3.74 6.36 
 C18 H39 N O 285.3033 2.075 2 2.31 2.34 6.62 
 C39 H49 O2 P S 612.3203 2.173 9 1.90 1.97 6.84 
 C35 H54 O8 602.3817 2.408 27 3.77 3.71 6.91 
 C90 H153 O7 P 1377.134 7.145 20 5.13 5.2 6.94 
 C56 H100 N2 O8 P2 990.6933 3.894 26 4.99 5.05 6.98 
 C37 H76 N2 O3 596.5861 6.372 21 3.51 3.64 7.00 
 C27 H42 366.3288 3.025 4 2.61 2.63 7.14 
 C72 H144 N O11 P S 1262.019 10.007 3 3.74 3.83 7.29 
 C41 H90 N9 O8 P 867.6653 3.399 24 3.25 3.2 7.35 
 C14 H29 N 211.23 1.259 14 2.65 2.6 7.37 
 C11 H25 N10 O P 344.1948 0.899 16 3.80 3.81 7.38 
 C59 H88 N10 O2 968.7116 3.896 29 4.30 4.36 7.64 
 C60 H99 N O5 913.7529 9.545 10 3.05 3.12 7.64 
 C19 H38 O8 394.2566 1.566 20 2.60 2.53 7.65 
 C16 H29 N O3 283.2149 1.59 19 2.76 2.84 7.67 
 C34 H54 O2 494.4131 3.868 20 7.17 7.44 7.68 
 C22 H48 N9 P 469.377 1.797 16 2.01 2.03 7.73 
 C32 H64 N3 O4 P S2 649.4076 2.019 10 2.12 2.14 7.80 
 C35 H53 N4 O2 P S 624.3643 2.404 6 3.77 3.7 7.85 
 C27 H45 N6 O8 P 612.3018 2.88 21 2.16 2.13 7.95 
 C46 H107 N10 O5 P3 972.7618 8.931 11 4.10 4.1 8.05 
 C21 H44 N10 O6 P2 594.2913 3.43 27 3.09 3.1 8.08 
 C19 H28 256.2192 10.007 3 3.45 3.33 8.12 
 C64 H105 N5 943.8361 10.112 4 4.37 4.5 8.17 
 C34 H57 N O5 559.424 4.249 8 3.17 3.31 8.20 
 C35 H53 N O2 519.408 5.8 15 3.35 3.31 8.27 
 C35 H57 N O8 619.4089 2.405 3 3.21 3.18 8.30 
 C35 H70 N5 O7 P 703.503 2.403 8 3.12 3.03 8.38 
 C35 H51 O5 P S 614.3177 3.314 11 3.74 3.79 8.50 
 C61 H99 N O5 925.753 9.192 15 3.76 3.83 8.53 
 C25 H54 N5 O6 P 551.3826 2.694 9 3.39 3.27 8.53 
 C17 H44 N9 O2 P 437.3355 1.949 10 3.47 3.48 8.66 
 C31 H53 N O5 519.3927 3.415 6 3.01 3.12 8.73 
 C17 H41 N7 O S 391.3088 2.486 14 3.18 3.22 8.87 
 C63 H105 N O4 939.805 9.838 10 3.33 3.49 9.20 
 C74 H155 N9 O9 S2 1378.139 7.144 18 4.35 4.45 9.28 
 C37 H82 N9 O7 P 795.6079 3.044 6 2.35 2.44 9.33 
 C38 H47 O2 P S 598.3047 2.172 14 2.77 2.63 9.39 
 C13 H28 O4 S 280.1712 1.552 14 2.94 2.95 9.54 
 C28 H70 N9 O7 P3 737.4602 2.023 23 2.43 2.52 9.55 
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 C4 H7 O5 P3 227.9507 4.497 18 2.03 1.98 9.62 
 C61 H93 N6 O2 P3 1034.657 3.925 15 2.77 2.82 9.69 
 C27 H66 Cl N9 O5 P2 693.4339 2.022 17 2.49 2.55 9.70 
 C57 H108 N5 P3 S 987.7534 8.061 27 3.41 3.54 9.71 
 C58 H92 O5 868.6952 8.708 19 3.52 3.66 9.72 
 C27 H42 366.3288 2.87 5 3.56 3.66 9.75 
 C62 H101 N O7 971.7583 8.94 13 4.22 4.3 9.76 
 C30 H62 N5 P3 S 617.3931 2.352 11 2.69 2.78 9.78 
 C31 H48 O5 500.3505 3.012 4 2.92 3.03 9.85 
 C25 H61 N7 P2 S 553.4193 2.233 8 2.99 3.05 9.85 
 C27 H53 N5 O7 S 591.3657 1.831 14 1.56 1.52 10.16 
 C65 H103 N5 953.8205 9.838 10 3.13 3.31 10.52 
 C38 H49 O4 P 600.3383 4.839 7 3.11 3.19 10.53 
 C33 H63 N O8 601.4558 1.774 13 2.41 2.48 10.63 
 C32 H47 O2 P S 526.3038 3.432 19 2.56 2.59 10.79 
 C35 H59 N5 S 581.4506 2.48 6 3.13 3.32 10.88 
 C26 H48 N9 P 517.377 3.01 4 2.86 2.97 10.96 
 C24 H42 O6 426.2984 1.79 10 2.26 2.36 11.02 
 C29 H57 N3 O13 655.3878 2.172 17 2.44 2.34 11.06 
 C64 H111 N O4 957.8519 10.112 2 3.82 4.06 11.18 
 C28 H47 N5 O3 501.3669 1.784 25 1.84 1.91 11.29 
 C26 H56 N9 O2 P 557.4295 1.785 15 2.12 2.13 11.31 
 C41 H55 N O S2 641.3722 2.174 2 2.50 2.4 11.34 
 C42 H99 N10 O11 P3 1012.672 10.01 9 2.23 2.33 11.44 
 C18 H28 N6 O2 360.2278 1.801 8 2.00 2.11 11.45 
 C26 H45 N4 O P S 492.3065 1.785 23 2.71 2.85 11.60 
 C25 H54 N5 P S2 519.3563 2.505 23 3.76 3.72 11.60 
 C21 H38 N2 O 334.2986 3.171 7 4.31 4.03 11.86 
 C62 H105 N O4 927.8052 10.008 6 2.65 2.74 12.02 
 C26 H46 O7 470.3246 1.784 6 2.18 2.28 12.14 
 C29 H49 N5 O 483.3927 1.796 8 2.13 2.21 12.18 
 C26 H49 N O7 487.3512 1.783 4 2.14 2.24 12.21 
 C19 H52 N9 O3 P3 547.3394 1.816 14 1.58 1.65 12.32 
 C28 H53 N O8 531.3774 1.775 3 2.09 2.17 12.41 
 C28 H50 O8 514.3509 1.775 4 2.11 2.19 12.58 
 C32 H67 N O10 625.4769 2.462 8 2.65 2.61 12.70 
 C38 H35 N10 P 662.2789 3.426 21 2.91 3.01 12.72 
 C75 H155 N9 O14 1406.169 7.317 23 3.74 3.85 12.80 
 C32 H47 N9 O3 605.3814 2.013 13 2.47 2.55 13.10 
 C37 H59 N O3 565.4498 4.394 11 5.86 6.01 13.14 
 C36 H54 O2 P2 580.3589 1.765 12 2.40 2.42 13.17 
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 C36 H52 N P S 561.355 2.004 26 2.46 2.54 14.35 
 C24 H49 N4 O7 P 536.3328 1.776 15 2.59 2.65 14.43 
 C56 H99 N4 O8 P 986.722 7.164 24 4.31 4.2 14.44 
 C16 H22 214.1722 10.008 17 2.50 2.63 14.52 
 C22 H38 O5 382.2721 1.795 7 2.21 2.33 14.64 
 C63 H107 N O4 941.8205 10.007 5 2.57 2.71 14.65 
 C34 H56 N10 S2 668.4115 1.75 12 2.15 2.17 14.70 
 C23 H50 N9 O P 499.3876 1.792 17 2.17 2.17 14.75 
 C23 H44 O2 352.3343 2.372 13 1.32 1.3 14.85 
 C33 H51 N4 P3 596.3331 1.762 8 2.52 2.53 15.28 
 C90 H154 N4 O13 S 1531.122 4.626 8 7.13 7.25 15.30 
 C63 H103 N O4 937.7895 9.669 15 3.16 3.2 15.41 
 C27 H49 Cl O9 552.3068 1.772 9 2.38 2.49 15.44 
 C51 H100 N3 O4 P3 911.6917 3.322 10 3.73 4.03 15.51 
 C65 H111 N S2 969.8156 8.705 12 3.72 3.89 15.53 
 C23 H56 N9 O5 P 569.4145 1.921 7 4.11 4.09 15.58 
 C31 H60 N3 P S 537.4244 2.501 22 2.54 2.57 15.58 
 C31 H69 N3 O3 P2 593.4812 4.394 24 3.59 3.88 15.64 
 C28 H55 N5 O2 493.4346 2.168 22 2.51 2.56 15.67 
 C64 H109 N O4 955.8358 10.007 6 2.48 2.62 15.83 
 C15 H42 N9 P 379.33 2.181 29 1.58 1.52 15.86 
 C27 H54 N6 S 494.4131 2.994 18 3.13 3.24 15.98 
 C63 H105 N O5 955.8 8.704 17 3.93 3.99 16.23 
 C26 H57 N10 O7 P S 684.3856 1.749 17 2.34 2.32 16.45 
 C28 H61 N10 O9 P 712.4378 1.742 12 2.22 2.32 16.52 
 C18 H32 N4 O2 336.2526 0.918 29 3.29 3.22 16.67 
 C22 H40 N4 O2 392.3153 0.917 4 3.39 3.41 16.69 
 C90 H153 N6 O10 P 1509.14 4.622 7 6.06 6.21 16.98 
 C31 H58 N6 O P2 S 624.3852 1.758 8 2.27 2.38 17.20 
 C18 H34 N4 O2 S 370.2411 1.556 8 3.98 3.68 17.25 
 C19 H34 N2 O 306.2672 2.711 7 2.97 2.73 17.44 
 C21 H38 N4 O2 378.2996 0.917 3 3.35 3.36 17.89 
 C7 H8 N2 O4 184.0484 0.866 13 5.24 5.36 18.05 
 C15 H18 O5 278.1157 0.892 5 3.77 3.86 18.71 
 C16 H40 N10 O6 P2 S 562.2335 1.962 14 3.04 3.15 18.72 
 C29 H68 N9 O7 P 685.4981 2.197 8 3.47 3.09 18.97 
 C27 H65 N7 O P2 S 597.4456 2.22 15 2.62 2.35 18.99 
 C27 H51 N5 O4 509.393 2.243 26 2.18 2.38 19.03 
 C30 H65 N10 O10 P 756.4641 1.734 14 2.05 1.9 19.36 
 C37 H39 O P3 592.2231 2.172 6 2.12 2.05 19.78 
 C38 H86 N9 O3 P S2 811.6028 2.682 11 2.96 3.26 19.86 
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 C23 H42 N2 346.3349 2.202 12 3.54 3.61 19.87 
 C16 H25 N3 O2 291.1948 0.918 4 2.28 2.21 19.93 
 C25 H60 N8 O16 728.4119 1.74 5 2.34 2.35 20.06 
 C32 H57 O4 P 536.3981 4.622 15 4.15 4.45 20.35 
 C39 H86 N9 O9 P 855.6289 2.644 9 3.34 3.64 20.49 
 C35 H79 N7 O2 P2 S 723.5502 2.775 7 1.95 2.05 20.67 
 C35 H41 N O6 571.2939 2.173 14 2.41 2.33 20.73 
 C16 H32 N6 O2 340.2591 2.19 22 1.60 1.66 20.88 
 C45 H79 N5 O P2 767.5764 2.725 19 2.91 3.07 21.38 
 C31 H53 N O7 551.3826 2.419 21 3.09 2.85 21.47 
 C37 H65 N5 P2 641.472 2.205 16 3.04 2.83 21.57 
 C20 H51 N9 O12 S 641.3359 1.896 5 4.04 4.53 21.60 
 C20 H52 N9 P 449.4083 2.182 9 1.54 1.36 21.95 
 C63 H107 O8 P 1022.769 4.617 11 4.82 4.94 22.02 
 C22 H45 N O3 371.3401 2.712 22 1.45 1.3 22.23 
 C31 H72 N9 O7 P 713.5296 2.428 16 2.00 1.82 22.65 
 C48 H109 N10 O12 P3 
S 
1142.717 2.119 8 4.83 4.41 23.11 
 C65 H111 N O4 969.8516 10.007 6 2.82 3.05 23.15 
 C48 H106 N9 O12 P3 S 1125.69 2.118 4 4.75 4.35 23.58 
 C30 H63 N O11 613.4406 1.911 10 3.38 3.27 23.69 
 C27 H43 N6 P3 S 576.2492 2.173 2 2.02 1.81 24.01 
 C87 H142 N6 O11 P2 S 1540.994 3.934 22 5.10 4.86 24.27 
 C32 H46 N4 O2 518.361 2.726 17 2.46 2.33 24.43 
 C30 H48 N2 436.3819 4.621 11 4.42 4.56 24.73 
 C31 H73 N7 O2 P2 S 669.5033 2.446 8 2.34 2.26 24.77 
 C37 H50 P2 556.338 2.695 22 2.30 2.27 25.21 
 C34 H50 N2 O3 534.3824 3.946 11 5.08 5.13 25.31 
 C45 H90 N2 O2 690.7007 3.907 29 3.53 3.83 26.08 
 C20 H36 N4 O2 364.2838 0.925 6 3.29 3.55 26.82 
 C22 H47 N 325.3711 2.962 20 2.54 2.16 26.94 
 C17 H44 N8 O10 520.3168 2.707 14 2.43 2.27 27.14 
 C62 H117 N5 O 947.9247 9.608 15 1.47 1.47 27.49 
 C17 H46 N9 O P 423.3562 2.17 15 1.38 1.31 27.92 
 C48 H101 N7 O P2 853.7532 2.899 9 1.36 1.55 29.27 
 C45 H61 N2 O P 676.4511 2.211 19 1.26 1.31 30.25 
 C29 H66 N5 O6 P S 643.4454 1.213 26 3.05 3.32 30.43 
 C32 H66 N2 O 494.5178 4.347 16 2.04 2.03 31.82 
 C20 H40 N6 O4 428.3116 2.171 26 1.52 1.45 31.88 
 C36 H75 N O11 697.5345 2.745 21 2.20 1.96 32.09 
 C20 H42 O5 362.3034 2.226 22 1.45 1.27 32.51 
 C20 H44 N3 O14 P S 613.2269 1.43 29 2.55 2.56 33.29 
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 C5 H12 N6 O12 P2 409.9988 0.779 22 1.37 1.21 33.31 
 C19 H27 N9 O2 413.2293 1.384 10 4.10 4.84 33.66 
 C23 H51 O7 P3 532.2858 1.475 3 8.16 7.61 34.33 
 C22 H52 N4 P2 434.3663 3.944 16 3.95 3.96 34.56 
 C27 H64 N9 O7 P 657.4668 1.902 9 2.28 2.16 36.25 
 C22 H43 N 321.3397 2.643 11 2.71 3.02 37.07 
 C3 H4 N2 O6 P2 225.955 4.531 15 1.58 1.56 37.11 
 C55 H99 N7 O6 S2 1017.711 2.863 14 3.25 3.63 37.40 
 C44 H62 N9 O6 P 843.4564 1.98 29 2.14 2.53 37.47 
 C34 H57 O18 P 784.3284 1.381 24 2.31 1.84 37.71 
 C16 H33 N O3 287.2461 1.517 20 2.79 2.69 38.34 
 C30 H59 N O P2 511.4087 2.147 7 1.32 1.03 39.03 
 C41 H81 N O 603.6323 4.926 10 2.62 2.49 39.36 
 C35 H70 N5 O4 P 655.5156 1.696 12 3.71 3.02 41.28 
 C53 H103 N9 O18 S 1185.712 2.122 20 4.19 3.65 41.75 
 C42 H83 N5 O10 817.6135 2.441 22 1.71 1.41 41.77 
 C26 H36 N5 P 449.2697 2.106 13 2.36 2.64 42.89 
 C54 H103 N 765.8098 7.542 17 2.07 2.51 42.90 
 C38 H75 N5 O8 729.5608 2.471 8 1.44 1.12 43.07 
 C32 H52 P2 S 530.3275 1.881 16 2.31 2.3 43.79 
 C34 H80 N9 O8 P 773.5871 2.458 6 1.33 1.03 44.03 
 C56 H100 N7 O9 P3 1107.68 2.2 21 3.43 2.6 44.46 
 C30 H72 N9 O6 P 685.5345 2.487 9 1.36 1.19 44.77 
 C19 H41 N 283.324 2.297 7 2.50 2.71 44.79 
 C49 H111 N10 O12 P3 
S 
1156.733 2.117 5 3.81 3.32 45.10 
 C23 H49 N 339.3866 2.948 8 2.12 2.25 45.68 
 C26 H51 N O 393.3973 4.362 16 1.86 1.85 46.16 
 C55 H104 N3 O13 P3 1107.68 2.194 7 3.21 2.52 46.27 
 C61 H106 N O14 P S 1139.706 2.117 6 3.68 3.18 47.25 
 C21 H45 N 311.3553 2.574 18 1.90 1.97 47.57 
 C41 H90 N9 O9 P 883.66 2.889 25 2.97 3.16 47.63 
 C44 H97 N8 O6 P3 926.6754 4.642 15 3.30 3.41 47.91 
 C30 H72 N9 O7 P 701.5294 2.231 16 1.68 1.65 48.15 
 C47 H97 N7 O P2 837.7216 3.905 20 3.73 4.56 48.33 
 C33 H71 N8 O2 P S 674.5141 3.008 16 2.27 2.83 48.64 
 C45 H92 N2 O2 692.7163 3.927 15 3.93 4.6 49.27 
 C41 H86 N5 O4 P 743.6435 3.91 20 2.54 2.97 49.57 




Table A.3: Lipidomics results of detergent-solubilized CFTR and analysis results. 
The abbreviation FC is the fold change.  For these listed features, only molecular weight 


















   1103.648 3.912 18 3.37 3.37 0.17 
   169.9792 4.421 25 5.92 5.90 0.49 
   913.7894 10.006 8 2.98 2.97 1.69 
   1723.43 9.836 10 4.27 4.26 1.89 
   1990.451 4.609 8 4.18 4.16 2.19 
   1022.683 2.87 20 3.37 3.32 3.20 
   457.3406 1.79 24 2.09 2.06 3.80 
   1810.552 10.007 14 6.13 6.05 3.85 
   1727.461 10.009 7 4.74 4.75 3.91 
   258.2692 1.665 17 3.19 3.25 4.21 
   1956.455 3.905 8 5.97 5.83 4.65 
   1811.555 10.002 13 5.14 5.10 4.82 
   1989.448 4.612 12 3.84 3.74 4.82 
   1955.452 3.904 4 6.21 6.20 4.83 
   645.4821 1.765 26 2.82 2.76 4.83 
   969.7141 3.909 8 5.42 5.34 4.89 
   279.2539 1.676 18 1.72 1.71 4.97 
   1520.015 3.9 10 3.33 3.42 5.03 
   220.9817 4.513 6 3.10 3.18 5.14 
   1796.536 10.006 17 5.34 5.32 5.35 
   1797.54 10.003 7 5.24 5.21 5.37 
   1957.458 3.903 7 5.19 5.26 5.61 
   1799.546 9.997 9 4.68 4.60 5.63 
   1812.558 10.004 8 4.45 4.41 5.67 
   485.372 1.791 19 2.07 2.09 6.13 
   1090.67 2.881 26 3.82 3.92 6.19 
   611.3179 2.126 10 1.82 1.87 6.24 
   258.2349 10.005 7 2.54 2.50 7.40 
   1228.635 3.309 8 3.70 3.73 7.61 
   592.3357 3.019 16 2.44 2.48 7.75 
   1148.647 10.009 18 2.78 2.79 8.29 
   981.9459 7.329 16 1.86 1.90 8.49 
   366.3288 8.542 18 2.56 2.58 8.80 
   1982.389 3.903 13 4.07 3.95 9.34 
   539.3592 2.7 8 1.47 1.46 9.88 
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   470.3804 1.811 1 2.03 2.08 10.03 
   1022.683 2.875 28 3.45 3.53 10.46 
   973.7648 8.93 15 3.77 3.63 10.83 
   1960.404 3.899 28 3.62 3.82 12.55 
   689.5083 1.759 6 3.12 3.24 12.63 
   349.246 1.472 22 3.25 3.39 13.16 
   516.3614 2.737 13 2.17 2.03 13.64 
   366.3288 8.804 20 2.04 2.09 14.42 
   1035.66 3.934 19 2.64 2.53 14.83 
   271.2876 1.882 8 1.77 1.77 15.00 
   1983.392 3.904 18 3.54 3.59 15.61 
   990.7295 9.477 19 2.54 2.60 16.27 
   1057.796 8.423 14 2.69 2.89 17.00 
   955.7994 9.424 16 2.23 2.31 17.05 
   614.3175 3.029 13 2.03 2.08 18.30 
   1070.775 2.518 19 1.78 1.93 20.19 
   435.2848 1.388 22 3.07 3.27 20.66 
   1044.751 4.626 12 5.05 5.21 21.25 
   3405.6 4.512 16 3.14 3.08 21.54 
   228.1879 10.021 21 2.59 2.87 22.60 
   1967.527 4.524 20 1.48 1.38 22.73 
   1143.72 2.114 10 4.55 4.10 24.31 
   188.1565 4.542 27 1.21 1.14 24.47 
   653.5083 2.769 20 2.03 2.20 24.82 
   1510.144 4.621 9 4.13 4.13 26.25 
   386.3744 10.024 10 2.81 3.21 29.32 
   481.3982 2.178 21 1.39 1.31 30.31 
   997.8944 3.001 21 2.97 3.02 30.38 
   383.3554 3.897 13 2.55 2.91 31.76 
   423.4078 4.609 24 1.77 1.81 32.83 
   582.6432 2.079 7 2.13 2.28 34.27 
   1382.947 5.04 27 1.27 1.08 34.79 
   562.325 2.717 21 2.73 3.08 34.96 
   374.351 1.67 26 1.77 1.70 35.71 
   371.3544 4.51 12 1.29 1.08 36.19 
   551.592 3.825 27 1.56 1.46 36.32 
   1018.713 2.863 11 2.49 2.75 37.77 
   340.39 2.965 27 2.69 2.92 39.43 
   316.2016 1.798 22 1.71 1.39 39.44 
   455.2142 1.057 29 1.62 1.69 42.45 
   237.2457 1.037 21 1.40 1.44 43.64 
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   1742.721 9.97 14 3.29 4.02 46.83 
   639.3465 1.488 29 1.92 1.40 48.73 
   386.3591 4.614 21 2.99 3.41 49.11 










Table A.4: Lipidomics results of CFTR-SMALPs and analysis results. The abbreviation FC is the fold change. These features 
determined at a confidence level of 4 with the identification of the formulas only.  
 
 



























C19 H36 N7 O16 P3 S2 775.0873 5.622 13 7.17 6.88 7.24 7.12 6.86 7.21 0.24 10.56 8.42 
 
C60 H124 N5 P 945.9598 12.377 9 2.58 2.60 2.37 2.51 2.53 2.47 0.37 26.40 12.68 
 
C38 H79 N O 565.6154 5.173 9 2.22 2.17 2.25 2.21 2.20 2.23 0.49 9.39 8.57 
 
C18 H38 N2 O2 314.2926 0.896 17 2.36 0.37 2.37 2.40 0.73 2.35 0.49 45.47 13.14 
 
C27 H44 368.3435 11.256 2 9.95 9.96 9.92 9.95 10.08 9.94 0.64 15.66 2.03 
 
C29 H53 O2 P S 496.3521 5.825 14 2.53 2.30 2.58 2.51 2.33 2.55 0.69 5.80 8.15 
 
C24 H56 N7 O9 P S 649.3624 2.296 22 2.26 1.40 2.29 2.31 1.51 2.30 0.76 38.50 3.51 
 
C27 H39 N O6 473.2771 2.062 15 9.93 8.66 10.04 9.89 8.77 9.90 0.76 25.95 20.94 
 
C23 H53 N7 O2 459.4258 3.884 19 2.33 2.48 2.44 2.47 2.43 2.49 0.77 9.33 7.32 
 
C28 H46 382.3592 11.365 15 2.99 3.12 3.19 3.06 3.54 3.15 0.78 43.68 9.30 
 
C46 H92 Cl N2 O2 P3 832.6068 5.129 3 4.14 4.10 4.11 4.17 4.29 4.14 0.79 24.37 13.49 
 
C46 H75 O8 P 786.5193 5.182 9 4.81 4.83 4.76 4.81 4.60 4.80 0.97 31.25 6.60 
 
C18 H43 N6 O5 P 454.3054 3.974 7 1.72 1.52 1.59 1.76 1.52 1.63 1.05 10.35 8.56 
 
C43 H73 O10 P 780.495 5.465 9 1.01 1.04 1.12 1.00 1.01 1.02 1.07 6.51 15.16 
 
C42 H83 N2 O8 P 774.5857 5.619 6 11.29 11.35 11.28 11.30 11.39 11.27 1.12 6.27 1.86 
C53 H110 N2 O6 870.8362 9.624 22 6.07 5.88 6.04 6.07 5.74 6.05 1.13 27.90 2.46 
C33 H62 O4 522.4639 9.627 3 6.00 5.85 5.95 5.97 5.76 5.92 1.14 11.53 3.67 
C42 H83 N O4 665.6313 6.574 8 2.08 1.92 2.15 2.11 2.06 2.55 1.23 31.79 46.87 
 
C23 H54 N5 P3 493.3609 2.314 5 5.03 4.18 5.02 4.99 4.27 4.99 1.23 36.16 5.79 
 









C81 H166 N8 O12 P2 1505.21 5.615 4 10.45 10.42 10.49 10.46 10.62 10.47 1.29 22.88 1.79 
 
C20 H47 N10 O3 P 506.3579 3.401 14 3.19 2.77 3.20 3.24 2.71 3.23 1.52 15.60 11.31 
 
C35 H71 N O4 569.539 9.624 6 7.79 7.65 7.72 7.81 7.60 7.75 1.53 7.68 3.72 
 
C30 H47 N O4 485.3519 2.666 18 2.96 2.93 3.06 2.93 2.91 3.04 1.64 5.94 8.39 
 
C49 H73 N O6 771.5402 3.547 17 1.66 1.30 1.76 1.66 1.34 1.81 1.67 6.87 22.68 
 
C54 H101 N3 O3 P2 901.7321 9.624 8 6.72 6.72 6.74 6.75 6.74 6.72 1.71 2.50 4.40 
 
C20 H46 N5 O2 P 419.337 3.061 7 2.63 2.33 2.79 2.70 2.10 2.86 1.76 35.82 15.63 
 
C48 H93 O8 P 828.6569 5.206 10 4.08 4.18 4.25 4.13 4.17 4.18 1.76 15.03 10.81 
 
C29 H54 N O11 P S 655.3176 2.36 7 1.59 0.84 1.68 1.67 1.01 1.68 1.79 25.79 3.72 
 
C34 H47 N O6 565.3413 3.471 19 2.37 1.90 2.53 2.41 1.98 2.58 1.80 14.82 23.54 
 
C31 H70 N8 554.5731 7.628 6 5.63 5.57 5.64 5.65 5.59 5.64 1.87 6.07 1.37 
 
C18 H35 N O4 329.2557 2.29 11 2.15 1.30 2.23 2.22 1.42 2.20 1.90 36.05 3.64 
 
C28 H36 N6 O2 S 520.261 2.314 17 2.09 1.24 2.17 2.16 1.37 2.15 1.91 35.88 3.81 
 
C25 H53 N 367.4171 3.458 3 2.61 2.58 2.67 2.62 2.65 2.68 1.94 9.84 7.59 
 
C53 H104 N O8 P 913.7494 9.08 4 2.21 2.11 2.18 2.20 2.10 2.21 1.96 5.60 3.76 
 
C27 H56 N6 S 496.4268 2.314 9 2.07 1.21 2.15 2.14 1.35 2.12 1.97 35.79 3.90 
 
C50 H104 N2 O6 828.7895 9.623 5 13.79 13.61 13.76 13.79 13.58 13.76 2.01 7.70 0.43 
 
C77 H159 N7 O16 P2 1500.132 5.203 22 2.86 2.70 3.04 2.96 2.55 3.03 2.02 20.74 15.30 
 
C40 H86 N5 O12 P 859.6011 4.452 2 3.16 3.32 3.08 3.17 3.64 3.09 2.04 39.07 3.39 
 
C42 H83 N5 O5 737.6393 4.611 4 4.95 4.94 4.96 4.94 4.95 4.96 2.05 1.93 0.96 
 
C35 H71 N O4 569.539 5.208 3 7.74 7.69 7.73 7.77 7.75 7.78 2.05 6.50 6.09 
 
C37 H74 N4 O13 782.5252 8.07 15 6.50 6.23 6.46 6.42 6.06 6.45 2.07 37.41 7.55 
 
C47 H95 N4 P3 808.6767 4.669 3 2.77 2.60 2.69 2.79 2.61 2.70 2.08 4.80 1.90 
 
C15 H33 N4 O14 P 524.1723 2.316 13 2.06 1.97 2.13 2.12 1.77 2.18 2.09 40.49 12.13 
 
C63 H97 N O6 963.731 9.622 9 4.78 4.83 4.84 4.77 4.79 4.82 2.16 7.17 3.92 









C23 H40 N O7 P 473.2561 2.296 13 2.01 1.17 2.07 2.07 1.26 2.05 2.22 36.69 3.36 
 
C50 H75 N O6 785.5603 3.858 5 4.93 4.74 4.93 4.98 4.78 4.95 2.23 7.49 1.98 
 
C11 H19 N7 249.1702 3.137 12 4.46 4.25 4.54 4.50 4.28 4.51 2.23 12.48 9.71 
 
C42 H87 Cl N5 O2 P 759.6287 10.55 3 7.75 7.65 7.72 7.64 7.56 7.72 2.24 12.14 1.03 
 
C21 H36 N O7 P 445.2249 2.284 1 1.99 1.08 2.00 2.03 1.27 2.01 2.27 35.62 4.32 
 
C24 H55 N7 O S 489.4177 6.482 16 2.76 2.70 2.81 2.89 2.67 2.80 2.31 11.26 7.41 
 
C42 H80 N O8 P 757.5611 3.506 14 5.64 5.13 5.59 5.63 5.00 5.30 2.33 43.16 37.52 
 
C26 H53 N6 O3 P 528.3913 2.642 3 11.29 11.25 11.24 11.37 11.23 11.27 2.35 3.11 5.82 
 
C46 H79 O10 P 822.5421 5.227 13 6.65 6.66 6.57 6.66 6.85 6.52 2.41 24.38 7.63 
 
C44 H57 Cl N9 O P3 S2 919.3036 7.755 8 2.58 2.42 2.68 2.58 2.45 2.67 2.42 4.19 1.76 
 
C46 H90 N O2 P S2 783.616 4.775 12 1.52 1.25 1.66 1.55 1.05 1.62 2.45 31.26 5.68 
 
C27 H51 P3 468.3211 4.383 4 2.75 2.82 2.74 2.81 2.79 2.62 2.50 4.53 16.05 
 
C63 H133 N3 O2 P2 1025.987 11.249 2 8.95 8.94 8.96 8.95 8.98 9.01 2.50 6.46 5.73 
 
C39 H77 N2 O8 P 732.54 5.886 9 4.42 4.34 4.53 4.44 4.34 4.48 2.50 2.52 8.09 
 
C39 H81 N3 O2 623.6323 6.651 4 1.88 1.29 1.71 1.89 1.31 1.66 2.51 13.63 22.07 
 
C25 H54 N2 O P2 S 492.3422 3.928 11 2.91 2.65 2.91 2.93 2.66 2.91 2.53 0.81 2.24 
 
C49 H75 N O6 773.5563 3.532 12 1.50 1.24 1.62 1.50 1.26 1.72 2.65 3.21 19.32 
 
C43 H95 N9 O5 S 849.7182 9.629 14 8.13 8.07 8.20 8.10 8.03 8.16 2.67 10.60 9.07 
 
C26 H42 O4 418.3077 3.892 9 3.62 3.50 3.56 3.60 3.58 3.59 2.71 20.60 7.62 
 
C22 H49 N7 O8 539.3666 2.275 6 3.84 2.79 3.98 3.94 3.05 4.01 2.72 47.51 8.20 
 
C56 H116 N2 O6 912.8831 9.623 3 9.75 9.49 9.70 9.73 9.51 9.69 2.72 6.05 1.79 
 
C19 H39 N O4 345.2873 2.366 14 1.18 0.41 1.18 1.25 0.64 1.29 2.76 25.82 13.97 
 
C29 H28 O2 408.2082 2.301 12 2.07 1.24 2.11 2.12 1.31 2.10 2.78 36.86 3.15 
 
C28 H46 O4 446.339 4.384 4 2.32 2.32 2.29 2.37 2.34 2.25 2.79 3.33 6.95 
 
C27 H44 N O7 P 525.2851 2.317 8 1.82 0.91 1.87 1.85 1.09 1.85 2.80 35.44 4.45 









C35 H77 N7 O7 P2 769.5364 5.594 23 7.24 7.12 7.09 7.34 7.18 7.02 2.88 16.18 20.15 
 
C36 H84 N10 O S5 832.5444 5.626 23 6.44 6.33 6.29 6.54 6.38 6.22 2.88 16.05 20.26 
 
C15 H44 N10 O P2 442.3186 2.706 2 8.33 8.35 8.34 8.40 8.33 8.35 2.92 3.46 3.07 
 
C21 H37 N O3 351.2768 2.31 18 2.22 1.39 2.28 2.47 1.45 2.31 2.92 36.96 4.83 
 
C39 H82 N9 O6 P 803.6118 3.557 15 0.99 0.68 0.98 1.01 0.70 1.03 2.93 5.71 14.77 
 
C33 H73 N10 O4 P 704.5542 5.896 6 2.04 2.03 2.08 2.11 2.09 2.10 2.96 10.49 2.77 
 
C17 H37 N O 271.2869 10.093 11 1.29 0.49 1.01 1.17 0.09 0.99 2.97 41.33 10.54 
 
C31 H68 N8 O 568.554 4.156 6 3.12 3.15 3.16 3.19 3.13 3.16 3.05 3.23 1.63 
 
C22 H48 N2 O4 S2 468.3061 2.37 17 1.71 0.96 1.88 1.78 1.18 1.84 3.10 29.17 9.61 
 
C42 H82 N O8 P 759.5815 5.206 3 8.16 8.11 8.20 8.19 8.12 8.17 3.10 4.22 6.96 
 
C25 H43 O6 P S 502.2501 2.312 22 2.08 1.25 2.12 2.13 1.31 2.10 3.12 37.10 3.06 
 
C36 H72 N2 O2 564.5588 7.352 3 1.03 0.59 1.05 1.06 0.59 1.06 3.12 8.10 10.31 
 
C49 H52 O8 768.3654 2.304 7 1.96 1.03 2.00 1.98 1.23 1.98 3.15 35.38 4.62 
 
C29 H64 N10 O6 648.499 2.669 17 2.78 2.59 2.95 2.90 2.59 2.94 3.21 20.14 17.79 
 
C42 H75 N3 O3 P2 731.5277 8.064 13 4.96 4.87 5.33 4.84 4.59 5.33 3.23 36.91 19.64 
 
C38 H75 N6 O4 P 710.5581 5.89 2 5.66 5.63 5.70 5.68 5.63 5.68 3.23 4.87 6.04 
 
C82 H97 N8 O18 P S4 1640.554 9.622 4 7.74 7.48 8.72 7.70 7.47 8.39 3.25 5.21 45.29 
 
C14 H27 O7 P 338.1499 2.321 5 1.92 0.98 1.96 1.94 1.19 1.94 3.29 35.36 4.69 
 
C11 H33 N10 O P 352.2584 3.076 4 7.23 6.61 7.33 7.27 6.45 7.42 3.33 27.31 13.38 
 
C23 H58 N9 O P 507.4499 3.992 5 2.05 2.03 2.14 2.12 2.00 2.10 3.36 3.63 7.62 
 
C41 H47 N10 O5 P 790.3481 2.288 10 2.19 1.36 2.22 2.24 1.41 2.21 3.37 37.26 3.00 
 
C19 H41 Br P2 410.1874 1.885 21 3.17 2.53 3.38 3.22 2.36 3.17 3.38 31.47 29.77 
 
C37 H80 N10 O9 S 840.5824 5.671 12 7.53 7.45 7.66 7.53 7.45 7.65 3.39 6.15 2.30 
 
C36 H75 N5 O11 S 785.5162 5.21 7 6.51 6.39 6.45 6.49 6.25 6.45 3.43 18.90 1.51 
 
C27 H55 N 393.4331 3.329 9 3.28 1.74 2.95 3.29 1.80 2.97 3.46 29.02 21.52 









C33 H38 S3 530.2154 2.311 19 2.00 1.17 2.03 2.05 1.22 2.02 3.57 37.41 2.96 
 
C28 H52 N O7 P 545.3499 2.316 15 2.26 1.31 2.29 2.27 1.53 2.27 3.59 35.34 4.83 
 
C24 H51 N O2 385.3914 2.827 12 1.64 0.14 1.34 1.56 0.17 1.21 3.60 37.64 29.81 
 
C53 H105 Cl N6 O3 908.7939 9.083 6 2.46 2.18 2.38 2.43 2.22 2.40 3.61 6.23 2.88 
 
C49 H82 N O8 P 843.5767 5.631 19 5.62 5.71 5.82 5.66 5.60 5.80 3.61 17.94 7.34 
 
C40 H78 N O10 P 763.5335 5.217 9 6.31 6.17 6.28 6.32 6.15 6.27 3.62 3.92 1.72 
 
C24 H42 N O9 P 519.2599 2.309 24 2.41 1.59 2.44 2.46 1.63 2.43 3.67 37.49 2.95 
 
C46 H92 N2 O2 704.7157 7.844 11 1.72 1.81 1.67 1.73 1.81 1.73 3.70 9.50 7.97 
 
C40 H82 N5 O P 679.6248 11.245 6 8.52 8.51 8.51 8.52 8.45 8.52 3.70 16.79 2.31 
 
C47 H79 O10 P 834.5422 5.62 25 4.44 4.23 4.26 4.45 4.23 4.39 3.80 1.53 15.93 
 
C19 H37 N O 295.2869 1.932 13 2.16 0.28 1.59 2.00 0.55 1.59 3.81 41.95 6.21 
 
C15 H41 N9 O P2 425.2921 2.706 6 6.27 6.17 6.25 6.32 6.19 6.26 3.84 6.31 4.96 
 
C22 H41 N4 O3 P 440.2897 3.866 6 3.84 3.79 3.80 3.84 3.88 3.81 3.87 31.57 8.05 
 
C47 H89 Cl2 N O P2 815.5798 5.124 6 4.51 4.55 4.49 4.58 4.61 4.53 3.87 8.01 10.80 
 
C39 H81 N7 O7 759.6197 5.177 4 8.35 8.51 8.26 8.39 8.67 8.23 3.88 23.95 3.97 
 
C30 H66 N10 O6 662.5149 2.676 20 2.63 2.60 2.70 2.68 2.58 2.76 3.90 12.93 11.75 
 
C32 H52 N6 S 552.3997 3.85 11 2.59 2.45 2.42 2.61 2.43 2.47 4.00 14.13 20.37 
 
C52 H83 N4 O2 P S 858.5977 4.382 9 3.39 3.46 3.37 3.35 3.50 3.34 4.01 13.73 7.49 
 
C24 H38 O4 390.2761 3.453 3 1.61 1.58 1.57 1.60 1.57 1.56 4.04 2.75 2.43 
 
C41 H78 N O7 P 727.5493 5.923 4 4.13 4.10 4.22 4.17 4.09 4.20 4.05 2.95 9.91 
 
C21 H33 O7 P 428.1977 1.884 16 3.06 2.48 3.26 3.13 2.29 3.03 4.06 34.68 30.18 
 
C25 H52 N6 S 468.3957 2.308 4 1.77 0.80 1.79 1.77 1.04 1.77 4.08 35.32 5.06 
 
C16 H41 N10 O P 420.3209 3.869 4 2.49 2.56 2.54 2.54 2.56 2.54 4.09 5.88 1.02 
 
C27 H50 N O7 P 531.3345 2.283 10 2.11 1.16 2.11 2.12 1.38 2.12 4.12 37.43 5.22 
 
C50 H101 N O6 811.7629 9.623 7 11.16 11.01 11.15 11.16 10.95 11.12 4.12 9.01 4.14 









C27 H55 N O8 521.3922 2.316 2 3.35 2.53 3.35 3.43 2.64 3.37 4.14 38.55 2.49 
 
C16 H30 N O7 P 379.1764 2.321 11 1.89 0.91 1.90 1.88 1.15 1.89 4.15 35.32 5.09 
 
C37 H75 N O 549.5846 5.515 2 1.10 0.45 0.73 1.07 0.19 0.81 4.16 43.08 12.38 
 
C37 H71 N O5 609.532 7.314 5 8.32 8.40 8.30 8.36 8.46 8.30 4.18 16.07 0.96 
 
C26 H54 N6 S 482.4113 2.323 4 1.98 1.01 1.99 1.98 1.24 1.98 4.18 35.33 5.11 
 
C42 H78 N O8 P 755.5453 5.213 6 7.38 7.36 7.41 7.41 7.37 7.41 4.22 0.89 1.18 
 
C16 H35 N9 S 385.2722 2.19 5 2.99 1.91 3.18 3.06 1.99 3.16 4.22 43.42 15.18 
 
C37 H81 N9 O5 S 763.6088 5.131 12 5.59 5.60 5.57 5.64 5.62 5.57 4.24 5.24 2.44 
 
C29 H65 N7 O2 S 575.4906 4.385 7 2.33 2.36 2.46 2.39 2.38 2.45 4.25 4.19 3.23 
 
C31 H65 N3 O 495.5126 3.891 7 2.81 2.56 2.74 2.81 2.59 2.74 4.26 11.78 1.11 
 
C42 H89 N2 O8 P 780.6356 5.135 12 6.74 6.75 6.71 6.79 6.77 6.71 4.29 5.59 2.13 
 
C44 H87 N O4 693.6629 8.279 16 1.02 0.91 1.27 1.04 0.88 1.26 4.30 11.55 2.70 
 
C33 H41 N O3 499.3082 2.281 10 2.10 1.15 2.15 2.13 1.40 2.13 4.31 35.53 5.37 
 
C45 H75 N O7 741.5516 5.204 8 7.86 7.80 7.88 7.90 7.81 7.88 4.35 0.52 4.08 
 
C34 H69 N O3 539.5268 5.598 9 2.60 2.58 2.57 2.62 2.66 2.56 4.36 10.63 3.38 
 
C41 H87 N3 S2 685.6347 8.27 15 1.00 1.14 0.90 1.04 1.48 0.90 4.36 40.25 5.83 
 
C53 H109 N2 O9 P 948.7875 6.662 13 3.41 3.35 3.63 3.38 3.21 3.70 4.36 17.50 12.03 
 
C33 H63 N3 O 517.4966 3.889 7 2.03 1.78 1.96 2.04 1.80 1.96 4.39 11.22 1.15 
 
C31 H46 N4 474.3703 5.813 6 2.72 2.30 2.93 2.74 2.34 2.93 4.45 10.22 31.87 
 
C21 H40 N2 320.3186 2.825 8 1.38 0.18 1.13 1.25 0.40 1.08 4.47 28.35 10.56 
 
C23 H44 O5 400.3179 2.792 29 3.38 2.48 3.50 3.60 2.29 3.53 4.52 33.10 22.39 
 
C69 H86 O S 962.6402 8.343 8 2.57 2.50 2.48 2.60 2.46 2.55 4.52 7.08 7.83 
 
C27 H53 N O5 471.3911 2.744 15 2.89 2.83 2.87 2.92 2.70 2.95 4.52 17.02 10.54 
 
C26 H50 N O7 P 519.3323 2.36 15 1.78 1.53 1.96 1.84 1.44 1.90 4.53 30.75 9.97 
 
C28 H43 N 393.339 4.778 8 1.77 1.28 1.86 1.78 1.37 1.89 4.53 28.52 4.23 









C43 H62 N O11 P 799.407 2.321 15 2.06 1.08 2.08 2.06 1.33 2.06 4.62 35.35 5.30 
 
C39 H69 N O6 647.5118 5.472 8 3.09 3.29 3.02 3.08 3.28 3.06 4.63 11.71 5.37 
 
C33 H73 N9 595.6009 6.65 8 2.56 2.27 2.49 2.65 2.25 2.55 4.63 18.93 14.69 
 
C26 H41 N7 O2 483.3342 2.601 14 1.44 0.37 1.34 1.42 0.33 1.53 4.66 21.38 37.24 
 
C33 H77 N9 O2 P2 S3 789.4866 8.11 19 3.84 3.67 3.82 3.88 3.67 3.67 4.66 6.41 21.32 
 
C36 H74 N2 534.5844 5.561 19 2.61 1.21 2.21 2.61 1.31 2.19 4.66 39.03 13.38 
 
C57 H115 N3 O4 P2 S 999.8091 7.314 16 4.13 4.31 4.09 4.20 4.25 4.12 4.67 9.88 5.00 
 
C30 H50 N O7 P 567.3319 2.318 12 1.92 0.94 1.93 1.92 1.19 1.92 4.69 35.35 5.33 
 
C15 H20 200.156 11.259 10 3.43 3.68 3.22 3.42 3.66 3.25 4.70 23.42 5.01 
 
C20 H32 N9 O P 445.2454 1.341 20 6.88 6.44 7.02 7.00 6.59 6.98 4.73 35.36 49.26 
 
C21 H40 N8 O3 S 484.2951 4.377 10 3.20 3.29 3.18 3.23 3.28 3.22 4.76 3.42 4.90 
 
C26 H53 N O8 507.3766 2.315 3 3.75 2.77 3.71 3.81 2.95 3.71 4.78 37.63 2.28 
 
C36 H72 N6 O 604.5766 7.314 4 7.38 7.44 7.35 7.46 7.44 7.34 4.78 7.70 3.09 
 
C47 H71 N O6 745.5247 3.529 10 1.54 1.27 1.59 1.50 1.27 1.68 4.79 4.12 20.44 
 
C34 H74 N3 O2 P 587.5502 7.315 3 6.68 6.75 6.66 6.73 6.79 6.65 4.80 13.39 1.92 
 
C35 H52 O S 520.3737 4.508 5 2.96 2.79 2.92 3.02 2.97 2.91 4.82 21.50 6.28 
 
C39 H82 Cl N3 O10 787.5701 4.023 12 3.11 3.12 3.05 3.12 3.12 3.06 4.83 5.64 3.08 
 
C49 H83 N3 O S 761.6256 10.55 4 5.65 5.55 5.60 5.68 5.57 5.60 4.83 2.22 6.15 
 
C60 H125 N6 P S 992.9427 2.69 28 0.11 0.58 0.08 1.28 0.73 0.08 4.83 44.18 22.97 
 
C26 H49 N 375.3874 5.571 15 6.27 6.28 6.24 6.28 6.20 6.26 4.84 18.49 2.47 
 
C27 H40 O2 396.3021 2.337 25 2.16 1.78 2.25 2.23 1.58 2.24 4.91 42.41 3.04 
 
C19 H38 O4 330.2764 2.335 16 2.12 1.34 2.20 2.19 1.39 2.18 4.94 36.95 4.23 
 
C87 H143 N9 O12 1506.086 5.205 21 2.39 2.34 2.32 2.32 2.32 2.28 4.95 3.99 20.16 
 
C33 H59 N O2 501.4539 7.081 15 1.79 1.25 2.04 1.81 1.14 1.98 4.96 42.51 29.72 
 
C53 H89 P 756.6699 10.55 7 5.78 5.51 5.82 5.77 5.41 5.84 4.96 19.15 4.48 









C44 H77 O8 P 764.5369 5.249 4 5.94 5.94 5.94 5.97 6.17 5.97 4.97 25.95 3.30 
 
C25 H62 N9 O2 P 551.4758 3.935 6 2.03 1.95 2.03 2.10 1.96 2.05 4.97 5.46 6.69 
 
C57 H96 O15 P2 S 1114.595 3.512 9 5.81 3.03 5.69 5.80 3.22 5.78 4.98 40.86 43.52 
 
C37 H73 N O6 627.5424 5.4 22 2.21 1.49 2.40 2.52 1.39 2.66 5.03 43.36 28.40 
 
C65 H65 Cl2 N O13 S2 1201.327 8.025 6 1.22 1.07 1.25 1.16 0.90 1.31 5.07 42.31 14.12 
 
C85 H166 N3 O16 P 1516.201 5.625 14 4.77 4.78 4.81 4.84 4.61 4.80 5.08 22.63 4.34 
 
C19 H40 N2 O5 S 408.2654 2.7 10 2.18 1.86 2.02 2.20 1.80 2.06 5.08 9.38 10.96 
 
C29 H66 N10 O 570.5423 5.206 3 5.93 5.86 5.86 5.95 5.90 5.90 5.11 7.32 5.62 
 
C7 H15 Br3 Cl2 N5 O11 
P3 S4 
872.5798 1.481 17 1.59 0.81 1.32 1.70 0.85 1.41 5.14 23.28 11.97 
 
C63 H114 Cl P S 968.8067 9.187 16 1.55 1.40 1.54 1.43 1.35 1.54 5.14 7.69 5.84 
 
C18 H42 N9 O2 P 447.3192 2.429 25 5.29 5.11 5.30 5.34 5.11 5.23 5.17 34.48 13.06 
 
C13 H23 N O2 225.1725 3.133 22 1.61 1.25 1.49 1.46 1.28 1.49 5.20 2.93 8.09 
 
C54 H112 N O2 P S 869.815 9.622 8 4.21 4.11 4.31 4.29 4.05 4.30 5.21 23.20 2.50 
 
C45 H89 N3 O3 P2 781.6384 5.135 2 5.93 5.84 5.89 5.98 5.91 5.91 5.23 10.49 5.04 
 
C27 H56 N2 O 424.4386 3.832 9 2.14 0.59 1.64 2.09 0.83 1.68 5.25 28.92 17.68 
 
C41 H90 Br Cl N8 O 824.6109 10.472 22 5.43 5.21 5.37 5.44 5.25 5.43 5.26 13.57 7.30 
 
C13 H29 N8 O2 P 360.2141 2.431 11 4.16 4.14 4.18 4.26 4.15 4.12 5.28 2.73 7.86 
 
C52 H97 N2 P 780.7387 9.671 23 1.00 0.71 0.94 1.04 0.79 0.95 5.28 22.50 1.06 
C10 H31 N10 O8 P3 S 544.1255 3.079 13 0.92 0.54 0.84 1.08 0.41 0.77 5.29 18.41 10.24 
C23 H47 N6 O3 P 486.3446 2.662 2 8.70 8.78 8.80 8.67 8.79 8.81 5.32 2.33 2.28 
C46 H60 N P 657.4454 3.136 7 3.06 1.91 3.21 3.08 2.15 3.21 5.32 39.60 8.10 
 
C46 H75 N O7 753.5536 4.494 20 3.46 2.54 3.40 3.48 2.36 3.60 5.33 37.48 44.48 
 
C26 H41 N3 O8 P2 585.2392 2.353 15 1.87 1.24 1.99 1.98 1.22 1.96 5.34 27.47 6.54 
 
C18 H34 O3 298.2502 7.317 18 2.57 2.70 2.72 2.55 2.72 2.73 5.34 2.47 3.11 
 









C27 H26 O3 398.1875 1.884 26 2.84 2.02 3.02 2.94 1.99 2.78 5.36 16.14 33.29 
 
C30 H49 N O4 487.3675 2.749 15 3.68 3.65 3.58 3.81 3.59 3.67 5.42 11.21 14.65 
 
C29 H43 N O 421.3337 3.918 10 1.72 1.70 1.81 1.82 1.71 1.75 5.42 5.27 8.74 
 
C24 H53 N7 O6 535.4078 2.316 3 3.56 2.72 3.50 3.60 2.80 3.49 5.45 37.96 1.74 
 
C34 H68 N2 O2 536.5276 6.648 3 2.43 1.86 2.32 2.42 1.91 2.38 5.47 10.90 9.08 
 
C36 H73 N 519.5739 4.637 7 1.49 0.37 1.38 1.48 0.71 1.31 5.55 41.92 9.69 
 
C22 H46 N O7 P 467.3006 1.856 6 3.20 2.97 3.38 3.17 3.21 3.21 5.63 30.59 29.15 
 
C27 H62 N9 O5 P 623.4613 1.813 11 3.85 3.72 3.97 3.86 3.63 3.76 5.64 10.76 27.93 
 
C42 H88 N2 O 636.6889 8.899 3 2.00 0.59 1.83 1.97 0.82 1.87 5.64 42.66 8.16 
 
C36 H70 N O10 P 707.4724 3.552 20 1.11 0.88 1.18 1.16 0.79 1.21 5.67 13.57 10.28 
 
C20 H36 N O7 P 433.2247 1.876 19 3.05 2.50 3.28 3.09 2.28 3.06 5.68 32.60 33.11 
 
C20 H43 N9 O2 S 473.3278 1.949 12 2.47 1.74 2.59 2.49 1.65 2.46 5.73 18.28 29.09 
 
C12 H37 N10 O P 368.2899 3.034 8 4.49 3.88 4.48 4.46 4.13 4.73 5.73 29.04 39.56 
 
C12 H37 N10 O P 368.2899 3.097 8 4.29 3.69 4.28 4.26 3.93 4.54 5.73 28.95 39.56 
 
C15 H12 O 208.0883 2.287 14 1.77 0.90 1.79 1.78 1.07 1.77 5.73 34.49 5.89 
 
C35 H75 N2 P S 586.5407 7.34 4 3.85 3.36 3.89 3.92 3.39 3.90 5.74 8.95 9.79 
 
C37 H32 N4 532.2609 2.344 11 2.07 1.11 2.06 2.04 1.32 2.06 5.79 34.31 3.24 
 
C48 H77 O10 P 844.5242 5.24 13 4.38 4.61 4.40 4.36 4.49 4.24 5.81 30.88 26.11 
 
C20 H27 N 281.2138 3.078 14 1.72 1.10 1.98 1.79 1.01 2.01 5.82 48.10 3.66 
 
C22 H36 N4 356.2922 2.501 22 3.17 2.43 3.37 3.17 2.33 3.57 5.84 29.88 23.01 
 
C38 H79 N3 O2 609.6163 5.525 10 1.05 0.79 1.14 1.18 0.79 1.13 5.85 18.92 11.95 
 
C42 H79 O8 P 742.555 5.205 5 4.43 4.50 4.46 4.47 4.53 4.51 5.85 7.42 6.28 
 
C46 H66 O8 746.4724 4.384 10 3.22 3.29 3.14 3.29 3.32 3.19 5.86 4.51 9.68 
 
C29 H51 N O4 477.3813 3.414 10 2.16 2.34 2.20 2.21 2.33 2.20 5.91 2.76 5.44 
 
C80 H102 Br N10 O8 P3 
S5 









C44 H77 N9 O P2 809.5737 4.865 4 2.23 2.20 2.14 2.23 2.41 2.14 5.95 26.35 0.97 
 
C26 H53 O4 P S 492.3404 2.314 4 4.58 3.82 4.59 4.57 3.89 4.59 6.02 35.98 1.02 
 
C30 H60 N5 P 521.457 4.133 5 3.29 3.38 3.39 3.39 3.34 3.36 6.02 13.34 4.44 
 
C86 H171 O5 P 1315.287 11.249 8 11.59 11.66 11.58 11.57 11.41 11.58 6.11 33.35 0.97 
 
C37 H83 N7 S 657.6435 11.248 7 10.78 10.83 10.80 10.75 10.62 10.78 6.12 28.17 1.64 
 
C27 H56 N8 O S 540.4287 3.212 11 5.24 5.33 5.31 5.22 5.31 5.35 6.13 4.78 5.10 
 
C19 H37 N O7 391.2566 11.261 18 2.37 1.94 2.25 2.29 1.94 2.15 6.13 6.77 15.89 
 
C25 H49 N4 P S3 532.2864 2.299 17 2.31 1.53 2.32 2.38 1.51 2.37 6.18 38.95 8.04 
 
C63 H91 N O6 957.6845 8.334 19 4.48 4.28 4.54 4.52 4.27 4.54 6.18 12.88 4.17 
 
C38 H75 N O4 609.5694 4.712 10 1.91 1.84 2.10 1.95 1.84 2.42 6.21 8.42 47.99 
 
C16 H26 218.2029 11.257 12 3.47 3.65 3.40 3.46 3.69 3.39 6.21 22.98 3.77 
 
C43 H85 N O6 711.637 8.037 20 2.58 0.93 2.43 2.68 0.72 2.66 6.24 28.01 37.52 
 
C28 H57 N O 423.4434 6.363 5 1.62 0.41 1.47 1.60 0.61 1.39 6.24 34.29 18.89 
 
C50 H99 N2 O6 P 854.7276 5.652 19 2.44 2.77 2.54 2.45 2.59 2.53 6.25 23.38 2.26 
 
C26 H49 N O2 407.3757 5.5 5 2.98 1.35 2.49 3.02 1.49 2.57 6.26 30.76 22.05 
 
C34 H71 N 493.558 5.511 3 1.98 0.45 1.75 1.99 0.64 1.73 6.27 43.01 16.26 
 
C22 H47 N O2 357.3601 2.703 15 5.13 5.20 5.21 5.10 5.06 5.23 6.30 22.27 10.45 
 
C42 H81 N O5 679.6114 8.074 5 1.87 1.53 2.03 1.89 1.54 2.03 6.31 11.30 6.04 
 
C27 H62 N9 O4 P 607.4661 3.149 7 2.48 2.34 2.49 2.55 2.21 2.51 6.33 18.96 11.18 
 
C29 H50 O2 430.3795 3.512 19 3.98 2.60 3.39 4.11 3.02 3.61 6.34 42.20 46.02 
 
C11 H30 N10 O11 478.2111 2.291 18 2.06 1.35 2.10 2.17 1.30 2.12 6.34 39.96 2.90 
 
C23 H37 O7 P 456.2295 2.282 8 2.00 1.14 2.07 2.05 1.27 2.07 6.39 38.15 1.84 
 
C28 H58 N2 O6 518.4309 5.931 18 4.67 4.81 4.45 4.24 4.77 4.67 6.39 9.25 24.92 
 
C12 H34 N10 O6 414.2651 3.411 8 2.73 3.02 2.93 2.78 3.02 2.82 6.39 14.69 22.32 
 
C34 H80 N10 S3 724.5737 4.799 15 1.69 1.53 1.70 1.84 1.67 1.68 6.42 22.39 16.91 









C28 H58 N O6 P 535.3994 3.53 14 1.59 1.32 1.46 1.48 1.29 1.58 6.43 9.97 15.51 
 
C22 H57 N10 O2 P3 S 618.3608 2.644 16 4.61 4.55 4.73 4.59 4.52 4.75 6.46 9.87 4.04 
 
C41 H82 N4 O3 678.6379 3.482 29 2.37 1.80 2.56 2.45 1.96 2.59 6.49 21.96 25.55 
 
C38 H67 N O6 633.4961 5.469 9 4.13 4.20 4.04 4.12 4.23 4.05 6.53 18.90 2.38 
 
C23 H47 N O8 465.3296 2.311 6 1.93 1.09 2.04 1.89 1.36 2.04 6.53 43.95 3.02 
 
C46 H80 N O7 P 789.5655 5.636 11 6.05 6.14 6.00 5.92 6.11 6.00 6.53 13.75 0.69 
 
C34 H71 N9 O8 733.5434 5.909 4 3.15 3.07 3.15 3.13 3.07 3.14 6.56 3.12 4.28 
 
C16 H34 O3 274.2502 2.801 11 2.64 2.04 2.49 2.45 2.02 2.46 6.56 22.34 6.81 
 
C39 H83 N3 O15 P2 895.5298 1.449 14 1.18 0.23 0.97 1.22 0.36 1.03 6.57 17.50 13.13 
 
C22 H51 N9 O16 697.3466 1.44 12 1.02 0.04 0.80 1.05 0.18 0.86 6.60 16.75 13.56 
 
C17 H35 O9 P 414.2032 1.34 23 2.64 2.03 2.62 2.68 1.92 2.47 6.63 45.25 48.65 
 
C29 H61 N6 O3 P 572.4542 2.749 7 5.12 5.30 5.00 5.38 5.26 5.07 6.63 13.67 12.09 
 
C20 H53 Cl N10 O2 P2 562.3526 2.243 4 4.43 4.35 4.50 4.46 4.36 4.47 6.64 16.54 13.21 
 
C44 H92 N2 O 664.7208 9.417 16 3.42 1.69 3.07 3.40 1.97 3.11 6.66 45.66 12.01 
 
C9 H21 N3 O4 235.1542 3.132 14 1.68 1.50 1.50 1.68 1.36 1.56 6.69 19.32 7.65 
 
C23 H52 N5 O2 P 461.3836 3.547 23 5.03 4.64 4.65 5.14 4.70 4.69 6.72 11.06 5.08 
 
C24 H54 N9 O P 515.4184 4.507 7 1.60 1.52 1.53 1.61 1.51 1.57 6.80 6.67 6.33 
 
C32 H70 N O12 P3 753.4092 2.3 21 2.20 1.46 2.21 2.28 1.40 2.23 6.80 39.86 2.94 
 
C53 H96 N O8 P 905.6882 8.099 14 1.04 0.71 1.22 1.07 0.49 1.18 6.82 33.98 18.63 
 
C15 H26 N2 O2 P2 328.1455 2.287 14 2.20 1.45 2.27 2.26 1.53 2.28 6.88 37.59 3.38 
 
C35 H71 N O 521.5532 8.467 12 3.85 2.51 3.71 3.87 2.75 3.67 6.88 34.98 9.23 
 
C21 H44 N6 O6 S 508.3021 1.462 12 1.32 0.43 1.13 1.39 0.56 1.18 6.89 16.63 13.40 
 
C41 H86 Cl N4 P S4 828.5168 4.873 17 3.02 2.86 2.85 3.06 3.22 2.81 6.94 37.25 18.44 
 
C28 H57 N O2 439.4384 6.553 2 1.18 0.11 0.89 1.22 0.11 0.95 7.01 39.70 13.25 
 
C31 H67 N9 O7 677.5193 7.315 16 3.80 3.66 3.82 3.79 3.49 3.82 7.02 32.37 3.55 









C29 H64 N8 O17 796.4379 1.439 16 1.06 0.19 0.87 1.11 0.29 0.94 7.03 19.58 12.31 
 
C25 H52 N8 O S 512.3972 2.707 9 4.95 5.02 4.91 5.07 4.95 4.83 7.03 9.53 9.65 
 
C26 H57 N4 O5 P S 568.377 4.62 7 1.29 1.26 1.41 1.35 1.18 1.45 7.03 15.23 9.70 
 
C39 H75 N7 O12 833.5474 5.615 13 4.99 5.01 5.01 5.07 4.97 4.99 7.05 8.01 8.74 
 
C18 H26 242.2029 11.256 9 5.34 5.36 5.30 5.39 5.51 5.29 7.06 19.07 7.00 
 
C22 H46 N6 O6 S 522.3182 1.958 10 2.05 1.43 2.19 2.12 1.30 2.10 7.15 23.57 29.62 
 
C12 H16 160.1249 11.257 3 5.89 6.21 5.95 5.91 6.30 5.95 7.22 13.25 3.27 
 
C24 H46 N2 O3 410.3502 2.678 18 2.95 2.91 2.72 3.06 2.80 2.73 7.23 25.28 7.38 
 
C26 H49 N O3 423.3702 5.132 15 1.41 0.49 0.99 1.39 0.23 1.01 7.23 35.81 16.36 
 
C26 H46 N2 O6 482.3363 5.339 9 4.04 3.93 3.92 4.06 3.94 3.92 7.25 4.17 5.43 
 
C38 H58 O P2 592.399 2.423 14 2.00 0.06 1.60 1.90 0.43 1.41 7.26 46.44 28.23 
 
C31 H59 N7 O 545.48 7.076 8 1.65 0.92 1.65 1.63 0.94 1.56 7.28 19.43 16.39 
 
C22 H37 O7 P 444.2293 2.292 23 2.34 1.61 2.35 2.43 1.54 2.37 7.31 40.46 3.03 
 
C69 H115 N6 O11 P 1234.836 5.181 22 5.33 5.13 5.34 5.49 5.34 5.26 7.32 43.35 11.44 
 
C28 H51 N8 O P 546.3915 5.47 6 2.68 2.67 2.65 2.68 2.79 2.63 7.37 24.92 3.99 
 
C32 H52 S 468.3789 4.065 6 2.88 2.88 2.87 2.85 2.93 2.88 7.38 5.55 3.30 
 
C25 H50 N O7 P 507.3329 2.68 5 5.92 5.96 6.00 5.90 5.96 6.05 7.39 3.78 9.01 
 
C27 H43 O9 P 542.267 1.986 21 2.33 1.59 2.51 2.43 1.54 2.37 7.41 10.44 35.92 
 
C26 H55 N 381.4329 3.319 3 1.37 0.23 0.98 1.34 0.03 1.09 7.42 37.79 12.91 
 
C36 H78 N5 O12 P 803.5382 3.43 10 2.01 2.46 1.90 1.93 2.40 1.90 7.42 9.01 17.78 
 
C88 H158 N8 O7 P2 1501.173 5.196 18 3.73 3.75 3.71 3.76 3.46 3.72 7.44 41.26 5.25 
 
C34 H80 N10 O3 P2 738.5886 5.21 8 4.92 4.80 4.85 5.01 4.99 4.88 7.46 22.45 4.62 
 
C31 H69 N9 567.5698 6.656 11 2.37 1.93 2.31 2.32 1.96 2.33 7.47 20.93 5.26 
 
C38 H81 N3 O3 627.6288 10.023 19 2.64 0.97 2.31 2.58 1.36 2.34 7.52 45.99 9.60 
 
C26 H58 N8 O 498.4757 3.373 18 2.60 2.18 2.63 2.69 2.29 2.62 7.52 18.17 1.68 









C23 H55 Cl N6 O6 P2 608.3321 2.643 12 5.76 5.70 5.85 5.80 5.62 5.91 7.53 15.68 7.59 
 
C88 H166 N7 O17 P3 1686.154 2.976 23 1.24 1.24 1.77 1.44 1.23 1.87 7.56 3.53 34.19 
 
C15 H33 N3 O4 319.2479 2.249 17 0.97 1.01 0.97 1.05 0.74 1.04 7.58 36.20 10.15 
 
C28 H41 N3 O6 515.2978 2.753 11 5.57 5.32 5.66 5.59 5.32 5.64 7.59 10.15 6.46 
 
C25 H53 N3 O5 475.3997 3.892 22 2.17 2.01 2.23 2.39 2.05 2.17 7.62 12.28 12.09 
 
C32 H67 N 465.5271 4.676 2 1.47 0.14 1.20 1.46 0.07 1.26 7.65 42.88 11.89 
 
C54 H44 N8 O2 836.3594 1.902 29 3.08 2.40 3.29 3.27 2.30 3.04 7.66 17.86 34.41 
 
C8 H12 O3 156.0784 2.314 7 5.47 4.29 5.52 5.56 4.52 5.48 7.69 48.56 4.57 
 
C29 H54 N O7 P 559.3658 2.342 16 2.11 1.12 2.06 2.03 1.37 2.06 7.73 34.18 4.27 
 
C34 H71 N O 509.5529 10.2 4 1.81 0.44 1.52 1.78 0.49 1.55 7.75 39.88 10.67 
 
C22 H33 O9 P 472.1875 3.076 10 3.82 3.36 3.96 3.89 3.17 3.80 7.75 31.11 21.11 
 
C20 H40 N6 O 380.3261 4.199 12 1.62 1.69 1.59 1.69 1.68 1.69 7.75 4.85 19.39 
 
C31 H55 N O S 489.4025 2.83 1 1.36 0.38 1.52 1.38 0.61 1.49 7.77 45.18 7.45 
 
C22 H48 N8 O2 S 488.3602 2.758 8 3.59 3.55 3.61 3.67 3.59 3.66 7.78 5.42 8.48 
 
C83 H174 N5 O P S2 1352.29 11.287 15 2.51 2.53 2.49 2.52 2.67 2.46 7.81 31.64 15.03 
 
C27 H35 N2 O2 P S 482.2164 3.076 19 3.45 2.98 3.80 3.38 2.79 3.83 7.82 38.46 16.84 
 
C22 H41 N7 403.3427 3.289 13 1.77 0.54 1.55 1.99 0.64 1.55 7.83 13.58 32.86 
 
C43 H85 N O 631.6628 9.845 5 1.19 1.24 0.89 1.29 0.77 1.08 7.83 49.55 22.73 
 
C21 H34 286.2653 11.259 13 4.43 4.34 4.54 4.51 4.52 4.53 7.84 20.90 5.72 
 
C27 H45 N5 O2 471.3555 2.734 9 1.71 1.07 1.85 1.70 1.03 1.81 7.87 39.38 7.96 
 
C47 H75 O10 P 830.5134 4.869 4 1.62 1.66 1.36 1.55 1.79 1.33 7.87 36.07 18.88 
 
C39 H82 N5 O13 P 859.564 5.632 17 4.00 3.94 4.18 3.94 3.75 4.06 7.87 28.71 24.35 
 
C36 H74 N5 O16 P 863.4858 2.784 29 1.10 0.43 1.32 1.68 0.59 1.40 7.89 19.72 41.54 
 
C83 H141 N2 P 1197.083 7.314 19 5.05 5.06 5.02 5.11 5.08 4.98 7.91 21.67 4.88 
 
C24 H39 O7 P 470.2454 2.308 6 4.17 3.25 4.20 4.15 3.34 4.18 7.93 42.44 3.06 









C23 H48 N6 S 440.3641 1.985 19 1.92 1.38 2.08 1.98 1.21 1.98 7.93 27.54 26.45 
 
C87 H178 N P S2 1332.314 11.244 7 12.96 13.05 13.03 12.99 12.89 13.02 7.95 22.94 2.46 
 
C12 H32 N8 O3 P2 398.2087 2.322 17 4.39 3.29 4.82 4.52 3.38 4.76 7.96 26.46 47.77 
 
C40 H83 N3 O2 637.6479 6.651 17 2.00 1.27 1.83 2.02 1.30 1.91 7.97 12.14 9.86 
 
C16 H33 N2 O P S3 396.15 1.845 8 3.18 2.98 3.45 3.21 3.04 3.22 8.01 12.83 34.30 
 
C26 H55 N O2 413.4226 6.402 6 1.44 0.19 1.16 1.44 0.20 1.16 8.02 40.08 17.19 
 
C32 H64 N2 O2 508.4961 5.543 8 2.41 1.94 2.58 2.53 1.99 2.53 8.02 10.12 11.25 
 
C4 H4 O7 P2 225.9438 6.74 22 5.03 4.81 5.07 4.85 4.82 5.04 8.04 13.52 3.38 
 
C77 H163 Br N7 O9 P S2 1504.087 5.211 3 2.88 2.88 2.92 2.97 2.85 2.95 8.06 4.88 3.08 
 
C39 H79 N O 577.616 5.961 19 1.96 0.29 1.66 2.01 0.55 1.63 8.07 44.18 15.63 
 
C26 H51 N O3 425.3863 3.382 6 2.33 1.95 2.36 2.45 1.98 2.32 8.08 6.23 10.86 
 
C32 H53 O9 P 612.3438 2.657 19 4.15 4.11 4.08 4.16 4.12 4.11 8.09 7.23 8.85 
 
C29 H65 N10 O3 P 632.4983 5.468 9 4.11 4.08 4.07 4.08 4.10 4.11 8.10 7.86 8.87 
 
C19 H37 N O 295.287 3.346 16 1.67 0.37 1.41 1.77 0.45 1.36 8.11 21.48 14.94 
 
C42 H93 N5 O10 P2 S2 953.5835 3.489 10 1.66 1.31 1.74 1.63 1.33 1.85 8.11 4.59 20.22 
 
C10 H18 O2 170.1304 2.828 4 1.38 0.37 1.54 1.42 0.55 1.59 8.14 43.13 9.04 
 
C24 H47 N O3 397.3552 3.014 10 2.35 2.18 2.26 2.31 2.12 2.26 8.14 9.11 4.66 
 
C37 H73 N O5 611.5483 4.136 5 1.23 1.05 1.49 1.39 1.49 1.50 8.18 44.73 41.99 
 
C36 H77 N7 O11 783.5693 3.442 10 4.55 4.98 4.30 4.58 5.04 4.20 8.18 13.37 31.56 
 
C42 H75 N10 O5 P 830.5663 3.802 14 2.56 2.87 2.70 2.53 2.84 2.70 8.18 15.22 0.81 
 
C36 H80 Br N9 O2 749.5632 10.758 10 3.66 3.41 3.30 3.60 3.46 3.42 8.19 22.31 17.42 
 
C30 H44 N4 460.3547 5.321 10 2.95 2.85 2.80 2.95 2.91 2.81 8.22 10.02 3.88 
 
C38 H76 N3 O3 P S 685.5342 3.126 13 1.72 1.78 2.00 1.94 1.75 2.03 8.23 9.02 15.76 
 
C62 H93 O12 P S 1092.612 3.517 6 5.28 2.99 5.13 5.34 3.02 5.28 8.24 23.68 36.21 
 
C24 H47 O12 P 558.2792 2.643 20 2.33 2.47 2.62 2.46 2.36 2.64 8.24 21.31 15.60 









C18 H38 O3 302.2816 3.12 11 3.77 3.52 3.90 3.78 3.55 3.87 8.27 5.91 4.89 
 
C19 H41 N3 O5 391.3055 2.753 15 3.03 2.59 2.95 3.07 2.51 3.06 8.27 29.56 19.41 
 
C30 H34 O4 458.2449 2.333 24 2.36 1.65 2.36 2.44 1.54 2.38 8.27 41.42 4.05 
 
C26 H51 N5 O3 481.3974 2.829 12 2.73 1.85 2.91 2.73 1.80 3.13 8.33 27.27 34.08 
 
C15 H43 N10 P 394.3425 4.769 13 3.09 2.80 3.33 3.20 2.76 3.36 8.35 29.47 6.30 
 
C19 H38 O4 330.2765 3.075 10 5.83 5.05 5.91 5.86 4.84 6.03 8.36 28.19 17.81 
 
C36 H66 N2 O2 558.5096 6.661 4 2.64 2.10 2.58 2.64 2.14 2.63 8.40 12.43 8.43 
 
C39 H84 Cl N9 P2 775.6023 10.553 8 4.35 4.21 4.33 4.33 4.14 4.29 8.40 23.45 5.02 
 
C37 H75 N O 549.5846 5.02 3 1.94 0.53 1.67 1.93 0.73 1.72 8.44 42.58 8.99 
 
C13 H27 N O 213.2089 2.178 12 1.37 0.83 0.88 1.48 0.61 0.83 8.44 33.65 17.40 
 
C50 H106 N10 O2 P2 940.797 8.077 20 1.33 0.97 1.52 1.37 1.32 1.50 8.46 43.32 11.69 
 
C59 H103 N2 O5 P S2 1014.705 3.465 19 5.45 2.15 5.37 5.29 2.59 5.33 8.47 48.68 25.32 
 
C20 H43 N O3 345.3254 7.317 16 2.35 2.42 2.27 2.35 2.49 2.22 8.50 9.40 9.82 
 
C39 H76 O2 S2 640.5312 3.831 7 2.76 2.67 2.75 2.84 2.72 2.76 8.52 12.43 4.58 
 
C52 H95 O13 P 958.6504 5.471 5 2.78 2.74 2.76 2.86 2.99 2.77 8.53 40.26 7.47 
 
C42 H87 N O6 701.6526 8.063 15 1.04 0.83 1.16 1.11 1.03 1.24 8.56 24.65 14.02 
 
C37 H82 N6 O7 P2 784.5717 3.442 9 3.92 4.51 3.77 4.05 4.56 3.62 8.57 10.01 47.75 
 
C35 H71 N O4 569.5387 7.315 7 5.54 5.62 5.50 5.58 5.59 5.53 8.58 5.65 4.20 
 
C23 H48 N O7 P 481.3161 3.852 8 1.72 1.65 1.81 1.73 1.48 1.67 8.58 32.64 20.89 
 
C27 H66 N9 O4 P 611.4966 3.362 7 3.12 3.16 3.37 3.24 3.24 3.37 8.58 12.23 21.94 
 
C31 H51 N4 P3 S 604.3074 4.836 15 1.15 0.22 1.60 1.09 0.17 1.38 8.59 27.21 48.48 
 
C82 H175 N10 O16 P3 
S2 
1713.183 3.271 7 3.56 3.75 4.10 3.87 3.72 4.06 8.59 3.62 8.42 
 
C40 H86 N5 O2 P 699.6509 8.457 4 1.86 2.16 1.96 1.95 2.24 1.95 8.60 22.43 6.89 
 
C40 H79 N O6 669.59 8.091 15 4.48 3.17 4.32 4.38 3.35 4.61 8.61 23.63 40.56 
 









C14 H24 O5 272.1618 2.312 5 3.90 2.98 4.18 3.91 3.16 4.20 8.64 47.16 3.17 
 
C35 H73 N 507.5733 6.2 17 3.88 1.59 3.71 3.81 1.97 3.49 8.67 45.30 29.37 
 
C85 H172 N2 O3 P2 S2 1395.228 11.251 12 5.51 5.58 5.51 5.60 5.27 5.55 8.71 40.09 11.67 
 
C16 H35 N O 257.2715 2.341 5 3.09 2.94 3.21 3.40 2.86 3.70 8.72 9.60 49.35 
 
C63 H103 N O6 969.776 8.079 18 1.25 0.76 1.37 1.30 0.65 1.44 8.73 34.00 13.98 
 
C37 H77 N O 551.5998 5.436 3 1.13 0.17 0.81 1.17 0.13 0.84 8.73 42.26 6.44 
 
C31 H55 N O4 505.4128 4.387 11 2.27 2.35 2.32 2.35 2.37 2.35 8.76 11.12 7.28 
 
C22 H46 N8 O S 470.3502 3.214 8 3.78 3.76 3.90 3.77 3.76 3.83 8.76 4.04 12.88 
 
C19 H35 N3 305.2825 1.831 10 8.08 8.01 8.16 8.07 8.03 8.22 8.78 2.41 11.86 
 
C37 H73 N2 O8 P 704.5089 8.057 28 8.06 7.34 7.70 8.10 7.30 7.89 8.80 9.15 22.61 
 
C27 H55 N O 409.4277 5.924 6 2.05 0.60 1.76 1.97 0.88 1.74 8.82 37.21 18.97 
 
C44 H88 N9 O13 P S 1013.596 3.529 6 6.99 6.79 7.23 7.14 6.81 7.25 8.83 44.82 39.08 
 
C51 H108 N5 O3 P 869.8188 5.047 15 3.82 2.48 3.35 3.78 2.36 3.41 8.88 45.80 18.00 
 
C13 H25 O7 P 324.1342 1.969 7 1.92 1.43 2.10 2.03 1.24 1.99 8.89 25.31 29.53 
 
C87 H150 N9 O5 P S3 1528.068 5.215 21 2.30 2.36 2.41 2.34 2.32 2.37 8.90 9.84 8.76 
 
C30 H73 N9 O2 P2 653.5389 7.313 8 2.18 2.47 2.18 2.28 2.29 2.16 8.90 22.18 15.01 
 
C27 H53 N O2 423.4069 7.321 4 1.91 0.37 1.62 1.88 0.58 1.66 8.97 39.90 15.92 
 
C25 H52 N O7 P 509.3479 4.379 7 2.93 3.02 2.90 2.87 3.01 2.90 8.98 3.38 1.52 
 
C22 H47 N O2 357.36 4.886 6 2.55 1.37 2.10 2.66 1.46 2.27 9.01 19.17 19.65 
 
C32 H41 N P2 501.2717 1.696 13 8.45 8.55 8.73 8.45 8.57 8.72 9.04 24.22 13.86 
 
C37 H87 N8 O5 P3 816.6025 3.59 14 1.95 2.06 2.25 2.08 2.08 2.24 9.05 9.55 11.51 
 
C39 H76 N6 O2 660.6048 8.064 12 1.11 0.92 1.22 1.17 0.85 1.28 9.07 9.17 13.96 
 
C40 H84 N2 O2 624.6521 5.978 16 1.75 0.28 1.76 1.77 0.29 1.45 9.12 44.14 41.12 
 
C23 H42 N O7 P 475.2719 2.323 27 2.50 1.81 2.51 2.60 1.68 2.53 9.14 41.94 3.48 
 
C48 H80 N O8 P 829.566 10.474 3 4.34 4.28 4.40 4.38 4.27 4.39 9.14 11.05 7.17 









C31 H51 N3 S 497.3815 3.878 17 3.80 3.85 3.93 3.77 3.88 3.92 9.18 14.60 4.65 
 
C27 H55 N O 409.4277 7.678 7 1.40 0.08 1.07 1.38 0.01 1.13 9.22 33.64 29.20 
 
C35 H53 Cl N6 O 608.3945 2.622 10 3.89 3.75 3.76 3.94 3.74 3.81 9.23 7.61 14.56 
 
C13 H20 O2 208.146 3.129 18 1.83 1.41 1.65 1.67 1.42 1.61 9.24 7.82 12.45 
 
C38 H79 N O 565.6156 4.917 7 4.38 4.62 4.37 4.34 4.61 4.45 9.24 11.78 11.46 
 
C20 H32 N2 O2 332.2458 2.186 2 2.13 0.83 1.77 2.05 0.77 1.80 9.25 44.76 8.07 
 
C27 H53 N O 407.4121 5.5 5 2.64 1.48 2.46 2.61 1.55 2.38 9.26 41.64 18.88 
 
C40 H30 N9 O2 P 699.226 4.73 8 2.11 2.12 2.17 2.04 2.15 2.17 9.29 12.16 3.13 
 
C58 H115 N O6 921.8715 11.632 4 2.30 1.41 2.25 2.31 1.67 2.43 9.30 36.82 35.93 
 
C65 H129 N O6 1019.982 11.757 7 2.70 1.79 2.85 2.67 2.18 3.10 9.33 47.34 38.61 
 
C21 H32 Br3 Cl4 N6 O3 
P3 S2 
949.7501 8.078 14 1.13 0.95 1.23 1.14 1.30 1.28 9.34 49.32 13.97 
 
C25 H51 N O2 397.3914 6.959 16 1.84 0.67 1.69 1.92 0.66 1.63 9.34 34.73 12.24 
 
C39 H73 N O13 763.5063 1.961 11 2.07 1.69 2.24 2.14 1.83 2.15 9.35 20.68 25.44 
 
C51 H97 N10 P 880.7636 8.185 16 2.12 2.25 2.28 2.37 2.27 2.29 9.35 6.24 10.60 
 
C86 H163 N O18 1498.189 8.073 12 0.99 0.84 1.28 1.05 0.90 1.16 9.39 15.56 16.97 
 
C24 H47 N O7 461.3344 2.427 12 1.81 1.81 1.89 1.81 1.72 1.88 9.40 16.08 15.76 
 
C38 H77 N O 563.6002 4.248 22 1.28 1.70 1.39 1.19 1.56 1.36 9.45 30.27 10.20 
 
C37 H73 N5 O8 715.5437 2.909 10 5.09 4.17 5.26 5.15 4.12 5.39 9.47 14.90 43.22 
C17 H45 N9 O P2 453.3232 3.236 9 3.68 3.63 3.73 3.59 3.65 3.65 9.49 2.54 14.19 
C12 H20 O6 260.1254 2.314 25 5.16 3.62 5.51 5.26 3.80 5.50 9.54 29.60 5.82 
C26 H51 N O2 409.3913 7.036 4 1.11 0.51 0.63 1.13 0.22 0.78 9.55 34.40 19.31 
 
C36 H35 N4 O6 P S 682.202 2.659 11 3.48 3.54 3.46 3.73 3.54 3.43 9.58 2.37 8.36 
 
C35 H73 N O 523.5687 4.875 5 1.10 0.21 0.92 1.22 0.21 0.96 9.60 40.54 16.70 
 
C36 H76 N2 O 552.5951 7.319 7 1.26 0.21 0.98 1.19 0.08 0.99 9.63 35.49 9.75 
 









C35 H71 N 505.558 5.307 9 1.90 0.70 1.77 1.85 0.65 1.70 9.63 41.44 17.33 
 
C21 H48 N5 O2 P 433.3524 3.12 13 2.78 2.35 3.13 2.96 2.38 3.15 9.67 16.58 3.75 
 
C59 H61 Cl2 N7 O4 P2 
S2 
1127.308 7.909 10 3.77 3.78 3.70 3.71 3.69 3.76 9.68 17.42 13.31 
 
C27 H50 N4 O2 462.3926 2.306 13 1.65 0.24 1.17 1.55 0.56 1.13 9.68 34.86 18.43 
 
C19 H33 O9 P 436.1853 3.397 12 2.98 1.97 2.83 3.08 1.90 2.95 9.72 14.82 29.95 
 
C28 H59 N2 O4 P 518.4192 2.327 19 2.18 0.97 1.12 2.14 0.93 1.19 9.72 9.75 15.11 
 
C15 H35 N7 S2 377.2414 2.418 17 4.84 4.81 4.84 5.05 4.90 4.83 9.74 11.22 2.97 
 
C57 H126 N8 O6 P2 S 1112.9 9.659 21 5.50 5.58 5.63 5.55 5.44 5.62 9.79 23.82 10.58 
 
C15 H36 N5 O P S 365.2384 2.927 14 2.19 1.29 2.43 2.36 1.41 2.42 9.79 45.69 9.74 
 
C27 H58 N8 O2 S 558.4387 2.746 4 6.32 6.17 6.11 6.47 6.16 6.14 9.82 11.87 6.99 
 
C21 H44 N O7 P 453.2848 3.418 16 1.31 1.70 1.41 1.34 1.72 1.35 9.85 3.81 11.18 
 
C30 H61 N O 451.4749 7.948 18 1.55 0.16 1.31 1.50 0.24 1.44 9.87 37.15 24.95 
 
C16 H23 N3 O4 321.1682 1.806 20 2.86 1.87 2.53 2.71 2.08 2.57 9.92 23.94 7.78 
 
C26 H47 N O2 405.3603 4.304 4 2.47 0.82 1.83 2.38 0.99 1.97 10.01 39.03 19.79 
 
C15 H35 N10 O2 P 418.2671 11.257 8 3.99 3.76 3.73 3.91 3.89 3.82 10.04 28.10 11.25 
 
C24 H49 N7 O 451.4016 3.497 17 3.12 3.04 2.94 3.12 3.09 2.99 10.05 8.17 12.91 
 
C56 H104 O12 P2 1030.7 2.79 25 3.88 1.94 3.48 3.79 2.00 3.46 10.05 33.22 33.81 
 
C63 H93 N O6 959.7003 8.579 16 2.49 2.35 2.43 2.61 2.24 2.40 10.06 19.28 6.94 
C25 H56 N5 P 457.4277 6.832 7 1.43 0.64 1.37 1.48 0.51 1.28 10.06 44.63 14.41 
C18 H43 N6 O14 P 598.2548 1.444 26 0.93 0.21 0.84 1.11 0.15 0.88 10.08 17.56 16.63 
C31 H70 N10 O 598.5726 8.028 13 0.94 0.63 1.05 1.01 0.42 1.12 10.11 40.42 16.94 
 
C56 H74 N2 O2 806.5745 3.926 19 1.09 1.26 1.10 1.26 1.14 1.12 10.12 26.00 2.16 
 
C43 H87 N O4 681.663 8.089 22 1.60 1.18 1.25 1.53 1.15 1.25 10.13 18.04 1.69 
 
C28 H46 O4 446.3401 3.223 6 2.63 2.11 2.63 2.79 2.18 2.53 10.15 8.88 33.03 
 









C35 H77 N4 O2 P 616.5784 8.071 9 1.14 0.96 1.23 1.15 1.33 1.27 10.15 49.72 14.03 
 
C29 H45 N O4 471.3339 2.748 2 6.54 6.52 6.62 6.53 6.51 6.62 10.19 1.57 5.18 
 
C31 H65 N O 467.5061 9.652 4 2.97 1.54 2.71 2.98 1.69 2.71 10.21 40.66 11.96 
 
C25 H53 N O 383.412 8.187 5 1.88 0.38 1.58 1.87 0.56 1.68 10.23 38.70 18.86 
 
C59 H99 N S 853.7484 9.631 18 4.51 4.48 4.54 4.68 4.78 4.48 10.28 33.81 14.98 
 
C41 H58 Cl N7 P2 S5 905.2513 7.547 8 2.55 2.44 2.46 2.50 2.41 2.54 10.30 22.45 9.91 
 
C40 H84 N2 O 608.6574 8.466 5 1.40 0.15 1.21 1.33 0.10 1.28 10.30 47.73 12.55 
 
C20 H45 N3 O5 S 439.3056 2.752 9 3.15 3.23 3.30 3.30 3.32 3.34 10.33 11.70 6.76 
 
C21 H17 N5 O16 P2 S 688.9863 3.052 15 3.48 3.56 4.04 3.94 3.55 4.13 10.37 9.79 21.87 
 
C28 H45 N O4 459.3349 2.283 6 4.81 4.78 4.85 4.85 4.73 4.82 10.42 6.49 6.97 
 
C16 H28 O6 316.1881 2.314 2 2.07 1.11 2.13 2.07 1.25 2.16 10.45 45.85 4.63 
 
C37 H80 N4 O10 P2 802.5357 3.338 6 3.41 3.72 3.29 3.32 3.72 3.24 10.48 9.66 15.22 
 
C54 H74 O3 S 802.5349 3.421 6 1.79 2.10 1.67 1.70 2.10 1.62 10.48 9.66 15.22 
 
C39 H77 N O5 639.5798 4.781 7 2.30 2.34 2.42 2.54 2.71 2.64 10.51 39.18 32.85 
 
C50 H104 N4 O3 S2 872.7552 3.385 27 5.75 5.12 5.96 6.03 5.13 5.81 10.51 12.35 20.35 
 
C24 H54 N5 O P 459.407 6.628 7 1.58 0.29 1.32 1.61 0.33 1.32 10.52 38.49 12.26 
 
C21 H35 N 301.2763 4.185 8 1.17 0.24 0.98 1.12 0.19 1.00 10.52 38.49 6.18 
 
C21 H38 N O7 P 447.2403 1.919 17 2.50 1.94 2.68 2.59 1.74 2.50 10.54 32.94 28.21 
 
C28 H60 N2 O 440.4702 4.11 7 2.52 0.40 1.85 2.39 0.75 1.92 10.54 40.13 20.53 
 
C24 H49 N O 367.3813 2.616 14 1.59 0.41 1.47 1.54 0.47 1.47 10.55 42.69 15.46 
 
C5 H14 N O4 P 183.0657 5.62 16 3.24 3.17 3.23 3.29 3.35 3.21 10.56 21.46 3.05 
 
C37 H67 O10 P 702.4458 4.867 19 6.35 5.42 6.39 6.25 5.23 6.47 10.58 38.52 24.37 
 
C82 H164 N10 O9 P2 S 1527.188 5.617 7 7.84 7.82 7.87 7.99 7.89 7.92 10.60 14.90 10.70 
 
C16 H45 N10 O4 P 472.3372 2.751 4 5.83 5.53 5.82 5.70 5.53 5.83 10.61 2.12 12.47 
 
C21 H33 N3 O4 391.2466 2.08 8 1.19 0.43 0.55 1.19 0.58 0.58 10.69 44.64 26.56 









C44 H25 O9 P3 790.0713 5.652 17 2.32 2.22 2.33 2.36 1.95 2.35 10.70 46.60 1.78 
 
C19 H31 N O4 337.2244 1.883 22 2.85 2.33 2.98 3.30 2.11 2.80 10.71 37.70 27.98 
 
C60 H120 N2 O15 S 1140.841 3.499 16 3.07 3.07 3.30 3.31 3.16 3.30 10.71 13.38 20.76 
 
C27 H55 N O2 425.4227 6.492 2 1.03 0.09 0.76 1.01 0.03 0.81 10.74 30.81 13.40 
 
C23 H58 N10 O6 570.4528 2.717 3 3.20 2.42 3.36 3.22 2.44 3.45 10.74 9.85 36.70 
 
C21 H39 N O 321.3025 5.033 15 1.81 0.56 1.57 1.82 0.69 1.51 10.76 17.62 10.94 
 
C19 H34 O4 326.2451 2.33 15 5.33 4.07 5.21 5.61 4.16 5.47 10.78 15.11 32.71 
 
C25 H45 N3 O2 419.3508 2.186 3 1.42 0.16 0.96 1.33 0.04 0.90 10.80 40.47 10.14 
 
C13 H18 174.1405 11.257 7 5.04 5.22 5.17 5.06 5.28 5.16 10.81 8.15 9.88 
 
C38 H76 N2 O2 592.5902 7.658 4 1.20 0.45 1.43 1.38 0.56 1.33 10.82 22.11 24.33 
 
C20 H46 N10 426.3897 4.814 23 1.66 1.32 1.43 1.67 1.37 1.47 10.82 10.10 8.05 
 
C37 H75 N O 549.5847 8.894 6 3.05 1.54 2.76 2.99 1.80 2.78 10.83 37.66 10.10 
 
C21 H33 N3 O3 375.2511 1.54 9 2.28 1.26 2.06 2.34 1.35 2.09 10.87 16.57 5.38 
 
C15 H22 202.1717 11.258 22 4.10 4.36 4.29 4.18 4.33 4.28 10.94 20.23 8.61 
 
C23 H31 O7 P 450.1806 2.28 6 1.96 1.05 2.00 1.92 1.24 2.01 10.96 37.58 1.24 
 
C23 H48 N O7 P 481.3164 2.291 6 5.92 5.90 5.97 5.96 5.86 5.93 10.96 5.56 7.57 
 
C30 H61 O4 P 516.4294 3.085 6 3.18 1.91 3.37 3.19 2.32 3.40 10.98 45.34 7.06 
 
C21 H49 N10 O6 P 568.357 3.557 22 4.82 4.63 4.55 4.75 4.66 4.58 10.99 9.17 6.07 
 
C21 H49 N10 O6 P 568.3569 3.54 22 4.90 4.88 4.76 4.83 4.89 4.73 10.99 12.07 9.68 
 
C27 H53 N O 407.4121 5.892 4 1.91 0.59 1.49 1.87 0.76 1.45 11.00 31.92 8.16 
 
C23 H43 N O2 365.329 3.752 19 1.08 0.83 0.67 1.11 0.53 0.69 11.02 43.06 15.08 
 
C29 H59 N O6 517.4341 3.113 7 3.04 1.76 3.23 3.05 2.18 3.25 11.06 45.39 7.18 
 
C58 H63 N8 O18 P3 S2 1316.291 11.245 5 7.12 7.16 7.26 7.14 7.09 7.25 11.06 19.54 2.04 
 
C22 H48 N9 O2 P 501.3661 2.618 4 3.61 3.17 3.80 3.78 3.08 3.82 11.10 10.98 20.55 
 
C25 H52 N6 S 468.3958 2.357 4 1.45 0.68 1.58 1.51 0.98 1.66 11.10 36.87 12.32 









C54 H98 Cl N3 O S2 903.6839 9.187 13 3.82 3.92 4.02 3.76 3.89 4.12 11.14 11.27 12.08 
 
C23 H54 N9 O P 503.4181 2.831 3 1.63 0.38 1.68 1.52 0.72 1.68 11.15 38.49 7.16 
 
C12 H27 N9 O4 361.2172 11.25 8 4.02 4.31 4.36 4.11 4.20 4.37 11.17 17.95 9.71 
 
C72 H144 N5 O2 P3 1204.053 9.629 13 4.37 4.48 4.57 4.38 4.52 4.51 11.17 10.27 9.29 
 
C18 H46 N8 O6 S 502.3247 2.312 17 3.37 2.69 3.36 3.37 2.84 3.30 11.20 38.22 8.43 
 
C27 H44 O3 416.3283 3.472 23 2.37 2.05 2.42 2.31 2.06 2.58 11.22 8.90 17.31 
 
C25 H58 N9 O P S 563.4217 4.621 12 1.51 1.46 1.66 1.62 1.47 1.69 11.23 5.24 11.62 
 
C30 H69 N10 O7 P 712.5096 4.882 16 3.48 2.69 3.59 3.62 2.79 3.94 11.24 24.19 46.59 
 
C18 H48 N9 P3 483.3251 3.081 7 3.52 2.00 3.66 3.47 1.98 3.75 11.25 18.87 41.67 
 
C8 H19 N8 P 258.1462 8.042 13 4.02 2.94 3.70 3.86 3.07 3.79 11.26 49.11 31.98 
 
C49 H98 Cl N3 O8 891.7034 9.625 20 6.09 6.06 6.13 6.29 6.34 6.08 11.26 31.98 15.48 
 
C23 H47 N3 O2 397.3661 1.889 11 2.49 1.98 2.62 2.53 1.95 2.44 11.28 13.88 27.67 
 
C25 H58 N9 O3 P 563.4391 2.314 3 3.49 2.56 3.39 3.48 2.62 3.40 11.28 42.50 1.53 
 
C20 H46 N7 O P 431.3507 2.048 23 1.63 0.40 1.30 1.48 0.01 1.36 11.30 48.94 10.69 
 
C23 H49 N 339.3858 2.812 9 1.16 0.21 1.06 1.15 0.08 1.10 11.31 38.38 10.72 
 
C68 H75 Cl N O14 P S3 1291.378 7.748 18 2.80 2.33 2.89 2.75 2.45 2.90 11.35 17.17 9.78 
 
C80 H173 N10 O18 P3 S 1687.186 3.288 13 1.91 1.68 2.04 2.16 1.53 2.10 11.36 18.41 16.53 
 
C26 H45 N O 387.3494 4.729 5 1.29 0.54 1.01 1.39 0.10 0.99 11.38 44.74 22.14 
 
C39 H61 N9 O P2 S2 797.3912 2.321 30 2.54 1.91 2.58 2.66 1.72 2.58 11.39 44.10 4.27 
 
C37 H77 N O 551.6002 5.055 5 1.60 0.08 1.18 1.50 0.13 1.16 11.43 47.85 17.51 
 
C12 H27 N9 O4 361.2173 7.747 8 1.56 1.03 1.96 1.48 0.89 1.93 11.46 25.72 37.22 
 
C33 H51 N O13 669.3334 2.363 27 2.11 1.63 2.11 2.13 1.34 2.15 11.48 45.93 7.68 
 
C39 H59 N5 O3 P2 707.4062 3.458 1 4.65 4.16 4.93 4.76 4.06 5.03 11.52 27.98 42.55 
 
C23 H51 N7 O 441.4178 4.574 11 1.46 0.03 0.91 1.40 0.02 0.97 11.53 41.40 14.10 
 
C28 H59 N 409.4643 3.632 4 2.12 0.46 1.63 2.04 0.68 1.76 11.55 33.68 17.56 









C28 H57 N 407.4485 3.408 10 1.33 0.19 0.60 1.30 0.09 0.67 11.60 41.70 15.54 
 
C51 H92 N O8 P 877.6574 8.028 29 1.03 0.28 0.97 1.06 0.27 1.10 11.61 20.00 15.23 
 
C38 H77 N O 563.5998 5.977 17 2.67 2.96 2.72 2.66 2.82 2.75 11.63 17.48 3.59 
 
C42 H86 N2 O4 682.6582 3.074 12 3.44 1.75 3.07 3.49 2.07 2.77 11.65 38.90 47.82 
 
C43 H81 O7 P 740.5695 6.532 14 3.38 3.60 3.57 3.35 3.49 3.48 11.69 26.75 17.27 
 
C20 H45 O P3 394.2693 2.49 10 8.98 7.97 8.80 9.07 7.70 8.88 11.77 47.89 16.38 
 
C31 H36 O8 S 568.2129 2.358 13 1.73 1.05 1.85 1.80 1.17 1.85 11.80 37.57 2.92 
 
C25 H43 N3 O2 417.3347 2.047 4 1.31 0.77 0.90 1.20 0.44 0.95 11.91 49.52 6.93 
 
C47 H39 Cl N7 O2 P S 831.2317 7.396 5 2.93 2.67 2.86 2.77 2.66 2.82 11.92 15.61 5.57 
 
C23 H51 N7 O2 457.4123 5.812 18 2.13 1.01 2.57 2.22 1.29 2.48 11.92 43.38 42.11 
 
C14 H33 N4 O3 P S2 400.1734 1.902 15 2.56 2.13 2.71 2.66 1.86 2.55 11.93 41.16 25.94 
 
C82 H158 N8 O14 1479.191 5.194 16 3.54 3.62 3.66 3.66 3.46 3.62 11.93 21.51 7.18 
 
C26 H50 N4 418.4051 2.542 23 0.87 0.77 0.58 1.08 0.71 0.47 11.95 27.46 14.57 
 
C21 H43 N O 325.3338 2.809 3 2.40 1.93 2.43 2.44 1.80 2.57 11.96 18.81 19.92 
 
C75 H137 N9 O S 1212.066 6.075 5 1.21 0.94 0.97 1.09 0.95 0.99 11.97 30.51 7.17 
 
C27 H46 O10 530.3085 2.668 7 5.44 5.52 5.71 5.44 5.50 5.62 11.98 3.67 17.08 
 
C31 H63 N O3 497.4801 6.799 3 1.32 0.25 1.09 1.28 0.18 1.05 11.99 41.75 13.53 
 
C18 H44 N6 O S 392.3283 8.069 8 1.06 0.64 1.14 1.02 0.42 1.15 12.00 45.95 14.24 
 
C90 H175 P S2 1351.285 11.277 26 3.39 3.55 3.29 3.42 3.46 3.32 12.04 19.41 15.73 
 
C35 H78 N9 O2 P 687.6005 7.494 5 4.60 3.63 4.45 4.51 3.38 4.53 12.05 46.67 14.03 
 
C28 H57 N O2 439.4384 7.06 5 1.61 0.40 1.30 1.57 0.45 1.33 12.06 32.01 12.04 
 
C17 H44 N9 O4 P 469.3244 4.899 12 1.98 2.21 2.50 2.05 2.23 2.29 12.15 12.21 34.15 
 
C19 H45 N9 O4 463.3597 1.955 7 1.96 1.01 1.42 1.82 0.72 1.29 12.20 48.65 36.05 
 
C22 H45 N O4 387.3342 2.711 7 2.92 2.66 2.81 3.05 2.79 2.82 12.21 15.29 7.63 
 
C13 H34 N10 O7 442.2598 3.498 10 3.79 3.52 3.79 3.85 3.33 3.79 12.21 38.78 3.22 









C16 H24 O4 280.1671 2.291 17 2.12 2.04 2.14 2.26 2.31 2.17 12.24 38.51 9.66 
 
C28 H51 N9 O S 561.3943 2.667 9 2.09 1.93 2.30 2.15 2.00 2.22 12.24 18.84 10.58 
 
C48 H73 N O6 759.5454 5.793 9 1.43 0.19 1.05 1.39 0.09 0.98 12.26 45.45 12.49 
 
C87 H174 N5 O17 P3 S 1686.184 3.28 19 2.20 1.77 2.16 2.06 1.75 2.28 12.27 4.77 14.56 
 
C22 H47 N O2 357.3601 2.81 3 2.42 1.95 2.44 2.45 1.81 2.59 12.28 19.63 20.14 
 
C22 H38 N4 O3 406.2935 1.498 11 2.91 2.49 2.75 2.67 2.42 2.75 12.29 18.28 2.95 
 
C12 H22 O4 230.1512 3.498 4 2.02 2.14 2.10 2.01 2.05 2.10 12.33 12.80 0.72 
 
C57 H75 N9 O2 917.6047 3.466 17 3.71 1.72 4.15 3.32 1.74 3.96 12.35 2.62 25.23 
 
C41 H80 Cl N6 O4 P 786.5659 4.943 9 2.96 2.88 2.84 2.82 2.88 2.80 12.36 2.36 9.39 
 
C16 H24 Cl N3 O2 325.1551 1.296 4 2.00 0.78 1.71 1.86 0.92 1.63 12.37 28.28 11.52 
 
C29 H61 N 423.4798 3.835 2 1.19 0.28 0.84 1.11 0.04 0.92 12.42 33.73 11.52 
 
C20 H39 N 293.3077 2.6 19 1.28 0.94 0.89 1.22 0.44 0.81 12.42 48.59 15.89 
 
C21 H50 N5 O P 419.3757 3.751 7 2.31 0.88 1.99 2.34 1.19 2.06 12.43 38.40 15.32 
 
C23 H43 P3 412.2583 3.421 11 1.53 1.56 1.36 1.41 1.60 1.27 12.45 7.56 13.54 
 
C41 H80 Cl N6 O4 P 786.5664 3.862 14 7.01 6.92 7.06 7.00 6.98 7.00 12.47 7.91 13.12 
 
C19 H28 256.2184 11.257 10 4.82 4.74 4.84 4.76 4.85 4.79 12.48 13.43 10.56 
 
C41 H65 N2 O8 P3 S 838.3668 1.876 17 2.72 2.25 2.85 2.76 2.00 2.65 12.51 41.19 25.44 
 
C7 H17 N O5 195.1102 1.932 22 2.33 1.82 2.52 2.46 1.63 2.38 12.53 30.23 27.32 
 
C58 H113 N O7 935.8509 9.699 21 1.10 0.84 0.99 1.01 0.94 0.99 12.55 17.74 3.03 
 
C38 H79 N O 565.6155 4.432 13 1.72 1.58 1.52 1.62 1.62 1.54 12.55 27.68 3.19 
 
C25 H51 N O2 397.3912 5.287 9 2.04 0.89 1.69 2.01 0.83 1.76 12.57 36.37 12.81 
 
C60 H119 N O6 949.9026 11.232 6 3.64 2.36 3.77 3.63 2.53 3.99 12.59 21.38 47.77 
 
C32 H63 N O3 509.4805 3.604 9 1.84 1.99 2.03 2.01 1.96 2.10 12.62 5.64 12.02 
 
C48 H100 N O14 P3 1007.636 3.475 10 8.90 8.11 9.16 8.95 8.18 9.18 12.62 12.19 37.21 
 
C18 H38 N2 O 298.2977 3.285 12 1.36 0.19 1.07 1.20 0.12 0.99 12.65 45.12 11.59 









C45 H79 N O7 745.5865 3.501 8 9.71 9.35 9.62 9.69 9.37 9.69 12.67 10.55 9.32 
 
C21 H39 N7 389.3263 3.91 10 4.33 2.65 4.03 4.25 2.95 4.00 12.71 37.76 15.27 
 
C37 H69 N 527.5426 4.444 4 1.52 0.35 1.22 1.50 0.45 1.28 12.81 39.30 25.70 
 
C20 H43 N O3 345.3255 2.751 4 6.94 6.89 6.98 7.04 6.90 6.98 12.82 3.54 14.75 
 
C34 H43 N O7 577.3035 2.279 26 2.16 1.45 2.24 2.34 1.52 2.26 12.84 36.76 6.39 
 
C23 H48 N O7 P 481.3163 2.114 19 1.96 1.07 1.05 1.72 1.20 1.17 12.89 24.58 28.73 
 
C24 H54 N5 O2 P 475.3998 7.308 12 1.50 1.64 1.14 1.43 1.64 1.14 12.90 37.46 19.62 
 
C39 H77 N2 O7 P 716.5464 2.894 18 3.60 2.71 3.87 3.65 2.59 3.94 12.90 28.01 41.43 
 
C22 H49 N5 O3 431.383 3.389 18 1.45 0.65 1.12 1.32 0.19 1.11 12.92 48.44 32.09 
 
C42 H75 O8 P 738.517 4.884 18 6.55 5.96 6.65 6.86 5.95 6.58 12.93 7.01 12.45 
 
C36 H72 N4 560.5771 2.623 29 0.60 0.13 0.68 1.27 0.32 0.69 12.94 28.22 5.85 
 
C28 H57 O9 P 568.3733 5.48 5 5.01 5.00 4.97 5.00 5.12 4.92 12.97 35.33 6.15 
 
C35 H70 N9 O P S 695.5181 3.105 13 2.45 2.04 2.64 2.63 2.11 2.62 12.97 15.49 8.82 
 
C19 H36 O3 312.2659 2.963 15 1.85 1.44 1.33 1.90 1.33 1.52 12.98 33.37 43.94 
 
C25 H53 N O S2 447.3557 3.108 5 2.89 1.49 2.99 2.83 1.77 2.99 13.03 45.32 5.50 
 
C32 H66 N2 O 494.5169 5.502 4 1.74 0.86 1.76 1.73 0.96 1.74 13.04 40.20 9.24 
 
C23 H44 N2 O 364.3451 3.203 4 1.21 0.19 0.67 1.21 0.04 0.81 13.06 31.94 17.37 
 
C17 H46 N10 O8 P2 S 612.2713 1.946 20 2.43 1.78 2.64 2.57 1.67 2.49 13.08 25.60 27.50 
 
C22 H56 N9 O2 P 509.4291 3.231 8 3.25 2.99 3.59 3.26 2.97 3.53 13.08 6.06 24.36 
 
C46 H90 Cl N4 P3 826.6072 10.469 7 3.10 3.09 3.06 3.06 3.01 3.03 13.09 16.16 6.94 
 
C28 H70 N10 O3 P2 S 688.4848 3.051 19 2.65 2.03 3.04 2.88 2.10 3.16 13.11 23.00 24.15 
 
C13 H22 O2 210.1617 3.117 11 1.70 1.79 1.99 1.78 1.92 1.99 13.12 16.70 3.14 
 
C35 H48 N3 O7 P 653.3241 2.713 13 5.01 4.37 5.24 5.00 4.44 5.45 13.13 35.42 45.23 
 
C13 H25 N O2 227.1883 3.111 12 1.44 1.54 1.75 1.53 1.67 1.76 13.14 16.93 2.86 
 
C28 H35 N5 O2 473.2769 1.666 17 9.41 9.18 9.45 9.32 9.07 9.25 13.14 17.12 38.59 









C11 H30 N9 O6 P 415.2067 1.745 15 11.16 10.82 11.30 11.36 10.87 11.18 13.18 19.45 25.45 
 
C29 H62 N O P S 503.4308 4.532 25 2.84 2.84 2.77 2.91 2.94 2.81 13.20 16.06 14.11 
 
C20 H47 N7 385.3911 5.236 5 1.17 0.42 0.71 1.09 0.23 0.80 13.20 36.56 14.95 
 
C11 H19 N7 249.17 1.142 14 2.23 2.63 0.96 2.00 2.26 0.61 13.21 46.91 49.18 
 
C21 H43 N O2 341.329 4.684 8 1.52 0.07 0.99 1.55 0.08 1.08 13.24 36.28 13.38 
 
C24 H52 N9 O3 P 545.3927 2.611 4 3.85 3.40 4.06 3.95 3.45 3.99 13.25 7.27 17.96 
 
C75 H151 N10 O17 P S 1527.072 5.202 19 3.38 3.53 3.47 3.38 3.32 3.45 13.27 31.52 7.41 
 
C26 H56 N9 O14 P S3 845.2848 7.622 10 2.46 2.24 2.37 2.36 2.22 2.34 13.28 3.35 5.71 
 
C19 H43 N8 O P 430.329 3.111 5 3.57 2.29 3.71 3.52 2.51 3.75 13.30 45.31 6.50 
 
C27 H55 N O 409.4276 5.256 14 1.56 0.22 1.35 1.66 0.32 1.44 13.32 42.19 11.00 
 
C12 H26 O3 218.1879 2.179 4 6.72 6.34 6.00 6.71 6.16 6.01 13.36 28.48 2.96 
 
C28 H41 Br N6 O7 S 684.1941 6.404 17 3.48 3.30 3.29 3.38 3.23 3.34 13.37 11.38 7.49 
 
C27 H48 N O7 P 529.3164 2.688 8 5.86 5.93 6.16 5.83 5.93 6.09 13.39 0.82 9.44 
 
C48 H65 N6 O P 772.4965 8.097 12 5.03 5.14 5.43 5.07 5.19 5.44 13.39 9.35 7.72 
 
C55 H81 N8 O8 P 1012.592 3.451 16 10.82 10.81 11.27 11.08 10.92 11.26 13.40 47.77 39.05 
 
C14 H35 N10 O2 P 406.2685 2.755 19 1.29 1.58 1.34 1.14 1.52 1.35 13.42 23.08 4.54 
 
C16 H41 N8 P 376.3185 2.867 7 2.75 2.00 3.01 2.72 2.05 3.01 13.43 15.05 41.35 
 
C9 H14 O3 170.0939 3.5 8 2.12 2.10 2.18 1.96 2.08 2.18 13.43 7.11 2.07 
 
C21 H44 N O7 P 453.2846 5.467 20 3.48 3.37 3.38 3.53 3.54 3.42 13.46 18.72 7.71 
 
C42 H76 N O7 P 737.5325 4.873 13 5.12 4.23 5.23 5.12 4.20 5.44 13.49 43.80 46.24 
 
C44 H88 N5 P3 779.6261 5.926 13 1.30 1.55 1.52 1.31 1.60 1.50 13.50 7.51 3.52 
 
C29 H70 N9 O4 P 639.528 3.838 13 2.37 2.14 2.42 2.45 2.22 2.36 13.52 12.56 8.39 
 
C23 H47 N O2 369.3601 4.37 2 1.27 0.11 0.85 1.20 0.02 0.94 13.54 30.85 13.09 
 
C25 H49 N O 379.3809 4.575 5 1.16 0.03 0.92 1.12 0.17 0.93 13.56 30.44 10.96 
 
C38 H77 N O12 739.5441 3.085 7 3.48 3.07 3.56 3.56 3.10 3.59 13.62 9.75 10.18 









C43 H87 N O5 697.6581 8.071 17 2.23 2.37 1.94 2.07 2.38 2.03 13.66 3.12 20.34 
 
C56 H102 N O6 P3 S5 1137.552 2.032 16 1.55 1.14 1.73 1.64 0.95 1.63 13.69 29.58 31.45 
 
C24 H51 N O 369.3965 7.858 2 1.33 0.13 0.99 1.26 0.08 1.06 13.70 31.47 14.66 
 
C28 H50 N O7 P 543.3339 2.348 25 1.72 0.88 1.85 1.68 1.20 1.80 13.74 36.17 13.69 
 
C43 H69 N O7 711.5062 4.878 18 5.27 4.77 5.43 5.42 4.68 5.66 13.74 18.23 49.10 
 
C12 H20 O 180.1511 3.207 6 1.75 1.77 1.90 1.79 1.72 1.87 13.74 11.60 6.25 
 
C13 H36 N9 O4 P 413.2616 3.41 9 3.54 3.61 3.44 3.46 3.68 3.41 13.76 9.12 17.06 
 
C27 H57 N 395.4483 3.454 2 1.01 0.02 0.67 1.05 0.18 0.69 13.77 32.89 30.43 
 
C28 H55 N O2 437.4228 7.545 2 1.24 0.33 0.83 1.14 0.14 0.92 13.78 39.62 14.14 
 
C23 H49 N O 355.3809 2.909 3 1.38 0.21 0.91 1.28 0.04 0.98 13.78 32.96 12.23 
 
C34 H46 N4 O4 P2 636.2969 2.789 11 5.15 4.52 5.40 5.18 4.59 5.62 13.79 34.98 45.32 
 
C33 H70 N3 O7 P 651.4922 3.127 4 1.66 1.07 1.64 1.53 1.18 1.57 13.80 16.43 13.21 
 
C18 H38 N2 O 298.2978 1.894 10 2.72 2.34 2.88 2.78 2.48 2.71 13.83 20.90 26.33 
 
C27 H46 370.3587 11.258 12 3.33 3.23 3.42 3.38 3.28 3.36 13.86 10.73 9.06 
 
C46 H38 O 606.2935 1.915 24 2.82 2.23 3.07 2.99 2.26 2.93 13.87 9.80 27.07 
 
C18 H36 N2 280.2873 2.473 10 2.14 1.45 1.74 2.11 1.53 2.04 13.92 29.26 33.73 
 
C8 H28 N9 O2 P S 345.182 1.292 6 1.12 0.01 0.95 1.07 0.11 0.85 13.93 36.11 14.77 
 
C36 H82 N9 O3 P 719.6284 6.356 5 3.97 4.07 4.11 3.99 4.20 4.13 13.95 15.40 8.17 
 
C27 H57 N 395.4483 3.869 13 1.15 0.01 0.75 1.07 0.04 0.80 13.97 30.31 10.02 
 
C8 H12 O4 172.0733 2.314 4 4.69 3.65 4.78 4.63 3.82 4.81 13.98 45.47 3.12 
 
C30 H59 N O3 481.4489 6.44 9 1.35 0.01 0.64 1.48 0.20 0.91 13.98 24.71 35.91 
 
C30 H61 N 435.4799 3.848 7 2.75 1.09 2.35 2.57 1.39 2.37 14.01 37.19 8.25 
 
C18 H12 N6 312.1118 2.368 11 1.34 0.49 1.47 1.26 0.60 1.55 14.06 42.08 11.71 
 
C36 H71 N O P2 595.5017 3.882 15 2.07 2.04 2.08 2.14 2.02 2.12 14.15 9.53 6.99 
 
C24 H47 N O 365.3654 4.199 3 1.70 0.62 1.83 1.66 0.58 1.93 14.18 5.96 33.09 









C24 H49 N O9 495.3402 2.289 3 3.93 2.86 3.94 3.88 3.03 3.99 14.18 46.44 6.11 
 
C62 H119 O5 P3 1036.828 8.091 10 5.99 6.49 6.01 6.08 6.48 6.08 14.20 16.61 12.41 
 
C43 H83 N7 O2 729.6626 3.411 12 2.78 0.95 2.21 2.62 1.26 1.99 14.22 33.68 28.80 
 
C14 H17 O P 232.1029 2.044 19 0.77 0.06 0.99 1.87 0.00 1.01 14.23 7.18 38.68 
 
C24 H47 N O2 381.36 5.724 4 2.19 0.73 1.85 2.16 0.86 1.90 14.24 35.43 11.42 
 
C33 H58 Cl N6 P 604.4155 2.492 20 1.30 1.63 0.45 1.04 1.16 0.46 14.25 46.79 22.94 
 
C41 H90 N5 O2 P 715.6838 3.249 16 0.99 0.12 1.05 1.19 0.07 1.03 14.28 39.13 11.71 
 
C38 H68 N8 O17 908.4714 8.094 26 2.98 2.82 2.60 3.07 2.75 2.68 14.28 37.07 11.24 
 
C38 H77 N O 563.6002 4.978 21 2.02 1.90 1.98 1.94 1.94 1.99 14.32 14.53 2.02 
 
C37 H63 N O2 P2 S2 679.3752 3.456 12 7.52 7.07 7.85 7.55 7.00 7.85 14.33 15.32 49.95 
 
C27 H42 S 398.3004 2.857 9 5.05 4.04 5.51 5.16 4.21 5.38 14.38 19.03 47.88 
 
C29 H61 N O S 471.4479 2.734 10 1.70 1.67 1.70 1.83 1.68 1.68 14.39 3.05 2.95 
 
C23 H49 N O 355.3808 11.268 3 2.14 0.54 1.68 2.04 0.63 1.75 14.40 40.70 8.87 
 
C45 H73 N O7 739.5377 4.883 9 5.12 4.16 5.16 5.13 4.26 5.42 14.43 28.90 45.23 
 
C19 H35 N O 293.2713 2.988 11 1.60 1.26 1.37 1.48 1.05 1.42 14.44 28.19 18.28 
 
C55 H109 N O6 879.8243 11.226 1 4.83 3.59 4.92 4.78 3.73 5.13 14.51 19.19 44.72 
 
C25 H52 N2 O4 444.3924 3.15 20 2.85 3.04 2.82 2.84 2.77 2.81 14.52 43.04 8.04 
 
C22 H42 O5 386.3026 2.964 8 3.69 2.67 3.51 3.66 2.49 3.67 14.52 31.26 32.98 
 
C59 H127 N10 O9 P3 1212.9 2.759 13 2.24 2.16 2.45 2.68 2.26 2.34 14.54 16.29 14.65 
 
C25 H53 N2 O5 P 492.3674 2.087 8 1.16 0.27 0.68 1.12 0.45 0.73 14.55 43.15 26.09 
 
C27 H62 N10 O S 574.4811 1.503 10 3.03 2.24 2.75 3.18 2.14 2.92 14.56 49.64 21.92 
 
C13 H18 O 190.1354 3.124 16 2.25 2.17 1.92 2.04 2.19 1.98 14.62 10.13 8.58 
 
C36 H71 N O7 629.5222 2.629 4 2.83 1.23 2.51 2.96 1.47 2.39 14.64 27.59 33.36 
 
C41 H82 N3 O3 P S 727.58 3.752 5 3.30 2.96 3.33 3.43 2.98 3.31 14.67 4.28 13.71 
 
C86 H183 N10 O18 P3 
S2 









C33 H68 N2 O 508.5326 5.501 9 1.32 0.05 1.09 1.33 0.36 1.20 14.69 34.35 12.90 
 
C64 H108 O11 1052.789 3.55 7 3.10 2.96 3.14 3.27 2.92 3.09 14.72 6.30 15.57 
 
C46 H92 N2 O2 704.7158 8.01 12 1.93 1.35 1.61 1.69 1.47 1.56 14.73 39.06 9.82 
 
C46 H87 N6 P 754.6733 10.549 13 5.63 5.39 5.96 5.72 5.36 5.96 14.73 13.42 2.90 
 
C32 H68 N2 O 496.5324 5.248 18 1.42 0.26 1.20 1.33 0.12 1.24 14.76 42.80 15.14 
 
C26 H54 N5 P3 529.3581 1.936 7 2.23 1.69 2.46 2.40 1.59 2.33 14.78 23.63 26.04 
 
C13 H34 N9 O P 363.2615 2.352 10 2.62 1.26 2.37 2.53 1.58 2.38 14.79 37.21 6.50 
 
C41 H81 N O 603.6309 9.268 27 1.45 0.36 1.54 1.90 0.43 1.54 14.83 16.62 23.16 
 
C44 H89 N O6 727.6682 8.043 20 1.16 0.86 1.19 1.02 0.70 1.17 14.86 31.81 15.22 
 
C70 H95 O P 982.7117 2.701 9 2.87 2.54 2.87 3.04 2.57 2.92 14.89 10.47 12.14 
 
C21 H42 N2 O2 354.3242 2.009 9 1.61 0.98 1.86 1.82 1.28 1.81 14.89 34.67 33.51 
 
C26 H53 N O2 411.407 5.759 4 2.82 1.42 2.60 2.74 1.42 2.57 14.89 34.45 5.88 
 
C27 H53 N5 O4 511.4082 2.704 3 7.19 6.14 7.51 7.18 6.25 7.50 14.92 14.47 49.93 
 
C28 H55 N5 O4 525.4235 2.817 8 2.31 1.53 2.78 2.27 1.52 2.71 14.95 8.07 42.96 
 
C19 H39 N 281.3078 4.838 4 1.78 0.05 1.15 1.64 0.23 1.29 14.97 33.09 17.61 
 
C35 H71 N O5 585.5326 7.471 4 3.24 2.55 3.23 3.17 2.70 3.38 14.97 37.95 31.61 
 
C16 H31 N 237.2451 2.008 12 2.73 1.31 2.12 2.56 1.44 2.02 14.98 18.70 19.62 
 
C21 H50 N9 O P 475.3869 2.831 7 2.54 1.83 2.77 2.68 1.87 2.67 15.01 39.62 13.50 
 
C22 H38 O2 334.2866 2.788 12 1.02 0.98 1.24 1.16 0.93 1.17 15.04 17.58 34.97 
 
C24 H45 N4 P S 452.3109 3.118 13 4.22 3.25 4.63 4.20 3.38 4.59 15.16 43.72 12.73 
 
C22 H35 N O4 377.2579 1.48 3 2.31 1.54 2.00 2.26 1.57 2.06 15.17 17.64 18.50 
 
C29 H67 N7 O8 641.508 3.147 12 2.08 2.15 2.55 2.36 2.10 2.54 15.19 12.87 27.22 
 
C22 H46 N6 O5 P2 536.299 2.714 17 1.34 1.23 1.29 1.48 1.34 1.64 15.24 33.11 37.09 
 
C40 H85 N2 O8 P 752.6044 5.616 18 12.56 12.02 12.55 12.55 12.40 12.49 15.27 40.46 22.45 
 
C32 H73 N10 O4 P 692.556 7.499 8 4.73 4.02 4.66 4.61 3.81 4.82 15.28 30.96 26.21 









C22 H51 N7 O2 445.4121 5.194 20 2.99 1.67 3.11 3.00 1.83 3.13 15.34 46.73 15.27 
 
C62 H123 N O6 977.9341 11.49 6 6.57 5.27 6.55 6.49 5.22 6.82 15.36 9.15 37.14 
 
C33 H65 N5 O7 643.4866 2.675 2 6.14 5.19 6.39 6.17 5.04 6.48 15.38 18.05 48.96 
 
C17 H35 N 253.2766 2.2 6 2.74 0.35 2.20 2.60 0.65 2.11 15.43 43.77 21.12 
 
C39 H84 N9 O2 P3 803.5961 2.895 14 3.29 2.40 3.60 3.38 2.50 3.66 15.48 16.09 46.50 
 
C29 H61 O2 P S 504.4147 5.504 28 3.21 3.17 3.30 3.27 3.15 3.35 15.52 18.62 8.83 
 
C40 H61 N5 O3 P2 721.4219 3.456 2 4.53 4.02 4.89 4.66 3.96 4.97 15.53 27.71 45.80 
 
C44 H85 N8 O9 P 900.6177 3.244 8 2.43 1.99 2.26 2.47 2.01 2.47 15.54 4.68 23.93 
 
C40 H77 N O9 S 747.5344 2.412 10 1.51 0.68 1.51 1.47 0.65 1.39 15.57 7.88 35.58 
 
C19 H33 O9 P 436.1856 3.919 7 3.28 2.82 3.28 3.08 2.87 3.22 15.58 8.36 24.38 
 
C18 H45 N8 O P 420.3447 2.852 6 2.47 1.78 2.63 2.44 1.70 2.90 15.58 12.05 35.36 
 
C23 H45 N O 351.3496 4.101 4 1.92 0.06 1.24 1.88 0.34 1.35 15.61 45.57 18.29 
 
C5 H13 N8 P 216.0994 2.313 5 3.70 2.71 3.71 3.51 2.78 3.70 15.61 48.58 8.53 
 
C17 H42 N9 P 403.3295 2.501 13 5.20 4.08 5.44 5.50 4.01 5.42 15.62 41.33 36.04 
 
C46 H89 N O4 719.6781 8.064 9 1.60 1.80 2.23 1.65 1.62 2.10 15.62 46.37 32.95 
 
C31 H65 P S 500.4544 3.547 23 1.21 0.75 1.11 1.14 0.74 1.13 15.63 9.22 17.47 
 
C29 H52 N O7 P 557.3501 2.275 14 1.90 0.98 1.93 1.82 1.22 1.91 15.66 35.38 6.17 
 
C28 H49 N O2 S 463.3503 2.781 10 1.38 0.70 1.40 1.33 0.79 1.63 15.67 15.19 32.33 
 
C51 H92 N5 O5 P S2 949.6277 3.334 19 1.99 1.22 2.40 2.10 1.28 2.42 15.68 7.53 43.10 
 
C55 H114 N9 O10 P S 1123.815 3.493 12 3.36 3.37 3.62 3.59 3.41 3.56 15.69 9.41 22.53 
 
C16 H37 N8 P 372.2874 2.501 13 7.68 6.61 7.53 7.69 6.44 7.71 15.71 40.14 20.83 
 
C19 H34 N4 O4 S 414.2288 3.075 6 4.29 3.55 4.27 4.22 3.40 4.31 15.71 29.96 11.86 
 
C20 H41 N O 311.3184 2.578 6 1.99 0.82 1.51 1.87 0.95 1.56 15.72 23.74 14.22 
 
C45 H89 O10 P 820.619 3.396 22 5.32 5.30 5.33 5.17 5.29 5.37 15.75 4.59 5.19 
 
C63 H89 N O6 955.6683 7.956 20 3.17 2.74 3.06 3.08 2.79 3.06 15.77 14.81 10.10 









C25 H59 N6 P 474.4546 4.727 5 1.86 0.15 1.48 1.81 0.45 1.47 15.83 40.87 18.94 
 
C17 H28 232.2185 11.257 12 3.33 3.62 3.51 3.46 3.72 3.47 15.84 11.94 11.71 
 
C27 H56 N2 O3 456.4287 2.715 8 2.11 2.80 2.29 2.24 2.59 2.32 15.84 26.08 23.59 
 
C24 H51 N7 O5 517.3974 3.26 23 2.02 2.04 1.78 2.32 2.24 1.79 15.85 24.36 4.93 
 
C8 H23 N4 O3 P 254.1513 2.314 11 3.14 2.16 3.37 3.11 2.48 3.40 15.93 45.11 7.37 
 
C27 H54 S 410.3946 6.516 11 1.42 0.25 1.16 1.27 0.28 1.13 15.94 28.63 19.00 
 
C33 H65 N O2 P2 569.4496 2.806 8 2.63 1.58 2.73 2.62 1.62 2.82 15.95 16.35 44.84 
 
C39 H74 N O10 P 747.5039 4.836 12 2.33 1.85 2.36 2.50 2.09 2.56 16.00 35.84 38.47 
 
C21 H47 N4 O6 P 482.3217 3.077 8 6.05 4.64 6.40 6.17 4.75 6.32 16.00 22.47 36.82 
 
C32 H63 N5 O6 613.4756 2.794 11 2.66 1.54 2.84 2.72 1.70 2.95 16.03 19.12 43.27 
 
C27 H58 N9 O4 P 603.4341 2.684 11 3.47 3.35 3.36 3.44 3.38 3.44 16.03 5.03 9.71 
 
C23 H50 N8 438.4179 2.797 10 0.93 1.09 0.99 1.02 1.14 1.11 16.06 18.55 16.62 
 
C45 H87 N O6 737.6528 8.403 21 1.18 1.16 1.41 1.33 1.23 1.37 16.06 47.22 18.24 
 
C24 H47 O9 P 510.2981 1.505 20 2.71 1.75 2.37 2.85 1.81 2.49 16.06 48.51 15.15 
 
C12 H28 N2 O9 344.1787 1.297 4 1.78 0.54 1.51 1.63 0.66 1.42 16.11 28.31 14.70 
 
C25 H54 N9 O3 P 559.4079 2.694 19 1.13 1.05 1.30 1.17 0.81 1.30 16.13 37.73 21.61 
 
C21 H49 N8 O6 P S 572.3213 1.488 18 1.82 0.70 1.50 1.98 0.89 1.59 16.15 36.50 17.14 
 
C18 H35 N O 281.2712 6.652 5 2.03 1.47 1.92 1.85 1.40 1.91 16.18 49.60 12.35 
 
C37 H65 N7 O5 P2 749.4533 3.457 4 7.48 7.07 7.85 7.64 6.96 7.95 16.19 34.05 44.35 
 
C24 H49 O7 P 480.3214 3.078 8 5.62 4.30 5.97 5.64 4.25 5.94 16.19 17.44 47.59 
 
C25 H44 O6 440.3132 2.622 3 3.56 3.02 3.68 3.59 2.96 3.72 16.21 15.24 18.41 
 
C27 H51 N O2 S 453.3661 2.601 7 3.15 2.43 3.06 3.21 2.33 3.28 16.25 27.11 25.08 
 
C25 H49 N O3 411.3707 3.122 20 1.49 1.58 1.71 1.48 1.60 1.70 16.25 4.50 4.54 
 
C26 H56 N9 O4 P 589.4189 2.603 6 3.66 3.03 3.77 3.67 3.05 3.71 16.26 10.35 12.95 
 
C14 H36 N10 O2 S 408.2731 2.067 10 1.87 0.84 1.41 2.20 0.65 1.53 16.26 40.59 26.02 









C23 H43 N O 349.3339 3.924 19 1.56 1.41 1.35 1.52 1.66 1.34 16.29 28.37 3.35 
 
C25 H47 N O6 457.3398 2.627 4 3.77 3.22 3.89 3.79 3.16 3.92 16.30 15.32 17.38 
 
C22 H46 O5 390.3342 3.067 12 5.50 4.34 5.81 5.49 4.45 5.82 16.30 21.29 47.68 
 
C36 H67 N O3 561.5113 4.855 5 1.44 1.04 1.30 1.33 1.03 1.26 16.40 8.97 16.82 
 
C35 H74 N9 P S 683.5541 3.789 6 2.15 1.94 2.18 2.19 1.90 2.12 16.41 7.22 11.69 
 
C31 H49 N O4 499.3655 3.268 19 1.79 1.40 1.63 1.78 1.50 1.55 16.43 14.81 25.45 
 
C54 H100 N O8 P 921.7142 3.624 14 3.06 3.01 3.24 3.46 3.02 3.28 16.44 4.98 14.84 
 
C17 H46 N9 P 407.3608 3.03 16 3.45 2.27 3.77 3.42 2.36 3.78 16.53 22.03 47.64 
 
C29 H63 O12 P3 696.3545 2.789 4 7.30 6.70 7.54 7.28 6.69 7.79 16.55 31.05 46.78 
 
C36 H53 N3 O3 575.4099 2.668 15 1.49 1.00 1.38 1.46 0.94 1.35 16.57 30.97 23.04 
 
C43 H88 N4 O P2 738.6427 4.612 6 3.34 3.32 3.33 3.36 3.38 3.38 16.58 8.42 5.87 
 
C45 H78 N O10 P 823.5331 5.236 21 1.71 1.98 1.66 1.89 1.96 1.64 16.61 17.57 6.21 
 
C23 H38 N9 O2 P 503.2879 2.162 11 2.77 1.67 2.22 2.86 1.69 2.26 16.61 32.24 9.72 
 
C16 H33 N 239.2608 2.477 9 1.89 0.95 1.57 1.65 1.18 1.59 16.62 36.93 31.82 
 
C14 H31 O12 P 422.1555 1.917 15 2.21 1.93 2.45 2.39 1.63 2.34 16.64 40.93 24.17 
 
C29 H57 N5 O2 507.4497 2.852 17 2.90 1.77 3.05 2.84 2.01 3.15 16.70 37.00 45.51 
 
C57 H104 O6 884.7797 11.225 8 6.58 5.43 6.71 6.58 5.51 6.92 16.70 17.04 46.26 
 
C21 H46 N P S 375.3105 3.77 16 2.20 2.12 2.09 2.16 2.04 2.11 16.71 12.28 9.25 
 
C41 H76 N7 P S 729.5602 3.107 5 2.54 2.37 2.60 2.75 2.32 2.79 16.73 15.88 22.25 
 
C34 H79 N7 O6 P2 743.558 5.214 15 2.51 2.63 2.63 2.67 2.67 2.64 16.78 12.80 2.44 
 
C20 H45 N4 O4 P 436.316 3.719 14 4.29 3.04 4.59 4.25 2.99 4.55 16.81 13.92 38.92 
 
C19 H44 N10 O 428.3692 2.394 6 1.61 0.45 0.45 1.72 0.49 0.44 16.82 33.07 18.61 
 
C16 H24 N8 S 360.1844 3.531 14 1.48 0.18 1.33 1.42 0.12 1.12 16.82 38.49 37.98 
 
C20 H37 N7 O2 407.3009 3.108 13 3.57 3.60 3.74 3.60 3.52 3.72 16.87 14.44 6.87 
 
C30 H59 N O3 481.449 2.775 18 1.07 0.34 1.33 1.31 0.12 0.98 16.89 47.91 47.70 









C22 H53 N10 O P 504.4144 5.557 28 1.99 2.37 2.79 2.45 2.24 2.85 17.02 27.22 8.24 
 
C41 H81 N O6 683.6056 7.75 5 5.08 4.20 5.07 4.94 4.05 5.21 17.03 22.58 29.92 
 
C56 H111 N O11 P2 1035.763 3.541 7 3.38 3.14 3.39 3.49 3.13 3.36 17.03 1.70 17.87 
 
C36 H72 N2 O8 660.5299 6.821 14 6.27 5.67 7.04 6.56 5.88 6.87 17.04 24.06 33.36 
 
C50 H99 N3 O2 773.7738 8.444 19 1.95 1.97 2.11 1.95 2.00 2.10 17.04 16.11 9.46 
 
C29 H51 Cl P2 496.3174 1.946 15 0.91 0.88 0.36 1.03 0.68 0.14 17.05 39.18 28.11 
 
C39 H68 N10 O4 740.5405 4.879 7 3.60 2.67 3.60 3.53 2.67 3.85 17.07 30.01 45.12 
 
C24 H51 N O 369.3967 2.599 11 1.79 0.04 1.35 1.70 0.44 1.30 17.07 40.51 22.08 
 
C58 H115 N O6 921.8716 11.494 20 2.15 1.19 2.23 2.03 1.14 2.39 17.15 14.09 34.51 
 
C20 H45 O P3 394.2694 2.575 6 7.78 6.86 7.76 7.84 6.73 7.82 17.15 40.35 16.64 
 
C26 H53 N O3 427.4022 5.129 21 2.09 0.70 1.82 1.97 0.84 1.91 17.18 17.14 16.73 
 
C37 H85 N10 O8 P 828.6291 2.001 8 1.82 1.34 2.00 1.94 1.41 1.93 17.22 11.87 33.15 
 
C23 H43 N O5 413.3135 2.634 18 3.67 2.71 3.80 3.53 2.74 3.79 17.23 5.24 25.04 
 
C27 H63 N7 O7 597.482 3.17 6 3.30 3.21 3.37 3.51 3.26 3.49 17.23 10.45 14.54 
 
C47 H80 N2 O3 P2 782.5651 3.442 23 4.68 5.37 4.64 4.62 5.34 4.38 17.24 21.35 43.37 
 
C42 H81 N O4 663.6158 8.025 2 3.35 2.83 3.64 3.36 3.14 3.59 17.25 37.80 30.62 
 
C61 H121 N O6 963.9183 11.225 7 3.28 1.98 3.32 3.20 2.07 3.53 17.25 19.36 47.10 
 
C17 H37 N O 271.287 2.285 9 1.66 1.01 0.58 1.25 0.87 0.61 17.30 33.43 9.19 
 
C18 H42 N9 O2 P 447.3188 7.067 15 4.45 4.48 4.50 4.31 4.69 4.58 17.31 28.23 19.32 
 
C16 H29 N O3 283.2144 2.005 7 1.85 1.35 2.10 2.09 1.28 2.05 17.34 14.19 33.65 
 
C22 H33 N O4 375.2407 2.429 11 2.60 2.59 2.64 2.74 2.63 2.73 17.35 4.97 16.26 
 
C38 H75 P3 624.5112 7.32 6 2.12 1.82 1.98 1.95 2.11 1.96 17.36 42.15 4.17 
 
C29 H69 Cl N9 O P 625.5059 7.316 14 3.25 3.32 3.19 3.08 3.41 3.19 17.37 17.22 2.06 
 
C21 H45 N O 327.3496 2.638 4 1.70 0.07 1.25 1.57 0.10 1.28 17.39 26.60 9.97 
 
C19 H36 N6 O2 380.2895 3.506 10 9.19 8.61 9.03 9.20 8.32 9.07 17.39 45.33 11.79 









C44 H86 Cl4 N2 O2 814.5452 10.68 14 4.03 3.32 3.84 3.83 3.38 3.97 17.43 17.98 17.43 
 
C29 H51 N O S 461.3709 2.828 8 2.31 1.04 2.19 2.24 1.38 2.35 17.44 35.75 20.21 
 
C13 H20 O 192.1511 3.12 7 1.95 1.78 2.02 1.87 1.79 2.00 17.46 7.49 10.67 
 
C32 H73 N7 O11 731.5389 2.657 3 5.11 4.18 5.41 5.21 4.16 5.45 17.48 19.74 47.14 
 
C42 H65 N O6 679.4795 3.073 8 2.45 1.00 2.72 2.30 1.00 2.91 17.51 40.79 26.46 
 
C30 H64 N9 O6 P 677.4714 2.589 4 3.31 2.80 3.29 3.35 2.82 3.41 17.54 11.95 17.61 
 
C35 H69 N O6 599.5117 7.75 22 0.73 0.16 1.38 1.09 0.24 1.46 17.57 14.32 37.20 
 
C62 H123 N O6 977.9347 12.139 21 2.85 2.40 3.22 2.90 2.67 3.26 17.58 36.51 37.28 
 
C79 H151 N4 O8 P 1315.127 8.039 12 5.20 4.67 5.65 5.36 4.34 5.57 17.59 47.60 39.59 
 
C28 H58 N8 506.4803 5.182 20 2.08 2.26 1.92 2.13 2.20 1.89 17.60 26.01 9.94 
 
C15 H26 N7 P 335.1991 2.276 18 1.46 0.48 1.50 1.34 0.78 1.46 17.62 36.87 6.67 
 
C49 H86 Cl O2 P S 804.5773 3.934 7 3.81 3.88 4.05 3.84 3.89 4.03 17.62 11.26 7.16 
 
C63 H126 O4 S 978.9375 12.141 8 1.68 0.68 2.35 1.94 0.97 2.35 17.63 42.83 13.54 
 
C27 H53 N O3 439.4022 4.966 9 1.44 0.23 1.14 1.49 0.02 1.13 17.67 38.67 13.83 
 
C25 H49 N O 379.3808 5.204 12 2.26 0.92 2.00 2.20 1.15 2.05 17.71 37.60 6.74 
 
C30 H55 N2 P S 506.3828 2.74 15 1.23 0.89 1.42 1.44 0.82 1.39 17.88 9.33 7.07 
 
C23 H47 N O 353.3652 5.887 5 2.13 0.54 1.72 2.03 0.71 1.76 17.89 36.06 9.73 
 
C23 H49 N 339.3859 3.044 14 3.40 2.94 3.26 3.26 2.85 3.29 18.01 16.03 5.91 
 
C22 H47 P S 374.3152 2.981 13 2.10 0.41 1.93 2.20 0.70 2.03 18.01 31.26 21.41 
 
C55 H105 N O6 875.7922 11.225 7 6.22 5.05 6.30 6.17 5.23 6.51 18.02 23.82 45.11 
 
C40 H61 N4 P3 690.4105 3.413 26 2.80 3.56 2.29 2.40 3.24 2.65 18.05 43.40 43.19 
 
C32 H43 N4 O8 P 642.2833 3.484 2 11.03 9.95 11.26 11.05 9.90 11.43 18.05 13.61 42.71 
 
C21 H54 N9 P 463.4235 2.866 6 3.89 3.08 4.20 3.93 3.09 4.23 18.06 22.78 36.24 
 
C16 H43 N10 O6 P 502.3112 1.961 9 7.72 6.75 7.85 7.92 6.50 7.60 18.06 42.16 49.39 
 
C46 H85 N5 O3 P2 817.6122 3.066 16 1.86 1.63 1.99 2.15 1.63 2.06 18.11 0.61 45.12 









C23 H45 N7 419.3757 4.688 7 1.41 0.44 1.07 1.39 0.13 1.08 18.11 43.49 12.95 
 
C17 H41 N8 O P 404.3133 2.968 5 4.15 3.46 4.33 4.45 3.23 4.38 18.12 39.44 29.63 
 
C63 H125 N O6 991.9498 11.49 5 6.07 4.80 6.02 5.97 4.77 6.34 18.14 8.97 37.64 
 
C48 H99 N6 O3 P 838.7515 4.688 7 1.35 0.50 1.01 1.33 0.18 1.02 18.14 43.49 12.92 
 
C31 H61 N5 O6 599.4605 2.685 3 5.32 4.43 5.57 5.38 4.34 5.66 18.14 16.77 47.22 
 
C25 H53 N O2 399.407 7.102 3 1.24 0.39 1.04 1.27 0.05 1.04 18.16 36.98 13.64 
 
C28 H58 N8 506.4807 3.753 6 1.51 0.19 1.16 1.41 0.38 1.12 18.17 31.54 8.46 
 
C23 H47 N O 353.3653 4.798 3 1.56 0.50 1.54 1.44 0.62 1.38 18.19 24.94 20.98 
 
C29 H62 N O13 P S 695.3704 2.789 6 5.83 5.13 6.26 6.12 5.29 6.38 18.21 35.60 49.76 
 
C36 H71 N5 O8 701.5279 2.771 2 4.39 3.46 4.49 4.43 3.47 4.64 18.22 11.11 44.34 
 
C17 H44 N9 O P 421.3398 2.963 5 3.72 3.17 3.67 3.84 2.88 3.88 18.23 44.73 24.11 
 
C34 H70 Br N S 603.4409 3.926 9 1.88 1.69 1.91 1.98 1.89 1.98 18.25 23.13 16.49 
 
C36 H65 N9 O4 687.5128 2.666 3 5.96 4.94 6.18 5.98 4.90 6.25 18.26 14.20 47.52 
 
C35 H73 N4 O5 P 660.5298 6.472 10 7.22 6.67 7.67 7.29 6.74 7.56 18.27 19.31 30.52 
 
C38 H75 N O2 577.5795 9.761 11 1.20 0.40 0.93 1.05 0.15 0.95 18.35 29.96 23.16 
 
C25 H43 N O4 421.3185 3.417 20 2.94 3.16 3.13 2.98 3.25 3.01 18.36 19.61 16.18 
 
C33 H65 N5 O6 627.4915 2.932 4 5.26 4.21 5.38 5.33 4.22 5.54 18.38 20.71 47.72 
 
C26 H59 N7 O5 P2 S5 771.2658 7.471 22 2.62 2.50 2.50 2.50 2.49 2.49 18.38 4.26 3.52 
 
C29 H51 N O2 S 477.3662 3.073 13 3.46 1.25 3.52 3.47 1.54 3.78 18.42 46.21 40.84 
 
C76 H131 N4 O12 P3 1384.897 3.485 8 8.09 6.98 8.19 8.01 7.10 8.27 18.44 17.91 31.42 
 
C18 H30 246.2341 11.258 15 3.34 3.43 3.18 3.24 3.25 3.23 18.48 32.15 10.10 
 
C44 H94 N9 O5 P3 921.6601 2.717 15 2.69 2.77 3.02 2.84 2.66 3.17 18.52 15.21 17.94 
 
C25 H48 N2 376.381 3.58 11 1.43 0.21 0.72 1.33 0.00 0.94 18.54 36.67 31.87 
 
C30 H59 N O 449.4593 3.883 17 0.99 0.63 1.39 1.14 0.53 1.44 18.55 13.33 29.14 
 
C35 H71 N O4 569.5392 5.891 13 1.32 1.15 1.43 1.29 1.17 1.38 18.57 5.67 6.74 









C33 H60 N9 O3 P3 723.4015 3.032 21 6.04 5.10 6.14 6.00 5.19 6.51 18.61 11.07 44.46 
 
C54 H83 N O6 841.6208 2.783 4 5.43 4.73 5.57 5.61 4.62 5.60 18.62 14.31 39.66 
 
C23 H58 N9 O2 P 523.4441 3.428 19 1.67 1.92 1.89 1.72 2.04 1.93 18.63 21.50 7.79 
 
C27 H60 N8 O 512.4913 3.857 15 1.41 1.40 1.64 1.64 1.47 1.64 18.65 19.81 13.07 
 
C34 H76 N9 P3 S 735.5125 2.66 10 3.52 3.11 3.47 3.56 3.07 3.47 18.66 5.87 3.07 
 
C26 H53 N O 395.4119 5.59 10 2.84 1.37 2.74 2.80 1.65 2.54 18.69 35.77 28.93 
 
C27 H58 N6 O5 S 578.4196 3.116 3 2.77 2.46 2.80 2.89 2.44 2.81 18.71 3.88 24.59 
 
C41 H81 N5 O5 723.6231 4.823 6 1.51 1.34 1.40 1.35 1.69 1.41 18.75 37.55 1.49 
 
C57 H113 N O6 907.8557 11.489 2 7.30 6.02 7.19 7.15 6.02 7.54 18.76 6.73 39.91 
 
C23 H49 N3 O 383.3869 1.952 16 1.87 1.66 2.11 2.05 1.77 2.01 18.78 21.24 23.17 
 
C20 H41 N O 311.3183 3.765 5 1.67 0.47 1.32 1.52 0.65 1.24 18.78 23.05 13.71 
 
C43 H72 N7 O2 P 749.5491 6.047 3 1.74 0.85 1.39 1.55 1.04 1.44 18.82 26.14 8.62 
 
C10 H29 N10 P 320.232 2.691 8 2.43 1.89 2.59 2.83 1.96 2.56 18.83 7.42 21.49 
 
C20 H22 O4 326.1515 2.252 8 3.15 1.75 2.65 3.05 1.75 2.65 18.84 41.49 10.01 
 
C36 H69 N O7 S 659.4821 2.427 8 1.97 1.40 2.14 2.15 1.37 2.19 18.89 11.77 26.73 
 
C21 H47 O P3 408.2845 3.355 5 3.79 2.23 4.01 4.01 2.39 4.04 18.89 29.84 49.05 
 
C21 H56 N10 O P2 526.4124 2.705 10 3.78 3.67 3.65 3.94 3.65 3.63 18.96 3.93 9.41 
 
C20 H43 N2 O3 P 390.3018 3.445 10 3.61 2.68 2.65 3.24 2.61 2.70 18.97 22.30 18.94 
 
C9 H26 N4 O7 P2 364.1284 2.335 16 4.08 4.36 4.24 3.98 4.06 4.32 18.99 45.64 9.84 
 
C49 H74 O P2 740.5218 4.908 8 2.15 1.60 2.22 2.30 1.67 2.31 18.99 13.11 29.49 
 
C27 H56 N2 O4 472.4241 3.148 12 2.16 2.00 2.02 2.01 2.04 1.99 19.00 5.39 9.53 
 
C18 H34 O3 298.2504 2.672 16 1.35 1.31 2.15 1.61 1.30 2.12 19.01 43.19 4.73 
 
C17 H24 228.1872 11.256 13 3.79 4.12 3.83 3.58 4.06 3.81 19.03 15.40 6.54 
 
C37 H67 N7 O P2 S2 751.4331 2.79 3 5.55 4.99 5.82 5.54 4.98 6.02 19.07 35.91 43.72 
 
C35 H69 O10 P 680.4638 4.878 2 8.43 7.65 8.47 8.41 7.57 8.70 19.09 35.57 43.29 









C17 H42 N8 O4 S 454.3055 4.508 14 2.79 2.72 2.84 2.89 2.82 2.81 19.16 12.57 3.37 
 
C31 H66 N9 O6 P 691.4865 2.663 13 3.07 2.63 3.20 3.26 2.70 3.04 19.20 18.19 21.32 
 
C29 H60 N8 520.4964 3.753 17 1.71 0.54 1.70 1.95 0.51 1.60 19.22 38.85 17.81 
 
C66 H128 N8 O16 P2 1350.892 3.448 22 1.61 1.38 1.71 1.54 1.35 1.89 19.23 7.51 25.53 
 
C41 H81 N O5 667.6095 5.605 23 3.53 3.83 4.17 4.10 4.32 4.04 19.25 47.47 20.27 
 
C20 H32 272.2496 11.259 17 3.62 3.58 3.62 3.65 3.59 3.52 19.28 7.70 12.16 
 
C19 H38 O S2 346.2349 2.356 9 4.01 2.47 3.85 3.92 2.80 3.81 19.32 46.16 5.92 
 
C22 H45 N O 339.3496 5.345 5 1.56 0.23 1.06 1.43 0.22 1.11 19.35 27.66 13.98 
 
C31 H74 N9 O6 P 699.5493 3.303 5 3.21 2.90 3.28 3.28 2.97 3.30 19.37 16.51 14.17 
 
C24 H52 N8 O2 484.4234 4.4 18 2.92 2.62 2.93 2.75 2.48 2.92 19.41 49.88 6.01 
 
C40 H67 N O7 P2 735.4377 3.46 2 6.22 5.62 6.64 6.40 5.48 6.78 19.44 27.20 49.99 
 
C44 H50 N10 O3 P2 828.3525 9.627 20 3.13 2.82 2.63 2.88 2.46 2.64 19.46 47.56 8.08 
 
C22 H51 N10 O3 P 534.3894 3.891 19 1.74 1.47 2.38 1.77 1.91 2.36 19.50 44.54 8.87 
 
C29 H61 N5 O2 P2 573.4301 3.697 3 5.58 4.24 5.22 5.48 4.37 5.26 19.51 39.40 5.58 
 
C23 H40 O5 396.287 2.63 14 2.75 1.71 2.90 2.60 1.71 2.82 19.52 0.32 33.78 
 
C31 H67 N4 O4 P 590.488 7.472 3 5.72 5.05 5.78 5.59 5.01 5.84 19.52 21.60 30.09 
 
C43 H77 O10 P 784.5217 6.037 24 1.22 0.36 0.46 1.72 0.40 0.58 19.57 35.88 16.63 
 
C20 H24 N8 O4 S 472.1626 2.279 8 1.92 0.82 1.89 1.73 1.07 1.84 19.62 45.69 7.03 
 
C20 H39 N O2 325.298 3.22 11 3.62 2.55 3.84 3.51 2.49 3.82 19.64 25.61 34.13 
 
C23 H55 N6 O5 P 526.3951 3.556 4 2.77 2.77 2.94 3.06 2.80 2.91 19.64 4.00 17.41 
 
C30 H66 N6 O4 P2 636.4601 3.431 15 3.20 2.99 3.10 3.36 3.06 3.20 19.71 9.07 21.74 
 
C49 H95 O8 P 842.6725 5.208 21 2.71 2.99 2.83 2.73 2.94 2.90 19.73 13.27 10.59 
 
C24 H48 O6 432.3446 3.357 2 7.82 6.96 8.11 8.13 6.70 8.15 19.75 36.20 31.83 
 
C38 H77 N O3 595.5897 9.761 11 1.39 0.22 1.12 1.24 0.04 1.14 19.76 29.50 22.05 
 
C24 H56 N5 P 445.4276 3.563 17 1.84 0.27 0.86 1.65 0.44 1.05 19.77 20.19 31.80 









C44 H89 N O15 871.6235 3.037 9 1.51 1.06 1.74 1.73 1.25 1.60 19.81 26.73 21.46 
 
C25 H62 N9 O3 P 567.4705 3.394 7 2.60 2.48 2.79 2.44 2.60 2.92 19.82 36.54 19.75 
 
C51 H74 O2 718.5714 7.974 12 1.68 0.62 1.34 1.71 0.39 1.72 19.86 46.98 38.45 
 
C16 H25 N3 O3 307.189 2.073 12 1.91 0.26 1.23 1.92 0.26 1.31 19.91 34.61 13.85 
 
C20 H45 N6 O3 P 448.3291 11.259 17 3.33 3.79 3.48 3.45 3.91 3.45 19.92 13.94 3.84 
 
C29 H59 N O S2 501.4024 3.399 22 2.46 2.14 2.22 2.54 2.16 2.18 19.93 8.34 28.23 
 
C34 H75 N10 O6 P 750.5601 4.159 7 6.23 5.48 6.26 6.23 5.49 6.53 19.94 26.46 45.77 
 
C41 H81 N O2 619.6263 10.23 12 1.71 0.48 1.29 1.83 0.05 1.23 19.95 48.07 12.56 
 
C15 H29 N O4 287.2089 1.926 7 5.23 3.72 5.09 4.93 4.14 5.18 19.96 43.92 12.29 
 
C19 H51 N10 O5 P 530.3789 2.813 15 3.75 3.01 4.09 3.76 2.92 4.18 19.96 36.21 46.96 
 
C17 H33 N O3 299.2455 1.881 13 1.02 0.19 0.12 1.45 0.20 0.01 19.99 7.52 17.26 
 
C25 H49 N O5 443.3603 3.568 19 1.28 0.73 1.17 1.14 0.75 1.26 20.02 9.98 10.64 
 
C41 H81 N O6 683.6055 7.264 16 3.41 2.38 3.63 3.43 2.51 3.60 20.03 32.50 23.53 
 
C16 H40 N10 O 388.3386 2.958 6 3.69 2.95 3.88 4.01 2.77 3.88 20.03 30.92 30.35 
 
C25 H53 N 367.4172 3.038 2 2.31 0.54 1.93 2.25 0.85 2.06 20.04 40.13 16.45 
 
C38 H49 N O6 615.3554 2.772 22 3.20 2.58 3.48 3.40 2.55 3.31 20.07 15.63 34.58 
 
C34 H63 N 485.4957 3.853 18 1.55 0.02 1.14 1.70 0.06 1.15 20.09 17.57 19.01 
 
C20 H38 N6 O4 426.2951 2.97 7 5.63 4.90 5.85 5.97 4.71 5.84 20.09 35.24 31.85 
 
C16 H35 N 241.2766 2.291 4 2.21 0.70 1.78 2.06 0.85 1.77 20.10 32.13 11.58 
 
C41 H65 N O7 683.4757 4.163 18 4.23 3.03 4.21 4.11 3.00 4.44 20.14 38.83 44.97 
 
C33 H67 N7 O10 721.4977 2.582 5 2.87 2.58 2.85 3.09 2.54 2.93 20.21 5.65 12.21 
 
C38 H77 N O 563.5997 7.275 10 2.75 2.68 2.98 2.90 2.94 2.84 20.22 32.27 18.40 
 
C8 H6 O4 166.0263 2.447 6 2.20 2.21 2.25 2.12 2.32 2.37 20.22 25.29 22.37 
 
C43 H83 N O5 693.6264 8.025 3 3.70 3.10 3.76 3.52 3.15 3.70 20.27 8.81 20.24 
 
C29 H52 N4 O3 504.4029 1.476 15 1.67 0.55 0.65 1.50 0.42 0.90 20.33 37.91 29.31 









C18 H37 N O4 331.2719 2.019 26 2.09 1.08 2.12 2.21 1.11 2.10 20.33 12.26 45.05 
 
C54 H77 Cl N9 O17 P S4 1317.375 8.128 28 2.60 2.29 3.02 2.70 2.15 2.82 20.35 26.87 37.01 
 
C34 H74 N6 O4 P2 692.5228 3.257 2 2.11 1.91 1.98 2.01 1.91 2.01 20.35 3.07 5.45 
 
C19 H33 N 275.2608 2.614 12 1.05 0.27 0.76 1.22 0.30 0.65 20.39 38.91 14.74 
 
C46 H89 N O3 703.684 8.273 10 1.55 1.58 1.51 1.47 1.52 1.47 20.45 8.26 16.36 
 
C41 H83 N O3 637.6362 8.072 7 1.22 1.44 0.98 1.48 1.40 1.17 20.46 5.76 32.90 
 
C28 H58 N8 O S 554.4442 3.214 21 4.45 4.38 4.43 4.18 4.37 4.43 20.47 6.90 3.39 
 
C14 H20 188.156 11.258 11 3.17 3.33 3.00 3.26 3.61 3.08 20.47 35.23 18.17 
 
C21 H40 O3 340.297 3.362 11 4.58 3.51 4.60 4.67 3.36 4.75 20.48 21.31 26.99 
 
C45 H70 N P 655.5232 3.332 7 3.52 3.22 3.51 3.56 3.26 3.60 20.49 13.56 17.38 
 
C30 H65 N9 O7 663.5024 3.211 5 2.26 2.04 2.22 2.20 2.09 2.20 20.49 6.83 3.18 
 
C22 H49 O P3 422.3002 3.347 3 8.39 7.54 8.69 8.73 7.26 8.73 20.50 35.72 30.46 
 
C31 H66 N10 O8 706.5059 8.054 18 5.96 5.70 5.78 5.67 5.44 5.77 20.50 35.59 0.62 
 
C30 H69 N7 O11 703.508 2.423 10 1.04 0.59 1.42 1.25 0.35 1.39 20.55 39.49 18.50 
 
C26 H58 N O10 P3 637.3281 3.62 25 5.54 5.05 6.10 5.68 4.94 5.95 20.56 28.37 44.21 
 
C29 H59 N9 O6 629.4567 3.273 6 1.37 0.25 0.74 1.18 0.02 0.73 20.60 41.06 10.58 
 
C43 H75 O8 P 750.517 4.884 12 3.54 3.00 3.67 3.77 3.20 3.84 20.60 38.52 37.63 
 
C47 H77 N O7 767.5685 4.883 5 8.84 8.08 8.88 8.86 8.12 9.13 20.63 23.72 43.72 
 
C25 H45 N5 O 431.3613 2.573 20 2.96 2.10 2.38 2.98 2.17 2.16 20.67 27.66 29.48 
 
C43 H87 N O 633.6784 10.759 18 1.65 0.34 1.01 1.42 0.02 1.17 20.67 43.02 21.52 
 
C42 H71 O14 P 830.4554 8.105 24 4.15 4.15 4.22 4.03 4.27 4.11 20.71 17.52 21.60 
 
C29 H71 N10 O P 606.5579 11.489 4 5.02 3.62 4.88 4.87 3.58 5.31 20.72 6.41 43.39 
 
C35 H78 N9 O P3 S 765.5241 2.576 5 3.04 2.59 2.95 3.12 2.61 3.04 20.74 3.22 10.90 
 
C34 H75 N9 O3 P2 S 751.5207 4.896 12 1.84 1.32 1.92 2.10 1.47 2.10 20.75 40.75 40.69 
 
C74 H144 N5 O17 P 1406.028 6.043 24 0.94 0.65 0.89 1.06 0.51 0.83 20.77 34.45 12.73 









C48 H89 N O3 P2 S2 853.5768 2.566 4 2.51 2.11 2.33 2.60 2.14 2.46 20.79 4.35 15.11 
 
C38 H63 N O8 P2 723.4017 2.791 3 6.25 5.51 6.36 6.20 5.62 6.67 20.79 32.24 43.63 
 
C23 H45 N O2 367.3444 2.877 23 1.61 1.94 2.16 1.84 1.96 2.41 20.80 4.79 48.09 
 
C27 H52 N2 O 420.4072 4.384 7 1.37 0.01 0.85 1.10 0.04 0.87 20.81 41.63 10.32 
 
C65 H141 N10 O10 P3 
S2 
1378.947 2.614 21 5.14 4.73 4.74 5.43 4.82 4.87 20.88 27.43 18.08 
 
C35 H56 N O10 P 681.3625 3.474 4 9.31 8.15 9.52 9.29 8.16 9.71 20.88 13.91 49.92 
 
C82 H165 N7 O14 P2 S2 1598.132 3.313 18 4.29 3.98 4.22 4.21 4.01 4.36 20.89 4.71 19.61 
 
C41 H72 N4 O2 652.5634 7.492 16 1.76 0.96 1.88 1.58 0.66 1.86 20.92 44.45 17.64 
 
C25 H45 N7 443.3722 3.119 13 4.84 4.31 4.67 4.72 4.48 4.66 20.94 20.57 2.22 
 
C19 H30 258.2341 11.256 6 4.43 4.36 4.36 4.21 4.33 4.25 20.96 18.29 14.41 
 
C40 H61 N5 O4 P2 737.4173 2.79 2 6.56 5.78 6.72 6.50 5.91 6.97 20.97 30.31 42.89 
 
C31 H64 N6 O3 568.506 7.473 2 4.02 3.32 4.08 3.88 3.28 4.14 20.99 24.24 31.52 
 
C50 H107 N10 O10 P S 1070.764 2.658 13 4.13 4.06 4.11 4.39 4.05 4.12 21.01 5.71 20.44 
 
C19 H46 N9 O P S 479.3273 2.56 4 2.37 2.16 2.11 2.54 2.19 2.29 21.03 4.97 23.47 
 
C35 H68 N6 O2 604.5422 7.757 9 1.89 0.56 1.94 1.91 0.83 2.04 21.08 35.48 22.76 
 
C10 H25 N4 O P 248.1771 3.231 6 2.93 2.57 2.61 2.83 2.55 2.50 21.25 9.37 14.61 
 
C42 H89 N3 P2 697.6536 3.912 20 4.09 4.47 4.15 4.05 4.40 4.06 21.29 23.08 13.67 
 
C40 H38 N4 O16 830.2304 9.624 19 3.76 3.61 3.46 3.84 3.56 3.50 21.30 5.74 14.38 
C27 H56 N2 O3 456.4287 3.378 28 3.49 3.38 3.55 3.63 3.46 3.46 21.31 33.43 24.40 
C18 H41 O P3 366.2377 2.334 18 5.82 4.43 5.63 6.14 4.56 5.61 21.32 16.77 29.90 
C30 H61 N7 O8 647.4603 2.674 9 3.70 3.12 3.70 3.70 3.28 3.63 21.38 23.46 23.05 
 
C60 H119 N O6 949.9026 11.491 7 3.56 2.16 3.70 3.48 2.27 3.90 21.43 14.96 43.65 
 
C29 H59 N 421.4641 3.919 14 1.24 0.10 1.10 1.27 0.10 1.06 21.44 31.60 17.11 
 
C29 H54 N2 O2 462.4176 5.718 11 1.61 0.13 1.03 1.44 0.09 0.96 21.44 40.65 23.03 
 









C32 H63 N5 O7 629.4714 2.573 7 3.27 2.53 3.46 3.49 2.49 3.54 21.63 15.98 40.33 
 
C42 H83 N O6 697.6221 8.469 9 3.23 1.94 3.39 3.15 1.82 3.54 21.64 20.52 48.76 
 
C59 H118 O4 S 922.875 11.493 19 2.22 1.01 2.17 1.99 1.00 2.37 21.66 4.75 32.68 
 
C44 H79 N3 O8 777.5868 4.886 3 8.72 7.92 8.69 8.67 7.94 8.95 21.68 26.76 43.32 
 
C48 H79 N O7 781.5839 4.882 4 7.03 6.26 7.07 7.02 6.26 7.34 21.68 28.61 43.08 
 
C28 H60 N9 O5 P 633.4451 2.596 8 3.85 3.22 3.83 3.83 3.29 3.83 21.70 22.06 11.40 
 
C22 H43 N O2 353.3293 3.678 20 2.82 1.96 3.10 3.32 2.16 3.10 21.72 40.16 19.50 
 
C33 H65 O10 P 652.4333 4.161 1 6.65 5.80 6.64 6.59 5.76 6.91 21.74 39.38 44.68 
 
C37 H80 N6 O5 P2 750.565 3.363 7 2.41 2.45 2.42 2.26 2.44 2.40 21.76 3.27 6.73 
 
C28 H57 N3 S 467.427 3.39 17 1.65 1.85 1.94 1.93 1.70 1.93 21.76 19.98 6.96 
 
C31 H50 O2 S 486.3527 2.829 6 3.99 3.41 4.27 4.07 3.83 4.42 21.88 45.62 47.07 
 
C88 H179 N10 O12 P3 
S3 
1757.209 3.258 15 2.58 2.25 2.69 2.71 2.32 2.79 21.91 9.10 14.87 
 
C48 H79 N O7 781.584 4.602 6 4.80 4.05 4.79 4.80 3.94 5.09 21.92 45.10 45.54 
 
C73 H157 N10 O7 P3 S2 1443.089 3.308 5 1.43 1.28 1.27 1.32 1.25 1.30 21.93 4.14 4.32 
 
C36 H79 N6 P S2 690.5571 8.04 18 4.67 4.38 4.78 4.79 4.35 4.69 21.94 41.62 14.11 
 
C76 H165 N10 O16 P3 S 1599.134 3.308 12 2.67 2.29 2.69 2.76 2.26 2.61 21.94 11.57 22.32 
 
C20 H46 N5 O2 P 419.3371 2.974 7 2.76 2.69 3.23 2.92 2.69 3.18 21.95 14.72 20.49 
 
C49 H81 N O7 795.5991 4.886 3 7.77 7.03 7.82 7.78 7.07 8.09 21.95 25.94 43.17 
C18 H35 N 265.2767 2.558 3 2.25 0.40 1.80 2.07 0.59 1.74 21.95 34.58 17.35 
C30 H53 N P2 489.3658 3.187 13 2.18 2.10 2.47 2.40 2.09 2.50 21.97 17.72 18.47 
C23 H40 N3 O2 P 421.2865 3.914 11 2.66 2.73 2.83 2.75 2.79 2.79 22.03 13.33 7.29 
 
C61 H131 N10 O10 P S3 1290.895 2.627 8 2.18 1.70 2.09 2.49 1.84 2.11 22.04 28.30 18.77 
 
C37 H67 N O15 765.4487 2.792 3 3.74 3.03 3.82 3.67 3.10 4.23 22.10 42.64 46.77 
 
C86 H161 N8 O15 P S2 1641.127 2.978 20 2.86 2.69 3.13 3.25 2.60 3.36 22.15 11.92 27.14 
 









C38 H66 N4 578.5266 11.228 5 3.98 2.74 4.07 4.04 2.69 4.47 22.17 26.46 42.62 
 
C35 H69 O10 P 680.4639 4.6 4 6.50 5.77 6.52 6.53 5.61 6.80 22.17 49.69 44.10 
 
C40 H80 N O8 P 733.561 3.478 16 2.03 1.59 2.40 1.83 1.60 2.31 22.25 10.43 23.86 
 
C19 H17 N3 O7 399.1069 1.933 20 2.06 1.47 2.08 2.20 1.21 1.94 22.26 40.48 27.78 
 
C22 H43 N O 337.3339 3.907 7 1.78 1.52 1.73 1.79 1.81 1.73 22.28 31.85 4.32 
 
C33 H73 N9 595.6008 7.352 9 2.14 1.86 2.15 2.01 1.88 2.10 22.31 22.20 6.84 
 
C22 H45 N O 339.3496 5.483 3 2.26 0.70 1.82 2.12 0.86 1.87 22.35 33.82 16.40 
 
C29 H41 Cl2 N 473.26 1.658 14 8.02 8.24 7.95 7.83 8.00 7.74 22.37 32.94 31.85 
 
C37 H73 N O2 563.5633 7.488 3 3.36 3.11 3.69 3.23 3.00 3.50 22.40 22.45 30.89 
 
C28 H58 N2 O4 486.4398 3.153 29 2.40 2.07 2.14 2.35 2.24 2.15 22.44 27.58 11.09 
 
C40 H87 Cl N4 O2 P2 S2 816.5424 10.678 18 3.76 3.05 3.80 3.70 3.21 3.80 22.44 19.06 8.35 
 
C45 H60 N P 645.4477 2.629 12 2.12 2.03 2.01 2.51 1.89 1.99 22.48 34.66 11.64 
 
C60 H112 N3 O2 P 937.8477 3.074 28 2.71 0.25 2.64 3.11 0.00 2.65 22.48 43.52 2.27 
 
C45 H73 N O7 739.5381 4.16 11 8.68 7.85 8.74 8.67 7.80 8.95 22.49 36.24 46.93 
 
C42 H79 N O4 661.5999 5.379 3 4.52 4.50 4.53 4.38 4.41 4.36 22.52 40.96 24.84 
 
C24 H54 N6 O P2 504.3815 3.567 4 3.11 3.08 3.24 3.45 3.09 3.18 22.55 3.45 24.54 
 
C38 H61 N4 O2 P S2 700.4005 6.06 10 1.94 1.44 1.43 1.95 1.41 1.26 22.57 20.98 34.63 
 
C42 H85 N O3 651.6519 11.059 18 2.80 1.35 2.49 2.75 1.53 2.65 22.64 49.50 18.00 
 
C28 H50 N O7 P 543.3345 2.268 9 1.33 0.31 1.27 1.08 0.61 1.23 22.68 40.49 8.11 
 
C50 H83 N O7 809.6157 4.882 4 4.40 3.70 4.51 4.39 3.71 4.68 22.77 29.38 43.17 
 
C43 H64 N P 625.4766 3.09 17 1.63 1.50 1.78 1.49 1.55 1.80 22.79 9.76 18.14 
 
C18 H37 N O 283.2869 3.767 10 2.65 1.17 2.11 2.57 1.35 2.11 22.79 22.15 19.82 
 
C14 H17 N 199.1356 1.659 21 4.90 5.20 4.80 4.76 5.20 4.92 22.80 34.39 17.03 
 
C22 H43 N O2 353.329 2.685 3 1.85 1.74 1.61 1.85 1.59 1.74 22.80 35.16 15.04 
 
C27 H56 N6 O4 S 560.4108 3.123 8 1.79 0.48 1.32 1.51 0.70 1.35 22.83 38.28 6.14 









C39 H84 N9 O P3 787.6009 2.784 17 1.52 1.17 1.38 1.36 1.00 1.40 22.84 45.76 9.34 
 
C24 H49 N O2 383.3759 3.051 4 3.22 1.56 3.10 3.03 1.57 3.27 22.85 12.10 35.52 
 
C30 H56 N6 O2 532.4465 6.38 13 7.09 7.38 7.23 7.19 7.08 7.20 22.86 39.45 12.74 
 
C19 H44 N5 O2 P 405.3216 3.128 14 2.55 2.59 2.71 2.46 2.58 2.67 22.89 11.68 5.57 
 
C35 H78 N8 O4 P2 S 768.5323 1.546 4 4.04 2.37 3.24 4.26 2.41 3.52 22.89 43.63 31.46 
 
C22 H37 N6 O2 P S 480.2458 3.379 27 3.11 2.19 3.09 3.42 2.18 3.15 22.89 12.50 8.37 
 
C45 H81 N5 O6 S 819.5912 2.643 8 5.36 4.41 5.58 5.40 4.46 5.64 22.92 19.14 43.69 
 
C64 H132 N2 O12 P2 S2 1246.869 2.633 5 4.79 4.52 4.79 5.23 4.62 4.87 22.92 21.43 15.84 
 
C42 H83 N O2 633.6415 11.062 18 3.01 1.58 2.71 2.97 1.76 2.86 22.93 49.16 18.20 
 
C38 H77 N O3 595.5897 7.486 3 3.42 3.15 3.76 3.29 3.05 3.57 22.94 22.96 31.98 
 
C75 H141 N8 O3 P3 S 1327.005 3.216 4 2.03 1.76 1.98 1.92 1.85 1.96 22.96 10.30 3.51 
 
C34 H74 N9 O3 P 687.564 7.288 22 3.19 2.41 3.88 3.41 2.46 3.81 22.96 42.14 25.50 
 
C20 H45 N4 O4 P 436.316 3.842 12 5.85 4.54 6.24 6.09 4.73 6.33 23.01 26.87 46.38 
 
C24 H49 N7 O5 515.3815 2.703 11 2.34 2.16 2.46 2.33 2.17 2.49 23.03 18.05 11.69 
 
C85 H170 N5 O16 P3 S 1642.158 3.297 14 3.59 3.39 3.77 3.90 3.42 3.61 23.04 9.20 36.27 
 
C75 H147 N4 O11 P3 S 1405 3.375 2 2.87 2.75 3.05 3.15 2.79 3.09 23.10 5.28 19.55 
 
C77 H153 N7 O17 P2 1510.078 3.339 13 2.72 2.72 3.07 3.28 2.67 2.97 23.11 12.47 28.98 
 
C42 H83 N4 O2 P 706.6256 8.087 16 2.83 2.55 2.85 2.54 2.77 2.70 23.21 34.97 27.55 
 
C87 H142 N4 O5 P2 1385.046 3.26 3 2.35 2.02 2.13 2.23 2.11 2.14 23.22 11.68 6.66 
 
C11 H26 N6 O2 S 306.1824 4.385 16 2.29 2.28 2.09 2.10 2.19 2.09 23.23 18.18 1.06 
 
C25 H58 N9 O3 P 563.44 3.176 8 1.48 1.12 1.46 1.42 1.13 1.47 23.24 18.96 4.15 
 
C81 H148 N7 O7 P S2 1426.062 3.306 4 1.40 1.24 1.26 1.27 1.21 1.25 23.26 3.90 4.11 
 
C23 H55 N7 O7 541.419 2.586 12 2.46 1.57 2.32 2.41 1.47 2.46 23.29 12.94 22.45 
 
C20 H45 N6 O P 416.3373 3.771 18 2.24 2.18 2.22 2.16 2.07 2.17 23.30 18.36 10.26 
 
C33 H45 N6 P S 588.319 2.772 20 5.35 4.78 5.59 5.65 4.68 5.63 23.34 18.12 35.12 









C24 H60 N9 O3 P 553.4557 3.202 10 2.55 2.58 2.95 2.74 2.63 2.96 23.47 13.73 13.91 
 
C47 H77 N O7 767.5685 4.601 12 7.32 6.53 7.36 7.37 6.40 7.62 23.47 46.15 45.97 
 
C61 H101 N3 P2 S 969.7195 9.624 15 4.22 4.11 4.46 4.21 4.19 4.43 23.49 17.42 8.38 
 
C15 H5 N5 O13 P2 S 556.908 3.132 5 3.35 3.20 3.52 3.53 3.17 3.50 23.49 4.60 35.84 
 
C60 H92 N7 O2 P 973.7042 3.704 7 5.36 3.59 5.33 5.39 3.67 5.47 23.65 17.44 33.64 
 
C28 H58 N2 O 438.4544 3.866 7 1.22 0.33 0.70 1.05 0.04 0.84 23.65 41.48 17.09 
 
C47 H95 N O2 P2 S2 831.6277 3.24 4 4.48 4.09 4.53 4.62 4.15 4.52 23.66 8.36 23.23 
 
C57 H121 N10 O11 P S 1184.867 3.461 8 2.33 2.46 2.56 2.54 2.45 2.57 23.67 3.90 19.27 
 
C39 H84 N9 O P3 787.6013 3.256 6 3.44 3.13 3.39 3.66 3.17 3.47 23.69 9.40 30.61 
 
C43 H75 O10 P 782.507 5.21 15 1.21 1.42 1.15 1.30 1.45 1.13 23.73 22.08 7.57 
 
C67 H140 N9 O14 P3 1387.973 3.375 2 2.89 2.77 3.07 3.18 2.80 3.12 23.78 4.89 19.66 
 
C49 H94 N3 O8 P S 915.6505 3.023 15 1.31 1.29 1.74 1.85 1.28 1.78 23.79 1.23 20.58 
 
C32 H53 N10 P3 S 702.3411 3.481 10 5.28 3.71 5.78 5.55 3.76 5.93 23.85 31.32 47.22 
 
C19 H47 N7 O2 405.3809 2.785 15 2.28 1.01 2.27 2.18 1.23 2.17 23.88 28.74 43.21 
 
C42 H68 S 604.5038 7.607 7 1.36 0.51 1.56 1.22 0.42 1.44 23.88 30.21 30.75 
 
C84 H179 N9 O16 S5 1730.207 3.269 8 2.85 2.51 2.89 3.06 2.56 2.90 23.93 12.15 21.46 
 
C82 H146 O3 P2 1241.074 7.754 4 3.25 2.07 3.32 3.16 2.30 3.62 23.98 40.67 37.76 
 
C67 H142 N9 O5 P3 S2 1309.978 3.22 4 1.97 1.76 1.94 1.88 1.83 1.93 23.98 8.86 1.87 
 
C35 H78 N10 638.6402 8.072 16 1.26 1.38 1.34 1.24 1.41 1.23 23.99 49.58 15.46 
 
C37 H77 N3 O2 595.6008 5.532 15 2.07 1.76 2.31 2.09 1.61 2.21 24.01 22.94 12.55 
 
C28 H70 N9 P3 S 657.4667 2.548 8 2.34 2.36 2.32 2.24 2.33 2.01 24.02 17.57 44.29 
 
C32 H68 N2 O 496.5327 5.923 12 1.21 0.06 1.09 1.19 0.18 1.14 24.09 46.66 8.35 
 
C21 H43 N O 325.3339 2.357 24 1.68 0.14 0.46 2.18 0.06 0.47 24.11 41.92 48.60 
 
C54 H108 N2 O8 912.8108 11.489 16 9.92 8.87 9.82 9.79 8.82 10.13 24.15 7.32 39.19 
 
C22 H39 N 317.3075 5.131 9 1.33 0.16 1.15 1.16 0.04 1.11 24.19 23.65 9.15 









C33 H61 N8 O P 616.4728 4.977 18 1.51 0.41 1.04 1.40 0.47 1.04 24.24 45.41 7.87 
 
C75 H159 N10 O18 P3 1581.106 3.313 21 3.52 3.42 3.67 3.76 3.36 3.73 24.27 8.32 16.87 
 
C36 H73 N 519.5736 5.698 15 1.72 0.70 1.61 1.72 0.33 1.54 24.31 48.60 16.14 
 
C28 H60 N9 P S 585.4451 2.58 7 2.92 2.08 3.01 3.19 2.04 3.20 24.34 14.41 39.19 
 
C15 H24 N2 232.1933 0.923 20 1.91 0.78 2.01 1.86 0.84 2.25 24.37 23.08 49.51 
 
C25 H51 N O 381.3963 6.081 6 2.28 1.13 2.26 2.16 1.18 2.23 24.45 39.88 10.20 
 
C12 H32 N5 O P 293.2351 2.056 28 1.60 1.67 1.04 1.71 1.40 0.97 24.49 40.27 21.98 
 
C33 H48 O S 492.3426 3.304 10 1.08 0.63 0.91 1.26 0.56 1.01 24.51 18.42 21.07 
 
C32 H65 N 463.5114 4.213 19 1.60 0.24 1.22 1.48 0.16 1.18 24.52 49.45 20.33 
 
C22 H40 O 320.3073 3.908 9 1.24 1.10 1.25 1.18 1.41 1.29 24.54 34.58 5.72 
 
C18 H34 N2 278.2716 2.592 6 1.74 0.36 1.17 1.52 0.27 1.12 24.54 12.73 20.66 
 
C61 H79 N7 O2 941.629 2.554 6 2.77 2.51 2.69 3.01 2.54 2.83 24.56 6.78 19.09 
 
C51 H102 N3 O9 P S 963.7076 3.181 6 3.82 3.61 3.96 3.94 3.61 3.93 24.57 0.51 27.06 
 
C40 H84 Cl N3 O11 817.5787 5.169 28 4.82 4.79 4.93 5.21 4.83 4.90 24.58 6.97 4.90 
 
C87 H139 N3 O5 P2 1368.02 3.258 3 2.36 2.07 2.16 2.24 2.15 2.17 24.61 10.72 6.63 
 
C52 H109 N6 O P S2 928.7848 11.49 19 6.09 4.93 6.00 5.92 4.88 6.32 24.67 14.72 42.89 
 
C36 H67 N 513.5272 4.327 20 1.37 0.11 0.91 1.37 0.04 0.63 24.77 32.97 40.78 
 
C18 H48 N9 P 421.3762 3.24 19 1.21 1.40 2.05 1.40 1.43 1.77 24.78 5.73 46.45 
 
C26 H51 N5 O3 S 513.369 2.677 21 3.71 3.46 3.44 3.77 3.39 3.55 24.88 19.67 18.82 
 
C63 H130 N6 O11 S2 1210.922 3.116 14 1.80 1.64 1.69 1.75 1.71 1.70 24.88 10.89 6.56 
 
C19 H7 N7 O17 S 636.9623 3.437 7 3.32 3.26 3.34 3.53 3.26 3.42 24.90 6.02 23.38 
 
C33 H42 S 470.3006 3.351 15 3.11 2.58 3.63 3.49 2.39 3.59 24.93 24.67 34.21 
 
C38 H73 O10 P 720.4929 4.85 25 4.40 4.02 4.27 4.57 3.77 4.12 24.94 49.17 27.39 
 
C52 H101 N7 O12 1015.75 3.461 14 7.62 5.74 7.44 7.50 5.66 7.53 24.96 31.79 25.31 
 
C39 H63 N O6 641.4642 1.765 23 6.33 5.42 5.82 6.34 5.12 5.83 25.05 46.89 11.12 









C8 H15 N O3 173.1047 1.946 18 1.62 0.63 1.21 1.55 0.72 1.42 25.20 15.80 33.17 
 
C38 H70 N2 O P2 632.4984 5.394 13 1.42 0.85 1.63 1.36 0.82 1.64 25.21 21.07 36.14 
 
C15 H39 N8 P 362.3026 2.767 7 4.27 3.24 4.75 4.23 3.33 4.54 25.23 14.76 48.79 
 
C46 H87 N10 O8 P3 1000.592 3.492 6 8.70 7.29 8.51 8.47 6.99 8.74 25.23 46.26 27.98 
 
C59 H121 N4 O13 P S 1156.839 3.121 2 2.80 2.46 2.72 2.89 2.50 2.83 25.31 3.97 27.78 
 
C13 H37 N10 O P 380.2897 2.744 20 1.17 0.55 1.93 1.59 0.73 1.86 25.35 35.62 9.92 
 
C31 H51 O9 P 598.3293 2.627 3 5.74 5.69 6.35 6.00 5.87 6.14 25.38 27.81 31.75 
 
C16 H22 O4 278.1513 2.445 5 1.89 1.82 1.96 2.02 1.92 1.83 25.38 21.87 30.68 
 
C31 H59 N S 477.4392 3.03 10 4.68 3.60 4.83 4.47 3.68 4.82 25.40 22.55 45.19 
 
C34 H76 N10 624.6246 7.894 7 3.99 3.12 4.40 3.94 3.10 4.26 25.41 48.65 32.29 
 
C27 H48 S 404.3496 3.281 18 1.71 1.80 1.85 1.66 1.78 1.87 25.43 9.18 27.30 
 
C41 H87 N3 O6 717.66 8.265 22 1.77 1.67 1.87 2.11 1.58 1.84 25.45 38.36 7.40 
 
C68 H130 N6 O17 S 1334.922 2.625 7 4.89 4.93 4.82 5.01 4.80 4.90 25.50 17.62 14.31 
 
C57 H101 N8 O5 P 1008.763 3.571 3 2.97 2.97 3.15 3.29 3.00 3.10 25.54 3.39 21.12 
 
C22 H50 N6 O16 654.3269 3.065 9 4.74 3.20 4.72 4.58 3.26 4.96 25.56 20.70 45.60 
 
C49 H80 N O10 P 873.5484 4.446 14 3.51 3.27 3.23 3.32 3.35 3.30 25.57 13.90 10.24 
 
C38 H82 N9 O2 P3 789.5806 2.756 8 2.91 2.16 3.18 3.15 2.17 3.27 25.57 2.64 36.43 
 
C13 H23 N O 209.1776 3.103 10 2.34 2.23 2.58 2.41 2.03 2.60 25.64 40.49 3.23 
 
C41 H57 N O6 659.4175 2.772 4 7.99 7.44 8.31 8.21 7.39 8.36 25.64 19.38 43.85 
 
C10 H23 N O9 301.1365 2.452 26 2.68 3.02 2.64 2.84 3.02 2.71 25.66 3.91 18.31 
 
C20 H52 N9 O3 P 497.3924 2.592 9 3.47 2.60 3.50 3.51 2.46 3.69 25.67 24.10 21.70 
 
C14 H27 N O3 257.1986 1.985 16 3.14 3.00 2.60 3.07 3.00 2.63 25.71 15.76 21.88 
 
C42 H75 O8 P 738.5175 4.6 11 2.95 2.31 2.99 3.20 2.20 3.28 25.76 20.15 39.04 
 
C21 H40 O3 340.2975 2.5 22 2.12 0.85 2.30 2.40 0.91 2.32 25.77 10.77 41.59 
 
C22 H41 N O 335.3181 3.504 13 3.09 3.01 3.03 3.02 3.22 3.05 25.77 24.91 17.11 









C19 H48 N8 O4 S 484.3503 0.768 18 3.28 2.50 3.10 3.42 2.66 3.03 25.88 35.33 10.51 
 
C34 H71 N3 O S2 601.5038 4.854 6 1.36 0.80 1.03 1.13 0.87 0.96 25.89 10.48 10.41 
 
C38 H51 N O6 617.3705 2.772 4 11.37 10.74 11.60 11.54 10.69 11.69 25.91 14.94 46.71 
 
C57 H117 N4 O12 P S 1112.813 3.13 5 3.49 3.19 3.54 3.58 3.20 3.56 25.91 1.63 34.86 
 
C43 H89 N O 635.694 11.868 14 0.97 0.95 0.40 1.04 0.58 0.35 25.94 40.38 23.65 
 
C15 H20 O5 280.1304 1.701 9 12.10 12.05 12.32 12.27 11.78 12.21 25.95 46.82 26.65 
 
C73 H155 N10 O17 P3 1537.079 3.326 3 3.29 3.08 3.45 3.50 3.05 3.46 25.96 5.43 16.82 
 
C38 H51 P3 600.3191 2.772 16 4.41 3.68 4.73 4.51 3.63 4.72 25.96 7.62 44.81 
 
C15 H29 N O2 255.2192 3.57 8 2.31 2.12 2.15 2.15 2.12 2.14 26.01 6.72 6.97 
 
C13 H18 174.1406 3.119 12 1.65 1.48 1.65 1.33 1.48 1.56 26.02 12.73 24.20 
 
C46 H82 N O8 P 807.5761 4.861 6 3.65 3.64 3.63 3.45 3.88 3.45 26.02 28.89 23.76 
 
C34 H72 N8 O P2 S 702.4997 3.376 4 2.68 2.59 2.87 2.94 2.62 2.92 26.06 4.07 18.71 
 
C32 H76 N9 O8 P 745.5542 2.763 3 3.60 2.81 3.93 3.77 2.84 4.01 26.06 4.98 38.81 
 
C59 H79 N4 O3 P S 954.5615 3.583 12 1.65 0.42 1.82 1.74 0.50 2.14 26.12 22.89 48.22 
 
C36 H24 N3 O13 P3 799.0519 2.997 13 3.10 2.78 3.25 3.47 2.85 3.33 26.12 9.93 22.93 
 
C78 H166 N9 O17 P3 S 1626.133 3.296 5 2.91 2.72 3.19 3.03 2.68 3.19 26.13 5.53 13.38 
 
C21 H46 N O P S2 423.2748 3.153 23 3.04 2.93 3.06 2.92 2.89 3.08 26.16 11.23 13.04 
 
C29 H68 N9 O6 P 669.5021 3.076 15 1.89 1.65 1.98 1.88 1.67 1.86 26.18 5.51 20.24 
 
C69 H132 N6 O15 S 1316.947 3.412 2 2.67 2.82 2.99 3.10 2.83 3.04 26.21 0.54 18.42 
 
C32 H72 N10 O S 644.56 3.945 6 1.19 0.26 1.03 1.24 0.44 1.06 26.22 36.42 7.60 
 
C20 H37 N O4 355.2717 3.233 12 2.44 2.09 2.18 2.43 2.14 2.12 26.27 16.06 8.76 
 
C39 H53 N O6 631.3862 2.772 4 11.29 10.62 11.54 11.42 10.60 11.63 26.32 16.26 49.87 
 
C68 H135 N O17 P2 1299.921 3.414 2 2.76 2.87 3.05 3.18 2.88 3.10 26.32 0.55 18.81 
 
C49 H110 N9 O15 P 1095.786 3.132 3 3.53 3.22 3.58 3.61 3.21 3.59 26.34 2.57 33.22 
 
C18 H38 O4 318.2764 2.787 7 2.75 2.00 3.22 2.89 2.00 3.12 26.37 5.53 33.81 









C60 H117 N4 O6 P3 S 1114.791 2.652 8 4.18 3.83 4.14 4.29 3.84 4.08 26.46 2.01 21.28 
 
C59 H118 N3 O13 P S 1139.812 3.117 2 2.98 2.63 2.91 3.07 2.65 3.02 26.48 4.66 28.65 
 
C42 H90 N9 O2 P3 845.6435 2.833 14 2.79 2.48 2.71 2.58 2.46 2.70 26.49 4.17 7.43 
 
C18 H39 N O 285.3024 5.167 19 1.52 0.01 1.21 1.52 0.17 1.15 26.50 38.09 19.59 
 
C24 H43 Cl N4 O2 454.3067 1.3 9 4.44 2.53 3.41 4.63 2.62 3.43 26.50 39.24 17.48 
 
C39 H78 N5 O3 P3 S2 821.4737 3.798 15 1.42 0.07 0.61 1.07 0.11 0.75 26.51 35.32 18.01 
 
C69 H126 N7 O P3 S 1193.896 3.118 10 1.83 1.75 1.78 1.81 1.80 1.79 26.52 8.29 5.05 
 
C22 H52 N9 P 473.4079 2.514 20 4.51 2.80 4.42 4.81 2.81 4.46 26.56 7.78 15.29 
 
C18 H40 N5 O3 P 405.285 3.101 13 3.63 3.28 3.44 3.62 3.23 3.35 26.57 7.79 20.16 
 
C65 H123 N5 O12 P2 1227.864 3.09 3 2.66 2.41 2.80 2.84 2.42 2.88 26.63 9.93 26.79 
 
C27 H59 N9 O6 605.4607 3.12 2 1.45 1.34 1.48 1.35 1.36 1.46 26.64 7.73 6.70 
 
C59 H89 N3 O4 903.6854 3.617 4 3.02 2.78 3.03 3.23 2.83 3.09 26.65 6.43 19.92 
 
C20 H39 N O2 325.2979 2.959 14 1.98 0.87 2.03 1.84 0.88 1.92 26.71 31.38 33.49 
 
C34 H59 N7 O5 P2 S 739.3799 3.045 5 1.59 1.49 1.87 1.50 1.88 1.94 26.71 41.84 16.64 
 
C69 H141 N4 O18 P S 1376.969 3.051 4 3.22 3.10 3.47 3.47 3.09 3.57 26.74 3.02 25.21 
 
C41 H73 N4 O3 P S 732.5106 3.062 4 2.62 2.28 2.77 2.81 2.33 2.84 26.75 6.52 29.75 
 
C81 H156 N3 O14 P3 S 1520.052 3.327 2 3.16 2.93 3.31 3.37 2.92 3.33 26.80 5.25 16.96 
 
C39 H90 N9 O10 P 875.6544 3.222 4 4.28 3.94 4.25 4.30 3.94 4.30 26.81 10.16 23.55 
 
C47 H106 N9 O14 P 1051.76 3.146 2 2.87 2.71 3.08 3.06 2.72 3.08 26.81 1.89 27.82 
 
C25 H61 N10 O10 P S 724.406 3.057 14 4.42 3.20 4.63 4.27 3.49 4.81 26.83 35.75 45.01 
 
C28 H62 N6 O3 P2 592.434 3.495 7 2.24 2.47 2.56 2.60 2.48 2.53 26.83 2.16 18.18 
 
C19 H41 N O 299.3182 5.701 7 1.80 0.12 1.11 1.60 0.17 1.16 26.85 34.66 12.93 
 
C65 H130 N3 O16 P S 1271.89 3.076 4 2.95 2.64 3.15 3.12 2.66 3.19 26.85 4.80 29.19 
 
C87 H137 N10 O5 P S 1465.022 3.032 6 2.70 2.42 2.86 2.95 2.43 2.93 26.88 5.96 32.16 
 
C44 H65 N O6 703.4784 3.063 3 2.03 0.72 1.92 1.79 0.53 2.12 26.97 31.75 22.79 









C47 H97 N3 O10 P2 S 957.6371 3.905 18 4.07 3.29 3.93 3.84 3.31 4.11 27.04 25.40 40.18 
 
C55 H111 N O5 P2 S2 991.737 3.563 3 3.07 3.03 3.26 3.36 3.03 3.22 27.05 0.57 21.34 
 
C36 H71 N O 533.5532 7.95 21 0.89 0.28 1.06 1.22 0.31 1.06 27.06 48.78 7.00 
 
C83 H157 N9 O14 P2 S 1598.104 3.003 15 2.63 2.28 2.83 2.94 2.33 2.92 27.08 9.23 20.21 
 
C29 H54 O6 S 530.363 3.529 28 2.08 0.86 1.58 2.10 0.89 1.54 27.14 35.01 24.95 
 
C34 H76 N5 P 585.5823 8.41 9 1.03 0.95 0.55 1.07 0.56 0.51 27.18 46.34 32.68 
 
C51 H79 N9 O3 S 897.6031 2.562 8 3.76 3.48 3.71 3.83 3.40 3.66 27.20 10.92 14.60 
 
C55 H113 N4 O11 P S 1068.786 3.15 3 2.68 2.53 2.91 2.90 2.54 2.90 27.25 1.63 28.65 
 
C11 H25 N8 O4 P S 396.1457 1.852 24 3.32 2.80 3.46 3.49 2.84 3.29 27.29 4.64 26.79 
 
C18 H45 N10 O P 448.3523 3.408 11 2.50 2.39 2.42 2.32 2.39 2.30 27.31 1.88 16.11 
 
C32 H72 N9 O P S 661.5333 6.821 8 4.65 4.38 5.19 4.72 4.17 5.01 27.34 38.65 33.69 
 
C57 H120 N9 O10 P3 1183.838 3.103 2 3.12 2.90 3.19 3.32 2.93 3.28 27.44 4.38 29.64 
 
C24 H53 N9 O5 547.419 3.021 6 1.50 1.37 1.49 1.36 1.39 1.54 27.45 6.77 7.37 
 
C24 H49 N O 367.3809 5.856 4 1.51 0.60 2.10 1.42 0.61 1.87 27.46 38.48 31.10 
 
C64 H107 N6 O13 P S 1230.735 4.459 15 2.59 1.25 2.57 2.59 1.50 2.84 27.49 29.33 42.64 
 
C28 H26 O3 410.1877 2.283 9 3.04 2.45 2.85 3.62 2.32 2.94 27.52 24.04 22.49 
 
C30 H59 N9 O P2 623.4342 2.633 7 5.08 4.99 4.95 5.35 4.92 4.94 27.53 24.83 18.56 
 
C40 H79 N5 O9 773.5862 3.088 10 2.64 2.02 2.69 2.69 1.90 2.71 27.56 22.18 26.03 
 
C40 H81 N O3 623.621 7.89 24 3.73 2.59 4.25 3.79 2.91 4.15 27.59 35.52 30.04 
 
C33 H78 N9 O7 P 743.5752 3.278 5 2.83 2.53 2.65 2.81 2.54 2.74 27.59 10.50 14.27 
 
C38 H79 N3 O 593.6219 8.065 19 2.39 0.71 1.79 2.50 1.05 1.74 27.60 42.80 43.75 
 
C21 H41 N 307.3234 4.836 4 2.49 1.48 2.90 2.42 1.57 2.72 27.61 30.87 33.74 
 
C69 H124 N3 O P3 S2 1167.841 3.464 4 2.61 2.71 2.85 2.81 2.68 2.80 27.63 4.20 21.30 
 
C48 H79 N O7 781.5852 4.16 10 3.58 2.89 3.78 3.74 2.77 3.96 27.65 49.09 48.85 
 
C69 H147 N10 O15 P3 1449.026 3.358 3 3.27 3.05 3.38 3.40 3.07 3.43 27.76 2.56 21.21 









C58 H116 N3 O10 P S 1077.812 3.022 7 2.87 2.57 2.75 2.81 2.63 2.78 27.80 11.50 6.38 
 
C17 H34 N6 O2 354.2741 2.874 13 2.75 1.40 2.89 2.69 1.72 3.02 27.85 40.76 35.08 
 
C47 H70 N7 O P 779.5386 2.653 7 3.35 2.94 3.33 3.27 2.92 3.36 27.87 10.62 13.51 
 
C9 H9 O3 P 196.0293 5.125 19 1.12 0.39 0.95 1.17 0.55 1.28 27.93 22.08 36.52 
 
C33 H66 N10 O P2 680.4867 3.391 4 2.94 2.81 3.00 3.11 2.79 3.08 27.95 3.26 21.04 
 
C56 H86 O3 S 838.6289 4.385 4 4.55 4.28 4.45 4.17 4.18 4.43 27.95 28.85 4.95 
 
C12 H35 N10 O6 P 446.2488 1.744 15 13.90 13.56 13.84 13.45 13.42 13.87 27.95 49.96 20.53 
 
C49 H91 N5 O3 P2 859.6593 3.649 8 2.67 2.37 2.74 2.81 2.37 2.74 27.96 12.97 16.39 
 
C19 H39 N3 O4 373.295 2.796 14 1.05 1.36 1.01 1.10 1.44 0.94 27.98 12.11 16.57 
 
C22 H45 N O 339.3497 4.834 4 2.64 1.67 3.10 2.57 1.76 2.91 28.00 30.92 34.56 
 
C45 H79 N8 O3 P S 842.5736 5.628 19 7.15 6.43 6.70 6.95 6.44 6.69 28.04 14.23 3.15 
 
C30 H66 N8 O2 P2 632.4797 3.166 4 2.11 1.91 2.03 1.98 2.03 2.10 28.16 18.20 22.89 
 
C36 H54 S 518.3967 2.979 8 2.77 2.56 2.69 2.69 2.61 2.66 28.18 10.17 9.13 
 
C47 H100 N9 O4 P3 947.7111 3.587 4 2.84 2.60 2.81 2.95 2.64 2.92 28.19 6.07 20.76 
 
C45 H54 N3 O3 P 715.3932 3.337 8 2.91 1.55 2.87 2.77 1.75 3.13 28.20 23.08 48.24 
 
C23 H43 N3 O6 457.3139 2.559 11 3.10 2.68 3.02 3.33 2.70 2.99 28.27 10.21 18.89 
 
C41 H65 N O7 683.4754 4.493 9 3.76 2.92 3.79 3.67 2.76 4.06 28.27 47.18 49.13 
 
C54 H91 N O7 865.6763 3.858 17 2.30 2.40 2.29 2.40 2.42 2.30 28.32 13.98 10.71 
 
C16 H40 Cl N8 O P 426.2756 1.305 15 3.70 2.03 2.90 4.14 2.10 3.09 28.34 39.91 34.00 
 
C38 H79 N O 565.6155 3.715 15 0.92 0.91 1.20 1.15 1.40 1.20 28.35 47.26 8.85 
 
C63 H122 N6 O11 P2 1200.865 3.104 2 3.10 2.91 3.19 3.33 2.96 3.27 28.37 5.35 29.88 
 
C26 H51 N3 O2 S2 501.3403 2.55 12 3.43 2.99 3.44 3.53 3.00 3.32 28.38 23.30 31.30 
 
C77 H136 O13 S2 1332.943 3.064 4 3.07 2.87 3.30 3.22 2.89 3.32 28.40 3.22 27.73 
 
C5 H11 N4 O2 P 190.0627 2.44 10 3.27 3.22 3.37 3.35 3.37 3.40 28.42 26.53 11.45 
 
C31 H59 N O S 493.4336 2.748 16 3.59 2.80 4.38 3.67 2.86 4.12 28.44 14.53 46.45 









C69 H144 N9 O15 P3 1432 3.357 3 3.23 3.02 3.36 3.38 3.04 3.40 28.53 2.48 21.28 
 
C71 H107 N3 O P2 1079.789 3.521 3 2.94 2.92 2.99 3.10 2.96 3.01 28.56 6.04 19.50 
 
C40 H80 N4 O12 808.5792 5.621 6 3.75 4.61 4.21 3.59 4.29 3.94 28.57 46.73 34.57 
 
C78 H144 N10 O15 S 1493.053 3.342 20 3.75 3.47 3.71 3.86 3.49 3.88 28.58 6.86 21.89 
 
C13 H37 N9 O2 P2 413.2563 2.249 17 1.50 0.68 0.92 1.50 0.92 0.96 28.59 35.99 12.57 
 
C23 H36 312.281 11.259 20 2.95 3.24 3.01 2.73 3.28 3.03 28.63 10.56 20.17 
 
C35 H77 N10 O3 P 716.5924 8.406 19 2.26 1.97 2.00 2.05 2.07 1.95 28.69 15.75 26.63 
 
C39 H84 N9 P3 771.6061 3.715 3 2.76 2.58 2.94 3.01 2.58 2.91 28.70 2.52 16.17 
 
C82 H147 N3 O15 P2 1476.028 3.343 19 3.66 3.38 3.62 3.77 3.39 3.79 28.73 6.75 22.02 
 
C48 H91 N P2 743.663 8.027 13 3.10 0.67 2.78 2.95 0.43 3.06 28.74 39.12 38.48 
 
C37 H74 N6 O3 650.5843 8.019 2 2.89 2.44 3.05 2.77 2.79 3.11 28.76 45.43 30.41 
 
C36 H73 N2 O9 P 708.5028 3.074 6 3.65 3.06 3.73 3.61 3.01 3.87 28.77 11.96 26.11 
 
C18 H29 N 259.2296 2.237 10 1.42 0.42 0.61 1.31 0.22 0.76 28.79 34.91 17.96 
 
C51 H101 N5 O14 1007.734 3.162 6 3.84 3.48 3.85 3.91 3.50 3.91 28.93 4.50 25.69 
 
C30 H72 N9 O7 P S 733.4995 2.607 9 4.46 4.42 4.36 5.02 4.42 4.36 28.95 32.66 25.29 
 
C41 H94 N9 O11 P 919.6814 3.202 7 3.79 3.42 3.85 3.87 3.47 3.81 29.00 6.51 27.92 
 
C22 H44 N2 O 352.3448 2.53 22 1.70 1.24 1.83 1.60 1.24 1.86 29.01 35.10 7.98 
 
C41 H79 N O14 809.5503 2.571 4 2.35 1.88 2.22 2.46 1.92 2.28 29.04 6.19 13.71 
 
C40 H63 N O7 669.4598 3.946 6 4.15 3.27 4.19 4.14 3.23 4.43 29.08 44.60 48.80 
 
C59 H122 N9 O12 P S 1211.867 3.447 5 2.93 2.83 3.03 3.16 2.85 2.99 29.08 7.97 19.83 
 
C16 H30 O4 286.2138 3.213 20 1.57 1.24 1.37 1.49 1.35 1.41 29.08 14.12 7.88 
 
C19 H39 Cl O6 398.2441 1.308 10 2.62 0.73 1.61 3.07 0.85 1.66 29.12 43.09 36.04 
 
C63 H119 N5 O8 P2 1135.854 3.069 3 1.52 1.40 1.56 1.43 1.40 1.53 29.15 11.87 3.86 
 
C12 H23 N O2 213.1724 3.219 22 1.50 0.87 1.58 1.59 0.72 1.57 29.17 39.74 12.06 
 
C18 H20 O3 284.1409 2.227 7 1.76 0.09 0.91 1.53 0.02 1.04 29.17 33.53 18.07 









C51 H104 N6 O14 1024.761 3.157 7 3.83 3.46 3.85 3.92 3.49 3.92 29.34 4.20 27.21 
 
C19 H40 O4 332.2921 2.884 11 3.10 2.02 3.29 3.13 2.12 3.45 29.42 28.86 22.83 
 
C37 H73 N O6 627.5431 7.541 17 1.55 1.42 0.81 1.57 1.25 0.79 29.43 24.93 42.18 
 
C6 H13 N4 O2 P 204.0783 2.445 9 3.10 3.07 3.19 3.18 3.14 3.27 29.45 15.38 10.74 
 
C20 H45 N9 O5 491.3558 2.69 11 3.12 2.51 3.02 3.02 2.54 3.18 29.45 12.28 23.06 
 
C62 H104 N6 O S 980.7991 11.49 21 4.05 2.83 4.09 3.92 2.75 4.49 29.54 29.75 41.65 
 
C20 H41 N O4 359.3031 2.27 12 1.89 0.70 1.06 2.14 0.58 1.06 29.56 26.08 3.23 
 
C31 H71 N10 O7 P 726.5261 4.162 14 2.79 1.97 2.85 2.84 1.86 3.12 29.60 39.45 47.74 
 
C31 H48 N3 O11 P 669.3013 3.062 6 2.58 2.45 3.13 2.39 2.65 3.09 29.65 34.83 30.57 
 
C32 H57 P S 504.3919 4.399 22 2.02 2.53 2.26 2.39 2.61 2.18 29.68 21.48 22.32 
 
C21 H41 N4 O P S 428.2741 1.326 12 4.66 2.56 3.47 4.73 2.76 3.47 29.72 36.10 41.35 
 
C9 H6 N6 O18 P2 547.9211 3.022 8 1.32 1.25 1.28 1.14 1.21 1.29 29.74 7.84 6.20 
 
C32 H46 N4 O2 518.3604 4.164 15 2.23 1.43 2.40 2.27 1.32 2.65 29.77 32.34 48.74 
 
C62 H126 N2 O12 P2 1152.879 3.069 5 2.95 2.93 3.06 2.88 2.93 3.05 29.83 12.18 3.62 
 
C67 H144 N10 O15 P2 S 1423.001 3.039 14 3.29 2.99 3.14 3.34 2.96 3.31 29.83 11.42 27.24 
 
C71 H126 N7 O13 P 1315.916 3.063 4 3.11 2.88 3.33 3.26 2.90 3.35 29.95 3.21 28.23 
 
C76 H139 Br N O7 P3 1349.896 3.445 14 1.63 0.94 1.36 1.34 0.88 1.46 29.99 12.12 32.68 
 
C75 H120 N4 P2 S2 1202.843 2.641 11 3.87 3.67 3.92 4.00 3.67 3.89 29.99 11.71 9.88 
 
C15 H22 O 218.1666 2.316 15 1.80 0.09 0.84 1.46 0.13 0.81 30.00 44.25 6.43 
 
C79 H157 N7 O18 P2 1554.105 3.327 20 1.95 1.64 2.25 1.83 1.69 2.20 30.06 6.42 16.60 
 
C22 H46 N7 O P S 487.3213 3.221 15 1.57 0.43 1.49 1.37 0.61 1.32 30.15 21.89 23.59 
 
C69 H147 N10 O14 P S3 1467.001 2.602 8 3.92 3.88 3.96 4.42 3.83 3.90 30.17 29.63 13.73 
 
C30 H72 N9 O8 P 717.5238 2.563 8 3.20 2.09 2.89 3.15 2.14 3.14 30.20 6.61 33.73 
 
C26 H52 N8 O5 556.4061 3.134 3 3.43 3.29 3.58 3.60 3.26 3.62 30.21 4.61 30.68 
 
C50 H81 O10 P 872.5528 5.599 19 3.36 3.27 3.83 3.64 3.47 3.83 30.22 32.97 7.26 









C45 H73 N O7 739.5381 3.949 6 5.22 4.54 5.45 5.44 4.43 5.66 30.26 48.54 48.74 
 
C11 H21 N O2 199.1566 1.007 10 1.94 0.61 2.21 1.60 0.90 1.92 30.35 35.45 39.22 
 
C33 H65 O10 P 652.4334 3.946 2 4.30 3.29 4.24 4.17 3.26 4.50 30.38 42.64 48.63 
 
C23 H48 N2 O2 384.371 2.533 17 2.32 1.57 2.40 2.20 1.67 2.44 30.41 29.58 4.64 
 
C67 H139 N5 O10 S3 1269.968 3.162 5 2.36 2.22 2.18 2.19 2.23 2.18 30.44 10.81 2.73 
 
C42 H83 N O7 713.616 8.011 25 2.61 2.12 2.71 2.40 2.32 2.75 30.47 44.92 44.72 
 
C47 H71 N O6 745.5245 3.341 2 3.29 3.00 3.36 3.44 3.05 3.48 30.48 7.83 20.17 
 
C18 H40 N3 O6 P 425.267 2.053 4 2.39 1.33 2.25 2.24 1.39 2.26 30.49 46.66 6.46 
 
C22 H54 N10 P2 520.399 2.051 12 1.78 0.44 0.48 1.64 0.40 0.60 30.57 17.80 27.73 
 
C60 H115 N 849.9027 13.769 2 2.16 0.50 1.67 1.99 0.80 1.63 30.57 43.90 6.42 
 
C83 H163 N4 O16 P3 S 1597.1 2.998 17 3.16 2.93 3.41 3.38 2.89 3.37 30.58 7.61 12.81 
 
C39 H90 N10 O14 922.6634 2.742 24 3.14 2.15 3.37 3.32 2.16 3.35 30.68 33.06 17.92 
 
C35 H71 N O2 537.548 8.098 17 2.16 0.42 2.27 2.09 0.90 2.30 30.71 49.10 13.13 
 
C30 H45 N O6 515.3244 2.128 18 7.94 5.64 7.74 7.60 5.65 7.65 30.72 45.27 26.64 
 
C18 H42 N6 O4 406.3288 2.755 17 4.74 3.88 5.03 4.61 3.88 4.99 30.81 2.07 46.76 
 
C24 H48 N2 O 380.3761 2.483 12 1.04 0.58 0.72 1.00 0.16 0.73 30.84 44.80 16.68 
 
C18 H24 O2 272.1771 2.38 16 1.44 0.46 1.09 1.35 0.13 1.07 30.84 44.07 11.08 
 
C61 H95 N O6 937.712 3.206 11 2.12 1.83 2.25 2.05 1.78 2.09 30.85 6.97 47.00 
 
C38 H60 N9 P 673.4742 3.382 7 2.47 2.13 2.59 2.83 2.17 2.78 31.08 8.84 21.56 
 
C28 H57 N3 O9 579.4085 2.645 14 3.09 2.87 2.79 3.22 2.73 2.82 31.08 18.33 25.86 
 
C47 H103 N10 O4 P3 964.7374 3.596 5 2.75 2.57 2.80 2.80 2.61 2.84 31.09 9.95 20.57 
 
C31 H74 N9 O8 P 731.5389 2.267 13 1.61 1.32 2.17 2.19 1.20 2.35 31.12 16.09 30.30 
 
C22 H45 N3 O6 447.3294 2.738 13 2.77 2.32 3.71 3.42 2.28 3.85 31.15 19.18 28.29 
 
C23 H52 N6 O P2 490.3669 3.179 8 3.49 3.16 3.48 3.56 3.01 3.42 31.22 28.03 41.98 
 
C33 H77 N10 O P3 S 754.5239 3.021 6 3.75 3.46 4.16 3.99 3.51 4.12 31.26 12.00 31.98 









C24 H47 N O 365.3654 4.578 9 2.68 2.49 2.64 2.70 2.76 2.63 31.29 37.21 9.82 
 
C40 H71 O8 P 710.4867 4.163 7 3.93 3.24 4.01 4.17 3.35 4.11 31.50 19.36 38.58 
 
C58 H109 N O6 915.8215 11.486 19 4.35 3.29 4.24 4.11 3.20 4.58 31.64 17.74 38.03 
 
C31 H62 N3 O P S 555.4344 2.47 7 1.02 0.48 1.40 1.41 0.62 1.66 31.75 45.71 46.32 
 
C34 H75 N10 O6 P 750.5589 3.947 11 3.88 3.25 3.83 3.88 3.24 4.15 31.75 47.09 45.55 
 
C68 H144 N8 O14 P2 S2 1422.973 2.612 22 4.90 4.53 4.57 5.16 4.57 4.67 31.81 26.95 16.25 
 
C17 H36 N6 O4 388.2816 1.309 12 3.92 1.92 2.76 4.11 2.06 2.95 31.82 36.97 33.26 
 
C26 H57 N5 O5 519.4338 5.887 15 2.14 2.72 2.41 2.18 2.38 2.39 31.84 46.20 11.69 
 
C19 H37 N O2 311.2818 2.639 7 2.02 0.91 1.71 2.19 1.01 1.64 31.88 28.75 13.61 
 
C41 H71 O8 P 722.4867 4.167 10 1.96 1.36 1.74 2.09 1.60 2.03 31.99 49.11 41.65 
 
C21 H42 O4 358.3077 7.753 7 3.71 2.38 3.86 3.47 2.30 3.90 32.11 48.03 36.42 
 
C36 H80 N5 P 613.613 8.834 5 2.77 0.90 1.95 2.51 1.10 2.10 32.14 46.67 29.40 
 
C21 H37 Cl N4 O2 412.2598 1.295 12 5.19 3.17 4.08 5.37 3.32 4.21 32.24 45.36 39.27 
 
C51 H108 N5 O13 P 1029.768 3.635 12 3.14 0.72 2.73 2.95 0.84 2.93 32.24 40.03 25.59 
 
C53 H113 N10 O9 P S 1096.815 3.528 3 2.47 2.55 2.45 2.68 2.60 2.55 32.30 5.72 18.52 
 
C18 H38 N2 O8 410.2637 1.309 12 5.68 3.64 4.50 5.86 3.79 4.65 32.30 36.47 36.53 
 
C26 H58 N6 O3 P2 564.4028 2.861 17 2.13 1.97 2.66 2.27 2.29 2.62 32.36 34.15 44.56 
 
C27 H61 N8 O P S 576.4396 3.069 3 2.79 3.04 3.08 2.79 2.95 3.06 32.37 14.42 7.14 
 
C16 H31 N 237.245 1.294 7 1.43 1.39 0.43 1.13 0.92 0.24 32.42 49.85 27.27 
 
C32 H40 N8 O 552.334 4.078 7 3.59 2.03 3.06 3.46 2.37 3.08 32.52 39.15 5.94 
 
C46 H97 N7 O9 P2 S 985.6549 2.53 9 3.02 2.71 3.00 3.25 2.72 2.92 32.53 8.73 25.50 
 
C45 H77 O8 P 776.5372 3.012 4 4.22 4.11 4.51 4.54 4.09 4.71 32.55 7.83 21.52 
 
C90 H162 N10 O13 P2 S 1685.151 2.979 11 2.39 2.07 2.56 2.38 2.37 2.72 32.61 32.04 30.87 
 
C23 H56 N9 O5 P 569.4143 2.563 17 0.91 0.91 0.83 1.27 0.85 0.77 32.68 9.64 24.17 
 
C19 H41 N O2 315.3133 2.308 20 2.58 1.37 2.44 2.36 1.44 2.70 32.75 29.98 32.37 









C10 H23 N3 O5 265.1649 3.119 10 3.46 3.09 3.34 3.17 3.06 3.22 32.87 7.59 21.45 
 
C35 H61 N3 O S3 635.3975 2.749 22 0.84 0.12 1.33 1.15 0.16 1.08 32.98 7.05 33.32 
 
C59 H110 N5 O8 P 1047.809 4.864 7 3.92 1.77 3.46 3.81 1.94 3.78 33.14 30.53 38.32 
 
C28 H56 Cl P3 520.327 0.779 13 3.29 2.59 3.25 3.35 2.82 3.22 33.22 32.90 15.83 
 
C73 H155 N10 O18 P3 1553.074 3.009 4 2.92 2.60 3.06 3.08 2.59 3.21 33.24 7.92 19.29 
 
C43 H69 N O7 711.5071 3.627 7 1.82 1.26 1.97 1.97 1.29 2.21 33.53 36.68 41.14 
 
C20 H52 N9 O4 P 513.3874 2.262 23 2.01 1.23 2.82 2.70 1.28 2.94 33.54 42.87 43.09 
 
C34 H49 N5 O4 P2 653.3233 3.061 10 5.44 4.00 5.35 5.12 4.05 5.73 33.55 10.28 47.57 
 
C65 H138 N10 O10 P2 
S2 
1344.952 3.397 8 1.79 1.84 1.76 2.27 1.83 1.99 33.59 5.01 27.58 
 
C41 H78 N O10 P 775.5367 2.995 4 2.79 2.47 3.10 3.01 2.48 3.18 33.68 7.32 20.08 
 
C13 H20 N2 O6 300.1334 2.44 19 3.11 3.05 2.90 3.07 3.02 3.00 33.73 20.35 11.23 
 
C16 H31 N O2 269.2349 3.113 13 2.39 1.94 2.01 2.31 1.95 1.92 33.75 19.51 26.38 
 
C39 H70 N O8 P 711.4872 2.624 8 4.77 4.51 4.47 5.05 4.53 4.59 33.76 18.68 17.36 
 
C37 H75 N O5 613.5645 2.578 14 0.76 1.36 0.32 1.22 1.32 0.03 33.80 5.77 48.69 
 
C73 H143 N9 O18 S 1466.027 3.036 4 3.59 3.22 3.72 3.67 3.20 3.74 33.92 4.23 26.80 
 
C70 H139 N O18 P2 1343.947 3.394 4 3.00 2.83 3.01 3.08 2.80 3.08 34.05 4.07 20.60 
 
C26 H53 N 379.4173 3.199 11 1.51 0.17 1.18 1.42 0.34 1.27 34.21 39.17 12.92 
 
C47 H75 N O7 765.5531 4.884 28 1.04 0.69 1.46 1.37 0.45 1.65 34.22 46.53 37.71 
C57 H107 N5 O6 P2 1019.769 2.972 4 2.82 2.60 2.67 2.64 2.62 2.74 34.25 4.10 13.25 
C40 H79 N O6 669.5902 6.481 23 2.26 1.39 2.38 2.24 1.23 2.26 34.38 29.42 32.53 
C72 H110 N4 O12 1222.812 2.362 16 2.94 3.06 2.65 3.32 2.75 2.68 34.38 44.80 30.22 
 
C71 H151 N10 O17 P3 1509.049 3.019 3 3.58 3.49 3.93 3.92 3.30 4.03 34.51 29.24 32.42 
 
C42 H83 N O8 P2 791.5605 2.406 22 2.73 2.06 3.00 2.84 1.98 2.91 34.72 15.48 19.72 
 
C20 H48 N5 P 389.3652 3.045 8 1.41 0.52 1.14 1.32 0.08 1.17 34.73 48.97 4.15 
 









C47 H87 N4 P S 770.6381 3.134 21 3.83 3.24 3.65 3.83 3.27 3.72 34.94 22.57 8.70 
 
C18 H30 O2 278.224 2.328 12 1.48 0.78 0.95 1.30 0.75 1.07 34.96 7.10 33.64 
 
C73 H133 N8 O13 P 1360.973 3.394 4 2.96 2.79 2.98 3.05 2.76 3.04 34.99 4.00 20.47 
 
C55 H100 N2 O7 900.7535 11.222 14 4.65 3.07 4.80 4.43 3.09 5.04 35.01 18.53 47.69 
 
C18 H35 N 265.2767 2.289 13 2.42 0.57 2.03 2.15 0.73 1.93 35.14 46.70 19.57 
 
C45 H73 N O7 739.5381 4.599 19 2.11 1.77 1.89 2.13 1.70 2.15 35.17 33.85 37.29 
 
C28 H58 N2 O2 454.4494 2.977 18 1.40 1.81 0.55 1.43 1.71 0.92 35.18 29.18 38.82 
 
C36 H77 N10 O8 P 808.5654 4.39 15 2.95 2.22 2.90 2.53 2.24 2.84 35.22 38.43 11.10 
 
C10 H7 N O3 189.0422 2.444 12 2.10 2.11 2.18 2.07 2.24 2.17 35.28 28.45 17.33 
 
C30 H60 N9 O9 P S 753.3957 3.045 2 2.21 2.07 2.37 1.96 2.40 2.48 35.36 36.21 29.83 
 
C21 H44 N2 O 340.3447 3.945 6 1.35 1.40 1.31 1.39 1.41 1.37 35.42 9.35 20.10 
 
C12 H24 N5 P 269.1773 2.355 7 2.70 1.84 2.46 2.31 2.10 2.48 35.48 33.94 20.58 
 
C27 H54 N6 O7 574.4049 2.803 12 3.59 2.60 3.86 3.23 2.41 3.81 35.49 24.60 43.99 
 
C32 H61 O3 P3 586.3842 3.933 15 3.60 2.52 3.37 3.86 2.47 3.57 35.49 22.00 27.98 
 
C17 H42 N10 O4 P2 512.2855 3.363 22 2.42 1.04 2.69 2.84 0.92 2.76 35.63 39.93 36.83 
 
C57 H108 N6 O4 940.8432 11.752 17 3.79 2.98 3.70 3.50 3.28 3.99 35.69 40.49 37.21 
 
C22 H58 N9 O P3 557.3956 2.652 20 4.71 4.48 4.59 4.90 4.51 4.65 35.72 8.99 19.91 
 
C60 H124 N10 O15 S 1256.897 3.435 14 2.61 2.77 3.02 3.26 2.88 3.07 35.75 13.70 32.59 
 
C8 H21 N4 P 204.1512 2.091 4 2.73 0.63 1.40 2.38 0.90 1.38 36.05 35.73 11.43 
 
C9 H21 N10 O9 P3 S 538.0425 3.004 22 2.00 1.69 1.83 2.24 1.72 2.10 36.07 16.35 43.81 
 
C37 H73 N O5 P2 673.498 2.568 8 3.59 2.60 3.41 3.65 2.57 3.72 36.09 4.19 33.67 
 
C21 H40 O4 356.2919 4.387 12 1.87 1.44 1.70 1.35 1.52 1.72 36.15 15.49 4.65 
 
C46 H67 N O8 761.4857 2.818 10 5.87 4.62 5.51 5.60 4.65 5.85 36.20 46.63 49.41 
 
C23 H42 Cl N3 S 427.2788 1.325 11 1.34 1.11 0.08 1.46 0.76 0.32 36.23 38.09 32.36 
 
C26 H61 N10 O2 P 576.4727 7.31 24 1.47 1.54 1.38 1.30 1.70 1.41 36.28 28.56 8.17 









C29 H55 N O S 465.4026 3.256 11 2.71 2.36 2.93 2.83 2.46 2.80 36.59 12.73 28.07 
 
C37 H58 P2 564.4024 3.94 12 3.02 1.88 3.09 3.41 1.87 3.32 36.61 19.40 42.84 
 
C59 H120 N5 O P3 S2 1071.815 4.348 13 1.87 0.56 1.57 1.85 0.50 1.70 36.63 23.90 34.82 
 
C46 H75 N O7 753.5533 4.599 16 3.32 2.53 3.15 3.01 2.24 3.25 36.68 45.72 26.78 
 
C22 H52 N5 P 417.3968 3.153 4 1.46 0.09 1.62 1.47 0.22 1.49 36.73 32.98 23.00 
 
C35 H63 O10 P 674.4155 3.944 17 5.35 3.98 5.13 4.91 4.06 5.45 36.76 34.99 48.76 
 
C24 H47 O7 P 478.3077 3.118 11 3.19 2.33 3.41 3.71 2.17 3.39 36.86 34.28 10.06 
 
C24 H42 N4 O3 434.3247 1.492 21 4.59 3.23 4.15 4.76 3.36 4.20 36.99 30.23 16.36 
 
C41 H57 N O6 659.4177 2.97 16 3.03 2.66 3.37 2.93 2.47 3.54 37.17 28.01 47.75 
 
C52 H110 N5 O13 P 1043.783 3.823 11 2.04 0.87 2.51 2.55 0.87 2.59 37.22 7.08 20.87 
 
C36 H35 N5 537.2872 2.318 20 3.89 2.95 3.56 3.85 2.91 3.90 37.25 42.78 49.84 
 
C41 H81 N O5 667.6107 8.026 2 3.71 3.15 3.93 3.55 3.38 3.99 37.34 34.24 34.59 
 
C24 H48 O7 448.3403 1.474 20 5.03 4.66 4.95 5.75 4.57 4.94 37.43 15.82 34.22 
 
C18 H42 N5 O P 375.3109 2.999 15 2.37 1.61 1.37 1.91 1.67 1.34 37.51 28.61 26.36 
 
C20 H32 N9 O2 P 461.2401 1.681 23 8.50 8.05 8.49 8.27 8.44 8.40 37.57 40.74 19.09 
 
C59 H94 N3 O6 P 971.6881 3.599 7 2.97 0.51 2.93 3.00 0.59 3.23 37.66 36.48 42.23 
 
C48 H69 N O6 755.5143 2.601 9 3.13 2.62 2.71 3.20 2.62 2.67 37.71 37.14 9.20 
 
C28 H61 N9 O9 667.4605 2.624 23 4.62 4.45 4.49 4.76 4.51 4.48 37.82 16.38 14.83 
 
C37 H73 O8 P 676.5036 6.471 12 2.31 0.78 2.61 2.05 1.02 2.24 37.95 31.82 49.61 
 
C24 H57 N9 O8 P2 S 693.3554 2.791 19 1.93 1.32 2.39 2.16 1.47 2.63 37.96 39.25 41.19 
 
C41 H54 N2 574.4264 3.124 8 2.70 1.00 1.99 2.31 1.30 2.05 38.05 35.42 7.21 
 
C39 H80 N2 O6 P2 734.5477 3.092 19 5.35 3.40 5.28 4.90 3.39 5.46 38.25 21.12 36.90 
 
C18 H43 N9 O4 449.3435 1.493 6 3.69 2.91 3.05 4.15 2.80 3.19 38.49 31.08 16.76 
 
C21 H32 Cl N3 O3 409.2123 1.922 19 2.17 1.45 2.09 2.35 1.50 2.02 38.59 29.25 20.82 
 
C12 H35 N10 O6 P 446.2488 1.343 20 4.56 4.07 4.76 4.79 4.20 4.79 38.71 40.58 45.47 









C28 H59 N O S 457.4316 2.755 13 1.71 1.88 1.84 1.80 1.74 1.79 39.03 36.11 10.83 
 
C16 H33 N O3 287.2454 1.595 21 3.61 3.46 3.53 4.84 3.14 3.49 39.15 42.38 13.27 
 
C19 H36 O3 312.2659 7.752 3 2.87 1.77 3.05 2.58 1.63 2.97 39.17 38.54 43.48 
 
C16 H30 O3 270.2191 3.124 22 2.93 2.28 2.54 2.70 2.38 2.68 39.19 14.53 16.18 
 
C23 H13 N2 O18 P S 667.9622 2.616 15 4.22 4.07 3.79 4.29 4.00 3.84 39.23 11.32 13.83 
 
C13 H36 N7 O2 P 353.267 0.795 19 2.00 1.80 2.79 1.65 1.77 2.68 39.32 28.32 47.66 
 
C24 H49 N3 O2 411.3824 3.02 18 1.80 1.03 1.23 1.55 1.32 1.45 39.41 43.41 36.49 
 
C43 H52 O5 P2 710.328 3.043 5 2.76 2.48 2.79 2.85 2.54 2.98 39.43 8.69 26.72 
 
C14 H26 O2 226.1927 1.87 22 2.94 0.63 0.59 2.42 0.98 0.89 39.52 37.83 32.40 
 
C64 H100 N O P S 961.7267 2.929 16 2.19 2.36 2.07 1.71 2.35 2.15 39.56 2.70 22.98 
 
C19 H48 N7 O4 P 469.3503 3.369 13 5.81 3.84 5.90 6.21 4.00 5.80 39.85 21.59 34.08 
 
C19 H32 260.2497 11.261 23 2.19 2.30 2.38 2.03 2.23 2.32 40.01 12.97 28.13 
 
C50 H75 N O6 785.5586 2.764 16 0.53 0.10 0.27 1.50 0.12 0.44 40.04 10.29 34.17 
 
C18 H41 N9 O S 431.3143 2.323 10 1.75 1.01 1.42 1.42 0.98 1.43 40.34 11.73 5.29 
 
C80 H171 N10 O15 P3 
S2 
1669.158 3.284 15 3.56 3.25 3.69 3.50 3.22 3.71 40.61 5.32 15.58 
 
C13 H25 N O3 243.1832 3.203 18 2.25 1.84 1.99 2.11 1.90 1.94 40.64 23.65 6.97 
 
C31 H50 N8 O8 S 694.35 2.791 17 2.38 1.74 2.76 2.76 1.91 3.11 40.71 41.19 42.64 
 
C48 H76 N5 O3 P 801.5692 2.603 14 1.08 0.22 0.84 1.11 0.16 0.81 40.86 17.19 29.73 
C19 H40 N4 O13 532.257 1.985 22 2.93 1.51 2.50 3.24 1.52 2.37 40.95 0.77 33.48 
C22 H51 Cl N6 434.3844 2.599 9 2.53 1.17 2.22 2.36 1.16 2.47 41.05 25.76 30.77 
C11 H30 N10 O6 398.2365 1.459 11 3.84 3.01 3.61 4.76 2.99 3.87 41.06 34.02 29.11 
 
C17 H32 N2 O2 P2 358.1942 1.297 22 2.58 1.95 2.42 2.25 1.83 2.43 41.20 25.92 5.49 
 
C18 H17 N8 O3 P3 S 518.0354 3.326 7 1.67 1.31 1.85 1.69 1.29 1.88 41.26 5.39 20.50 
 
C16 H44 N9 O P 409.3398 2.611 4 1.56 0.67 1.49 1.58 0.69 1.82 41.39 14.24 35.18 
 









C11 H14 O 162.1042 1.249 2 2.30 0.87 0.24 2.03 0.86 0.13 41.49 38.51 16.51 
 
C20 H41 N O3 343.3083 2.629 7 3.10 2.52 2.61 3.39 2.37 2.57 41.59 30.88 10.51 
 
C27 H43 N3 O2 S 473.3059 3.229 10 1.61 0.74 0.67 1.23 0.66 0.83 41.66 15.60 27.35 
 
C45 H96 N9 O3 P3 903.6848 2.887 11 2.43 2.17 2.43 1.90 2.22 2.42 41.70 11.96 5.55 
 
C7 H6 N8 O S 250.0389 2.712 15 1.94 1.95 2.03 1.77 1.81 1.80 41.95 30.81 34.24 
 
C30 H55 N5 485.4438 4.387 8 3.77 3.12 3.55 3.21 2.97 3.51 42.03 49.12 5.55 
 
C51 H105 N O 747.8194 12.39 12 0.48 0.79 0.55 1.06 0.37 0.50 42.14 46.62 27.04 
 
C9 H20 N O4 P 237.1124 1.023 13 3.22 1.73 3.52 2.66 2.01 3.24 42.16 37.48 49.72 
 
C43 H83 N O4 677.6314 8.083 11 1.01 1.36 1.67 1.10 1.14 1.58 42.19 28.16 21.66 
 
C33 H71 N6 O P 598.5399 0.897 23 4.50 4.74 5.22 3.79 4.72 5.11 42.33 30.21 28.01 
 
C12 H22 N8 O P2 356.139 1.969 25 1.99 1.73 2.40 2.88 1.64 2.39 42.36 26.73 16.84 
 
C77 H148 N9 O14 P S2 1518.033 1.449 14 1.69 0.30 0.98 1.82 0.43 1.12 42.71 21.26 19.32 
 
C25 H49 N O3 411.3705 2.741 21 2.04 1.88 1.67 1.91 2.04 1.75 43.14 24.09 20.00 
 
C38 H85 N6 O4 P S 752.6079 3.11 16 3.50 2.12 3.33 3.61 2.18 3.69 43.33 23.57 39.79 
 
C29 H58 N6 O8 P2 680.3786 3.588 21 3.12 1.16 2.77 2.65 1.11 2.79 43.61 32.11 35.98 
 
C13 H24 O3 228.1721 3.115 14 1.26 1.32 0.99 1.03 1.23 1.02 43.70 12.58 24.16 
 
C22 H28 O4 356.1972 1.306 22 4.53 3.65 4.38 4.19 3.64 4.34 44.10 20.46 5.95 
 
C25 H49 N O4 427.3658 2.671 11 1.71 0.89 1.15 1.98 0.64 1.34 44.12 34.20 23.70 
 
C72 H133 N7 O8 1224.022 9.629 9 6.93 6.95 6.77 6.26 6.99 6.43 44.16 12.85 44.93 
 
C25 H49 N O3 411.3708 4.738 18 1.13 0.22 1.31 1.13 0.23 1.13 44.47 45.30 35.56 
 
C34 H50 N4 O9 S 690.3322 2.776 15 0.22 0.10 0.95 2.04 0.09 0.65 44.71 10.94 44.47 
 
C16 H32 O4 288.2297 2.058 4 0.99 0.54 0.73 1.45 0.45 0.58 44.85 35.51 19.30 
 
C18 H37 N2 O4 P 376.2488 1.527 17 3.78 3.00 3.56 3.53 3.01 3.74 44.85 18.78 24.66 
 
C20 H39 N O4 357.2874 2.713 21 1.64 0.49 1.71 1.70 0.36 1.53 44.93 31.84 40.34 
 
C15 H19 N10 P 370.1549 2.325 8 4.25 3.55 4.09 4.46 3.58 4.22 44.95 14.61 18.65 









C15 H36 Cl N8 O2 P 426.2391 1.922 25 1.30 0.90 1.32 1.50 0.80 1.40 44.98 29.31 12.64 
 
C74 H136 N10 O14 S 1420.996 3.042 4 3.19 2.71 3.31 3.04 2.67 3.44 45.20 5.68 28.56 
 
C48 H77 N O7 779.5709 3.524 22 1.83 1.94 1.17 1.71 1.77 1.28 45.26 31.71 30.45 
 
C38 H77 N7 O3 S 711.5815 3.087 12 3.97 2.69 4.43 3.88 2.57 4.50 45.46 25.21 41.90 
 
C5 H14 N O4 P 183.0657 2.651 21 1.46 1.78 1.86 1.41 1.53 1.67 45.63 33.01 38.36 
 
C37 H73 O8 P 676.5038 6.826 19 2.31 0.75 2.84 2.24 0.98 2.73 45.64 41.03 30.91 
 
C45 H79 N O6 729.5921 3.102 21 3.14 1.48 3.23 2.77 1.45 3.66 45.94 15.67 49.82 
 
C19 H36 O2 296.2707 2.649 21 1.03 1.17 0.71 1.40 1.25 0.80 46.00 24.02 33.58 
 
C35 H63 N O15 737.4174 3.054 8 4.80 3.44 4.95 4.58 3.49 4.98 46.42 12.87 49.07 
 
C28 H59 N4 P S 514.4175 2.529 13 3.32 3.26 3.37 3.92 3.24 3.53 46.60 12.09 19.66 
 
C67 H134 N3 O13 P S 1251.938 3.164 5 2.06 1.86 1.83 1.78 1.88 1.87 46.75 8.22 5.17 
 
C9 H21 N4 P 216.151 3.012 15 1.64 0.42 0.49 1.18 0.24 0.40 46.79 41.76 15.95 
 
C24 H47 Cl N4 426.349 2.751 11 3.13 2.43 3.04 2.29 2.53 3.17 47.01 11.84 27.29 
 
C9 H18 N2 O8 282.1073 0.893 16 0.08 0.18 0.06 1.02 0.18 0.24 47.31 22.54 48.47 
 
C17 H25 N3 O2 303.1939 1.06 22 1.91 0.21 1.29 2.04 0.43 1.17 47.40 42.71 45.63 
 
C22 H54 N6 O3 P2 512.3724 2.062 6 1.64 0.21 0.86 1.21 0.14 0.88 47.43 40.28 17.47 
 
C23 H50 N10 O4 530.4003 4.575 5 1.71 0.97 2.08 1.85 1.19 1.89 47.44 32.69 33.21 
 
C28 H55 N O4 469.4125 3.822 24 1.62 1.48 1.34 1.64 1.48 1.37 47.66 11.34 23.75 
 
C30 H68 N9 P S 617.5049 4.576 7 1.84 1.31 2.14 1.87 1.28 1.97 47.80 26.77 35.97 
 
C14 H37 N7 O5 S 415.2597 2.331 14 1.89 1.02 1.89 2.30 1.21 1.88 47.98 34.86 5.87 
 
C56 H123 N8 O2 P 970.9508 7.986 22 1.24 1.14 1.17 1.14 1.28 1.09 48.01 28.48 14.07 
 
C41 H84 N4 O4 696.6503 3.915 19 5.86 5.57 5.68 5.52 5.77 5.62 48.30 32.90 8.27 
 
C31 H61 O4 P 528.4329 2.525 10 4.24 3.87 4.16 4.72 3.90 4.15 48.31 3.69 32.95 
 
C27 H42 N5 O3 P S 547.2771 1.345 20 1.39 0.31 0.37 1.71 0.17 0.18 48.43 23.74 41.23 
 
C36 H75 N 521.589 5.34 22 3.89 3.51 3.87 4.08 3.64 3.68 48.57 17.96 27.05 









C78 H163 N10 O16 P S 1559.171 3.42 20 1.86 1.63 1.81 1.50 1.66 2.01 49.21 21.99 42.95 
 









Table A.5: Lipidomics results of CFTR-SMALPs and analysis results. The abbreviation FC is the fold change.  These features 































774.0836 5.635 6 9.90 10.00 9.88 9.91 9.98 9.88 0.21 5.61 0.88 
  
885.8559 9.625 6 4.85 4.69 4.76 4.83 4.67 4.75 0.35 5.76 1.48 
  
3058.397 5.619 7 5.84 5.72 5.85 5.88 5.86 5.85 0.73 18.28 2.34 
  
736.6315 5.176 4 9.81 9.83 9.79 9.76 9.72 9.79 0.78 15.99 9.16 
  
563.5463 5.205 4 7.19 7.16 7.21 7.16 7.12 7.17 0.86 6.40 6.50 
  
470.3271 2.754 10 3.49 3.44 3.53 3.54 3.53 3.54 0.88 14.03 8.94 
  
872.8436 9.621 8 3.77 3.61 3.71 3.79 3.64 3.71 0.93 5.91 5.47 
  
811.6595 5.626 22 4.69 4.72 4.65 4.61 4.66 4.67 1.22 8.35 4.48 
  
1997.926 11.244 5 7.57 7.27 7.55 7.56 7.63 7.54 1.25 49.16 2.56 
489.465 3.563 6 2.94 2.79 2.77 2.89 2.77 2.80 1.27 9.47 14.18 
  
1523.179 5.679 8 3.94 3.93 4.03 3.96 4.09 4.00 1.32 25.36 8.03 
  
638.6514 6.649 2 2.02 1.56 1.99 2.04 1.63 1.94 1.33 12.68 7.15 
  
1528.195 5.62 4 6.77 6.69 6.77 6.79 6.75 6.75 1.36 11.68 3.51 
  
871.8395 9.626 6 5.53 5.41 5.48 5.53 5.38 5.49 1.40 5.28 4.38 
  
2301.778 5.619 10 7.11 7.10 6.95 7.12 7.16 7.06 1.43 18.01 22.40 
  
812.7653 9.616 3 9.66 9.62 9.67 9.63 9.62 9.65 1.50 4.42 4.48 
  
1635.517 9.629 3 6.65 6.63 6.66 6.64 6.63 6.64 1.52 6.23 2.91 
  
1648.52 9.625 3 7.20 7.12 7.18 7.22 7.16 7.18 1.64 8.40 1.05 
  
1647.517 9.625 3 8.65 8.57 8.60 8.66 8.59 8.60 1.64 8.27 0.97 
  









527.3855 2.644 3 8.10 7.99 8.02 8.04 8.02 8.03 1.69 5.56 3.10 
  
755.6765 10.548 7 6.49 6.31 6.49 6.49 6.27 6.49 1.70 14.75 2.72 
  
662.6038 5.379 7 2.77 2.83 2.76 2.77 2.78 2.76 1.73 20.65 0.96 
  
753.667 10.55 8 5.99 5.82 5.99 5.97 5.77 5.98 1.75 8.96 3.47 
  
1992.904 11.25 5 10.07 9.71 10.04 10.08 10.03 10.03 1.78 48.54 2.41 
  
466.3243 4.381 3 3.36 3.34 3.31 3.30 3.38 3.30 1.84 5.01 5.26 
  
1026.991 11.249 3 8.71 8.65 8.68 8.72 8.63 8.67 1.92 2.84 2.52 
  
525.383 2.645 3 9.71 9.59 9.61 9.66 9.58 9.60 1.95 5.95 2.99 
  
994.9601 3.513 13 1.69 1.47 1.83 1.71 1.50 1.72 2.06 5.91 19.42 
  
3056.39 5.621 8 7.09 7.01 7.11 7.15 7.09 7.12 2.09 14.38 3.61 
  
1507.216 5.622 4 7.93 8.08 7.94 7.94 7.93 7.95 2.10 18.72 1.47 
  
1020.885 2.305 9 1.97 1.20 1.96 1.92 1.04 1.99 2.11 35.68 4.04 
  
368.473 11.263 9 1.76 2.26 1.82 1.92 2.09 2.02 2.19 28.55 33.48 
  
440.3219 2.631 18 4.44 3.62 4.45 4.31 3.59 4.06 2.21 14.04 43.50 
  
884.8524 10.884 14 3.24 3.33 3.42 3.35 3.32 3.41 2.23 14.93 7.43 
  
898.7283 9.19 20 4.46 3.95 4.39 4.49 4.08 4.39 2.24 29.16 3.42 
  
827.7848 9.625 5 13.16 12.93 13.10 13.13 12.95 13.09 2.26 7.68 0.68 
  
898.8674 9.622 3 10.96 10.75 10.94 10.98 10.74 10.94 2.34 7.36 1.44 
  
1724.07 1.486 17 1.77 0.97 1.47 1.74 0.96 1.48 2.41 26.81 23.19 
  
1502.176 5.192 18 3.21 3.07 3.17 3.19 2.99 3.19 2.45 11.87 7.20 
  
529.3951 2.575 18 8.12 8.02 8.00 8.01 8.02 8.00 2.48 9.22 3.08 
  
392.2836 3.401 7 3.42 3.39 3.37 3.42 3.40 3.36 2.55 20.91 15.81 
  
899.8708 9.623 2 9.61 9.41 9.60 9.63 9.41 9.60 2.56 6.63 2.04 
  
892.7071 9.621 4 4.53 5.00 4.32 4.47 4.66 4.39 2.56 37.62 11.09 
  
440.8237 2.656 21 1.93 1.00 2.18 2.02 0.96 1.92 2.58 5.60 35.25 









826.7783 9.627 5 8.93 8.71 8.91 8.93 8.77 8.92 2.64 6.92 2.19 
  
898.8672 9.806 15 4.27 4.20 4.28 4.33 4.35 4.24 2.69 40.81 4.29 
  
739.6437 5.173 3 7.28 7.28 7.25 7.22 7.15 7.18 2.71 15.25 10.01 
  
746.5287 3.525 15 1.80 1.58 2.00 1.79 1.56 1.92 2.72 1.90 20.96 
  
913.8866 9.624 3 8.55 8.31 8.53 8.57 8.30 8.51 2.76 4.85 3.71 
  
854.8048 9.625 14 5.25 5.08 5.07 5.21 4.87 5.18 2.77 28.51 21.01 
  
525.3769 2.647 9 4.08 4.09 4.10 4.03 4.15 4.11 2.84 7.34 5.94 
  
839.7085 5.62 24 4.69 4.98 4.86 4.70 5.00 4.86 2.90 8.30 4.96 
  
624.6358 6.647 20 1.70 1.28 1.59 1.76 1.41 1.57 2.92 17.64 7.29 
  
717.7713 11.486 4 1.55 0.17 0.96 1.60 0.34 0.94 2.95 36.97 6.55 
  
251.2608 2.307 21 1.88 1.26 1.86 1.84 1.32 1.84 2.99 38.52 4.68 
  
884.8517 9.625 4 6.14 6.02 6.09 6.12 6.02 6.09 3.08 2.08 1.28 
  
805.8358 7.849 15 2.33 2.55 2.42 2.34 2.53 2.39 3.22 3.00 7.08 
  
1525.686 5.617 13 5.74 5.66 5.69 5.78 5.78 5.70 3.33 18.16 5.39 
  
652.6668 7.352 4 1.09 0.60 0.99 1.08 0.64 0.95 3.35 8.54 9.88 
  
1983.919 11.256 8 6.99 6.97 6.98 6.94 7.00 6.94 3.41 4.79 6.57 
  
832.801 9.623 3 5.83 5.60 5.77 5.83 5.58 5.74 3.48 3.69 3.65 
  
3054.383 5.62 9 7.13 6.99 7.15 7.19 7.14 7.15 3.50 22.18 0.88 
  
1901.991 5.607 23 4.06 4.03 4.07 4.14 4.16 4.12 3.52 21.85 8.10 
  
825.7578 9.62 4 10.11 10.08 10.16 10.10 10.08 10.16 3.54 6.58 1.72 
  
757.6737 10.545 7 4.54 4.28 4.55 4.48 4.29 4.54 3.63 5.66 6.05 
  
773.2444 5.388 16 2.27 2.36 2.28 2.33 2.35 2.29 3.63 8.08 2.78 
  
756.5369 5.204 2 6.87 6.80 6.81 6.85 6.77 6.79 3.69 5.07 2.32 
  
1504.204 5.613 4 9.85 10.01 9.85 9.85 9.82 9.88 3.69 23.30 3.61 
  
206.5645 9.623 9 2.34 1.87 2.18 2.30 1.92 2.20 3.71 10.85 3.49 









736.5578 5.208 4 4.72 4.76 4.75 4.67 4.70 4.72 3.81 10.02 6.03 
  
1900.988 5.612 18 4.40 4.55 3.95 4.48 4.57 3.78 3.81 9.50 23.46 
  
1641.557 9.625 14 8.41 8.18 8.42 8.41 8.22 8.43 3.84 5.55 3.24 
  
187.2688 5.615 8 1.45 1.47 1.31 1.37 1.25 1.32 3.96 25.00 4.05 
  
1024.981 11.25 5 6.99 7.50 7.57 7.00 7.01 7.07 4.09 49.33 48.15 
  
2304.787 5.612 9 5.08 5.09 5.10 5.17 5.21 5.07 4.11 19.22 3.76 
  
1901.489 5.611 27 4.56 4.62 4.48 4.76 4.80 4.56 4.12 31.48 20.26 
  
541.1992 2.316 17 2.34 1.69 2.45 2.29 1.78 2.34 4.14 31.71 17.29 
  
374.3883 2.681 11 3.74 3.50 3.53 3.80 3.42 3.53 4.14 9.97 2.83 
  
1529.198 5.622 4 5.76 5.79 5.73 5.78 5.75 5.76 4.17 5.74 3.64 
  
1150.385 5.614 19 4.54 4.51 4.41 4.61 4.47 4.37 4.17 7.68 6.05 
  
903.7369 9.551 8 2.84 3.08 2.94 2.87 2.85 2.95 4.21 33.73 2.85 
  
791.8203 7.846 10 4.07 4.20 4.08 4.01 4.22 4.11 4.22 4.35 3.80 
  
557.4136 2.265 9 1.29 0.24 1.17 1.42 0.26 1.10 4.22 23.22 39.33 
  
573.4575 2.75 10 3.71 3.50 3.30 3.55 3.49 3.24 4.25 5.83 9.74 
  
424.2851 2.7 6 3.13 2.84 3.10 3.07 2.86 3.12 4.30 3.67 7.09 
  
484.3484 2.661 5 9.41 9.50 9.53 9.44 9.52 9.55 4.32 3.58 2.04 
  
323.3181 2.751 22 1.52 1.63 1.23 1.52 1.58 1.23 4.37 49.43 32.36 
  
552.479 3.935 8 3.16 2.95 3.15 3.12 2.93 3.08 4.40 8.76 10.46 
  
1519.067 5.201 14 2.31 2.41 2.31 2.30 2.27 2.29 4.48 23.93 9.93 
  
484.3392 2.661 8 5.12 5.10 5.19 5.15 5.06 5.22 4.51 8.25 10.42 
  
630.4833 5.462 9 3.23 3.43 3.21 3.24 3.44 3.17 4.52 11.64 5.35 
  
1338.273 11.249 6 10.84 10.63 10.80 10.82 10.84 10.80 4.54 32.16 3.17 
  
560.3898 2.674 12 2.00 1.85 2.21 1.91 1.70 2.30 4.62 17.39 23.45 
  
1472.193 5.196 14 3.00 2.89 3.03 2.98 2.70 3.02 4.68 29.77 18.11 









2302.781 5.62 16 6.76 6.78 6.75 6.82 6.87 6.75 4.72 16.56 1.09 
  
832.738 9.64 4 5.83 6.15 5.75 5.88 5.88 5.77 4.82 33.90 10.91 
  
711.5615 5.889 3 5.49 5.39 5.52 5.45 5.40 5.57 4.87 3.60 6.25 
  
2281.803 5.616 18 4.83 4.81 4.76 4.89 4.97 4.77 4.96 25.65 1.17 
  
1642.561 9.62 5 7.25 7.05 7.26 7.25 7.11 7.29 5.00 8.07 5.18 
  
837.7548 9.631 7 3.30 3.29 3.16 3.31 3.30 3.22 5.00 3.37 38.66 
  
1471.191 5.2 7 2.43 2.55 2.49 2.47 2.16 2.43 5.01 46.99 13.96 
  
510.4423 2.323 15 1.72 1.00 1.73 1.73 0.74 1.74 5.05 35.39 5.50 
  
920.3038 7.763 9 2.28 2.14 2.39 2.29 2.23 2.40 5.07 10.93 8.83 
  
187.5196 5.618 3 2.06 2.03 1.92 2.00 1.90 1.92 5.17 19.22 0.14 
  
993.3223 7.883 8 4.99 4.95 5.02 5.05 4.99 5.02 5.18 7.04 4.95 
  
299.2455 1.467 25 2.03 0.69 1.26 1.68 0.56 1.21 5.27 21.56 14.94 
  
366.3282 8.075 14 1.15 0.56 1.19 1.04 0.74 1.29 5.35 43.51 13.93 
  
1054.29 7.79 12 1.04 0.99 1.13 1.01 0.93 1.03 5.40 14.08 14.61 
  
1638.542 9.626 6 4.76 4.53 4.72 4.78 4.61 4.72 5.43 11.31 1.23 
  
3060.404 5.62 6 4.26 4.02 4.25 4.33 4.07 4.25 5.46 12.39 10.02 
  
868.809 9.62 6 4.63 4.42 4.59 4.60 4.48 4.60 5.53 20.62 0.69 
  
838.5827 5.665 24 6.60 6.54 6.66 6.55 6.49 6.65 5.59 7.49 8.43 
  
536.6063 7.127 3 1.46 0.07 1.16 1.55 0.11 1.39 5.60 45.57 29.75 
  
410.4313 5.927 11 1.28 0.13 1.00 1.30 0.24 1.08 5.62 42.45 21.48 
  
807.5669 4.831 4 2.56 2.76 2.44 2.52 2.53 2.44 5.62 28.54 0.80 
  
284.2904 2.314 15 1.90 1.19 1.91 1.91 0.91 1.92 5.67 35.49 5.78 
  
1027.678 9.627 22 4.30 4.40 4.36 4.24 4.43 4.41 5.72 7.94 11.33 
  
1198.087 7.31 7 4.71 5.03 4.67 4.69 4.71 4.63 5.72 42.75 8.10 
  
1510.227 5.611 17 3.84 3.52 3.74 3.69 3.43 3.81 5.75 13.14 11.65 









2303.786 5.613 13 6.93 6.88 6.91 7.05 6.99 6.93 5.82 17.16 2.94 
  
568.5327 9.628 7 3.16 2.89 3.23 3.22 2.83 3.20 5.89 8.84 5.55 
  
494.32 2.746 9 4.16 3.99 4.36 4.14 3.99 4.32 5.91 5.87 8.03 
  
1894.289 1.481 19 2.17 1.37 1.91 2.16 1.34 1.92 6.06 24.92 24.24 
  
1643.564 9.624 8 5.97 5.68 5.87 6.02 5.72 5.88 6.08 7.52 2.69 
  
996.9496 3.376 15 2.37 2.48 2.53 2.48 2.50 2.52 6.12 9.34 4.59 
  
3718.417 1.555 16 3.68 2.95 3.47 3.56 3.26 3.51 6.16 49.97 14.26 
  
820.5448 5.224 3 6.20 6.26 6.08 6.20 6.07 6.10 6.23 23.20 3.88 
  
440.2339 1.588 19 3.94 3.23 3.75 3.84 3.54 3.79 6.24 49.77 14.31 
  
1500.088 5.227 19 4.23 4.10 4.17 4.13 3.99 4.19 6.24 13.34 12.51 
  
441.3119 2.711 12 3.67 3.62 3.71 3.56 3.57 3.68 6.25 8.48 4.94 
  
539.1703 3.912 14 1.95 1.71 1.79 1.77 1.66 1.84 6.25 29.82 10.05 
  
3055.387 5.617 17 5.38 5.32 5.39 5.35 5.46 5.35 6.31 19.14 5.24 
  
843.0178 5.239 10 3.26 3.57 3.12 3.28 3.31 3.16 6.34 29.30 6.22 
  
1344.368 1.474 14 2.05 1.34 1.83 2.07 1.39 1.83 6.37 32.12 22.50 
  
700.5189 3.34 21 1.99 2.44 2.11 2.26 2.40 2.27 6.43 5.21 23.60 
  
940.9144 9.627 22 3.55 3.11 3.52 3.46 3.09 3.62 6.43 10.90 13.58 
  
1650.527 9.628 3 3.37 3.42 3.50 3.38 3.54 3.46 6.49 15.27 7.77 
  
757.6164 5.623 15 3.30 3.60 3.35 3.35 3.58 3.38 6.56 8.39 8.61 
  
1225.026 9.679 14 6.75 7.21 6.84 6.80 7.09 6.83 6.67 21.81 2.52 
  
706.7674 10.033 11 1.12 0.49 0.86 1.20 0.60 0.84 6.69 27.66 10.96 
  
326.3372 2.366 23 1.36 0.61 1.45 1.36 0.77 1.49 6.75 41.01 7.25 
  
206.5661 9.619 13 1.11 0.93 0.98 1.16 1.03 1.03 6.86 14.01 6.68 
  
478.3845 5.792 23 1.36 0.70 1.52 1.28 0.48 1.64 6.94 38.30 29.05 
  
478.4497 3.079 6 1.29 0.56 0.53 1.33 0.77 0.58 6.94 45.31 36.16 









1246.828 1.449 20 1.49 0.60 1.24 1.42 0.51 1.16 6.97 16.02 12.32 
  
1644.567 9.625 6 3.70 3.37 3.58 3.71 3.34 3.59 6.98 3.96 3.64 
  
485.3383 2.663 6 4.83 4.98 5.00 4.92 5.03 4.99 7.01 11.31 1.53 
  
573.3133 1.449 4 1.60 0.76 1.35 1.55 0.69 1.30 7.06 17.63 7.64 
  
916.6678 4.385 11 4.12 4.08 4.11 4.12 4.03 4.17 7.16 17.75 11.10 
  
790.5601 5.622 10 6.11 6.15 6.16 6.19 6.09 6.16 7.18 11.42 1.64 
  
950.7536 8.087 18 1.22 0.61 1.34 1.12 0.77 1.40 7.32 30.15 12.65 
  
821.6098 5.669 17 3.62 3.43 3.74 3.67 3.60 3.86 7.32 26.91 24.02 
  
1850.195 1.572 26 3.92 3.12 3.68 3.77 3.33 3.69 7.37 42.45 15.86 
  
624.5619 11.253 22 2.60 3.18 2.89 2.69 3.11 2.82 7.41 10.55 17.82 
  
806.481 1.587 25 3.55 2.84 3.85 3.44 3.09 3.39 7.48 48.41 46.69 
  
375.3706 4.194 14 2.15 2.18 2.16 2.20 2.18 2.11 7.51 1.41 5.96 
  
526.3793 2.648 12 3.87 3.69 3.80 3.71 3.72 3.80 7.57 3.94 4.23 
  
506.3221 2.648 3 6.32 6.41 6.50 6.39 6.39 6.48 7.59 3.71 6.44 
  
591.6506 7.28 4 2.98 1.68 2.40 3.05 1.41 2.50 7.59 40.85 21.27 
  
3716.417 1.562 21 3.73 2.98 3.51 3.58 3.25 3.55 7.62 46.75 15.14 
  
481.5488 5.321 6 1.79 0.54 1.57 1.77 0.38 1.61 7.70 49.83 11.29 
  
424.4466 6.345 8 1.09 0.16 0.85 1.05 0.07 0.91 7.80 36.49 16.77 
  
835.7501 9.623 5 8.21 8.15 8.25 8.22 8.13 8.30 7.85 3.81 7.24 
  
597.3228 2.621 15 3.60 3.13 3.34 3.44 3.09 3.26 7.87 4.92 9.27 
  
805.6671 7.353 20 1.20 1.77 1.10 1.23 1.43 1.14 7.89 39.18 5.64 
  
868.8215 9.629 22 3.74 3.47 3.83 3.68 3.44 3.69 7.90 19.10 27.02 
  
3012.172 5.212 11 2.03 1.78 1.82 1.99 1.84 1.77 8.09 12.08 16.09 
  
677.6798 11.256 7 1.83 1.93 2.11 1.72 1.97 2.14 8.09 10.90 8.55 
  
757.5725 5.204 20 4.47 4.64 4.54 4.47 4.31 4.60 8.11 36.51 7.20 









550.588 5.017 5 2.30 0.97 2.04 2.28 0.70 1.96 8.16 39.99 10.31 
  
922.7192 8.038 24 1.25 0.56 1.34 1.16 0.70 1.26 8.21 32.92 14.39 
  
1177.862 5.623 8 5.35 5.12 5.23 5.39 5.33 5.22 8.28 28.29 1.80 
  
834.6036 5.13 10 3.05 3.17 3.00 2.94 3.04 2.91 8.31 16.99 12.02 
  
1178.365 5.623 15 5.57 5.38 5.49 5.62 5.66 5.48 8.36 37.59 4.78 
  
1720.01 1.525 25 3.92 3.12 3.70 3.76 3.29 3.75 8.41 38.26 17.12 
  
706.5159 8.033 19 3.48 2.86 3.39 3.33 3.01 3.54 8.41 41.84 30.23 
  
2280.799 5.618 12 5.72 5.67 5.64 5.67 5.76 5.70 8.42 10.76 7.14 
  
843.8072 9.623 5 6.43 6.36 6.54 6.42 6.30 6.53 8.45 8.03 1.92 
  
366.3856 6.625 7 2.15 0.95 1.81 2.16 1.03 1.81 8.46 30.99 5.24 
  
443.2888 1.449 26 2.80 1.24 1.36 2.71 1.40 1.26 8.47 46.49 23.54 
  
1202.329 7.964 9 2.22 1.87 2.36 2.16 2.06 2.27 8.48 44.95 12.43 
  
762.5278 5.21 13 2.99 2.75 2.91 2.89 2.76 2.93 8.51 1.59 2.04 
  
1998.929 11.244 8 5.86 5.62 5.93 5.95 5.96 5.94 8.55 43.99 2.32 
  
216.1873 11.258 19 3.21 3.41 3.28 3.22 3.27 3.17 8.55 22.28 20.53 
  
524.24 1.724 26 9.33 8.94 9.29 9.24 9.06 9.33 8.56 48.99 31.48 
  
296.2905 1.915 20 1.48 0.57 1.43 1.36 0.60 1.62 8.57 11.75 37.78 
  
463.3423 3.394 15 4.01 3.39 3.90 3.85 3.41 3.96 8.59 5.96 13.98 
  
530.4782 5.537 9 1.79 1.20 1.73 1.64 1.26 1.70 8.66 11.45 4.89 
  
568.5328 5.214 13 3.19 3.28 3.17 3.12 3.34 3.19 8.68 7.14 3.88 
  
1292.378 7.745 30 1.88 1.54 1.92 1.92 1.52 1.98 8.69 12.32 8.65 
  
425.3163 2.749 16 4.46 3.70 4.92 4.16 3.66 4.80 8.84 5.66 41.17 
  
756.6799 10.547 6 4.13 3.88 4.06 4.07 3.89 4.09 8.86 15.05 15.14 
  
675.7247 10.565 6 1.63 0.02 1.45 1.76 0.44 1.60 8.89 47.76 22.24 
  
627.1755 1.824 19 3.75 3.53 3.79 3.79 3.64 4.00 8.92 15.37 28.45 









808.5793 4.856 5 2.31 2.47 2.15 2.20 2.27 2.17 9.08 27.41 12.01 
  
3810.001 5.618 20 3.78 4.02 3.95 3.93 4.03 3.94 9.13 5.97 11.75 
  
609.1759 5.688 14 1.96 2.11 2.27 2.01 2.10 2.29 9.15 10.00 7.70 
  
945.6222 3.532 10 1.11 0.80 1.05 1.06 0.88 0.97 9.17 15.96 12.77 
  
814.7751 9.386 11 2.95 2.74 2.92 2.98 2.73 2.92 9.27 1.76 1.21 
  
1499.193 8.066 12 1.11 0.54 1.22 1.06 0.76 1.35 9.44 37.83 16.85 
  
702.4513 1.74 17 6.42 5.19 5.83 5.95 5.51 5.93 9.50 49.71 13.05 
  
1317.295 11.254 10 6.28 6.19 6.32 6.25 6.36 6.31 9.51 22.33 1.55 
  
846.5212 5.228 22 2.65 3.19 2.73 2.72 3.23 2.65 9.51 28.32 17.67 
  
549.3671 2.644 8 4.65 4.47 4.43 4.52 4.47 4.56 9.55 0.22 16.14 
  
510.2474 3.514 28 3.98 3.83 3.90 3.88 4.14 4.01 9.63 43.23 22.84 
  
1152.73 1.469 12 1.62 0.92 1.43 1.59 0.91 1.41 9.65 38.13 19.63 
  
994.9604 6.8 7 1.31 0.30 0.97 1.43 0.39 0.98 9.67 34.47 11.89 
  
675.6728 11.254 9 8.82 8.89 8.90 8.84 8.93 8.89 9.69 10.29 5.76 
  
427.3768 2.675 10 3.30 2.92 2.88 3.14 2.92 2.92 9.70 22.47 7.98 
  
800.5752 4.838 2 2.95 3.24 2.70 2.85 2.81 2.79 9.71 45.44 17.05 
  
2450.811 3.597 11 3.03 3.21 3.06 3.26 3.16 3.05 9.73 11.22 12.63 
  
1579.505 1.471 21 2.06 1.21 1.79 1.95 1.07 1.83 9.82 17.26 27.68 
  
241.2763 3.374 13 1.83 1.67 1.97 1.77 1.60 1.93 9.85 24.91 21.00 
  
816.9386 3.592 19 3.25 3.42 3.27 3.47 3.42 3.26 9.92 2.56 13.74 
  
1028.683 9.618 8 2.83 2.83 2.92 2.84 2.82 2.93 9.93 4.74 4.15 
  
587.3087 2.79 24 1.12 0.47 1.23 0.95 0.36 1.17 10.04 15.60 37.76 
  
2306.46 1.518 26 2.20 1.07 1.85 2.01 0.93 1.79 10.09 19.06 8.41 
  
994.7624 3.881 16 3.91 3.92 4.08 3.89 3.81 4.10 10.11 13.08 2.88 
  
440.4051 3.586 16 1.69 1.51 1.75 1.71 1.50 1.78 10.19 4.99 4.26 









2279.795 5.618 27 5.78 5.53 5.70 5.61 5.56 5.65 10.24 7.00 5.29 
  
535.1578 4.989 7 1.18 1.27 1.36 1.24 1.25 1.35 10.27 5.65 1.55 
  
1649.523 9.623 12 5.60 5.63 5.81 5.77 5.61 5.77 10.28 7.58 7.04 
  
1246.836 5.16 28 3.61 3.70 3.60 3.50 3.64 3.50 10.29 35.09 21.11 
  
507.3525 3.475 19 5.35 2.66 5.37 5.59 2.20 5.40 10.29 46.57 30.05 
  
739.5908 5.215 7 3.97 4.05 3.91 3.86 3.92 3.90 10.39 16.49 2.66 
  
399.4066 3.948 17 2.38 2.06 2.16 2.09 1.94 2.21 10.41 17.81 14.67 
  
2282.806 5.628 22 4.89 4.95 4.99 4.96 5.04 4.96 10.42 14.98 3.75 
  
312.3575 2.81 4 1.56 1.52 1.42 1.66 1.48 1.44 10.52 8.16 21.78 
  
1216.618 1.467 25 2.14 1.22 1.86 2.00 1.17 1.90 10.57 21.56 28.16 
  
437.189 3.074 20 1.93 1.07 2.31 1.84 1.36 2.21 10.59 44.16 11.59 
  
1330.302 11.25 24 9.73 8.93 9.76 9.73 8.75 9.76 10.64 37.00 6.02 
  
1163.653 9.624 20 2.76 3.25 3.06 2.86 3.31 2.90 10.70 9.05 19.55 
  
960.7032 8.575 12 1.03 0.82 0.96 1.13 0.89 0.94 10.72 19.20 3.51 
  
515.3503 2.791 26 3.74 2.03 3.42 3.86 1.97 3.44 10.73 27.34 33.14 
  
833.2306 7.396 13 2.34 2.28 2.44 2.39 2.32 2.53 10.74 9.19 13.63 
  
559.4418 2.748 7 4.10 4.01 3.73 3.76 4.03 3.76 10.81 12.79 17.45 
  
618.4307 2.793 22 1.93 0.72 2.63 2.04 0.70 2.50 10.83 39.21 38.12 
  
756.5487 5.256 18 4.42 4.64 4.42 4.36 4.55 4.42 10.84 13.50 2.89 
  
545.3616 1.692 9 7.94 7.37 7.84 7.85 7.10 7.84 10.91 46.34 2.52 
  
758.2136 7.162 27 3.74 3.62 3.79 3.85 3.53 3.86 10.97 13.97 9.33 
  
446.3749 3.386 9 4.25 3.30 3.94 4.01 3.18 4.08 11.05 16.11 22.92 
  
451.3138 2.315 2 1.33 0.56 1.41 1.34 0.38 1.40 11.05 40.95 5.10 
  
158.1092 11.261 16 2.68 3.07 2.51 2.64 3.14 2.60 11.16 8.74 11.73 
  
1549.049 5.198 15 4.49 4.35 4.54 4.52 4.48 4.52 11.20 22.47 7.65 









797.4412 1.447 17 1.30 0.59 1.08 1.19 0.61 1.09 11.26 29.54 13.16 
  
594.6505 11.294 8 1.68 0.53 1.46 1.96 0.46 1.44 11.28 43.34 21.36 
  
1109.638 3.518 4 6.12 3.82 5.92 6.04 3.75 5.71 11.32 16.56 29.87 
  
866.6479 3.575 20 1.98 2.10 1.59 2.32 2.12 1.57 11.38 7.79 8.94 
  
781.5704 3.438 11 4.04 4.49 3.63 3.91 4.37 3.75 11.41 23.84 41.54 
  
1646.513 9.625 4 9.44 9.28 9.36 9.62 9.31 9.35 11.42 6.84 1.44 
  
634.6818 10.759 11 1.90 0.62 1.87 2.10 0.35 1.83 11.42 33.25 18.02 
  
2851.844 1.539 24 4.51 3.63 4.30 4.43 3.79 4.34 11.52 41.39 13.28 
  
2305.791 5.614 22 3.57 3.65 3.60 3.82 3.74 3.58 11.62 20.02 10.40 
  
1218.352 5.688 22 1.67 1.77 2.03 1.74 1.82 1.96 11.86 17.74 9.82 
  
751.3263 1.937 12 2.30 1.57 2.30 2.19 1.82 2.36 11.95 36.36 26.23 
  
351.1446 1.508 19 2.37 1.58 2.21 2.17 1.40 1.94 11.95 38.73 29.22 
  
429.3814 3.504 11 2.67 2.47 3.04 3.18 2.18 2.97 12.10 40.48 27.55 
  
1110.884 3.507 18 7.58 7.38 7.79 7.80 7.52 7.62 12.12 45.42 26.54 
  
995.3019 7.291 10 2.75 2.92 2.84 2.67 2.91 2.89 12.12 2.58 11.56 
  
819.7898 3.39 22 2.35 0.88 2.28 2.34 1.11 2.18 12.18 39.74 11.75 
  
506.2542 1.614 24 3.69 3.03 3.55 3.64 3.34 3.63 12.28 45.34 14.78 
  
454.2885 3.412 10 2.69 2.80 2.68 2.79 2.84 2.69 12.31 8.68 5.04 
  
1487.117 5.2 15 2.93 2.94 2.91 2.83 2.99 2.89 12.32 18.71 3.63 
  
1876.852 5.789 12 2.65 1.84 2.85 2.59 1.86 2.99 12.34 28.60 39.08 
  
539.1699 7.755 21 1.39 0.24 1.68 1.28 0.56 1.57 12.36 47.33 22.67 
  
1095.666 9.626 20 2.99 3.05 2.99 2.95 3.13 3.00 12.42 20.40 1.64 
  
959.6906 8.3 11 1.28 1.37 1.79 1.33 1.34 1.62 12.48 20.78 26.90 
  
764.5969 5.642 11 6.71 6.60 6.58 6.58 6.63 6.56 12.49 3.85 9.40 
  
610.5722 7.691 10 1.10 0.37 1.07 0.98 0.31 1.16 12.50 29.57 22.73 









466.4939 3.58 15 1.11 0.17 1.24 1.22 0.09 1.37 12.74 32.17 22.70 
  
665.7245 8.614 11 1.13 0.19 0.73 1.34 0.51 0.78 12.77 47.81 20.39 
  
1416.009 6.052 11 1.15 0.14 0.73 1.24 0.05 0.78 12.84 43.66 14.37 
  
720.6459 8.054 18 1.00 0.63 1.14 1.09 0.76 1.14 12.85 28.21 14.86 
  
3057.395 5.62 15 4.74 4.68 4.66 4.89 4.81 4.67 12.91 20.53 3.41 
  
2566.894 3.703 15 1.76 1.59 2.14 1.94 1.80 2.05 12.98 30.67 18.50 
  
550.5879 4.78 7 4.38 2.68 4.22 4.10 2.25 4.23 13.00 49.23 4.91 
  
474.2801 1.347 14 1.71 1.07 1.48 1.60 0.95 1.52 13.00 20.50 42.37 
  
557.2616 3.914 19 1.65 1.44 1.66 1.85 1.42 1.74 13.04 3.33 10.62 
  
881.7893 11.226 11 5.84 5.02 6.25 5.83 4.69 5.98 13.16 43.16 46.24 
  
841.7877 7.624 16 2.40 2.19 2.35 2.53 2.21 2.33 13.23 4.61 6.22 
  
1331.308 11.246 7 8.36 8.21 8.45 8.28 8.40 8.45 13.34 25.58 2.05 
  
1014.736 2.651 15 2.43 2.60 2.70 2.57 2.72 2.68 13.39 21.44 8.36 
  
621.0969 3.248 17 1.70 1.68 1.94 1.53 1.72 1.83 13.53 6.02 29.55 
  
221.1066 2.314 24 2.53 1.34 2.15 2.14 1.31 2.15 13.54 37.77 2.89 
  
421.3397 2.793 7 2.17 1.75 2.21 2.13 1.75 2.14 13.57 9.36 10.63 
  
1672.111 5.628 26 2.58 2.48 2.65 2.66 2.47 2.57 13.57 13.36 13.03 
  
602.5453 7.754 14 2.09 1.94 2.03 1.98 1.90 2.14 13.58 20.45 34.26 
  
1526.185 5.617 7 7.31 6.95 7.21 7.57 7.01 7.20 13.58 23.75 22.72 
  
1178.866 5.623 22 4.84 4.51 4.74 4.63 4.65 4.73 13.61 19.44 7.67 
  
393.3964 6.868 14 2.05 0.50 1.74 2.15 0.13 1.81 13.68 38.29 16.69 
  
1016.713 3.477 15 7.81 6.77 7.94 7.78 6.80 7.98 13.72 29.27 30.82 
  
1054.795 3.548 25 3.07 2.54 3.29 2.81 2.48 3.42 13.75 9.95 17.62 
  
1129.306 7.918 21 2.51 2.52 2.71 2.42 2.54 2.72 13.78 5.48 3.34 
  
313.2609 2.624 24 2.40 2.06 1.82 2.34 1.96 1.99 13.87 14.38 43.51 









495.5646 5.473 4 1.53 0.14 1.29 1.65 0.11 1.25 14.09 45.50 7.82 
  
436.312 1.5 15 2.03 1.44 1.87 2.11 1.45 1.96 14.16 11.73 17.56 
  
715.6453 8.264 10 2.23 2.29 2.44 2.35 2.36 2.43 14.17 10.74 6.66 
  
506.4163 4.384 10 2.05 1.93 1.80 1.92 1.93 1.74 14.18 4.51 11.70 
  
447.225 1.479 16 1.81 1.13 1.55 1.60 1.22 1.61 14.28 27.24 12.31 
  
1113.902 9.65 20 3.77 4.03 3.83 3.70 3.79 3.82 14.29 27.32 1.74 
  
384.4154 8.188 6 2.44 1.04 2.25 2.57 0.86 2.25 14.31 43.37 13.35 
  
829.2311 9.643 22 2.62 2.09 2.05 2.48 2.06 2.07 14.31 24.58 6.64 
  
577.4287 2.704 15 2.06 1.69 1.41 1.69 1.68 1.50 14.33 11.50 34.17 
  
337.2974 3.289 18 1.81 0.28 1.50 1.75 0.17 1.40 14.36 20.64 13.28 
  
214.1717 11.257 19 3.96 4.22 4.13 3.95 4.11 4.08 14.41 19.31 8.97 
  
3100.108 5.215 16 2.57 2.50 2.70 2.51 2.75 2.70 14.44 33.00 7.76 
  
670.5931 8.102 22 2.70 1.90 2.92 2.85 1.45 2.60 14.45 44.70 44.49 
  
1494.122 5.247 8 1.70 1.62 1.76 1.65 1.44 1.81 14.71 23.73 15.48 
  
736.6879 11.272 13 2.96 3.33 3.00 2.84 3.23 3.10 14.74 26.87 13.61 
  
738.6405 5.177 2 9.22 9.23 9.17 9.16 9.10 9.12 14.84 15.01 8.62 
  
3034.407 5.619 24 4.83 4.60 4.79 4.68 4.73 4.81 14.84 21.63 10.65 
  
434.2871 2.314 2 1.19 0.49 1.30 1.25 0.28 1.28 14.91 39.17 5.03 
  
2507.849 3.654 12 1.76 2.24 1.93 2.04 2.19 1.93 14.97 7.36 22.28 
  
1365.89 3.486 3 8.33 7.35 8.59 8.39 7.33 8.46 15.15 15.36 29.06 
  
1141.844 3.498 6 2.66 2.39 2.68 2.67 2.36 2.67 15.18 5.45 23.86 
  
1383.901 3.485 4 8.58 7.60 8.84 8.65 7.57 8.70 15.35 14.26 28.76 
  
738.5387 4.892 10 2.96 2.10 3.26 3.00 2.06 2.99 15.38 26.48 45.31 
  
772.5941 5.172 11 2.27 2.97 2.37 2.45 2.85 2.61 15.45 32.11 30.92 
  
1037.707 9.624 26 3.87 3.81 3.92 3.92 3.91 3.89 15.64 13.48 9.53 









395.2883 1.495 6 1.26 0.48 0.90 1.50 0.42 0.94 15.84 12.30 12.80 
  
368.5357 3.475 29 3.64 3.39 3.28 3.37 3.52 3.05 15.86 27.99 32.64 
  
696.6547 11.254 14 3.72 3.95 3.73 3.67 3.96 3.67 15.94 4.21 9.95 
  
644.2819 1.478 17 2.00 1.29 1.77 1.76 1.26 1.85 16.14 16.19 15.90 
  
959.9227 11.22 9 3.26 1.96 3.55 3.30 1.85 3.35 16.19 14.95 46.68 
  
509.3918 2.776 17 1.91 2.04 2.20 2.12 2.04 2.15 16.20 6.10 9.80 
  
3113.345 5.619 21 3.91 3.65 3.91 3.86 3.89 3.94 16.21 42.59 8.03 
  
1010.771 3.572 13 3.13 3.09 3.08 3.06 2.98 3.03 16.22 13.81 10.27 
  
517.2668 1.785 26 6.06 5.14 5.86 5.97 5.36 5.90 16.25 39.20 15.63 
  
796.9205 3.547 16 2.88 2.97 2.82 2.71 2.92 2.73 16.27 7.12 10.19 
  
1523.155 5.192 22 3.00 2.68 2.87 2.97 2.97 2.86 16.38 37.71 4.06 
  
1144.788 1.486 15 2.24 1.29 1.92 2.22 1.08 1.92 16.43 34.82 26.40 
  
901.1191 3.251 14 1.87 1.16 1.80 1.90 1.15 1.75 16.44 1.84 11.53 
  
877.8362 11.225 3 5.95 5.05 6.25 5.93 4.64 6.06 16.46 43.47 46.19 
  
349.3188 2.778 23 3.23 3.05 3.69 2.97 3.04 3.63 16.47 30.21 30.81 
  
836.753 9.628 15 6.10 5.85 6.01 5.94 5.81 6.00 16.53 7.41 1.51 
  
722.4102 3.102 8 1.32 0.30 1.08 1.56 0.24 0.87 16.63 37.79 26.99 
  
340.1854 1.292 5 1.64 0.72 1.42 1.78 0.63 1.47 16.75 29.07 10.60 
  
652.2344 1.924 16 2.40 1.65 2.35 2.23 1.95 2.46 16.95 41.72 23.96 
  
587.4391 2.871 24 2.84 2.50 3.37 3.12 2.61 3.04 17.07 26.07 36.76 
  
663.5485 6.378 19 3.97 2.91 3.80 4.07 2.89 4.09 17.27 49.60 44.99 
  
1802.239 3.244 16 2.12 1.42 2.06 2.15 1.41 2.00 17.29 2.44 11.21 
  
340.3527 3.904 10 2.18 0.81 1.81 2.30 0.69 1.80 17.43 36.99 22.83 
  
964.9219 11.497 10 3.40 2.45 3.77 3.46 2.51 3.47 17.53 11.15 35.88 
  
1874.848 5.791 10 4.37 3.60 4.61 4.41 3.61 4.60 17.67 18.59 30.93 









776.0914 5.623 19 4.04 4.07 4.18 3.98 4.10 4.22 17.74 14.25 10.82 
  
633.5324 6.638 11 1.73 1.79 1.76 1.57 1.46 1.66 17.76 40.92 46.06 
  
2431.777 3.592 11 1.90 1.88 1.96 2.06 1.78 2.02 17.84 18.83 18.74 
  
780.087 3.425 15 1.58 1.71 1.72 1.50 1.59 1.65 17.99 15.33 18.65 
  
1471.026 2.654 12 3.31 2.92 3.25 3.30 2.91 3.28 18.01 9.91 11.90 
  
350.3176 2.777 18 1.03 1.16 1.03 0.79 1.26 0.74 18.04 38.57 39.01 
  
429.3566 3.115 25 3.53 3.09 3.41 3.33 2.97 3.43 18.12 21.15 15.49 
  
606.4215 3.245 6 3.62 2.94 3.62 3.20 2.98 3.47 18.17 12.63 25.07 
  
856.8202 10.236 15 2.48 2.44 2.49 2.58 2.33 2.49 18.21 36.39 6.19 
  
898.8534 5.987 11 2.24 1.75 2.09 2.33 1.68 2.21 18.29 21.02 33.73 
  
678.6188 11.257 13 1.77 1.51 1.99 1.61 1.63 1.85 18.35 14.86 28.66 
  
635.9724 2.789 5 7.34 6.86 7.86 7.36 6.79 7.55 18.63 32.44 43.99 
  
445.3396 2.825 21 1.23 0.19 1.20 1.48 0.14 1.03 18.64 18.03 30.66 
  
2437.786 3.524 20 1.68 1.27 2.53 1.67 1.19 2.62 18.65 10.00 37.91 
  
592.6351 9.952 8 1.75 0.21 1.52 1.55 0.15 1.51 18.84 49.79 5.93 
  
1774.234 3.258 14 1.80 1.39 1.98 1.82 1.46 1.94 18.88 22.30 5.93 
  
491.8575 2.685 19 3.48 2.72 3.64 3.54 2.81 3.58 18.90 42.09 22.88 
  
346.3288 2.758 9 4.11 3.82 4.00 3.89 3.83 4.06 19.10 7.40 8.72 
  
692.7516 9.05 6 1.18 0.05 0.70 1.26 0.25 0.66 19.16 47.74 20.29 
  
303.2923 2.624 7 1.46 0.31 1.09 1.45 0.35 1.12 19.17 38.54 16.13 
  
751.5498 4.895 6 5.06 4.30 5.36 5.02 4.17 5.12 19.21 21.94 44.74 
  
1823.157 5.634 19 2.36 2.49 2.49 2.09 2.59 2.45 19.22 14.22 19.93 
  
877.6335 2.738 7 2.95 2.16 3.10 2.66 2.00 2.83 19.23 22.26 34.85 
  
1582.108 3.309 2 3.11 2.68 3.13 2.95 2.75 3.08 19.26 9.80 11.14 
  
1819.264 3.246 12 1.53 0.98 1.32 1.62 0.95 1.07 19.26 10.90 27.32 









522.5564 7.889 10 1.16 0.63 0.72 1.01 1.13 0.71 19.41 48.41 7.74 
  
1729.179 2.974 9 2.13 1.77 2.02 2.11 1.80 1.90 19.41 18.58 26.66 
  
460.8572 3.626 8 2.95 2.51 2.83 2.57 2.50 2.77 19.51 10.03 10.02 
  
761.5835 4.885 7 7.59 6.77 7.84 7.51 6.69 7.58 19.52 23.10 44.31 
  
426.4179 2.747 18 3.41 2.99 3.57 3.47 2.99 3.52 19.55 29.92 6.35 
  
363.3343 3.06 12 2.35 1.62 2.66 2.48 1.64 2.62 19.64 6.05 34.58 
  
493.3332 1.478 16 1.78 0.79 1.81 1.47 0.91 1.74 19.85 16.52 49.15 
  
250.1773 0.99 6 2.18 1.48 1.67 1.92 1.79 1.52 19.96 41.67 20.97 
  
904.865 11.489 5 7.70 6.70 8.09 7.85 6.54 7.72 20.09 20.84 41.52 
  
2623.933 3.755 18 2.03 1.99 1.99 1.89 1.99 1.98 20.11 3.39 1.81 
  
434.3367 4.063 10 2.31 2.45 2.34 2.31 2.41 2.39 20.34 10.68 30.25 
  
712.677 8.081 20 3.26 2.76 3.20 3.18 2.77 3.20 20.36 34.63 8.41 
  
1160.138 8.045 18 4.64 2.78 4.12 4.52 2.43 4.09 20.36 47.85 32.81 
  
905.8671 11.497 2 7.92 6.87 8.31 8.07 6.80 7.91 20.41 14.88 41.63 
  
514.3776 2.711 13 1.51 1.53 1.93 1.70 1.54 1.95 20.47 3.07 13.75 
  
340.3529 5.482 4 2.48 1.22 2.16 2.64 1.29 2.17 20.50 29.16 19.33 
  
1733.299 3.578 21 2.52 2.66 2.48 2.83 2.64 2.48 20.53 25.97 5.66 
  
415.3615 1.691 21 5.84 5.26 5.81 5.92 5.47 5.60 20.56 27.31 23.70 
  
689.7407 10.659 6 1.18 0.13 0.88 1.33 0.31 0.93 20.64 43.26 11.38 
  
382.3072 2.777 28 3.38 2.08 3.53 3.19 2.24 3.44 20.67 46.61 12.50 
  
2200.616 3.404 13 2.75 2.62 2.40 2.62 2.65 2.48 20.88 10.18 11.62 
  
913.6121 3.596 14 1.63 0.33 1.69 1.48 0.06 1.65 20.89 43.66 12.62 
  
842.6241 2.765 6 4.83 3.85 4.74 4.62 3.89 4.69 20.93 5.21 39.05 
  
368.3844 6.602 4 1.38 0.34 1.11 1.50 0.34 1.10 21.04 25.47 9.51 
  
778.5904 4.886 4 5.75 4.99 6.06 5.75 4.93 5.80 21.12 29.21 44.29 









548.9097 3.545 14 2.86 2.77 2.71 2.58 2.69 2.77 21.31 14.04 22.40 
  
1990.963 11.248 14 7.61 7.61 7.81 7.61 7.80 7.82 21.44 32.34 5.79 
  
404.292 3.59 14 1.36 0.96 1.21 1.39 0.86 1.15 21.44 14.51 12.12 
  
1991.967 11.25 11 6.95 6.95 7.11 6.94 7.16 7.13 21.49 32.23 3.31 
  
335.303 2.74 14 2.54 1.84 2.80 2.46 1.80 3.01 21.50 12.99 36.48 
  
970.7702 11.49 9 5.57 4.35 5.86 5.63 4.33 5.61 21.63 4.40 44.38 
  
306.2857 1.837 17 6.40 6.54 6.33 6.32 6.48 6.31 21.64 12.91 15.27 
  
1421.998 3.074 11 3.67 2.98 4.03 3.84 3.13 3.89 21.66 20.81 31.03 
  
842.8045 9.628 15 7.09 7.41 7.58 7.43 7.40 7.56 21.68 7.74 3.81 
  
508.6923 3.023 13 2.60 1.96 2.63 2.23 1.96 2.63 21.88 6.27 38.99 
  
679.358 3.462 25 8.75 7.99 8.94 8.57 8.02 8.90 21.91 38.85 50.21 
  
497.4224 7.232 18 1.92 0.06 1.52 1.91 0.14 1.46 22.00 39.55 19.45 
  
535.3175 2.274 21 1.37 0.51 1.30 1.41 0.21 1.23 22.01 40.25 21.95 
  
1818.263 3.247 7 3.16 2.58 3.22 2.92 2.58 3.04 22.19 17.86 22.70 
  
547.7211 3.309 5 2.46 2.00 2.36 2.09 1.96 2.37 22.20 13.73 11.70 
  
1950.34 3.213 13 1.28 0.80 1.29 1.43 0.79 1.19 22.33 9.31 26.80 
  
867.1498 3.575 16 2.64 2.56 2.67 2.52 2.79 2.68 22.35 32.89 21.38 
  
603.5703 7.318 8 2.76 2.75 2.61 2.61 2.83 2.63 22.37 11.50 4.14 
  
339.3297 3.677 5 1.40 0.12 1.05 1.37 0.21 0.99 22.53 35.72 13.20 
  
379.3808 3.393 21 2.38 2.03 2.18 2.37 2.13 2.03 22.53 24.10 23.52 
  
310.3232 4.506 2 1.37 0.14 1.15 1.50 0.13 1.17 22.59 34.03 18.93 
  
937.6935 9.627 15 3.68 3.66 3.90 3.69 3.58 3.92 22.72 16.79 8.14 
  
787.7883 9.717 16 1.08 0.07 0.12 1.05 0.13 0.12 22.75 13.40 9.99 
  
965.6864 2.698 10 3.65 3.20 3.51 3.31 3.25 3.58 22.79 11.15 16.20 
  
725.5962 3.075 17 6.47 4.91 7.07 6.75 4.97 7.02 22.84 8.80 23.52 









2681.975 3.804 16 2.10 2.04 2.44 1.98 2.07 2.66 22.92 13.13 30.65 
  
1583.111 3.31 3 2.73 2.14 2.61 2.28 2.10 2.50 23.07 4.60 16.02 
  
301.1364 3.237 12 3.04 2.83 2.77 3.10 2.85 2.76 23.11 11.80 3.87 
  
774.4915 1.463 12 1.15 0.55 0.17 0.71 0.55 0.06 23.24 25.66 27.33 
  
473.3836 3.504 30 4.20 4.06 3.90 4.00 4.20 4.10 23.24 19.26 31.17 
  
675.6715 3.908 6 1.64 1.76 1.59 1.61 1.45 1.55 23.38 34.86 6.48 
  
562.0611 3.279 6 1.28 0.85 1.33 1.22 0.94 1.28 23.51 11.48 20.48 
  
797.2547 3.547 28 1.83 1.93 1.71 1.44 1.72 1.71 23.59 35.06 10.89 
  
1453.051 0.779 7 3.56 2.68 3.07 3.35 2.45 3.10 23.64 39.09 5.47 
  
1025.763 3.161 7 4.15 3.70 4.13 4.05 3.67 4.15 23.69 9.96 29.40 
  
1538.083 3.323 4 3.73 3.31 3.77 3.57 3.34 3.68 23.71 4.23 15.74 
  
690.4103 7.953 25 1.09 1.04 0.80 1.26 0.96 0.70 23.84 30.42 12.97 
  
660.4211 2.771 9 6.85 5.98 6.97 6.60 6.06 6.98 23.99 18.03 47.46 
  
621.6784 7.683 20 1.72 0.70 1.42 1.59 0.36 1.59 24.15 36.06 34.42 
  
763.5972 3.506 15 9.49 9.43 9.60 9.59 9.41 9.58 24.17 4.95 7.43 
  
1520.187 5.668 11 1.07 3.03 1.52 0.71 3.00 1.70 24.27 13.29 45.49 
  
1027.75 3.45 26 2.56 1.76 2.64 2.56 1.73 2.54 24.38 11.62 30.96 
  
501.8426 2.547 14 2.90 2.65 2.34 2.66 2.67 2.22 24.43 20.74 25.87 
  
395.2855 1.509 10 1.98 1.32 1.86 1.91 1.26 1.99 24.45 7.73 17.73 
  
331.3236 2.875 26 1.31 0.18 1.38 1.00 0.27 1.48 24.54 29.46 48.38 
  
224.2135 2.835 25 1.09 0.47 0.22 1.07 0.37 0.37 24.58 14.79 29.90 
  
326.3369 5.06 4 1.78 0.47 1.57 1.93 0.14 1.59 24.63 34.39 17.24 
  
567.7266 2.976 21 2.07 2.34 2.72 1.81 2.35 2.84 24.70 4.93 35.62 
  
535.3819 2.656 13 3.83 3.25 3.52 3.29 3.31 3.51 24.74 10.67 19.08 
  
1992.97 11.246 17 5.78 5.87 5.77 5.76 6.07 5.86 24.78 28.01 14.36 









367.2848 2.258 9 3.40 2.65 2.66 3.58 2.73 2.52 24.89 36.89 21.26 
  
435.3282 1.477 17 3.59 2.74 2.89 3.45 2.78 3.01 24.91 8.36 16.67 
  
503.6945 3.339 15 2.15 1.40 2.11 1.78 1.38 2.23 24.94 7.90 31.13 
  
769.5358 1.522 12 5.57 3.31 4.75 5.18 3.31 4.41 25.02 12.10 37.63 
  
1617.508 3.532 23 1.75 2.38 1.96 1.89 2.44 2.03 25.03 8.16 33.92 
  
579.9089 2.643 9 3.89 3.28 3.42 3.70 3.24 3.44 25.05 9.61 8.25 
  
1158.817 2.644 8 3.66 3.14 3.30 3.13 3.08 3.33 25.14 7.52 16.50 
  
593.6204 8.057 17 2.02 0.84 1.32 1.94 0.84 1.35 25.15 43.23 40.43 
  
1543.427 11.23 12 4.96 3.72 5.26 4.99 3.70 4.91 25.17 19.43 47.77 
  
579.6229 4.487 14 1.14 0.57 0.95 1.09 0.74 0.93 25.18 43.29 43.59 
  
1366.948 4.49 10 3.84 2.96 4.25 3.94 3.05 4.03 25.33 40.39 49.04 
  
689.4738 2.617 4 4.43 3.95 3.94 4.20 4.01 3.82 25.62 21.66 17.81 
  
1510.052 3.025 7 4.13 3.64 4.11 3.88 3.59 4.02 25.63 10.55 26.03 
  
213.1724 2.758 16 1.00 1.54 1.13 0.86 1.59 1.07 25.63 21.64 18.82 
  
842.5761 2.984 20 2.89 2.59 3.19 2.83 2.72 3.05 25.67 18.05 29.66 
  
889.7361 4.397 18 1.24 0.16 2.18 1.47 0.12 2.12 25.84 35.29 34.31 
  
805.6177 4.838 4 2.91 2.24 3.24 2.89 2.15 3.10 25.84 23.49 43.44 
  
474.2799 1.678 7 7.27 7.13 7.12 7.13 7.11 7.09 25.91 32.63 6.20 
  
393.4175 5.587 21 1.85 0.55 1.81 2.01 0.27 2.12 25.92 44.92 40.16 
  
751.067 3.363 13 2.66 2.70 2.76 2.90 2.73 2.76 25.94 5.53 5.00 
  
994.9103 3.578 20 1.04 1.24 0.71 1.10 0.81 0.72 25.97 48.00 6.22 
  
307.3232 2.34 17 2.25 0.90 1.71 2.32 0.81 1.72 26.10 36.56 3.16 
  
568.5332 7.309 18 2.26 2.25 1.82 2.16 2.35 1.77 26.18 17.58 8.35 
  
1643.162 3.3 13 2.73 2.25 2.70 2.23 2.32 2.71 26.45 18.13 9.21 
  
622.4453 3.108 1 2.67 2.23 2.75 2.65 2.20 2.68 26.53 5.36 26.69 









425.4228 2.959 25 1.62 1.30 0.79 1.63 1.36 0.95 26.68 8.70 39.24 
  
623.9363 2.634 8 4.53 4.03 3.90 4.02 4.04 3.91 26.95 23.71 22.42 
  
420.4435 2.995 19 1.12 0.39 1.20 1.24 0.58 1.17 26.97 25.87 4.41 
  
495.8686 3.562 4 3.36 2.98 3.26 3.10 2.99 3.29 27.05 3.24 21.49 
  
982.7256 9.267 26 2.77 1.86 2.22 2.50 1.89 2.25 27.08 9.00 23.21 
  
1714.186 3.275 10 1.14 0.66 1.17 1.09 0.58 1.12 27.11 8.75 10.41 
  
503.3596 3.34 8 3.25 2.67 3.24 2.85 2.71 3.37 27.31 8.35 22.73 
  
523.7017 3.004 14 2.37 2.01 2.24 2.44 2.12 1.94 27.36 16.52 34.66 
  
1550.051 5.205 22 2.89 2.96 2.75 2.75 3.20 2.96 27.68 32.93 27.41 
  
721.6492 8.084 3 3.75 3.85 3.98 4.02 3.88 4.16 27.82 30.98 30.86 
  
490.8689 3.181 5 3.51 3.06 3.47 3.46 3.12 3.53 27.92 9.52 26.97 
  
547.4443 3.841 19 1.91 1.54 1.76 1.65 1.52 1.68 28.05 10.86 10.99 
  
942.7382 11.224 18 3.61 1.56 3.86 3.44 1.44 3.52 28.09 37.20 49.39 
  
1215.744 5.402 18 2.06 1.48 2.41 2.23 1.34 2.56 28.54 25.80 34.20 
  
553.0514 2.982 11 2.74 2.10 2.82 2.17 2.08 2.69 28.62 5.78 16.94 
  
468.8553 3.201 12 2.27 1.95 2.30 2.33 1.93 2.44 28.95 3.37 46.42 
  
342.3321 3.678 18 1.86 0.59 1.74 1.86 0.53 1.69 29.00 47.35 6.67 
  
355.3638 3.915 19 2.24 2.42 2.43 2.13 2.24 2.41 29.01 32.57 7.22 
  
374.3388 3.522 17 3.94 3.93 3.86 4.11 3.97 3.98 29.11 18.12 27.44 
  
1043.013 11.251 17 3.67 3.36 2.95 3.64 3.22 2.83 29.26 16.17 18.94 
  
783.5909 4.892 21 4.40 3.61 4.89 4.44 3.64 4.52 29.59 40.10 44.92 
  
408.2658 3.063 17 1.23 0.55 0.93 1.24 0.47 0.89 29.62 17.69 20.21 
  
700.2423 3.471 23 4.23 2.68 5.14 4.01 2.55 5.11 29.74 33.62 49.84 
  
677.6785 3.908 11 2.04 2.23 2.03 2.06 1.87 2.02 29.74 37.78 8.85 
  
955.587 3.331 17 2.57 1.35 2.82 2.20 1.20 2.57 29.77 19.80 47.16 









437.3193 3.718 12 2.39 0.92 2.58 2.49 1.07 2.45 30.16 44.46 34.48 
  
996.7857 11.485 18 3.10 1.78 3.60 3.32 1.93 3.25 30.72 21.02 39.71 
  
1511.024 2.621 17 4.31 3.64 3.67 3.88 3.74 3.60 30.93 34.35 11.07 
  
508.3079 3.695 3 2.11 0.77 1.92 2.24 0.33 1.96 31.15 45.72 7.33 
  
673.6634 11.254 3 5.43 5.70 5.71 5.60 5.72 5.75 31.34 2.97 6.64 
  
387.3859 2.925 14 2.54 2.11 2.26 2.06 2.16 2.45 31.36 5.95 24.37 
  
661.5319 6.513 11 5.60 4.97 5.89 5.72 5.06 5.97 31.62 35.89 48.86 
  
1642.13 2.995 11 1.58 0.92 1.56 0.99 0.95 1.33 31.70 4.80 27.52 
  
1378.976 3.042 9 2.02 1.73 2.03 1.52 1.71 2.03 31.89 7.32 33.39 
  
1377.974 3.052 6 3.85 3.50 3.96 3.64 3.50 3.90 31.97 0.50 24.79 
  
586.3675 3.539 20 1.70 2.46 2.11 2.07 2.14 2.17 32.03 45.24 35.71 
  
296.2321 2.816 13 2.45 2.13 2.82 2.82 2.23 2.81 32.10 21.91 0.86 
  
454.4208 7.09 20 1.59 1.34 1.19 1.55 1.16 1.07 32.22 30.30 41.50 
  
707.4985 3.072 3 3.22 2.73 3.35 3.19 2.73 3.18 32.36 8.69 28.54 
  
997.7892 11.49 21 3.10 1.77 3.54 3.36 1.83 3.27 32.38 17.97 33.62 
  
529.3676 3.529 24 1.70 0.50 1.08 1.67 0.47 1.08 32.69 47.01 16.32 
  
1335.924 2.628 10 4.24 3.91 3.81 3.84 4.02 3.72 32.76 15.36 12.20 
  
374.3025 2.352 21 2.52 1.13 2.16 2.14 1.21 2.27 32.80 40.99 14.61 
  
787.789 9.441 3 1.80 0.51 1.48 2.09 0.32 1.54 33.07 47.14 11.38 
  
576.9414 3.07 7 1.61 1.70 1.80 1.75 1.69 1.89 33.13 11.45 13.46 
  
413.2074 1.464 23 3.67 2.73 3.11 3.87 2.48 3.12 33.20 29.29 24.89 
  
389.2671 1.793 16 2.07 1.39 1.57 1.90 1.44 1.60 33.43 9.09 7.03 
  
359.3547 2.697 11 2.67 2.09 2.53 2.04 1.98 2.46 33.57 12.84 46.80 
  
692.6506 7.817 16 1.09 0.76 1.65 1.29 0.77 1.53 33.65 20.01 30.31 
  
1197.753 5.136 25 2.14 1.99 2.46 2.42 1.78 2.64 33.73 36.53 41.14 









502.2748 1.66 20 6.09 6.46 5.89 5.96 6.40 5.77 34.13 26.21 20.01 
  
712.0009 3.05 13 1.93 1.26 2.16 1.77 1.36 1.90 34.45 21.86 32.17 
  
523.3533 2.533 11 3.19 2.78 2.57 3.20 2.73 2.66 34.50 6.33 30.97 
  
476.4079 2.306 18 1.13 0.67 0.99 1.73 0.70 1.05 35.17 43.34 14.91 
  
680.3343 2.791 12 1.28 0.32 1.98 0.83 0.04 1.91 35.22 32.97 31.23 
  
1143.784 1.452 22 2.02 0.69 1.60 1.70 0.55 1.22 35.45 17.19 39.30 
  
725.4345 3.46 24 2.85 1.91 2.61 2.74 1.63 2.41 35.72 30.42 32.22 
  
1203.846 2.65 8 4.19 3.93 4.10 4.04 3.92 4.08 35.97 16.89 18.39 
  
601.923 2.662 8 4.17 3.91 4.08 4.02 3.91 4.06 36.09 16.75 18.34 
  
1009.711 2.648 5 3.31 2.69 2.90 2.55 2.71 2.85 36.22 6.09 30.10 
  
162.1405 11.257 18 3.08 2.89 3.14 3.20 2.91 3.09 36.91 23.67 27.02 
  
423.2977 2.701 6 6.37 5.64 5.91 6.24 5.72 5.82 36.93 18.96 21.82 
  
1846.266 3.241 13 1.52 1.32 1.56 1.58 1.44 1.64 36.94 18.65 48.18 
  
689.4881 3.054 18 1.83 1.28 1.84 1.17 1.30 1.94 36.95 4.12 26.63 
  
1758.213 3.257 7 1.43 1.13 1.52 1.41 1.13 1.46 38.23 9.12 11.94 
  
599.5433 0.863 7 3.03 2.74 3.53 3.13 2.63 3.45 38.84 40.77 16.97 
  
827.7726 4.379 19 1.06 0.12 0.19 0.43 0.05 0.01 38.99 12.72 23.57 
  
904.7422 9.615 17 1.03 1.50 2.24 0.99 1.48 2.38 39.40 36.16 47.82 
  
326.2927 2.835 10 1.57 1.03 1.93 1.84 0.99 2.17 39.63 10.61 34.42 
  
710.999 3.042 6 2.79 2.46 2.96 2.71 2.42 2.78 39.76 8.87 25.08 
  
431.0656 1.592 30 5.53 4.97 5.69 5.08 4.93 5.71 40.01 40.08 44.44 
  
2359.736 5.622 18 4.41 4.37 4.41 4.20 4.30 4.20 40.26 17.86 30.48 
  
514.4167 2.362 19 4.47 2.99 3.29 3.47 2.95 3.30 40.84 29.04 19.92 
  
545.3667 2.532 14 2.52 1.72 2.24 2.54 1.75 2.28 40.91 27.45 12.51 
  
518.3692 3.333 12 1.90 1.50 2.06 1.88 1.53 1.96 41.15 5.44 20.48 









1509.094 5.112 5 4.35 5.21 5.46 4.56 5.12 5.75 41.78 13.29 37.98 
  
1498.405 8.518 10 3.15 2.44 3.05 2.70 2.37 3.35 42.08 18.67 48.88 
  
2361.741 5.621 24 5.20 4.64 4.49 4.44 4.53 4.22 42.63 26.53 44.64 
  
626.1074 8.083 22 1.53 0.73 0.91 1.37 0.66 0.91 45.50 21.18 10.84 
  
512.3595 3.427 18 1.91 0.38 2.12 1.91 0.29 2.08 45.56 13.47 18.79 
  
978.5478 5.636 19 2.38 3.12 2.78 3.10 3.18 3.02 45.95 19.99 35.46 
  
489.3923 2.717 13 1.91 0.07 0.58 1.24 0.09 0.48 47.06 8.37 28.84 
  
1584.116 3.316 7 1.64 1.16 1.68 1.63 1.19 1.58 48.73 11.59 31.21 
  
428.2678 3.536 13 1.45 0.80 1.35 2.14 0.56 1.31 48.80 46.46 20.08 
  
1845.261 3.238 13 2.40 1.84 2.42 2.30 1.82 2.27 48.87 6.91 22.71 
  
411.1811 2.312 18 4.78 3.48 4.13 4.40 3.55 3.77 49.23 28.67 37.88 
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